No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2ncdA, 0.7186, 2.16, 0.118, 358, 76, NCD (NON-CLARET DISJUNCTIONAL) DIMER FROM D. MELANOGASTER
2, 5zbrB, 0.7174, 2.09, 0.147, 330, 75, CRYSTAL STRUCTURE OF KINESIN-3 KIF13B MOTOR DOMAIN IN AMPPNP FORM 
3, 6g6zA, 0.7164, 2.22, 0.143, 333, 77, EG5-INHIBITOR COMPLEX 
4, 5zo7B, 0.7157, 2.22, 0.143, 332, 77, KINESIN SPINDLE PROTEIN EG5 IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0138 
5, 5zbrC, 0.7146, 2.12, 0.133, 324, 75, CRYSTAL STRUCTURE OF KINESIN-3 KIF13B MOTOR DOMAIN IN AMPPNP FORM 
6, 3j8yK, 0.7113, 2.10, 0.093, 330, 75, HIGH-RESOLUTION STRUCTURE OF ATP ANALOG-BOUND KINESIN ON MICROTUBULES
7, 1n6mB, 0.7088, 2.30, 0.105, 335, 76, ROTATION OF THE STALK/NECK AND ONE HEAD IN A NEW CRYSTAL STRUCTURE OF THE KINESIN MOTOR PROTEIN NCD
8, 5zbsB, 0.7087, 2.17, 0.133, 333, 75, CRYSTAL STRUCTURE OF KINESIN-3 KIF13B MOTOR Y73C MUTANT 
9, 5nd2C, 0.7084, 2.07, 0.135, 280, 74, MICROTUBULE-BOUND MKLP2 MOTOR DOMAIN IN THE PRESENCE OF ADP
10, 1ry6A, 0.7062, 2.36, 0.143, 319, 77, CRYSTAL STRUCTURE OF INTERNAL KINESIN MOTOR DOMAIN
11, 3gbjC, 0.7046, 2.07, 0.149, 294, 74, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF KINESIN KIF13B BOUND WITH ADP
12, 2owmC, 0.7027, 2.37, 0.130, 328, 77, MOTOR DOMAIN OF NEUROSPORA CRASSA KINESIN-3 (NCKIN3)
13, 2owmA, 0.7026, 2.36, 0.130, 328, 77, MOTOR DOMAIN OF NEUROSPORA CRASSA KINESIN-3 (NCKIN3)
14, 3u06B, 0.7012, 2.34, 0.107, 344, 75, CRYSTAL STRUCTURE OF THE KINESIN-14 NCDG347D
15, 2owmB, 0.7009, 2.38, 0.130, 327, 77, MOTOR DOMAIN OF NEUROSPORA CRASSA KINESIN-3 (NCKIN3)
16, 6a20A, 0.7000, 2.39, 0.143, 395, 77, CRYSTAL STRUCTURE OF AUTO-INHIBITED KINESIN-3 KIF13B 
17, 5zbrA, 0.6992, 2.19, 0.160, 329, 75, CRYSTAL STRUCTURE OF KINESIN-3 KIF13B MOTOR DOMAIN IN AMPPNP FORM 
18, 2owmD, 0.6988, 2.42, 0.130, 325, 77, MOTOR DOMAIN OF NEUROSPORA CRASSA KINESIN-3 (NCKIN3)
19, 1n6mA, 0.6976, 2.14, 0.122, 362, 74, ROTATION OF THE STALK/NECK AND ONE HEAD IN A NEW CRYSTAL STRUCTURE OF THE KINESIN MOTOR PROTEIN NCD
20, 3gbjB, 0.6966, 2.15, 0.149, 298, 74, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF KINESIN KIF13B BOUND WITH ADP
21, 3wpnA, 0.6959, 2.27, 0.158, 309, 76, KINESIN SPINDLE PROTEIN EG5 IN COMPLEX WITH ATP-COMPETITIVE INHIBITOR PVZB1194
22, 3zfdA, 0.6953, 2.24, 0.080, 340, 75, CRYSTAL STRUCTURE OF THE KIF4 MOTOR DOMAIN COMPLEXED WITH MG-AMPPNP
23, 5w3dB, 0.6949, 2.27, 0.095, 313, 74, THE STRUCTURE OF KINESIN-14 WILD-TYPE NCD-ADP DIMER
24, 3zfcA, 0.6935, 2.25, 0.080, 337, 75, CRYSTAL STRUCTURE OF THE KIF4 MOTOR DOMAIN COMPLEXED WITH MG-AMPPNP
25, 3u06A, 0.6934, 2.45, 0.118, 359, 76, CRYSTAL STRUCTURE OF THE KINESIN-14 NCDG347D
26, 3l1cB, 0.6933, 2.45, 0.107, 331, 75, KINESIN-14 PROTEIN NCD T436S MUTANT
27, 3l1cA, 0.6925, 2.17, 0.096, 355, 73, KINESIN-14 PROTEIN NCD T436S MUTANT
28, 3gbjA, 0.6924, 2.17, 0.135, 302, 74, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF KINESIN KIF13B BOUND WITH ADP
29, 1cz7B, 0.6902, 2.28, 0.118, 337, 76, THE CRYSTAL STRUCTURE OF A MINUS-END DIRECTED MICROTUBULE MOTOR PROTEIN NCD REVEALS VARIABLE DIMER CONFORMATIONS
30, 4hnaK, 0.6897, 2.22, 0.093, 333, 75, KINESIN MOTOR DOMAIN IN THE ADP-MG-ALFX STATE IN COMPLEX WITH TUBULIN AND A DARPIN
31, 1cz7C, 0.6894, 2.28, 0.118, 364, 76, THE CRYSTAL STRUCTURE OF A MINUS-END DIRECTED MICROTUBULE MOTOR PROTEIN NCD REVEALS VARIABLE DIMER CONFORMATIONS
32, 6a1zA, 0.6893, 2.23, 0.160, 352, 75, CRYSTAL STRUCTURE OF DIMERIC KINESIN-3 KIF13B 
33, 1cz7D, 0.6875, 2.33, 0.118, 365, 76, THE CRYSTAL STRUCTURE OF A MINUS-END DIRECTED MICROTUBULE MOTOR PROTEIN NCD REVEALS VARIABLE DIMER CONFORMATIONS
34, 1cz7A, 0.6874, 2.41, 0.117, 342, 77, THE CRYSTAL STRUCTURE OF A MINUS-END DIRECTED MICROTUBULE MOTOR PROTEIN NCD REVEALS VARIABLE DIMER CONFORMATIONS
35, 5w3dA, 0.6859, 2.24, 0.122, 354, 74, THE STRUCTURE OF KINESIN-14 WILD-TYPE NCD-ADP DIMER
36, 3b6vB, 0.6851, 2.34, 0.080, 302, 75, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINESIN FAMILY MEMBER 3C IN COMPLEX WITH ADP
37, 3b6uA, 0.6837, 2.34, 0.092, 323, 76, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINESIN FAMILY MEMBER 3B IN COMPLEX WITH ADP
38, 3kinA, 0.6826, 2.32, 0.118, 238, 76, KINESIN (DIMERIC) FROM RATTUS NORVEGICUS
39, 5ocuK, 0.6792, 2.27, 0.147, 333, 75, MOLECULAR BASIS OF HUMAN KINESIN-8 FUNCTION AND INHIBITION
40, 5zbsA, 0.6779, 2.28, 0.149, 330, 74, CRYSTAL STRUCTURE OF KINESIN-3 KIF13B MOTOR Y73C MUTANT 
41, 5nd7C, 0.6766, 2.35, 0.133, 300, 75, MICROTUBULE-BOUND MKLP2 MOTOR DOMAIN IN THE PRESENCE OF AMPPNP
42, 3b6vA, 0.6766, 2.27, 0.081, 306, 74, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINESIN FAMILY MEMBER 3C IN COMPLEX WITH ADP
43, 1mkjA, 0.6760, 2.37, 0.105, 336, 76, HUMAN KINESIN MOTOR DOMAIN WITH DOCKED NECK LINKER
44, 2vvgB, 0.6759, 2.24, 0.149, 309, 74, CRYSTAL STRUCTURE OF THE G.INTESTINALIS KINESIN 2 GIKIN2A MOTOR DOMAIN
45, 2vvgA, 0.6757, 2.25, 0.149, 304, 74, CRYSTAL STRUCTURE OF THE G.INTESTINALIS KINESIN 2 GIKIN2A MOTOR DOMAIN
46, 3kinC, 0.6725, 2.38, 0.118, 238, 76, KINESIN (DIMERIC) FROM RATTUS NORVEGICUS
47, 5wdhA, 0.6717, 2.36, 0.145, 296, 76, MOTOR DOMAIN OF HUMAN KINESIN FAMILY MEMBER C1
48, 4uxtC, 0.6711, 2.64, 0.133, 320, 75, CONSERVED MECHANISMS OF MICROTUBULE-STIMULATED ADP RELEASE ATP BINDING AND FORCE GENERATION IN TRANSPORT KINESINS
49, 4atxC, 0.6685, 2.41, 0.118, 309, 76, RIGOR KINESIN MOTOR DOMAIN WITH AN ORDERED NECK-LINKER DOCKED ON TUBULIN DIMER MODELLED INTO THE 8A CRYO-EM MAP OF DOUBLECORTIN-MICROTUBULES DECORATED WITH KINESIN
50, 3b6uB, 0.6684, 2.68, 0.104, 343, 77, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINESIN FAMILY MEMBER 3B IN COMPLEX WITH ADP
51, 6mlqC, 0.6668, 2.61, 0.145, 327, 76, CRYO-EM STRUCTURE OF MICROTUBULE-BOUND KIF7 IN THE ADP STATE 
52, 5lt0A, 0.6665, 2.42, 0.105, 303, 76, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P212121 CRYSTAL FORM
53, 2y65B, 0.6662, 2.44, 0.118, 341, 76, CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER-TAIL COMPLEX
54, 2y65C, 0.6661, 2.43, 0.118, 343, 76, CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER-TAIL COMPLEX
55, 2kinA, 0.6655, 2.41, 0.118, 238, 76, KINESIN (MONOMERIC) FROM RATTUS NORVEGICUS
56, 5lt4C, 0.6650, 2.50, 0.107, 308, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P1 CRYSTAL FORM
57, 2p4nK, 0.6649, 2.44, 0.118, 323, 76, HUMAN MONOMERIC KINESIN (1BG2) AND BOVINE TUBULIN (1JFF) DOCKED INTO THE 9-ANGSTROM CRYO-EM MAP OF NUCLEOTIDE-FREE KINESIN COMPLEXED TO THE MICROTUBULE
58, 1bg2A, 0.6649, 2.44, 0.118, 323, 76, HUMAN UBIQUITOUS KINESIN MOTOR DOMAIN
59, 2repA, 0.6642, 2.68, 0.156, 289, 77, CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINESIN FAMILY MEMBER C1
60, 5lt4A, 0.6639, 2.54, 0.107, 313, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P1 CRYSTAL FORM
61, 4uxyC, 0.6638, 2.54, 0.120, 332, 75, CONSERVED MECHANISMS OF MICROTUBULE-STIMULATED ADP RELEASE ATP BINDING AND FORCE GENERATION IN TRANSPORT KINESINS
62, 5lt4E, 0.6634, 2.54, 0.107, 305, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P1 CRYSTAL FORM
63, 5lt2C, 0.6632, 2.49, 0.107, 308, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P1 CRYSTAL FORM
64, 5lt4D, 0.6624, 2.54, 0.107, 311, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P1 CRYSTAL FORM
65, 5lt2A, 0.6623, 2.51, 0.107, 314, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P1 CRYSTAL FORM
66, 5lt1A, 0.6613, 2.43, 0.118, 309, 76, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P21 CRYSTAL FORM
67, 5lt2D, 0.6607, 2.54, 0.107, 313, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P1 CRYSTAL FORM
68, 5lt4K, 0.6606, 2.54, 0.107, 307, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P1 CRYSTAL FORM
69, 4a14A, 0.6603, 2.52, 0.171, 296, 76, HUMAN KIF7 A KINESIN INVOLVED IN HEDGEHOG SIGNALLING
70, 2xt3A, 0.6599, 2.52, 0.171, 300, 76, HUMAN KIF7 A KINESIN INVOLVED IN HEDGEHOG SIGNALLING
71, 5lt3A, 0.6596, 2.52, 0.107, 307, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T87A MUTANT P1 CRYSTAL FORM
72, 2h58A, 0.6593, 2.62, 0.120, 316, 75, CRYSTAL STRUCTURE OF THE KIFC3 MOTOR DOMAIN IN COMPLEX WITH ADP
73, 5wdeA, 0.6592, 2.61, 0.120, 320, 75, CRYSTAL STRUCTURE OF THE KIFC3 MOTOR DOMAIN IN COMPLEX WITH ADP
74, 5lt3D, 0.6589, 2.57, 0.107, 311, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T87A MUTANT P1 CRYSTAL FORM
75, 3lreA, 0.6586, 2.61, 0.158, 289, 76, CRYSTAL STRUCTURE ANALYSIS OF HUMAN KINESIN-8 MOTOR DOMAIN
76, 5lt2E, 0.6584, 2.56, 0.107, 307, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P1 CRYSTAL FORM
77, 5lt3C, 0.6583, 2.52, 0.107, 300, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T87A MUTANT P1 CRYSTAL FORM
78, 2y65D, 0.6580, 2.47, 0.118, 338, 76, CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER-TAIL COMPLEX
79, 4lnuK, 0.6579, 2.55, 0.107, 309, 75, NUCLEOTIDE-FREE KINESIN MOTOR DOMAIN IN COMPLEX WITH TUBULIN AND A DARPIN
80, 5lt2K, 0.6578, 2.56, 0.107, 307, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P1 CRYSTAL FORM
81, 5lt4B, 0.6569, 2.59, 0.107, 308, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P1 CRYSTAL FORM
82, 3x2tB, 0.6569, 2.52, 0.118, 326, 76, CRYSTAL STRUCTURE OF THE KIF5C MOTOR DOMAIN WITH ADP
83, 3cvzB, 0.6563, 2.61, 0.160, 242, 75, STRUCTURAL INSIGHTS INTO THE MOLECULAR ORGANIZATION OF THE S-LAYER FROM CLOSTRIDIUM DIFFICILE
84, 3cvzD, 0.6558, 2.61, 0.160, 242, 75, STRUCTURAL INSIGHTS INTO THE MOLECULAR ORGANIZATION OF THE S-LAYER FROM CLOSTRIDIUM DIFFICILE
85, 5lt3B, 0.6554, 2.59, 0.107, 305, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T87A MUTANT P1 CRYSTAL FORM
86, 5lt3K, 0.6548, 2.59, 0.107, 312, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T87A MUTANT P1 CRYSTAL FORM
87, 5lt3E, 0.6545, 2.58, 0.107, 308, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T87A MUTANT P1 CRYSTAL FORM
88, 5lt2B, 0.6539, 2.60, 0.080, 307, 75, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN P1 CRYSTAL FORM
89, 5lt1B, 0.6539, 2.47, 0.118, 313, 76, NUCLEOTIDE-FREE KINESIN-1 MOTOR DOMAIN T92V MUTANT P21 CRYSTAL FORM
90, 5zo7A, 0.6528, 2.61, 0.079, 332, 76, KINESIN SPINDLE PROTEIN EG5 IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0138 
91, 4uy0C, 0.6526, 2.94, 0.130, 333, 77, CONSERVED MECHANISMS OF MICROTUBULE-STIMULATED ADP RELEASE ATP BINDING AND FORCE GENERATION IN TRANSPORT KINESINS
92, 2y5wB, 0.6516, 2.53, 0.118, 330, 76, CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER
93, 5nd3C, 0.6505, 2.64, 0.133, 296, 75, MICROTUBULE-BOUND MKLP2 MOTOR DOMAIN IN THE WITH NO NUCLEOTIDE
94, 5hnwK, 0.6505, 2.53, 0.120, 329, 75, STRUCTURAL BASIS OF BACKWARDS MOTION IN KINESIN-14: MINUS-END DIRECTED NKN664 IN THE AMPPNP STATE
95, 3x2tA, 0.6501, 2.47, 0.105, 311, 76, CRYSTAL STRUCTURE OF THE KIF5C MOTOR DOMAIN WITH ADP
96, 5zo9B, 0.6494, 2.62, 0.079, 331, 76, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (C2 TYPE) 
97, 3wrdA, 0.6494, 2.50, 0.092, 310, 76, CRYSTAL STRUCTURE OF THE KIF5C MOTOR DOMAIN WITHOUT ANY NUCLEOTIDE
98, 5t4dD, 0.6492, 2.58, 0.068, 463, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE PROTEIN 2 (PKD2) RESIDUES 198-703
99, 5t4dC, 0.6492, 2.58, 0.068, 463, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE PROTEIN 2 (PKD2) RESIDUES 198-703
100, 5t4dB, 0.6492, 2.58, 0.068, 463, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE PROTEIN 2 (PKD2) RESIDUES 198-703
101, 5t4dA, 0.6492, 2.58, 0.068, 463, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE PROTEIN 2 (PKD2) RESIDUES 198-703
102, 5zo9A, 0.6483, 2.62, 0.079, 331, 76, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (C2 TYPE) 
103, 6g6yA, 0.6455, 2.64, 0.079, 319, 76, EG5-INHIBITOR COMPLEX 
104, 5zo8A, 0.6445, 2.64, 0.079, 331, 76, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (P21 TYPE) 
105, 5nd4C, 0.6441, 2.52, 0.133, 337, 75, MICROTUBULE-BOUND MKLP2 MOTOR DOMAIN IN THE PRESENCE OF ADP.ALFX
106, 3nwnA, 0.6431, 2.65, 0.067, 308, 75, CRYSTAL STRUCTURE OF THE HUMAN KIF9 MOTOR DOMAIN IN COMPLEX WITH ADP
107, 6d1wD, 0.6426, 2.53, 0.068, 451, 74, HUMAN PKD2 F604P MUTANT 
108, 6d1wC, 0.6426, 2.53, 0.068, 451, 74, HUMAN PKD2 F604P MUTANT 
109, 6d1wB, 0.6426, 2.53, 0.068, 451, 74, HUMAN PKD2 F604P MUTANT 
110, 6d1wA, 0.6426, 2.53, 0.068, 451, 74, HUMAN PKD2 F604P MUTANT 
111, 3cvzA, 0.6421, 2.66, 0.147, 248, 75, STRUCTURAL INSIGHTS INTO THE MOLECULAR ORGANIZATION OF THE S-LAYER FROM CLOSTRIDIUM DIFFICILE
112, 3cvzC, 0.6418, 2.66, 0.147, 244, 75, STRUCTURAL INSIGHTS INTO THE MOLECULAR ORGANIZATION OF THE S-LAYER FROM CLOSTRIDIUM DIFFICILE
113, 5zo8B, 0.6415, 2.65, 0.079, 331, 76, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (P21 TYPE) 
114, 5mkfD, 0.6407, 2.80, 0.067, 481, 75, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CALCIUM AND LIPIDS
115, 5mkfC, 0.6407, 2.80, 0.067, 481, 75, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CALCIUM AND LIPIDS
116, 5mkfB, 0.6407, 2.80, 0.067, 481, 75, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CALCIUM AND LIPIDS
117, 5mkfA, 0.6407, 2.80, 0.067, 481, 75, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CALCIUM AND LIPIDS
118, 5hleA, 0.6376, 2.75, 0.104, 303, 77, STRUCTURAL BASIS OF BACKWARDS MOTION IN KINESIN-14: MINUS-END DIRECTED NKN664 IN THE ADP STATE
119, 3ty5A, 0.6354, 2.80, 0.153, 381, 72, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN IN COMPLEX WITH ATP
120, 6a70G, 0.6342, 2.75, 0.067, 471, 75, STRUCTURE OF THE HUMAN PKD1/PKD2 COMPLEX 
121, 5k47D, 0.6341, 2.58, 0.068, 484, 74, CRYOEM STRUCTURE OF THE HUMAN POLYCYSTIN-2/PKD2 TRP CHANNEL
122, 5k47C, 0.6341, 2.58, 0.068, 484, 74, CRYOEM STRUCTURE OF THE HUMAN POLYCYSTIN-2/PKD2 TRP CHANNEL
123, 5k47B, 0.6341, 2.58, 0.068, 484, 74, CRYOEM STRUCTURE OF THE HUMAN POLYCYSTIN-2/PKD2 TRP CHANNEL
124, 5k47A, 0.6341, 2.58, 0.068, 484, 74, CRYOEM STRUCTURE OF THE HUMAN POLYCYSTIN-2/PKD2 TRP CHANNEL
125, 5hnyK, 0.6337, 3.06, 0.130, 317, 77, STRUCTURAL BASIS OF BACKWARDS MOTION IN KINESIN-14: PLUS-END DIRECTED NKN669 IN THE AMPPNP STATE
126, 5ogcK, 0.6324, 2.66, 0.158, 328, 76, MOLECULAR BASIS OF HUMAN KINESIN-8 FUNCTION AND INHIBITION
127, 4ky3A, 0.6318, 2.47, 0.090, 157, 67, THREE-DIMENSIONAL STRUCTURE OF THE ORTHORHOMBIC CRYSTAL OF COMPUTATIONALLY DESIGNED INSERTION DOMAIN  NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
128, 3ty5B, 0.6303, 2.89, 0.139, 381, 72, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN IN COMPLEX WITH ATP
129, 3ty8A, 0.6297, 2.82, 0.167, 379, 72, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN APO FORM
130, 6du8D, 0.6274, 2.69, 0.095, 421, 74, HUMAN POLYCSYTIN 2-L1 
131, 6du8C, 0.6274, 2.69, 0.095, 421, 74, HUMAN POLYCSYTIN 2-L1 
132, 6du8B, 0.6274, 2.69, 0.095, 421, 74, HUMAN POLYCSYTIN 2-L1 
133, 6du8A, 0.6274, 2.69, 0.095, 421, 74, HUMAN POLYCSYTIN 2-L1 
134, 4kyzA, 0.6240, 2.39, 0.091, 164, 66, THREE-DIMENSIONAL STRUCTURE OF TRICLINIC FORM OF DE NOVO DESIGN INSERTION DOMAIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
135, 3j6hK, 0.6240, 2.15, 0.119, 277, 67, NUCLEOTIDE-FREE KINESIN MOTOR DOMAIN COMPLEXED WITH GMPCPP-MICROTUBULE
136, 4e6nA, 0.6232, 2.89, 0.153, 407, 72, CRYSTAL STRUCTURE OF BACTERIAL PNKP-C/HEN1-N HETERODIMER
137, 4kyzB, 0.6209, 2.41, 0.121, 164, 66, THREE-DIMENSIONAL STRUCTURE OF TRICLINIC FORM OF DE NOVO DESIGN INSERTION DOMAIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
138, 1ulzA, 0.6208, 2.74, 0.136, 451, 66, CRYSTAL STRUCTURE OF THE BIOTIN CARBOXYLASE SUBUNIT OF PYRUVATE CARBOXYLASE
139, 4ky3B, 0.6192, 2.50, 0.090, 157, 67, THREE-DIMENSIONAL STRUCTURE OF THE ORTHORHOMBIC CRYSTAL OF COMPUTATIONALLY DESIGNED INSERTION DOMAIN  NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
140, 4ky3C, 0.6188, 2.53, 0.119, 157, 67, THREE-DIMENSIONAL STRUCTURE OF THE ORTHORHOMBIC CRYSTAL OF COMPUTATIONALLY DESIGNED INSERTION DOMAIN  NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
141, 4kyzD, 0.6187, 2.42, 0.091, 164, 66, THREE-DIMENSIONAL STRUCTURE OF TRICLINIC FORM OF DE NOVO DESIGN INSERTION DOMAIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
142, 4kyzC, 0.6185, 2.40, 0.121, 164, 66, THREE-DIMENSIONAL STRUCTURE OF TRICLINIC FORM OF DE NOVO DESIGN INSERTION DOMAIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR327
143, 2y5wA, 0.6174, 2.99, 0.132, 334, 76, CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER
144, 2y65A, 0.6167, 3.02, 0.132, 328, 76, CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER-TAIL COMPLEX
145, 6mr1A, 0.6153, 2.70, 0.070, 88, 71, RBCS-LIKE SUBDOMAIN OF CCMM 
146, 1gojA, 0.6148, 2.69, 0.080, 354, 75, STRUCTURE OF A FAST KINESIN: IMPLICATIONS FOR ATPASE MECHANISM AND INTERACTIONS WITH MICROTUBULES
147, 5z1wD, 0.6141, 2.87, 0.081, 429, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE-LIKE CHANNEL PKD2L1
148, 5z1wC, 0.6141, 2.87, 0.081, 429, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE-LIKE CHANNEL PKD2L1
149, 5z1wB, 0.6141, 2.87, 0.081, 429, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE-LIKE CHANNEL PKD2L1
150, 5z1wA, 0.6141, 2.87, 0.081, 429, 74, CRYO-EM STRUCTURE OF POLYCYSTIC KIDNEY DISEASE-LIKE CHANNEL PKD2L1
151, 5tjbA, 0.6134, 2.58, 0.101, 156, 69, I-II LINKER OF TRPML1 CHANNEL AT PH 4.5
152, 2odpA, 0.6129, 3.18, 0.085, 490, 71, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
153, 2ybvN, 0.6125, 3.00, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
154, 2odqA, 0.6124, 3.16, 0.085, 492, 71, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
155, 2ybvD, 0.6122, 3.00, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
156, 2ybvH, 0.6115, 3.00, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
157, 2i6qA, 0.6114, 3.19, 0.099, 503, 71, COMPLEMENT COMPONENT C2A
158, 5fpoA, 0.6112, 2.64, 0.113, 305, 71, STRUCTURE OF BACTERIAL DNA LIGASE WITH SMALL-MOLECULE LIGAND 1H-INDAZOL-7-AMINE (AT4213) IN AN ALTERNATE BINDING SITE.
159, 4drfC, 0.6110, 2.86, 0.167, 408, 72, CRYSTAL STRUCTURE OF BACTERIAL PNKP-C/HEN1-N HETERODIMER
160, 4hqoA, 0.6108, 3.49, 0.096, 257, 73, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
161, 2ybvP, 0.6107, 3.01, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
162, 4drfA, 0.6105, 2.86, 0.167, 408, 72, CRYSTAL STRUCTURE OF BACTERIAL PNKP-C/HEN1-N HETERODIMER
163, 5oqm6, 0.6099, 3.43, 0.095, 335, 74, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
164, 5oqj6, 0.6099, 3.43, 0.095, 335, 74, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
165, 2ybvB, 0.6096, 3.02, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
166, 2i6sA, 0.6093, 3.20, 0.085, 497, 71, COMPLEMENT COMPONENT C2A
167, 2ybvF, 0.6092, 3.03, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
168, 2n41A, 0.6092, 1.93, 0.183, 106, 60, SOLUTION NMR STRUCTURE OF DE NOVO DESIGNED PROTEIN TOP7NNSTYCC NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR34
169, 6hbbB, 0.6085, 2.96, 0.111, 89, 72, CRYSTAL STRUCTURE OF THE SMALL SUBUNIT-LIKE DOMAIN 1 OF CCMM FROM SYNECHOCOCCUS ELONGATUS (STRAIN PCC 7942) 
170, 2ybvJ, 0.6084, 3.01, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
171, 4wfqA, 0.6080, 3.44, 0.095, 192, 74, CRYSTAL STRUCTURE OF TFIIH SUBUNIT
172, 4e6nC, 0.6080, 2.92, 0.167, 407, 72, CRYSTAL STRUCTURE OF BACTERIAL PNKP-C/HEN1-N HETERODIMER
173, 3ty9A, 0.6072, 2.87, 0.181, 376, 72, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN AMP-ADENYLATE
174, 2v69P, 0.6067, 3.06, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
175, 2v69J, 0.6062, 3.10, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
176, 2v69K, 0.6059, 3.09, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
177, 2fhzA, 0.6059, 2.05, 0.063, 106, 63, MOLECULAR BASIS OF INHIBITION OF THE RIBONUCLEASE ACTIVITY IN COLICIN E5 BY ITS COGNATE IMMUNITY PROTEIN
178, 1qysA, 0.6059, 1.81, 0.241, 91, 58, CRYSTAL STRUCTURE OF TOP7: A COMPUTATIONALLY DESIGNED PROTEIN WITH A NOVEL FOLD
179, 3ppvA, 0.6057, 3.33, 0.071, 184, 70, CRYSTAL STRUCTURE OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
180, 5oyaI, 0.6056, 2.91, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
181, 2v69O, 0.6054, 3.06, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
182, 2dfxI, 0.6054, 2.04, 0.063, 106, 63, CRYSTAL STRUCTURE OF THE CARBOXY TERMINAL DOMAIN OF COLICIN E5 COMPLEXED WITH ITS INHIBITOR
183, 5n9zL, 0.6053, 2.91, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
184, 6hbbA, 0.6052, 2.94, 0.111, 88, 72, CRYSTAL STRUCTURE OF THE SMALL SUBUNIT-LIKE DOMAIN 1 OF CCMM FROM SYNECHOCOCCUS ELONGATUS (STRAIN PCC 7942) 
185, 3tw0B, 0.6050, 3.14, 0.113, 361, 71, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
186, 6hbaA, 0.6048, 2.77, 0.113, 89, 71, CRYSTAL STRUCTURE OF THE SMALL SUBUNIT-LIKE DOMAIN 1 OF CCMM FROM SYNECHOCOCCUS ELONGATUS (STRAIN PCC 7942); THIOL-OXIDIZED FORM 
187, 2ybvL, 0.6047, 3.03, 0.027, 104, 75, STRUCTURE OF RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS
188, 2v69N, 0.6046, 3.10, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
189, 3jslB, 0.6040, 2.69, 0.113, 308, 71, CRYSTAL STRUCTURE OF THE ADENYLATION DOMAIN OF NAD+- DEPENDENT DNA LIGASE FROM STAPHYLOCOCCUS AUREUS
190, 6ftlK, 0.6037, 2.89, 0.055, 139, 73, RUBISCO FROM SKELETONEMA MARINOI 
191, 4f1jB, 0.6036, 3.36, 0.083, 200, 72, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
192, 4f1kA, 0.6035, 3.33, 0.083, 200, 72, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
193, 3ty9D, 0.6033, 2.89, 0.181, 374, 72, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN AMP-ADENYLATE
194, 3jslA, 0.6032, 2.69, 0.113, 308, 71, CRYSTAL STRUCTURE OF THE ADENYLATION DOMAIN OF NAD+- DEPENDENT DNA LIGASE FROM STAPHYLOCOCCUS AUREUS
195, 6hbaB, 0.6030, 2.82, 0.113, 87, 71, CRYSTAL STRUCTURE OF THE SMALL SUBUNIT-LIKE DOMAIN 1 OF CCMM FROM SYNECHOCOCCUS ELONGATUS (STRAIN PCC 7942); THIOL-OXIDIZED FORM 
196, 4f1kB, 0.6029, 3.36, 0.083, 200, 72, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
197, 4f1jA, 0.6029, 3.34, 0.083, 200, 72, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
198, 6hbcA, 0.6028, 2.80, 0.113, 86, 71, STRUCTURE OF THE REPEAT UNIT IN THE NETWORK FORMED BY CCMM AND RUBISCO FROM SYNECHOCOCCUS ELONGATUS 
199, 4hhhU, 0.6028, 3.10, 0.108, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO
200, 3ty8B, 0.6024, 2.87, 0.167, 379, 72, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN APO FORM
201, 5o5eA, 0.6023, 3.42, 0.041, 381, 73, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1) (V264G MUTANT) IN COMPLEX WITH TUNICAMYCIN
202, 1shtX, 0.6023, 3.23, 0.127, 177, 71, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
203, 1ir2L, 0.6023, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
204, 5ivw0, 0.6020, 3.53, 0.108, 188, 74, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
205, 5oyaO, 0.6019, 2.93, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
206, 4hqnA, 0.6018, 3.54, 0.096, 254, 73, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
207, 1b04B, 0.6018, 2.68, 0.070, 311, 71, STRUCTURE OF THE ADENYLATION DOMAIN OF AN NAD+ DEPENDENT LIGASE
208, 4hqkB, 0.6017, 3.24, 0.099, 199, 71, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
209, 5mz2N, 0.6016, 2.93, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
210, 5mz2K, 0.6016, 2.94, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
211, 5m6wJ, 0.6016, 3.27, 0.127, 505, 71, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
212, 6mr1B, 0.6015, 2.82, 0.057, 84, 70, RBCS-LIKE SUBDOMAIN OF CCMM 
213, 5mkeD, 0.6015, 2.95, 0.068, 475, 74, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CATIONS AND LIPIDS
214, 2v6aJ, 0.6015, 3.11, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
215, 1rlcS, 0.6015, 3.06, 0.081, 123, 74, CRYSTAL STRUCTURE OF THE UNACTIVATED RIBULOSE 1 5-BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE COMPLEXED WITH A TRANSITION STATE ANALOG 2-CARBOXY-D-ARABINITOL 15-BISPHOSPHATE
216, 4rubS, 0.6014, 3.14, 0.081, 123, 74, A CRYSTAL FORM OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE(SLASH) OXYGENASE FROM NICOTIANA TABACUM IN THE ACTIVATED STATE
217, 2v69L, 0.6014, 3.04, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
218, 5iy80, 0.6013, 3.53, 0.108, 188, 74, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
219, 5iy70, 0.6013, 3.53, 0.108, 188, 74, HUMAN HOLO-PIC IN THE OPEN STATE
220, 5iy60, 0.6013, 3.53, 0.108, 188, 74, HUMAN HOLO-PIC IN THE CLOSED STATE
221, 5hn5A, 0.6012, 2.98, 0.114, 327, 70, CRYSTAL STRUCTURE OF BETA-DECARBOXYLATING DEHYDROGENASE (TK0280) FROM THERMOCOCCUS KODAKARENSIS COMPLEXED WITH MN AND ISOCITRATE
222, 5n9zM, 0.6011, 2.94, 0.096, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
223, 5n9zK, 0.6011, 2.92, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
224, 5iy90, 0.6011, 3.53, 0.108, 188, 74, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
225, 5oyaP, 0.6009, 2.92, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
226, 5levA, 0.6009, 3.42, 0.041, 375, 73, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1) (V264G MUTANT)
227, 2v63P, 0.6008, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
228, 5oyaN, 0.6006, 2.94, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
229, 5n9zO, 0.6006, 2.93, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
230, 2v67L, 0.6006, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
231, 5mz2M, 0.6005, 2.94, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
232, 4hqkA, 0.6005, 3.23, 0.099, 200, 71, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
233, 5n9zN, 0.6004, 2.93, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
234, 6ftlI, 0.6003, 2.92, 0.055, 139, 73, RUBISCO FROM SKELETONEMA MARINOI 
235, 1uzdF, 0.6003, 3.08, 0.082, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
236, 2v6aL, 0.6002, 3.12, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
237, 2v67M, 0.6002, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
238, 2v69M, 0.6001, 3.08, 0.068, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
239, 6fwzA, 0.6000, 3.40, 0.041, 373, 73, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1) (V264G MUTANT) IN COMPLEX WITH UDP-GLCNAC 
240, 1uzdM, 0.6000, 3.12, 0.055, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
241, 5mz2I, 0.5999, 2.95, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
242, 4rubU, 0.5999, 3.13, 0.081, 123, 74, A CRYSTAL FORM OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE(SLASH) OXYGENASE FROM NICOTIANA TABACUM IN THE ACTIVATED STATE
243, 2vdhJ, 0.5999, 3.11, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
244, 2v67I, 0.5998, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
245, 1uzdW, 0.5998, 3.13, 0.055, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
246, 2v6aN, 0.5997, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
247, 5mz2P, 0.5996, 2.95, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
248, 5n9zJ, 0.5995, 2.94, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
249, 5mkeA, 0.5995, 2.96, 0.068, 475, 74, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CATIONS AND LIPIDS
250, 4hqlA, 0.5995, 3.54, 0.096, 254, 73, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
251, 2vdhM, 0.5995, 3.15, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
252, 1uzdC, 0.5995, 3.09, 0.082, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
253, 6nmiE, 0.5994, 3.51, 0.108, 366, 74, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
254, 1uzdT, 0.5994, 3.09, 0.082, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
255, 1uzdI, 0.5994, 3.09, 0.082, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
256, 5mkeC, 0.5993, 2.97, 0.068, 475, 74, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CATIONS AND LIPIDS
257, 5mkeB, 0.5993, 2.97, 0.068, 475, 74, CRYOEM STRUCTURE OF POLYCYSTIN-2 IN COMPLEX WITH CATIONS AND LIPIDS
258, 2v67K, 0.5993, 3.10, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
259, 1uzhM, 0.5993, 3.06, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
260, 1uzdJ, 0.5993, 3.13, 0.055, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
261, 1uzhF, 0.5992, 3.09, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
262, 1taeB, 0.5992, 2.72, 0.070, 321, 71, STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DNA LIGASE CRYSTAL
263, 2v67N, 0.5991, 3.11, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
264, 2v67J, 0.5991, 3.11, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
265, 2v63L, 0.5991, 3.14, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
266, 1uzhC, 0.5991, 3.09, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
267, 5oyaK, 0.5990, 2.96, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
268, 4rubV, 0.5990, 3.14, 0.081, 123, 74, A CRYSTAL FORM OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE(SLASH) OXYGENASE FROM NICOTIANA TABACUM IN THE ACTIVATED STATE
269, 3ty9C, 0.5990, 2.93, 0.192, 376, 73, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN AMP-ADENYLATE
270, 2v6aI, 0.5990, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
271, 2v63I, 0.5990, 3.14, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
272, 1uzhI, 0.5990, 3.09, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
273, 1b04A, 0.5990, 2.69, 0.085, 310, 71, STRUCTURE OF THE ADENYLATION DOMAIN OF AN NAD+ DEPENDENT LIGASE
274, 5oyaJ, 0.5989, 2.94, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
275, 4hqoB, 0.5989, 3.57, 0.096, 260, 73, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
276, 2v69I, 0.5989, 3.09, 0.068, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT MUTATION D473E
277, 1uzhW, 0.5989, 3.09, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
278, 6gym6, 0.5988, 3.48, 0.095, 335, 74, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
279, 6ftlJ, 0.5988, 2.94, 0.055, 139, 73, RUBISCO FROM SKELETONEMA MARINOI 
280, 6bw5D, 0.5988, 3.43, 0.041, 362, 73, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
281, 5mz2O, 0.5988, 2.94, 0.068, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
282, 2vdhL, 0.5988, 3.15, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
283, 2v6aO, 0.5988, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
284, 4rubT, 0.5987, 3.14, 0.081, 123, 74, A CRYSTAL FORM OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE(SLASH) OXYGENASE FROM NICOTIANA TABACUM IN THE ACTIVATED STATE
285, 5mz2J, 0.5986, 2.93, 0.068, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
286, 2v6aM, 0.5986, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
287, 2v63O, 0.5986, 3.14, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
288, 1uzhP, 0.5986, 3.09, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
289, 5oyaL, 0.5985, 2.95, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
290, 5n9zI, 0.5985, 2.94, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
291, 2v63K, 0.5985, 3.14, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
292, 1gk8M, 0.5985, 3.08, 0.082, 125, 73, RUBISCO FROM CHLAMYDOMONAS REINHARDTII
293, 1uwaM, 0.5984, 3.11, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
294, 5mz2L, 0.5983, 2.93, 0.068, 139, 73, RUBISCO FROM THALASSIOSIRA ANTARCTICA
295, 5hn4A, 0.5983, 3.00, 0.114, 329, 70, CRYSTAL STRUCTURE OF BETA-DECARBOXYLATING DEHYDROGENASE (TK0280) FROM THERMOCOCCUS KODAKARENSIS COMPLEXED WITH MN AND HOMOISOCITRATE
296, 2n4eA, 0.5983, 2.44, 0.180, 106, 61, SOLUTION NMR STRUCTURE OF DE NOVO DESIGNED PROTEIN TOP7NNSTYCC NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR34
297, 1uzhJ, 0.5983, 3.10, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
298, 1uwaC, 0.5983, 3.11, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
299, 1ir2N, 0.5983, 3.12, 0.055, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
300, 6bw6D, 0.5982, 3.43, 0.041, 369, 73, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
301, 5oyaM, 0.5982, 2.94, 0.068, 139, 73, UNUSUAL POSTTRANSLATIONAL MODIFICATIONS REVEALED IN CRYSTAL STRUCTURES OF DIATOM RUBISCO. 
302, 2vdhP, 0.5982, 3.11, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
303, 2vdhI, 0.5982, 3.12, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
304, 2v63N, 0.5982, 3.15, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
305, 2v63J, 0.5982, 3.14, 0.082, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
306, 1uwaI, 0.5982, 3.11, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
307, 5n9zP, 0.5981, 2.94, 0.082, 139, 73, RUBISCO FROM THALASSIOSIRA HYALINA
308, 1uzhT, 0.5981, 3.10, 0.082, 122, 73, A CHIMERIC CHLAMYDOMONAS SYNECHOCOCCUS RUBISCO ENZYME
309, 6ftlL, 0.5980, 2.94, 0.055, 139, 73, RUBISCO FROM SKELETONEMA MARINOI 
310, 4efbA, 0.5980, 2.75, 0.070, 313, 71, CRYSTAL STRUCTURE OF DNA LIGASE
311, 2v6aK, 0.5980, 3.13, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
312, 6fm9A, 0.5979, 3.46, 0.041, 378, 73, CRYSTAL STRUCTURE OF HUMAN UDP-N-ACETYLGLUCOSAMINE-DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (DPAGT1)
313, 3baaA, 0.5979, 2.72, 0.070, 312, 71, STRUCTURAL BASIS FOR THE INHIBITION OF BACTERIAL NAD+ DEPENDENT DNA LIGASE
314, 2v68L, 0.5979, 3.15, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
315, 6bw5C, 0.5978, 3.44, 0.041, 375, 73, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
316, 5nusA, 0.5978, 3.29, 0.041, 210, 74, STRUCTURE OF A MINIMAL COMPLEX BETWEEN P44 AND P34 FROM CHAETOMIUM THERMOPHILUM
317, 1uwaW, 0.5978, 3.12, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
318, 2vdhN, 0.5977, 3.12, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
319, 1uwaF, 0.5977, 3.11, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
320, 1ta8A, 0.5977, 2.73, 0.070, 313, 71, STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DNA LIGASE CRYSTAL
321, 2vdhO, 0.5976, 3.12, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
322, 6bw5A, 0.5975, 3.43, 0.041, 378, 73, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
323, 1uwaP, 0.5975, 3.12, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
324, 1uwaJ, 0.5975, 3.12, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
325, 2vdhK, 0.5974, 3.12, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C172S MUTATION
326, 1uwaT, 0.5974, 3.12, 0.082, 140, 73, L290F MUTANT RUBISCO FROM CHLAMYDOMONAS
327, 1taeD, 0.5974, 2.73, 0.070, 321, 71, STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DNA LIGASE CRYSTAL
328, 1t8yC, 0.5974, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE
329, 4efeA, 0.5973, 2.74, 0.070, 313, 71, CRYSTAL STRUCTURE OF DNA LIGASE
330, 1t8yE, 0.5973, 2.56, 0.108, 457, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE
331, 1t8yB, 0.5973, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE
332, 1ir24, 0.5973, 3.17, 0.082, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
333, 1t8yF, 0.5972, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE
334, 1t8yD, 0.5972, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE
335, 4hhhV, 0.5971, 3.10, 0.095, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO
336, 1t8rE, 0.5971, 2.54, 0.108, 459, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
337, 3hs0D, 0.5970, 3.37, 0.125, 699, 72, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
338, 1t8wB, 0.5970, 2.54, 0.108, 457, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
339, 1t8wA, 0.5970, 2.54, 0.108, 457, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
340, 1t8sC, 0.5970, 2.54, 0.108, 439, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5 -MONOPHOSPHATE
341, 2v68I, 0.5969, 3.15, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
342, 1t8wD, 0.5969, 2.54, 0.108, 457, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
343, 1t8sF, 0.5969, 2.54, 0.108, 439, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5 -MONOPHOSPHATE
344, 2vdiP, 0.5968, 3.14, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
345, 1t8yA, 0.5968, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE
346, 1t8wC, 0.5968, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
347, 1t8sA, 0.5968, 2.54, 0.108, 439, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5 -MONOPHOSPHATE
348, 4hhhT, 0.5967, 3.07, 0.108, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO
349, 1t8wE, 0.5967, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
350, 1t8sE, 0.5967, 2.54, 0.108, 439, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5 -MONOPHOSPHATE
351, 2v6aP, 0.5966, 3.15, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A G344S
352, 2v68K, 0.5966, 3.12, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
353, 1ir2O, 0.5966, 3.12, 0.068, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
354, 1ir2I, 0.5966, 3.09, 0.069, 139, 72, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
355, 3ba9A, 0.5965, 2.74, 0.070, 313, 71, STRUCTURAL BASIS FOR INHBITION OF NAD-DEPENDENT LIGASE
356, 1t8wF, 0.5964, 2.55, 0.108, 457, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
357, 2v68O, 0.5963, 3.16, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
358, 1t8sD, 0.5963, 2.54, 0.108, 439, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5 -MONOPHOSPHATE
359, 4mkvV, 0.5962, 3.13, 0.095, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO WITH ABA
360, 1t8rC, 0.5962, 2.54, 0.108, 459, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
361, 1t8rA, 0.5961, 2.54, 0.108, 459, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
362, 6bw6B, 0.5960, 3.46, 0.041, 374, 73, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
363, 2v68P, 0.5960, 3.14, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
364, 1t8sB, 0.5960, 2.54, 0.108, 440, 65, CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5 -MONOPHOSPHATE
365, 1t8rB, 0.5960, 2.54, 0.108, 459, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
366, 1gk8I, 0.5960, 3.10, 0.082, 125, 73, RUBISCO FROM CHLAMYDOMONAS REINHARDTII
367, 4mkvT, 0.5959, 3.12, 0.095, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO WITH ABA
368, 4cnbB, 0.5959, 3.29, 0.099, 391, 71, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
369, 1t8rF, 0.5959, 2.54, 0.108, 459, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
370, 1t8rD, 0.5959, 2.54, 0.108, 459, 65, CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE
371, 1gk8K, 0.5959, 3.13, 0.082, 125, 73, RUBISCO FROM CHLAMYDOMONAS REINHARDTII
372, 6bw5B, 0.5958, 3.42, 0.041, 369, 73, HUMAN GPT (DPAGT1) IN COMPLEX WITH TUNICAMYCIN
373, 1ir27, 0.5958, 3.14, 0.068, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
374, 4hqnB, 0.5957, 3.59, 0.096, 256, 73, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
375, 2v68J, 0.5956, 3.16, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
376, 4mkvU, 0.5955, 3.14, 0.095, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO WITH ABA
377, 2vdiJ, 0.5955, 3.15, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
378, 1uw9I, 0.5955, 3.17, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
379, 2vdiL, 0.5954, 3.14, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
380, 2v68N, 0.5954, 3.16, 0.082, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
381, 1uzdP, 0.5954, 3.13, 0.055, 129, 73, CHLAMYDOMONASSPINACH CHIMERIC RUBISCO
382, 1ir2M, 0.5953, 3.19, 0.055, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
383, 1ir21, 0.5953, 3.18, 0.082, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
384, 6oz6C, 0.5952, 3.44, 0.054, 322, 74, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
385, 3ba8A, 0.5952, 2.75, 0.070, 313, 71, STRUCTURAL BASIS FOR THE INHIBITION OF BACTERIAL NAD+ DEPENDENT DNA LIGASE
386, 2vdiI, 0.5952, 3.14, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
387, 1uw9W, 0.5952, 3.17, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
388, 1uw9F, 0.5952, 3.18, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
389, 6oyhD, 0.5951, 3.46, 0.054, 337, 74, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
390, 2vdiO, 0.5950, 3.15, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
391, 1uw9M, 0.5950, 3.17, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
392, 6oz6A, 0.5947, 3.50, 0.054, 331, 74, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
393, 3ppwA, 0.5947, 3.48, 0.071, 184, 70, CRYSTAL STRUCTURE OF THE D1596A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
394, 1svdM, 0.5947, 3.10, 0.080, 108, 75, THE STRUCTURE OF HALOTHIOBACILLUS NEAPOLITANUS RUBISCO
395, 2vdiN, 0.5946, 3.15, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
396, 2vdiK, 0.5945, 3.15, 0.055, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
397, 1uw9C, 0.5945, 3.18, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
398, 1ir28, 0.5945, 3.18, 0.055, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
399, 1uw9T, 0.5944, 3.18, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
400, 1uw9J, 0.5944, 3.18, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
401, 5griB, 0.5943, 3.21, 0.083, 335, 72, CRYSTAL STRUCTURE OF THE ALPHA GAMMA HETERODIMER OF HUMAN IDH3 IN COMPLEX WITH MG(2+) AND CITRATE
402, 4eeqA, 0.5943, 2.76, 0.070, 313, 71, CRYSTAL STRUCTURE OF E. FAECALIS DNA LIGASE WITH INHIBITOR
403, 1wddW, 0.5943, 3.15, 0.095, 121, 74, CRYSTAL STRUCTURE OF ACTIVATED RICE RUBISCO COMPLEXED WITH 2- CARBOXYARABINITOL-15-BISPHOSPHATE
404, 4f0kB, 0.5942, 3.02, 0.080, 138, 75, UNACTIVATED RUBISCO WITH MAGNESIUM AND CARBON DIOXIDE BOUND
405, 2v67P, 0.5940, 3.13, 0.068, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
406, 1uw9P, 0.5940, 3.18, 0.082, 140, 73, L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT
407, 3ppyA, 0.5938, 3.49, 0.071, 187, 70, CRYSTAL STRUCTURE OF THE D1596A/N1602A DOUBLE MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
408, 3babA, 0.5938, 2.74, 0.070, 312, 71, STRUCTURAL BASIS FOR THE INHIBITION OF BACTERIAL NAD+ DEPENDENT DNA LIGASE
409, 5grlB, 0.5935, 3.23, 0.083, 335, 72, CRYSTAL STRUCTURE OF THE ALPHA GAMMA HETERODIMER OF HUMAN IDH3 IN COMPLEX WITH MG(2+) ISOCITRATE AND ADP
410, 1bxnL, 0.5934, 3.06, 0.093, 129, 75, THE CRYSTAL STRUCTURE OF RUBISCO FROM ALCALIGENES EUTROPHUS TO 2.7 ANGSTROMS.
411, 1bxnI, 0.5934, 3.05, 0.093, 129, 75, THE CRYSTAL STRUCTURE OF RUBISCO FROM ALCALIGENES EUTROPHUS TO 2.7 ANGSTROMS.
412, 1wddS, 0.5933, 3.16, 0.095, 121, 74, CRYSTAL STRUCTURE OF ACTIVATED RICE RUBISCO COMPLEXED WITH 2- CARBOXYARABINITOL-15-BISPHOSPHATE
413, 1bxnK, 0.5933, 3.06, 0.093, 129, 75, THE CRYSTAL STRUCTURE OF RUBISCO FROM ALCALIGENES EUTROPHUS TO 2.7 ANGSTROMS.
414, 1bxnJ, 0.5933, 3.06, 0.093, 129, 75, THE CRYSTAL STRUCTURE OF RUBISCO FROM ALCALIGENES EUTROPHUS TO 2.7 ANGSTROMS.
415, 4uf6G, 0.5932, 2.50, 0.123, 287, 65, UCH-L5 IN COMPLEX WITH UBIQUITIN-PROPARGYL BOUND TO AN ACTIVATING FRAGMENT OF INO80G
416, 4mkvS, 0.5932, 3.17, 0.095, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO WITH ABA
417, 3hs0I, 0.5932, 3.23, 0.127, 704, 71, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
418, 1ir22, 0.5932, 3.16, 0.068, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
419, 1rscO, 0.5931, 3.13, 0.151, 109, 73, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
420, 1ir2P, 0.5931, 3.10, 0.069, 139, 72, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
421, 1ir26, 0.5931, 3.18, 0.068, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
422, 1rscP, 0.5930, 3.13, 0.151, 109, 73, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
423, 1ir23, 0.5930, 3.18, 0.068, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
424, 1ir2K, 0.5929, 3.11, 0.069, 139, 72, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
425, 3skuA, 0.5927, 3.31, 0.100, 230, 70, HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE HUMAN RECEPTOR NECTIN-1
426, 2vdiM, 0.5927, 3.16, 0.068, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT C192S MUTATION
427, 4xz3B, 0.5925, 2.68, 0.154, 224, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 (SE-MET DERIVATIVE) IN COMPLEX WITH COENZYME A AND MG- AMPPCP PHOSPHOHISTIDINE SEGMENT POINTING TOWARDS NUCLEOTIDE BINDING SITE
428, 2v68M, 0.5925, 3.16, 0.068, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH LARGE-SUBUNIT MUTATIONS V331A T342I
429, 3skuC, 0.5924, 3.31, 0.100, 228, 70, HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE HUMAN RECEPTOR NECTIN-1
430, 1ir25, 0.5924, 3.16, 0.068, 139, 73, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
431, 2v67O, 0.5923, 3.15, 0.068, 139, 73, CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII RUBISCO WITH A LARGE-SUBUNIT SUPRESSOR MUTATION T342I
432, 1taeC, 0.5923, 2.76, 0.070, 321, 71, STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DNA LIGASE CRYSTAL
433, 1ej7S, 0.5923, 3.16, 0.080, 123, 75, CRYSTAL STRUCTURE OF UNACTIVATED TOBACCO RUBISCO WITH BOUND PHOSPHATE IONS
434, 2v63M, 0.5922, 3.15, 0.068, 139, 73, CRYSTAL STRUCTURE OF RUBISCO FROM CHLAMYDOMONAS REINHARDTII WITH A LARGE-SUBUNIT V331A MUTATION
435, 4hhhS, 0.5920, 3.16, 0.108, 123, 74, STRUCTURE OF PISUM SATIVUM RUBISCO
436, 3u82A, 0.5917, 3.34, 0.100, 231, 70, BINDING OF HERPES SIMPLEX VIRUS GLYCOPROTEIN D TO NECTIN-1 EXPLOITS HOST CELL ADHESION
437, 4cn9B, 0.5916, 3.42, 0.097, 396, 72, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
438, 6oyhC, 0.5915, 3.48, 0.027, 328, 74, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
439, 4cn9A, 0.5915, 3.41, 0.097, 397, 72, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
440, 3hrzD, 0.5915, 3.24, 0.139, 693, 72, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
441, 2xggA, 0.5914, 3.41, 0.043, 147, 70, STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 2 A_I DOMAIN
442, 1t6bY, 0.5913, 3.34, 0.125, 170, 72, CRYSTAL STRUCTURE OF B. ANTHRACIS PROTECTIVE ANTIGEN COMPLEXED WITH HUMAN ANTHRAX TOXIN RECEPTOR
443, 5greB, 0.5912, 3.23, 0.083, 333, 72, CRYSTAL STRUCTURE OF THE ALPHA GAMMA HETERODIMER OF HUMAN IDH3 IN COMPLEX WITH MG(2+) CITRATE AND ADP
444, 3ppxA, 0.5912, 3.43, 0.086, 184, 70, CRYSTAL STRUCTURE OF THE N1602A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
445, 2c3aA, 0.5911, 3.16, 0.101, 252, 69, STRUCTURE OF UNLIGANDED HSV GD REVEALS A MECHANISM FOR RECEPTOR-MEDIATED ACTIVATION OF VIRUS ENTRY
446, 1rldS, 0.5907, 3.16, 0.080, 123, 75, SOLID-STATE PHASE TRANSITION IN THE CRYSTAL STRUCTURE OF RIBULOSE 15- BIPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE
447, 1ir2J, 0.5907, 3.11, 0.069, 139, 72, CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2-CARBOXYARABINITOL-15-BISPHOSPHATE (2- CABP)
448, 4f0mB, 0.5906, 3.04, 0.080, 138, 75, UNACTIVATED RUBISCO WITH MAGNESIUM AND A WATER MOLECULE BOUND
449, 1rldT, 0.5906, 3.16, 0.080, 123, 75, SOLID-STATE PHASE TRANSITION IN THE CRYSTAL STRUCTURE OF RIBULOSE 15- BIPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE
450, 6oyhB, 0.5905, 3.47, 0.027, 330, 74, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
451, 1gk8O, 0.5905, 3.17, 0.068, 125, 73, RUBISCO FROM CHLAMYDOMONAS REINHARDTII
452, 6oyhA, 0.5903, 3.48, 0.041, 326, 74, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
453, 3rubS, 0.5902, 3.13, 0.080, 123, 75, CRYSTAL STRUCTURE OF THE UNACTIVATED FORM OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM TOBACCO REFINED AT 2.0-ANGSTROMS RESOLUTION
454, 5grfB, 0.5899, 3.25, 0.083, 335, 72, CRYSTAL STRUCTURE OF THE ALPHA GAMMA MUTANT (GAMMA-K151A) OF HUMAN IDH3 IN COMPLEX WITH MG(2+) CITRATE AND ADP
455, 6a70F, 0.5898, 3.08, 0.092, 463, 76, STRUCTURE OF THE HUMAN PKD1/PKD2 COMPLEX 
456, 1taeA, 0.5898, 2.78, 0.070, 321, 71, STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DNA LIGASE CRYSTAL
457, 1iwaF, 0.5897, 3.07, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
458, 4dm9A, 0.5895, 2.92, 0.136, 223, 66, THE CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCHL1) BOUND TO A TRIPEPTIDE FLUOROMETHYL KETONE Z-VAE(OME)-FMK
459, 1rcoW, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
460, 1rcoT, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
461, 1rcoS, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
462, 1rcoP, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
463, 1rcoM, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
464, 1rcoI, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
465, 1rcoF, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
466, 1rcoC, 0.5895, 3.19, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2 2-DIOL-15-BISPHOSPHATE
467, 5ckrA, 0.5894, 3.49, 0.041, 329, 74, CRYSTAL STRUCTURE OF MRAY IN COMPLEX WITH MURAYMYCIN D2
468, 1iwaH, 0.5892, 3.07, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
469, 4j72B, 0.5891, 3.61, 0.053, 297, 76, CRYSTAL STRUCTURE OF POLYPRENYL-PHOSPHATE N-ACETYL HEXOSAMINE 1- PHOSPHATE TRANSFERASE
470, 3blwM, 0.5890, 3.45, 0.041, 339, 73, YEAST ISOCITRATE DEHYDROGENASE WITH CITRATE AND AMP BOUND IN THE REGULATORY SUBUNITS
471, 3blwK, 0.5890, 3.45, 0.041, 337, 73, YEAST ISOCITRATE DEHYDROGENASE WITH CITRATE AND AMP BOUND IN THE REGULATORY SUBUNITS
472, 1iwaP, 0.5888, 3.05, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
473, 5iu0J, 0.5886, 3.18, 0.080, 123, 75, RUBISCO FROM ARABIDOPSIS THALIANA
474, 1q0pA, 0.5886, 3.02, 0.114, 192, 70, A DOMAIN OF FACTOR B
475, 1iwaB, 0.5886, 3.07, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
476, 6dncE, 0.5885, 3.18, 0.110, 220, 73, struct.pdbx_descriptor              ribosome 
477, 6a70A, 0.5885, 2.93, 0.040, 448, 75, STRUCTURE OF THE HUMAN PKD1/PKD2 COMPLEX 
478, 4f0hB, 0.5885, 3.05, 0.080, 138, 75, UNACTIVATED RUBISCO WITH OXYGEN BOUND
479, 6oyzC, 0.5884, 3.46, 0.027, 306, 73, CRYSTAL STRUCTURE OF MRAY BOUND TO CAPURAMYCIN 
480, 1iwaD, 0.5882, 3.06, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
481, 1iwaJ, 0.5881, 3.08, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
482, 6msjH, 0.5879, 3.04, 0.044, 191, 68, struct.pdbx_descriptor               26S proteasome  
483, 1iwaN, 0.5879, 3.07, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
484, 5iu0I, 0.5876, 3.20, 0.080, 123, 75, RUBISCO FROM ARABIDOPSIS THALIANA
485, 4cnbA, 0.5875, 3.08, 0.087, 387, 69, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
486, 3txaA, 0.5875, 3.18, 0.113, 583, 71, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
487, 1iwaL, 0.5875, 3.08, 0.080, 138, 75, RUBISCO FROM GALDIERIA PARTITA
488, 6oyzB, 0.5874, 3.44, 0.027, 330, 73, CRYSTAL STRUCTURE OF MRAY BOUND TO CAPURAMYCIN 
489, 6ro4D, 0.5871, 3.60, 0.108, 280, 74, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
490, 4j72A, 0.5870, 3.66, 0.027, 323, 75, CRYSTAL STRUCTURE OF POLYPRENYL-PHOSPHATE N-ACETYL HEXOSAMINE 1- PHOSPHATE TRANSFERASE
491, 2xggB, 0.5869, 3.35, 0.043, 148, 69, STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 2 A_I DOMAIN
492, 5nv3P, 0.5867, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
493, 5nv3O, 0.5866, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
494, 5nv3L, 0.5866, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
495, 5nv3M, 0.5865, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
496, 5nv3I, 0.5865, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
497, 2x5nA, 0.5865, 3.37, 0.056, 188, 71, CRYSTAL STRUCTURE OF THE SPRPN10 VWA DOMAIN
498, 1ir1V, 0.5862, 3.25, 0.068, 122, 74, CRYSTAL STRUCTURE OF SPINACH RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH CO2 MG2+ AND 2- CARBOXYARABINITOL-15-BISPHOSPHATE
499, 6mseH, 0.5861, 3.01, 0.045, 191, 67, struct.pdbx_descriptor               26S proteasome  
500, 1ir1T, 0.5860, 3.24, 0.068, 122, 74, CRYSTAL STRUCTURE OF SPINACH RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH CO2 MG2+ AND 2- CARBOXYARABINITOL-15-BISPHOSPHATE
501, 5hbrB, 0.5859, 2.97, 0.152, 229, 66, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH PHOSPHATE AND COENZYME A
502, 4v91SA, 0.5857, 3.28, 0.173, 217, 75, 
503, 1rboS, 0.5856, 3.22, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR 2-CARBOXYARABINITOL-15- DIPHOSPHATE
504, 1rboI, 0.5856, 3.22, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR 2-CARBOXYARABINITOL-15- DIPHOSPHATE
505, 1rboF, 0.5856, 3.22, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR 2-CARBOXYARABINITOL-15- DIPHOSPHATE
506, 1rboC, 0.5856, 3.22, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR 2-CARBOXYARABINITOL-15- DIPHOSPHATE
507, 5nv3N, 0.5855, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
508, 5nv3K, 0.5855, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
509, 5nv3J, 0.5855, 3.04, 0.108, 129, 74, STRUCTURE OF RUBISCO FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH CABP
510, 1ir1S, 0.5855, 3.24, 0.068, 122, 74, CRYSTAL STRUCTURE OF SPINACH RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH CO2 MG2+ AND 2- CARBOXYARABINITOL-15-BISPHOSPHATE
511, 6fvuCA, 0.5854, 3.02, 0.059, 197, 68, struct.pdbx_descriptor              
512, 3blxE, 0.5854, 3.24, 0.068, 341, 74, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
513, 2xwbH, 0.5854, 3.31, 0.127, 711, 71, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
514, 6o9l6, 0.5852, 3.46, 0.110, 385, 73, HUMAN HOLO-PIC IN THE CLOSED STATE 
515, 6oyzA, 0.5851, 3.42, 0.027, 313, 73, CRYSTAL STRUCTURE OF MRAY BOUND TO CAPURAMYCIN 
516, 8rucI, 0.5850, 3.24, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE
517, 4dm9B, 0.5850, 2.89, 0.136, 223, 66, THE CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCHL1) BOUND TO A TRIPEPTIDE FLUOROMETHYL KETONE Z-VAE(OME)-FMK
518, 4cn8A, 0.5849, 3.22, 0.114, 392, 70, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS
519, 2winL, 0.5849, 2.97, 0.129, 507, 70, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
520, 2winK, 0.5849, 2.97, 0.129, 507, 70, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
521, 2winJ, 0.5849, 2.97, 0.129, 507, 70, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
522, 2winI, 0.5849, 2.97, 0.129, 507, 70, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
523, 1tzno, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
524, 1tznm, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
525, 1tznl, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
526, 1tznk, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
527, 1tznj, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
528, 1tzni, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
529, 1tznh, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
530, 1tzng, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
531, 1tznf, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
532, 1tzne, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
533, 1tznd, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
534, 1tznc, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
535, 1tznb, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
536, 1tzna, 0.5849, 3.38, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
537, 3jcoFA, 0.5848, 3.14, 0.028, 197, 71, 
538, 1rcxW, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
539, 1rcxT, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
540, 1rcxS, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
541, 1rcxP, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
542, 1rcxM, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
543, 1rcxI, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
544, 1rcxF, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
545, 1rcxC, 0.5846, 3.22, 0.068, 123, 74, NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15-BISPHOSPHATE
546, 4gosA, 0.5845, 2.99, 0.119, 115, 67, CRYSTAL STRUCTURE OF HUMAN B7-H4 IGV-LIKE DOMAIN
547, 6oz6B, 0.5844, 3.28, 0.041, 321, 73, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
548, 4uelA, 0.5844, 2.59, 0.123, 302, 65, UCH-L5 IN COMPLEX WITH UBIQUITIN-PROPARGYL BOUND TO THE RPN13 DEUBAD DOMAIN
549, 1rblP, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
550, 1rblO, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
551, 1rblN, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
552, 1rblM, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
553, 1rblL, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
554, 1rblK, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
555, 1rblJ, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
556, 1rblI, 0.5843, 3.23, 0.108, 109, 74, STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 15 BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE FROM SYNECHOCOCCUS PCC6301
557, 2xwjK, 0.5840, 3.14, 0.143, 713, 70, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
558, 1ir1U, 0.5840, 3.26, 0.068, 122, 74, CRYSTAL STRUCTURE OF SPINACH RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH CO2 MG2+ AND 2- CARBOXYARABINITOL-15-BISPHOSPHATE
559, 8rucL, 0.5839, 3.24, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE
560, 3jcpFA, 0.5838, 3.16, 0.028, 197, 71, 
561, 5grhB, 0.5837, 3.22, 0.071, 335, 70, CRYSTAL STRUCTURE OF THE ALPHA GAMMA HETERODIMER OF HUMAN IDH3 IN COMPLEX WITH MG(2+)
562, 3gxbA, 0.5837, 3.52, 0.086, 177, 70, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
563, 5of4E, 0.5836, 3.12, 0.099, 184, 71, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
564, 1shuX, 0.5836, 3.33, 0.125, 181, 72, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
565, 1rscN, 0.5836, 3.23, 0.108, 109, 74, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
566, 1rscM, 0.5836, 3.23, 0.108, 109, 74, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
567, 1rscK, 0.5836, 3.23, 0.108, 109, 74, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
568, 1rscJ, 0.5836, 3.23, 0.108, 109, 74, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
569, 5wskF, 0.5835, 3.24, 0.067, 122, 75, STRUCTURE OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE FROM WHEAT
570, 1rscL, 0.5835, 3.23, 0.108, 109, 74, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
571, 1rscI, 0.5835, 3.23, 0.108, 109, 74, STRUCTURE OF AN EFFECTOR INDUCED INACTIVATED STATE OF RIBULOSE BISPHOSPHATE CARBOXYLASE(SLASH)OXYGENASE: THE BINARY COMPLEX BETWEEN ENZYME AND XYLULOSE BISPHOSPHATE
572, 3ty9B, 0.5834, 3.07, 0.164, 374, 73, CRYSTAL STRUCTURE OF C. THERMOCELLUM PNKP LIGASE DOMAIN AMP-ADENYLATE
573, 1bwvY, 0.5834, 3.10, 0.080, 138, 75, ACTIVATED RIBULOSE 15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH THE REACTION INTERMEDIATE ANALOGUE 2-CARBOXYARABINITOL 15-BISPHOSPHATE
574, 1bwvU, 0.5834, 3.10, 0.080, 138, 75, ACTIVATED RIBULOSE 15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH THE REACTION INTERMEDIATE ANALOGUE 2-CARBOXYARABINITOL 15-BISPHOSPHATE
575, 5vfpU, 0.5833, 3.00, 0.045, 191, 67, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
576, 1upmI, 0.5833, 3.26, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
577, 1bwvW, 0.5833, 3.10, 0.080, 138, 75, ACTIVATED RIBULOSE 15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH THE REACTION INTERMEDIATE ANALOGUE 2-CARBOXYARABINITOL 15-BISPHOSPHATE
578, 1bwvS, 0.5833, 3.10, 0.080, 138, 75, ACTIVATED RIBULOSE 15-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH THE REACTION INTERMEDIATE ANALOGUE 2-CARBOXYARABINITOL 15-BISPHOSPHATE
579, 6msgH, 0.5832, 3.09, 0.044, 191, 68, struct.pdbx_descriptor               26S proteasome  
580, 2xwjI, 0.5832, 2.80, 0.132, 712, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
581, 2jvfA, 0.5832, 2.05, 0.153, 94, 59, SOLUTION STRUCTURE OF M7 A COMPUTATIONALLY-DESIGNED ARTIFICIAL PROTEIN
582, 1upmW, 0.5832, 3.25, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
583, 1upmT, 0.5831, 3.25, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
584, 1upmS, 0.5831, 3.26, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
585, 1upmP, 0.5831, 3.25, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
586, 1ausV, 0.5831, 3.19, 0.067, 123, 75, ACTIVATED UNLIGANDED SPINACH RUBISCO
587, 1ausU, 0.5831, 3.19, 0.067, 123, 75, ACTIVATED UNLIGANDED SPINACH RUBISCO
588, 1ausT, 0.5831, 3.19, 0.067, 123, 75, ACTIVATED UNLIGANDED SPINACH RUBISCO
589, 1ausS, 0.5831, 3.19, 0.067, 123, 75, ACTIVATED UNLIGANDED SPINACH RUBISCO
590, 2xwjL, 0.5830, 2.80, 0.132, 711, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
591, 2xwjJ, 0.5830, 3.14, 0.129, 713, 70, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
592, 1upmF, 0.5830, 3.25, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
593, 4ybzD, 0.5829, 2.71, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH ADP AND WITH PHOSPHORYLATED PHOSPHOHISTIDINE SEGMENT (SITE I ORIENTATION)
594, 4xymD, 0.5829, 2.69, 0.185, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH COENZYME A CA-AMPCP AND HGCL+
595, 1upmC, 0.5829, 3.26, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
596, 1uppI, 0.5828, 3.26, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE AND CALCIUM.
597, 6hbcD, 0.5827, 3.16, 0.120, 106, 75, STRUCTURE OF THE REPEAT UNIT IN THE NETWORK FORMED BY CCMM AND RUBISCO FROM SYNECHOCOCCUS ELONGATUS 
598, 1upmM, 0.5827, 3.26, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.
599, 1uppK, 0.5824, 3.25, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE AND CALCIUM.
600, 4pn7A, 0.5823, 3.47, 0.027, 209, 75, CRYSTAL STRUCTURE OF THE TFIIH P34 N-TERMINAL DOMAIN
601, 1uppL, 0.5823, 3.26, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE AND CALCIUM.
602, 8rucK, 0.5821, 3.25, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE
603, 8rucJ, 0.5821, 3.24, 0.068, 123, 74, ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE
604, 2mraA, 0.5821, 2.15, 0.233, 117, 60, SOLUTION NMR STRUCTURE OF DE NOVO DESIGNED PROTEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR459
605, 5vfsV, 0.5820, 3.02, 0.030, 191, 67, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
606, 6hbcE, 0.5818, 3.16, 0.107, 106, 75, STRUCTURE OF THE REPEAT UNIT IN THE NETWORK FORMED BY CCMM AND RUBISCO FROM SYNECHOCOCCUS ELONGATUS 
607, 1uppJ, 0.5818, 3.26, 0.068, 123, 74, SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE AND CALCIUM.
608, 1rxoS, 0.5817, 3.21, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15- BISPHOSPHATE AND CALCIUM
609, 1rxoI, 0.5817, 3.21, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15- BISPHOSPHATE AND CALCIUM
610, 1rxoF, 0.5817, 3.21, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15- BISPHOSPHATE AND CALCIUM
611, 1rxoC, 0.5817, 3.21, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-15- BISPHOSPHATE AND CALCIUM
612, 6a97A, 0.5815, 3.06, 0.106, 267, 66, CRYSTAL STRUCTURE OF MHC-LIKE MILL2 
613, 1aa1S, 0.5815, 3.20, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH THE PRODUCT 3- PHOSPHOGLYCERATE
614, 1aa1I, 0.5815, 3.20, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH THE PRODUCT 3- PHOSPHOGLYCERATE
615, 1aa1F, 0.5815, 3.20, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH THE PRODUCT 3- PHOSPHOGLYCERATE
616, 1aa1C, 0.5815, 3.20, 0.067, 123, 75, ACTIVATED SPINACH RUBISCO IN COMPLEX WITH THE PRODUCT 3- PHOSPHOGLYCERATE
617, 5wskG, 0.5813, 3.27, 0.067, 122, 75, STRUCTURE OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE FROM WHEAT
618, 5m6wL, 0.5813, 3.22, 0.113, 505, 71, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
619, 3gxbB, 0.5813, 3.41, 0.087, 177, 69, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
620, 5wskH, 0.5812, 3.26, 0.067, 120, 75, STRUCTURE OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE FROM WHEAT
621, 4bfgA, 0.5812, 3.12, 0.088, 190, 68, STRUCTURE OF THE EXTRACELLULAR PORTION OF MOUSE CD200R
622, 1rs0A, 0.5812, 3.06, 0.114, 480, 70, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP)
623, 4yb8D, 0.5810, 2.72, 0.185, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH PHOSPHATE AND ADP
624, 3blxK, 0.5810, 3.26, 0.080, 338, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
625, 3axmX, 0.5809, 3.23, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
626, 3wrdB, 0.5808, 3.23, 0.039, 324, 76, CRYSTAL STRUCTURE OF THE KIF5C MOTOR DOMAIN WITHOUT ANY NUCLEOTIDE
627, 3blxM, 0.5808, 3.26, 0.080, 337, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
628, 3blxO, 0.5807, 3.26, 0.080, 332, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
629, 3blxC, 0.5807, 3.27, 0.080, 338, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
630, 3axmU, 0.5807, 3.23, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
631, 5vfrb, 0.5806, 3.28, 0.043, 191, 70, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
632, 3blxI, 0.5806, 3.27, 0.080, 333, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
633, 6ahvA, 0.5805, 3.30, 0.137, 345, 73, CRYSTAL STRUCTURE OF HUMAN RPP40 
634, 4y8vD, 0.5805, 2.72, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH ADP AND ADDITIONAL ADP BOUND TO PHOSPHATE BINDING SITE
635, 3blxG, 0.5805, 3.27, 0.080, 334, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
636, 4yb8B, 0.5804, 2.73, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH PHOSPHATE AND ADP
637, 1rtkA, 0.5803, 3.06, 0.114, 486, 70, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
638, 6fvvCA, 0.5802, 3.01, 0.072, 197, 69, struct.pdbx_descriptor              
639, 3axmV, 0.5802, 3.24, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
640, 3nrqA, 0.5801, 3.34, 0.074, 150, 68, CRYSTAL STRUCTURE OF COPPER-RECONSTITUTED FETP FROM UROPATHOGENIC ESCHERICHIA COLI STRAIN F11
641, 4xymB, 0.5799, 2.73, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH COENZYME A CA-AMPCP AND HGCL+
642, 1dziA, 0.5798, 3.17, 0.118, 185, 68, INTEGRIN ALPHA2 I DOMAIN / COLLAGEN COMPLEX
643, 6o9m6, 0.5797, 3.46, 0.111, 385, 72, STRUCTURE OF THE HUMAN APO TFIIH 
644, 3axkS, 0.5797, 3.25, 0.093, 120, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH NADP(H)
645, 4yajB, 0.5796, 2.90, 0.152, 229, 66, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 (APO FORM)
646, 4glwB, 0.5796, 2.82, 0.099, 281, 71, DNA LIGASE A IN COMPLEX WITH INHIBITOR
647, 3zxwD, 0.5796, 3.32, 0.040, 93, 75, STRUCTURE OF ACTIVATED RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS COMPLEXED WITH 2-CARBOXYARABINITOL-15-DIPHOSPHATE
648, 3ifwA, 0.5796, 2.69, 0.141, 223, 64, CRYSTAL STRUCTURE OF THE S18Y VARIANT OF UBIQUITIN CARBOXY TERMINAL HYDROLASE L1 BOUND TO UBIQUITIN VINYLMETHYLESTER.
649, 3blxA, 0.5796, 3.27, 0.080, 335, 75, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
650, 1a21B, 0.5796, 3.00, 0.074, 197, 68, TISSUE FACTOR (TF) FROM RABBIT
651, 4y8vB, 0.5794, 2.77, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH ADP AND ADDITIONAL ADP BOUND TO PHOSPHATE BINDING SITE
652, 3zxwF, 0.5794, 3.32, 0.040, 93, 75, STRUCTURE OF ACTIVATED RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS COMPLEXED WITH 2-CARBOXYARABINITOL-15-DIPHOSPHATE
653, 4yakB, 0.5793, 2.90, 0.167, 229, 66, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH COENZYME A ACETYL-COENZYME A AND WITH PHOSPHORYLATED PHOSPHOHISTIDINE SEGMENT (SITE I ORIENTATION)
654, 3zxwB, 0.5793, 3.32, 0.040, 93, 75, STRUCTURE OF ACTIVATED RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS COMPLEXED WITH 2-CARBOXYARABINITOL-15-DIPHOSPHATE
655, 3zxwH, 0.5791, 3.32, 0.040, 93, 75, STRUCTURE OF ACTIVATED RUBISCO FROM THERMOSYNECHOCOCCUS ELONGATUS COMPLEXED WITH 2-CARBOXYARABINITOL-15-DIPHOSPHATE
656, 5i0yB, 0.5790, 3.35, 0.103, 158, 68, COPPER-BOUND E46Q VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
657, 5gjvF, 0.5790, 3.14, 0.116, 941, 69, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT NEAR ATOMIC RESOLUTION
658, 3axmZ, 0.5789, 3.25, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
659, 6etzA, 0.5788, 3.12, 0.058, 989, 69, COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB
660, 2lenA, 0.5787, 3.14, 0.106, 231, 66, SOLUTION STRUCTURE OF UCHL1 S18Y VARIANT
661, 5hbrD, 0.5785, 2.89, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH PHOSPHATE AND COENZYME A
662, 3axmY, 0.5783, 3.26, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
663, 6em4K, 0.5782, 3.02, 0.056, 246, 72, STATE B ARCHITECTURAL MODEL (NSA1-TAP FLAG-YTM1) - VISUALIZING THE ASSEMBLY PATHWAY OF NUCLEOLAR PRE-60S RIBOSOMES
664, 6em3K, 0.5782, 3.02, 0.056, 246, 72, STATE A ARCHITECTURAL MODEL (NSA1-TAP FLAG-YTM1) - VISUALIZING THE ASSEMBLY PATHWAY OF NUCLEOLAR PRE-60S RIBOSOMES
665, 4ihkA, 0.5782, 3.37, 0.087, 193, 69, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN R1061Q
666, 1rrkA, 0.5782, 3.07, 0.114, 480, 70, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B
667, 5wskE, 0.5781, 3.31, 0.067, 122, 75, STRUCTURE OF RIBULOSE-15-BISPHOSPHATE CARBOXYLASE/OXYGENASE FROM WHEAT
668, 4v9mFC, 0.5781, 3.37, 0.137, 228, 73, 
669, 4okrA, 0.5780, 3.31, 0.043, 235, 69, STRUCTURES OF TOXOPLASMA GONDII MIC2
670, 2oxhZ, 0.5780, 3.09, 0.076, 107, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
671, 2oxgE, 0.5780, 3.04, 0.076, 99, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
672, 5gjqW, 0.5779, 3.07, 0.029, 193, 70, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
673, 3axmS, 0.5779, 3.27, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
674, 3axmT, 0.5778, 3.27, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
675, 3axkT, 0.5775, 3.29, 0.093, 119, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH NADP(H)
676, 4okrB, 0.5773, 3.30, 0.043, 236, 69, STRUCTURES OF TOXOPLASMA GONDII MIC2
677, 4igiA, 0.5773, 3.36, 0.087, 197, 69, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN
678, 2oxgC, 0.5773, 3.06, 0.076, 101, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
679, 3axmW, 0.5769, 3.28, 0.093, 122, 75, STRUCTURE OF RICE RUBISCO IN COMPLEX WITH 6PG
680, 4ybzB, 0.5768, 2.72, 0.169, 229, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH ADP AND WITH PHOSPHORYLATED PHOSPHOHISTIDINE SEGMENT (SITE I ORIENTATION)
681, 3nrpD, 0.5760, 3.39, 0.103, 151, 68, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
682, 3jbrF, 0.5760, 3.18, 0.116, 872, 69, CRYO-EM STRUCTURE OF THE RABBIT VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT 4.2 ANGSTROM
683, 2oxhC, 0.5759, 3.08, 0.076, 107, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
684, 2oxgZ, 0.5759, 3.06, 0.076, 108, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
685, 6a97C, 0.5757, 3.14, 0.106, 225, 66, CRYSTAL STRUCTURE OF MHC-LIKE MILL2 
686, 4v9jHC, 0.5757, 3.37, 0.149, 228, 74, 
687, 2oxhE, 0.5757, 3.12, 0.076, 107, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
688, 2oxhA, 0.5757, 3.07, 0.076, 107, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
689, 3nrqB, 0.5756, 3.37, 0.103, 149, 68, CRYSTAL STRUCTURE OF COPPER-RECONSTITUTED FETP FROM UROPATHOGENIC ESCHERICHIA COLI STRAIN F11
690, 4zltB, 0.5754, 2.83, 0.104, 379, 67, CRYSTAL STRUCTURE OF VIRAL CHEMOKINE BINDING PROTEIN R17 IN COMPLEX WITH CCL3
691, 4v9lHC, 0.5754, 3.44, 0.149, 228, 74, 
692, 2o5nB, 0.5754, 2.75, 0.111, 267, 63, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
693, 4u7uH, 0.5753, 2.47, 0.100, 363, 60, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
694, 4v9jY, 0.5751, 3.27, 0.137, 228, 73, 
695, 4qyzH, 0.5751, 2.48, 0.100, 359, 60, CRYSTAL STRUCTURE OF A CRISPR RNA-GUIDED SURVEILLANCE COMPLEX CASCADE BOUND TO A SSDNA TARGET
696, 3n2nB, 0.5751, 3.48, 0.097, 185, 72, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
697, 2we6B, 0.5751, 2.82, 0.092, 207, 65, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 3 (UCHL3)
698, 2we6A, 0.5751, 2.84, 0.123, 208, 65, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 3 (UCHL3)
699, 5gjrP, 0.5750, 3.08, 0.029, 193, 70, 
700, 5gjrJB, 0.5750, 3.08, 0.029, 193, 70, 
701, 4u7uT, 0.5749, 2.47, 0.100, 360, 60, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
702, 1idoA, 0.5748, 3.08, 0.106, 184, 66, I-DOMAIN FROM INTEGRIN CR3 MG2+ BOUND
703, 5ln3W, 0.5746, 3.13, 0.029, 185, 68, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
704, 6ahrL, 0.5745, 3.38, 0.110, 362, 73, CRYO-EM STRUCTURE OF HUMAN RIBONUCLEASE P 
705, 3n2nD, 0.5744, 3.45, 0.097, 185, 72, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
706, 1m1uA, 0.5744, 3.07, 0.106, 184, 66, AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN
707, 6adrR, 0.5743, 3.45, 0.097, 185, 72, ANTHRAX TOXIN RECEPTOR 1-BOUND THE SENECA VALLEY VIRUS IN NEUTRAL CONDITIONS 
708, 2xwbF, 0.5742, 2.85, 0.147, 714, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
709, 4fx5A, 0.5740, 3.21, 0.058, 415, 69, VON WILLEBRAND FACTOR TYPE A FROM CATENULISPORA ACIDIPHILA
710, 4u7uR, 0.5739, 2.47, 0.100, 359, 60, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
711, 4bv1A, 0.5739, 3.27, 0.059, 109, 68, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
712, 3n2nC, 0.5738, 3.45, 0.099, 185, 71, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
713, 2oxgA, 0.5737, 3.11, 0.076, 108, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
714, 6gq8A, 0.5736, 3.26, 0.059, 109, 68, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
715, 6gq8C, 0.5735, 3.27, 0.059, 109, 68, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
716, 3n2nA, 0.5735, 3.48, 0.097, 185, 72, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
717, 6bw6C, 0.5734, 3.60, 0.054, 365, 74, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
718, 4okuB, 0.5734, 3.35, 0.043, 241, 69, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
719, 4bv1C, 0.5734, 3.27, 0.059, 109, 68, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
720, 1hyoA, 0.5731, 3.50, 0.159, 416, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID
721, 6oyzD, 0.5729, 3.50, 0.028, 304, 71, CRYSTAL STRUCTURE OF MRAY BOUND TO CAPURAMYCIN 
722, 4u7uF, 0.5729, 2.49, 0.100, 359, 60, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
723, 4bv1D, 0.5729, 3.26, 0.059, 109, 68, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
724, 1sq0A, 0.5728, 3.25, 0.145, 198, 69, CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION
725, 4u7uS, 0.5727, 2.47, 0.100, 361, 60, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
726, 6olgXA, 0.5725, 3.03, 0.120, 217, 75, Human ribosome nascent chain complex stalled by a drug-like small molecule (CDH1_RNC with PP tRNA)  
727, 6gq8D, 0.5725, 3.25, 0.059, 109, 68, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
728, 6gq8B, 0.5725, 3.26, 0.059, 109, 68, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
729, 4bv1B, 0.5725, 3.26, 0.059, 109, 68, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
730, 3lzlA, 0.5725, 3.41, 0.059, 157, 68, CRYSTAL STRUCTURE ANALYSIS OF THE AS-SOLATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.45 A AT PH 9.0
731, 6gz4EC, 0.5724, 3.21, 0.092, 217, 76, tRNA translocation by the eukaryotic 80S ribosome and the impact of GTP hydrolysis; Translocation-intermediate-POST-2 (TI-POST-2)  
732, 4qyzG, 0.5723, 2.47, 0.100, 360, 60, CRYSTAL STRUCTURE OF A CRISPR RNA-GUIDED SURVEILLANCE COMPLEX CASCADE BOUND TO A SSDNA TARGET
733, 2ox5E, 0.5723, 3.02, 0.077, 100, 65, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
734, 4zltA, 0.5722, 2.87, 0.119, 376, 67, CRYSTAL STRUCTURE OF VIRAL CHEMOKINE BINDING PROTEIN R17 IN COMPLEX WITH CCL3
735, 4v9mX, 0.5722, 3.17, 0.153, 228, 72, 
736, 4bfiA, 0.5722, 3.11, 0.090, 191, 67, STRUCTURE OF THE COMPLEX OF THE EXTRACELLULAR PORTIONS OF MOUSE CD200R AND MOUSE CD200
737, 3lzlB, 0.5721, 3.18, 0.061, 158, 66, CRYSTAL STRUCTURE ANALYSIS OF THE AS-SOLATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.45 A AT PH 9.0
738, 3hrzB, 0.5721, 3.43, 0.119, 233, 67, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
739, 6fvtCA, 0.5720, 3.25, 0.071, 197, 70, struct.pdbx_descriptor              
740, 3zqkC, 0.5720, 3.18, 0.103, 178, 68, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
741, 2ktlA, 0.5720, 3.13, 0.058, 164, 69, STRUCTURE OF C-TERMINAL DOMAIN FROM MTTYRRS OF A. NIDULANS
742, 4qyzF, 0.5718, 2.48, 0.100, 362, 60, CRYSTAL STRUCTURE OF A CRISPR RNA-GUIDED SURVEILLANCE COMPLEX CASCADE BOUND TO A SSDNA TARGET
743, 3zqkA, 0.5718, 3.38, 0.101, 181, 69, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
744, 3lzqB, 0.5715, 3.18, 0.061, 159, 66, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.41 A AT PH 9
745, 4u7uQ, 0.5714, 2.23, 0.102, 362, 59, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
746, 4brvA, 0.5714, 2.87, 0.062, 124, 65, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
747, 4w29Y, 0.5713, 3.41, 0.125, 228, 72, 
748, 4brvB, 0.5713, 2.87, 0.062, 124, 65, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
749, 4m7lT, 0.5712, 2.91, 0.090, 194, 67, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
750, 3lzrA, 0.5712, 3.40, 0.059, 158, 68, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.73 A AT PH 9 AND MANGANESE PEAK WAVELENGTH (1.893 A)
751, 6epfW, 0.5711, 3.24, 0.029, 195, 70, GROUND STATE 26S PROTEASOME (GS1)
752, 3n2nE, 0.5711, 3.49, 0.097, 185, 72, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
753, 2hzyA, 0.5710, 3.51, 0.159, 416, 69, MOUSE FUMARYLACETOACETATE HYDROLASE COMPLEXES WITH A TRANSITION-STATE MIMIC OF THE COMPLETE SUBSTRATE
754, 1wr2A, 0.5710, 2.83, 0.200, 235, 65, CRYSTAL STRUCTURE OF PH1788 FROM PYROCOCCUS HORIKOSHII OT3
755, 1qcoA, 0.5710, 3.55, 0.159, 416, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE
756, 4nwnX, 0.5709, 3.43, 0.044, 157, 68, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
757, 4brvD, 0.5709, 2.88, 0.062, 124, 65, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
758, 1qcoB, 0.5709, 3.15, 0.136, 418, 66, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE
759, 6admR, 0.5708, 3.47, 0.097, 185, 72, ANTHRAX TOXIN RECEPTOR 1-BOUND FULL PARTICLES OF SENECA VALLEY VIRUS IN ACIDIC CONDITIONS 
760, 5i0wB, 0.5708, 3.39, 0.059, 157, 68, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER REDUCING CONDITIONS
761, 4eq5A, 0.5707, 3.08, 0.091, 516, 66, DNA LIGASE FROM THE ARCHAEON THERMOCOCCUS SIBIRICUS
762, 4brvC, 0.5707, 2.87, 0.062, 124, 65, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
763, 2lyiA, 0.5707, 3.74, 0.135, 167, 74, REPETITIVE DOMAIN (RP) OF ACINIFORM SPIDROIN 1 FROM NEPHILA ANTIPODIANA
764, 4llwB, 0.5706, 3.33, 0.075, 207, 67, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE DOMAIN REDESIGN (VRD2) AT 1.95A
765, 3qoyA, 0.5706, 3.29, 0.149, 242, 74, CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L1 FROM AQUIFEX AEOLICUS
766, 3gn6C, 0.5706, 2.96, 0.014, 295, 70, CRYSTAL STRUCTURE OF CT0912 ORFAN PROTEIN FROM CHLOROBIUM TEPIDUM WITH A FERREDOXIN-LIKE DOMAIN REPEAT (NP_661805.1) FROM CHLOROBIUM TEPIDUM TLS AT 1.80 A RESOLUTION
767, 4nwnH, 0.5705, 3.44, 0.044, 157, 68, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
768, 5cw9A, 0.5704, 3.67, 0.056, 146, 72, CRYSTAL STRUCTURE OF DE NOVO DESIGNED FERREDOXIN-FERREDOXIN DOMAIN INSERTION PROTEIN
769, 3pihA, 0.5703, 2.82, 0.162, 836, 68, T. MARITIMA UVRA IN COMPLEX WITH FLUORESCEIN-MODIFIED DNA
770, 3lzoA, 0.5703, 3.18, 0.061, 159, 66, CRYSTAL STRUCTURE ANALYSIS OF THE COPPER-RECONSTITUTED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 10.0
771, 4qgbA, 0.5702, 3.16, 0.082, 216, 73, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN G219V TTHL1
772, 3nrpA, 0.5702, 3.22, 0.104, 152, 67, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
773, 5jnqA, 0.5701, 3.58, 0.054, 307, 74, MRAY TUNICAMYCIN COMPLEX
774, 5gjwF, 0.5701, 3.10, 0.118, 941, 68, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX FOR CLASSII MAP
775, 4zkqA, 0.5701, 2.93, 0.103, 388, 68, VIRAL CHEMOKINE BINDING PROTEIN R17 ENCODED BY RODENT GAMMAHERPESVIRUS PERU ( RHVP)
776, 3nmsB, 0.5701, 3.48, 0.132, 184, 68, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT C3C
777, 3jctK, 0.5701, 3.26, 0.135, 256, 74, 
778, 6mskH, 0.5700, 2.95, 0.015, 191, 68, struct.pdbx_descriptor               26S proteasome  
779, 4nwnR, 0.5700, 3.42, 0.044, 157, 68, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
780, 3n2nF, 0.5700, 3.49, 0.097, 185, 72, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
781, 6ahuL, 0.5699, 3.44, 0.111, 362, 72, CRYO-EM STRUCTURE OF HUMAN RIBONUCLEASE P WITH MATURE TRNA 
782, 3hs0G, 0.5699, 3.39, 0.104, 233, 67, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
783, 2ox5Z, 0.5698, 3.11, 0.076, 107, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
784, 2hzyB, 0.5698, 3.29, 0.134, 418, 67, MOUSE FUMARYLACETOACETATE HYDROLASE COMPLEXES WITH A TRANSITION-STATE MIMIC OF THE COMPLETE SUBSTRATE
785, 6fvyCA, 0.5697, 3.42, 0.056, 197, 72, struct.pdbx_descriptor              
786, 4okuA, 0.5696, 3.30, 0.058, 240, 69, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
787, 2or7A, 0.5696, 3.32, 0.088, 107, 68, TIM-2
788, 5z3gH, 0.5694, 3.30, 0.081, 256, 74, CRYO-EM STRUCTURE OF A NUCLEOLAR PRE-60S RIBOSOME (RPF1-TAP) 
789, 4brjA, 0.5694, 2.89, 0.062, 124, 65, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS T24K
790, 2wdtC, 0.5693, 2.84, 0.092, 206, 65, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM UCHL3 IN COMPLEX WITH THE SUICIDE INHIBITOR UBVME
791, 5tt5A, 0.5692, 2.79, 0.087, 581, 69, ESCHERICHIA COLI LIGA (K115M) IN COMPLEX WITH NAD+
792, 4q9bA, 0.5692, 3.51, 0.134, 101, 67, IGNAR ANTIBODY DOMAIN C2
793, 5ln1A, 0.5690, 3.04, 0.072, 188, 69, STRUCTURE OF UBIQUITYLATED-RPN10 FROM YEAST;
794, 5hgjA, 0.5690, 3.38, 0.130, 194, 69, STRUCTURE OF INTEGRIN ALPHA1BETA1 AND ALPHA2BETA1 I-DOMAINS EXPLAIN DIFFERENTIAL CALCIUM-MEDIATED LIGAND RECOGNITION
795, 1qqjA, 0.5690, 3.52, 0.159, 416, 69, CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION
796, 4bfeB, 0.5689, 3.42, 0.100, 188, 70, STRUCTURE OF THE EXTRACELLULAR PORTION OF MOUSE CD200RLA
797, 3vpcA, 0.5689, 2.56, 0.133, 282, 60, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH ADP
798, 2wdtA, 0.5689, 2.65, 0.094, 204, 64, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM UCHL3 IN COMPLEX WITH THE SUICIDE INHIBITOR UBVME
799, 1mhpB, 0.5689, 3.37, 0.116, 192, 69, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
800, 1mhpA, 0.5689, 3.36, 0.116, 184, 69, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
801, 5d1oA, 0.5688, 3.00, 0.174, 375, 69, ARCHAEAL ATP-DEPENDENT RNA LIGASE - FORM 1
802, 5obzA, 0.5687, 3.29, 0.071, 200, 70, LOW RESOLUTION STRUCTURE OF THE P34CT/P44CT MINIMAL COMPLEX
803, 3vpcC, 0.5687, 2.53, 0.133, 275, 60, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH ADP
804, 5g50B, 0.5686, 3.15, 0.091, 228, 66, VIBRIO CHOLERAE SCAFFOLDING PROTEIN RBMA IN COMPLEX WITH MAGNESIUM.
805, 2flbT, 0.5685, 2.91, 0.090, 151, 67, DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
806, 1pt6B, 0.5685, 3.31, 0.130, 195, 69, I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1
807, 1fg9D, 0.5684, 2.87, 0.108, 205, 65, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
808, 2cumA, 0.5683, 2.93, 0.106, 105, 66, THE SOLUTION STRUCTURE OF THE 33RD FIBRONECTIN TYPE III DOMAIN OF HUMAN TENASCIN-X
809, 1v8hB, 0.5683, 3.06, 0.106, 106, 66, CRYSTAL STRUCTURE OF TT0351 PROTEIN FROM THERMUS THERMOPHILUS HB8
810, 2oumA, 0.5682, 3.34, 0.108, 129, 74, THE FIRST DOMAIN OF L1 FROM THERMUS THERMOPHILUS
811, 3w9eC, 0.5681, 3.49, 0.070, 229, 71, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
812, 3q3gI, 0.5681, 3.20, 0.104, 189, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
813, 3ohxE, 0.5681, 3.64, 0.145, 184, 69, MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
814, 3ohxB, 0.5681, 3.64, 0.145, 184, 69, MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
815, 3l3oB, 0.5681, 3.64, 0.145, 184, 69, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
816, 5vfqV, 0.5680, 3.11, 0.043, 191, 69, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
817, 5h9eE, 0.5680, 2.19, 0.103, 354, 58, CRYSTAL STRUCTURE OF E. COLI CASCADE BOUND TO A PAM-CONTAINING DSDNA TARGET (32-NT SPACER) AT 3.20 ANGSTROM RESOLUTION.
818, 3ujzA, 0.5680, 3.11, 0.090, 592, 67, CRYSTAL STRUCTURE OF ENTEROHEMORRHAGIC E. COLI STCE
819, 3j8xK, 0.5680, 3.23, 0.055, 316, 73, HIGH-RESOLUTION STRUCTURE OF NO-NUCLEOTIDE KINESIN ON MICROTUBULES
820, 3hs0B, 0.5680, 3.48, 0.118, 233, 68, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
821, 3frpG, 0.5680, 3.35, 0.136, 215, 66, CRYSTAL STRUCTURE OF COBRA VENOM FACTOR A CO-FACTOR FOR C3- AND C5 CONVERTASE CVFBB
822, 1pt6A, 0.5680, 3.32, 0.130, 192, 69, I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1
823, 5l4kW, 0.5679, 3.08, 0.029, 196, 69, THE HUMAN 26S PROTEASOME LID
824, 3lzpB, 0.5679, 3.44, 0.043, 158, 69, CRYSTAL STRUCTURE ANALYSIS OF THE  AS-ISOLATED  P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 9.0
825, 1qc5A, 0.5679, 3.38, 0.130, 192, 69, I DOMAIN FROM INTEGRIN ALPHA1-BETA1
826, 3q3gE, 0.5678, 3.20, 0.104, 189, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
827, 2o5nA, 0.5678, 2.53, 0.097, 264, 62, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
828, 4bk8A, 0.5677, 2.89, 0.062, 123, 65, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS
829, 1wqvT, 0.5677, 2.91, 0.090, 191, 67, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D- THR-MET-P-AMINOBENZAMIDINE
830, 2ox5C, 0.5676, 3.13, 0.076, 102, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
831, 2a74E, 0.5675, 3.63, 0.145, 184, 69, HUMAN COMPLEMENT COMPONENT C3C
832, 1qhbD, 0.5675, 2.81, 0.109, 595, 64, VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS
833, 1a21A, 0.5675, 3.07, 0.074, 194, 68, TISSUE FACTOR (TF) FROM RABBIT
834, 5t0jb, 0.5674, 3.01, 0.045, 191, 67, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
835, 2ox5A, 0.5674, 3.12, 0.076, 107, 66, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
836, 4dohR, 0.5673, 2.84, 0.141, 204, 64, IL20/IL201/IL20R2 TERNARY COMPLEX
837, 6cb1K, 0.5672, 3.18, 0.160, 260, 75, YEAST NUCLEOLAR PRE-60S RIBOSOMAL SUBUNIT (STATE 3)
838, 6c0fK, 0.5672, 3.18, 0.160, 260, 75, YEAST NUCLEOLAR PRE-60S RIBOSOMAL SUBUNIT (STATE 2)
839, 4bfeC, 0.5672, 3.43, 0.100, 187, 70, STRUCTURE OF THE EXTRACELLULAR PORTION OF MOUSE CD200RLA
840, 1fyhB, 0.5671, 2.98, 0.123, 201, 65, 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR
841, 1dqtD, 0.5671, 2.91, 0.075, 117, 67, THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152)
842, 5h9eF, 0.5670, 2.20, 0.103, 361, 58, CRYSTAL STRUCTURE OF E. COLI CASCADE BOUND TO A PAM-CONTAINING DSDNA TARGET (32-NT SPACER) AT 3.20 ANGSTROM RESOLUTION.
843, 3d33B, 0.5668, 2.99, 0.045, 91, 66, CRYSTAL STRUCTURE OF A DUF3244 FAMILY PROTEIN WITH AN IMMUNOGLOBULIN- LIKE BETA-SANDWICH FOLD (BVU_0276) FROM BACTEROIDES VULGATUS ATCC 8482 AT 1.70 A RESOLUTION
844, 1na5A, 0.5668, 3.09, 0.106, 195, 66, INTEGRIN ALPHA M I DOMAIN
845, 1fyhE, 0.5668, 2.97, 0.108, 201, 65, 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR
846, 1dqtA, 0.5668, 3.38, 0.086, 117, 70, THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152)
847, 3q3gG, 0.5667, 3.26, 0.104, 189, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
848, 3l3oE, 0.5667, 3.48, 0.132, 184, 68, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
849, 3bx7C, 0.5667, 3.04, 0.119, 120, 67, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HUMAN CTLA-4
850, 2a74B, 0.5667, 3.52, 0.162, 183, 68, HUMAN COMPLEMENT COMPONENT C3C
851, 4bfeA, 0.5666, 3.42, 0.100, 188, 70, STRUCTURE OF THE EXTRACELLULAR PORTION OF MOUSE CD200RLA
852, 1n9zA, 0.5666, 3.16, 0.106, 184, 66, INTEGRIN ALPHA M I DOMAIN MUTANT
853, 1atzA, 0.5666, 3.21, 0.104, 184, 67, HUMAN VON WILLEBRAND FACTOR A3 DOMAIN
854, 4ylqT, 0.5665, 3.04, 0.074, 210, 68, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (FT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
855, 2or7B, 0.5665, 3.38, 0.088, 115, 68, TIM-2
856, 1hyoB, 0.5665, 3.55, 0.159, 419, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID
857, 1bhq2, 0.5665, 3.21, 0.106, 189, 66, MAC-1 I DOMAIN CADMIUM COMPLEX
858, 6gz5EC, 0.5664, 3.15, 0.107, 217, 75, tRNA translocation by the eukaryotic 80S ribosome and the impact of GTP hydrolysis; Translocation-intermediate-POST-3 (TI-POST-3)  
859, 3elaT, 0.5664, 2.92, 0.090, 191, 67, CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR
860, 4v7hY, 0.5663, 3.09, 0.147, 213, 75, 
861, 1up8D, 0.5663, 2.86, 0.109, 597, 64, RECOMBINANT VANADIUM-DEPENDENT BROMOPEROXIDASE FROM RED ALGAE CORALLINA PILULIFERA
862, 1qhbF, 0.5663, 2.61, 0.111, 595, 63, VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS
863, 4v5mKA, 0.5662, 3.23, 0.096, 228, 73, 
864, 2zp0T, 0.5662, 2.92, 0.090, 191, 67, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH BENZYLSULFONAMIDE-D- ILE-GLN-P-AMINOBENZAMIDINE
865, 3th2T, 0.5661, 2.92, 0.090, 198, 67, MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
866, 1ao3B, 0.5661, 3.05, 0.106, 187, 66, A3 DOMAIN OF VON WILLEBRAND FACTOR
867, 5yvtA, 0.5659, 3.38, 0.043, 332, 69, CRYSTAL STRUCTURE OF THE ALPHA GAMMA HETERODIMER OF HUMAN IDH3 IN COMPLEX WITH MG(2+) AND NADH
868, 5i0vB, 0.5659, 3.46, 0.043, 157, 69, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER OXIDIZING CONDITIONS
869, 5d1pB, 0.5659, 3.09, 0.159, 374, 69, ARCHAEAL ATP-DEPENDENT RNA LIGASE - FORM 2
870, 1fakT, 0.5659, 3.04, 0.074, 183, 68, HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
871, 4a0qA, 0.5658, 3.30, 0.132, 187, 68, ACTIVATED CONFORMATION OF INTEGRIN ALPHA1 I-DOMAIN MUTANT
872, 6epeW, 0.5657, 3.33, 0.042, 195, 71, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
873, 2or8B, 0.5657, 3.08, 0.106, 116, 66, TIM-1
874, 1tfhA, 0.5657, 2.90, 0.090, 202, 67, EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
875, 4v5nKA, 0.5656, 3.43, 0.095, 228, 74, 
876, 2zzuT, 0.5655, 3.05, 0.074, 191, 68, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5- (3-CARBOXYBENZYLOXY)-TRP-GLN-P-AMINOBENZAMIDINE
877, 1ck4B, 0.5655, 3.38, 0.130, 194, 69, CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN.
878, 5w06T, 0.5654, 2.94, 0.090, 198, 67, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
879, 3nrpB, 0.5654, 3.46, 0.072, 151, 69, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
880, 1qhbC, 0.5654, 2.59, 0.111, 595, 63, VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS
881, 5vgzb, 0.5653, 3.09, 0.045, 191, 67, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
882, 3zqkB, 0.5653, 3.18, 0.103, 178, 68, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
883, 1qqjB, 0.5653, 3.55, 0.159, 416, 69, CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION
884, 6ehgB, 0.5652, 3.52, 0.149, 903, 67, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
885, 2puqT, 0.5652, 3.06, 0.074, 190, 68, CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR
886, 1qhbE, 0.5652, 2.59, 0.111, 595, 63, VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS
887, 1qc5B, 0.5652, 3.39, 0.130, 190, 69, I DOMAIN FROM INTEGRIN ALPHA1-BETA1
888, 1o5dT, 0.5652, 2.92, 0.090, 151, 67, DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
889, 5wvkRA, 0.5650, 3.22, 0.043, 197, 69, 
890, 1up8C, 0.5650, 2.65, 0.111, 597, 63, RECOMBINANT VANADIUM-DEPENDENT BROMOPEROXIDASE FROM RED ALGAE CORALLINA PILULIFERA
891, 1ttfA, 0.5650, 2.59, 0.127, 94, 63, THE THREE-DIMENSIONAL STRUCTURE OF THE TENTH TYPE III MODULE OF FIBRONECTIN: AN INSIGHT INTO RGD-MEDIATED INTERACTIONS
892, 1qhbB, 0.5650, 2.59, 0.111, 595, 63, VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS
893, 1bho2, 0.5650, 3.27, 0.104, 189, 67, MAC-1 I DOMAIN MAGNESIUM COMPLEX
894, 4mz3A, 0.5649, 3.03, 0.058, 119, 69, CRYSTAL STRUCTURE OF THE VOLTAGE-GATED SODIUM CHANNEL BETA 4 SUBUNIT EXTRACELLULAR DOMAIN C131W MUTANT
895, 3vpbB, 0.5649, 2.49, 0.136, 282, 59, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH LYSW/GLU/ADP/MG/ZN/SULFATE
896, 2flrT, 0.5649, 2.93, 0.090, 151, 67, NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS
897, 1qhbA, 0.5649, 2.59, 0.111, 595, 63, VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS
898, 3vpbA, 0.5648, 2.50, 0.136, 281, 59, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH LYSW/GLU/ADP/MG/ZN/SULFATE
899, 2xskA, 0.5647, 3.16, 0.061, 94, 66, E. COLI CURLI PROTEIN CSGC - SECYS
900, 4a0qB, 0.5646, 3.30, 0.132, 192, 68, ACTIVATED CONFORMATION OF INTEGRIN ALPHA1 I-DOMAIN MUTANT
901, 3rr5A, 0.5646, 3.22, 0.136, 553, 66, DNA LIGASE FROM THE ARCHAEON THERMOCOCCUS SP. 1519
902, 2m32A, 0.5646, 3.20, 0.159, 192, 69, ALPHA-1 INTEGRIN I-DOMAIN IN COMPLEX WITH GLOGEN TRIPLE HELICAL PEPTIDE
903, 5hgjB, 0.5645, 3.40, 0.130, 193, 69, STRUCTURE OF INTEGRIN ALPHA1BETA1 AND ALPHA2BETA1 I-DOMAINS EXPLAIN DIFFERENTIAL CALCIUM-MEDIATED LIGAND RECOGNITION
904, 5d1oB, 0.5645, 2.95, 0.176, 374, 68, ARCHAEAL ATP-DEPENDENT RNA LIGASE - FORM 1
905, 4zflE, 0.5645, 3.23, 0.071, 229, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
906, 4m76B, 0.5645, 3.21, 0.106, 179, 66, INTEGRIN I DOMAIN OF COMPLEMENT RECEPTOR 3 IN COMPLEX WITH C3D
907, 4iblT, 0.5645, 2.92, 0.090, 198, 67, RUBIDIUM SITES IN BLOOD COAGULATION FACTOR VIIA
908, 2or8A, 0.5645, 3.19, 0.106, 116, 66, TIM-1
909, 1atzB, 0.5645, 3.17, 0.104, 189, 67, HUMAN VON WILLEBRAND FACTOR A3 DOMAIN
910, 2b8oT, 0.5643, 2.95, 0.090, 191, 67, CRYSTAL STRUCTURE OF GLU-GLY-ARG-CHLOROMETHYL KETONE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX
911, 6em5K, 0.5642, 3.37, 0.133, 257, 75, STATE D ARCHITECTURAL MODEL (NSA1-TAP FLAG-YTM1) - VISUALIZING THE ASSEMBLY PATHWAY OF NUCLEOLAR PRE-60S RIBOSOMES
912, 6em1LA, 0.5642, 3.37, 0.133, 257, 75, State C (Nsa1-TAP Flag-Ytm1) - Visualizing the assembly pathway of nucleolar pre-60S ribosomes  
913, 6elzFA, 0.5642, 3.37, 0.133, 257, 75, State E (TAP-Flag-Ytm1 E80A) - Visualizing the assembly pathway of nucleolar pre-60S ribosmes  
914, 1idn2, 0.5642, 3.30, 0.104, 189, 67, MAC-1 I DOMAIN METAL FREE
915, 4v8qM, 0.5641, 3.23, 0.096, 228, 73, 
916, 2rcjT, 0.5641, 3.46, 0.060, 523, 67, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
917, 2rcjP, 0.5641, 3.46, 0.060, 523, 67, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
918, 2rcjL, 0.5641, 3.46, 0.060, 523, 67, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
919, 2rcjH, 0.5641, 3.46, 0.060, 523, 67, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
920, 2rcjD, 0.5641, 3.46, 0.060, 523, 67, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
921, 1fc1B, 0.5641, 3.46, 0.060, 206, 67, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
922, 6epdW, 0.5640, 3.31, 0.029, 195, 69, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
923, 2zwlT, 0.5640, 3.04, 0.074, 191, 68, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH HIGHLY SELECTIVE PEPTIDE INHIBITOR
924, 2pkdB, 0.5640, 2.81, 0.076, 108, 66, CRYSTAL STRUCTURE OF CD84: INSITE INTO SLAM FAMILY FUNCTION
925, 2p9rA, 0.5640, 3.58, 0.086, 102, 70, HUMAN ALPHA2-MACROGLOGULIN IS COMPOSED OF MULTIPLE DOMAINS AS PREDICTED BY HOMOLOGY WITH COMPLEMENT COMPONENT C3
926, 1wssT, 0.5640, 3.05, 0.074, 191, 68, HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPTIDE-MIMETIC INHIBITOR THAT HAS TWO CHARGED GROUPS IN P2 AND P4
927, 4zflK, 0.5639, 3.24, 0.071, 228, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
928, 1uj3C, 0.5639, 3.00, 0.090, 205, 67, CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
929, 1ao3A, 0.5639, 3.21, 0.104, 187, 67, A3 DOMAIN OF VON WILLEBRAND FACTOR
930, 5ti1G, 0.5638, 3.31, 0.104, 429, 67, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
931, 5h9eH, 0.5638, 2.26, 0.103, 352, 58, CRYSTAL STRUCTURE OF E. COLI CASCADE BOUND TO A PAM-CONTAINING DSDNA TARGET (32-NT SPACER) AT 3.20 ANGSTROM RESOLUTION.
932, 5n7eA, 0.5637, 3.03, 0.076, 93, 66, CRYSTAL STRUCTURE OF THE DBL-HOMOLOGY DOMAIN OF BCR-ABL IN COMPLEX WITH MONOBODY MB(BCR-DH_4).
933, 3lznA, 0.5637, 3.43, 0.044, 158, 68, CRYSTAL STRUCTURE ANALYSIS OF THE APO P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.59 A AT PH 9
934, 2a2qT, 0.5637, 2.93, 0.090, 191, 67, COMPLEX OF ACTIVE-SITE INHIBITED HUMAN COAGULATION FACTOR VIIA WITH HUMAN SOLUBLE TISSUE FACTOR IN THE PRESENCE OF CA2+ MG2+ NA+ AND ZN2+
935, 1up8A, 0.5637, 2.65, 0.111, 597, 63, RECOMBINANT VANADIUM-DEPENDENT BROMOPEROXIDASE FROM RED ALGAE CORALLINA PILULIFERA
936, 5x5wC, 0.5636, 3.46, 0.099, 233, 71, CRYSTAL STRUCTURE OF PSEUDORABIES VIRUS GLYCOPROTEIN D
937, 5fobB, 0.5636, 3.69, 0.145, 902, 69, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH SMALLPOX INHIBITOR OF COMPLEMENT (SPICE)
938, 1v8hA, 0.5636, 3.19, 0.119, 106, 67, CRYSTAL STRUCTURE OF TT0351 PROTEIN FROM THERMUS THERMOPHILUS HB8
939, 1up8B, 0.5636, 2.66, 0.111, 597, 63, RECOMBINANT VANADIUM-DEPENDENT BROMOPEROXIDASE FROM RED ALGAE CORALLINA PILULIFERA
940, 1dwuB, 0.5636, 3.14, 0.173, 213, 75, RIBOSOMAL PROTEIN L1
941, 4ujeBC, 0.5635, 3.02, 0.139, 210, 72, 
942, 4ujdTA, 0.5635, 3.02, 0.139, 210, 72, 
943, 4d67QA, 0.5635, 3.02, 0.139, 210, 72, 
944, 4d5yQA, 0.5635, 3.02, 0.139, 210, 72, 
945, 1qcyA, 0.5635, 3.36, 0.130, 193, 69, THE CRYSTAL STRUCTURE OF THE I-DOMAIN OF HUMAN INTEGRIN ALPHA1BETA1
946, 4ujcWA, 0.5634, 3.02, 0.139, 210, 72, 
947, 3lzqA, 0.5634, 3.43, 0.044, 157, 68, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.41 A AT PH 9
948, 4zflC, 0.5633, 3.24, 0.071, 228, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
949, 4xw2A, 0.5633, 3.18, 0.103, 184, 68, STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF COMPLEMENT RECEPTOR 3
950, 3t4aE, 0.5633, 3.52, 0.132, 183, 68, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
951, 5vftb, 0.5632, 3.10, 0.043, 191, 69, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
952, 5t0hb, 0.5632, 3.10, 0.043, 191, 69, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
953, 4wi6B, 0.5632, 3.56, 0.090, 208, 67, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A
954, 3vpbD, 0.5632, 2.70, 0.133, 281, 60, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH LYSW/GLU/ADP/MG/ZN/SULFATE
955, 3th3T, 0.5632, 3.04, 0.074, 154, 68, MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
956, 2adfA, 0.5632, 3.13, 0.104, 189, 67, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
957, 1mcoH, 0.5632, 3.42, 0.061, 428, 66, THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
958, 5tzuC, 0.5631, 3.28, 0.075, 115, 67, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2
959, 5thpI, 0.5631, 3.48, 0.116, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
960, 4zflD, 0.5631, 3.25, 0.071, 227, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
961, 3vpbC, 0.5631, 2.70, 0.133, 281, 60, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH LYSW/GLU/ADP/MG/ZN/SULFATE
962, 5uypZA, 0.5630, 3.14, 0.111, 134, 72, 
963, 5griA, 0.5630, 3.13, 0.015, 323, 68, CRYSTAL STRUCTURE OF THE ALPHA GAMMA HETERODIMER OF HUMAN IDH3 IN COMPLEX WITH MG(2+) AND CITRATE
964, 4zflJ, 0.5630, 3.24, 0.071, 229, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
965, 1wunT, 0.5630, 3.05, 0.074, 191, 68, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE
966, 5mpbIA, 0.5629, 3.23, 0.057, 197, 70, 
967, 2pkdE, 0.5628, 2.83, 0.075, 109, 67, CRYSTAL STRUCTURE OF CD84: INSITE INTO SLAM FAMILY FUNCTION
968, 4myvB, 0.5627, 3.09, 0.056, 176, 71, FREE HSV-2 GD STRUCTURE
969, 5o32B, 0.5626, 3.67, 0.130, 903, 69, THE STRUCTURE OF COMPLEMENT COMPLEX
970, 4v4xZ, 0.5626, 3.57, 0.122, 228, 74, 
971, 3t4aB, 0.5626, 3.52, 0.132, 183, 68, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
972, 2rcjS, 0.5626, 3.27, 0.062, 523, 65, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
973, 2rcjO, 0.5626, 3.27, 0.062, 523, 65, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
974, 2rcjK, 0.5626, 3.27, 0.062, 523, 65, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
975, 2rcjG, 0.5626, 3.27, 0.062, 523, 65, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
976, 2rcjC, 0.5626, 3.27, 0.062, 523, 65, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
977, 2ok5A, 0.5626, 2.83, 0.138, 710, 65, HUMAN COMPLEMENT FACTOR B
978, 1fc1A, 0.5626, 3.27, 0.062, 206, 65, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
979, 1dqtB, 0.5626, 3.12, 0.088, 117, 68, THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152)
980, 4d7pA, 0.5625, 3.50, 0.043, 96, 70, SUPEROXIDE REDUCTASE (1FE-SOR) FROM GIARDIA INTESTINALIS
981, 1wv7T, 0.5625, 3.06, 0.074, 191, 68, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE
982, 1wtgT, 0.5625, 3.06, 0.074, 191, 68, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE
983, 5fo7B, 0.5624, 3.41, 0.152, 900, 66, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B AT 2.8 ANGSTROM RESOLUTION
984, 2f9bT, 0.5624, 3.06, 0.074, 149, 68, DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS
985, 1ahwC, 0.5624, 3.04, 0.090, 200, 67, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
986, 5o32F, 0.5623, 3.54, 0.132, 903, 68, THE STRUCTURE OF COMPLEMENT COMPLEX
987, 4mywA, 0.5623, 3.35, 0.071, 232, 70, STRUCTURE OF HSV-2 GD BOUND TO NECTIN-1
988, 2cuhA, 0.5623, 2.80, 0.094, 115, 64, SOLUTION STRUCTURE OF THE 31ST FIBRONECTIN TYPE III DOMAIN OF THE HUMAN TENASCIN X
989, 2b7dT, 0.5623, 3.06, 0.074, 149, 68, FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION PRECLINICAL PHARMACOKINETICS PHARMACODYNAMICS AND EFFICACY IN A BABOON THROMBOSIS MODEL
990, 4v4nOA, 0.5622, 3.02, 0.099, 216, 71, 
991, 2bc4D, 0.5622, 3.29, 0.091, 197, 66, CRYSTAL STRUCTURE OF HLA-DM
992, 2bc4B, 0.5622, 3.27, 0.091, 191, 66, CRYSTAL STRUCTURE OF HLA-DM
993, 5cd4R, 0.5621, 2.43, 0.102, 357, 59, THE TYPE IE CRISPR CASCADE COMPLEX FROM E. COLI WITH TWO ASSEMBLIES IN THE ASYMMETRIC UNIT ARRANGED BACK-TO-BACK
994, 1t89A, 0.5621, 3.50, 0.075, 210, 67, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
995, 1ahwF, 0.5621, 3.07, 0.090, 200, 67, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
996, 5x5vA, 0.5620, 3.47, 0.099, 236, 71, CRYSTAL STRUCTURE OF PSEUDORABIES VIRUS GLYCOPROTEIN D
997, 2mbmA, 0.5620, 2.66, 0.274, 120, 62, SOLUTION NMR STRUCTURE OF DE NOVO DESIGNED TOP7 FOLD PROTEIN TOP7M13 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR33
998, 1s7hA, 0.5620, 2.88, 0.048, 186, 63, STRUCTURAL GENOMICS 2.2A CRYSTAL STRUCTURE OF PROTEIN YKOF FROM BACILLUS SUBTILIS
999, 1eg0N, 0.5620, 3.41, 0.108, 220, 74, FITTING OF COMPONENTS WITH KNOWN STRUCTURE INTO AN 11.5 A CRYO-EM MAP OF THE E.COLI 70S RIBOSOME
1000, 5t0gb, 0.5619, 3.17, 0.043, 191, 69, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1001, 5t0cNA, 0.5619, 3.17, 0.043, 191, 69, 
1002, 5t0cH, 0.5619, 3.17, 0.043, 191, 69, 
1003, 3th4T, 0.5619, 3.07, 0.074, 191, 68, MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
1004, 2ov7B, 0.5619, 3.37, 0.095, 133, 74, THE FIRST DOMAIN OF THE RIBOSOMAL PROTEIN L1 FROM THERMUS THERMOPHILUS
1005, 1mf7A, 0.5619, 3.20, 0.104, 194, 67, INTEGRIN ALPHA M I DOMAIN
1006, 4z6aT, 0.5618, 3.07, 0.074, 201, 68, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (YT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
1007, 4myvA, 0.5617, 3.50, 0.070, 176, 71, FREE HSV-2 GD STRUCTURE
1008, 3t2cA, 0.5617, 3.04, 0.116, 389, 69, FRUCTOSE-16-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS DHAP-BOUND FORM
1009, 2aeiT, 0.5617, 3.07, 0.074, 195, 68, CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR AND 2-[[6-[3-(AMINOIMINOMETHYL)PHENOXY]-35-DIFLURO-4-[(1-METHYL-3- PHENYLPROPYL)AMINO]-2-PYRIDINYL]OXY]-BENZOIC ACID
1010, 1tfhB, 0.5617, 3.06, 0.074, 182, 68, EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
1011, 6gz3EC, 0.5616, 3.19, 0.118, 217, 76, tRNA translocation by the eukaryotic 80S ribosome and the impact of GTP hydrolysis; Translocation-intermediate-POST-1 (TI-POST-1)  
1012, 5i0wA, 0.5616, 3.21, 0.045, 159, 67, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER REDUCING CONDITIONS
1013, 3g6jB, 0.5616, 3.51, 0.132, 903, 68, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1014, 1jpsT, 0.5616, 3.14, 0.090, 200, 67, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
1015, 1dqtC, 0.5616, 2.95, 0.075, 117, 67, THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152)
1016, 6h3cI, 0.5615, 3.18, 0.119, 237, 67, CRYO-EM STRUCTURE OF THE BRISC COMPLEX BOUND TO SHMT2 
1017, 6h3cD, 0.5615, 3.18, 0.119, 237, 67, CRYO-EM STRUCTURE OF THE BRISC COMPLEX BOUND TO SHMT2 
1018, 3q3gL, 0.5613, 3.28, 0.104, 189, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
1019, 3dlqR, 0.5613, 3.21, 0.090, 201, 67, CRYSTAL STRUCTURE OF THE IL-22/IL-22R1 COMPLEX
1020, 2winH, 0.5613, 3.44, 0.152, 900, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
1021, 2winF, 0.5613, 3.44, 0.152, 900, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
1022, 2winD, 0.5613, 3.44, 0.152, 901, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
1023, 2winB, 0.5613, 3.44, 0.152, 901, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
1024, 1z6jT, 0.5613, 3.07, 0.074, 207, 68, CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR
1025, 1s7hC, 0.5613, 2.96, 0.047, 182, 64, STRUCTURAL GENOMICS 2.2A CRYSTAL STRUCTURE OF PROTEIN YKOF FROM BACILLUS SUBTILIS
1026, 1hdmB, 0.5613, 3.28, 0.091, 183, 66, HISTOCOMPATIBILITY ANTIGEN HLA-DM
1027, 6e3kC, 0.5612, 3.01, 0.123, 207, 65, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1028, 4rf8B, 0.5612, 3.40, 0.068, 693, 74, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS IN COMPLEX WITH ADP
1029, 1jlmA, 0.5612, 3.44, 0.101, 187, 69, I-DOMAIN FROM INTEGRIN CR3 MN2+ BOUND
1030, 6df3L, 0.5611, 2.98, 0.092, 199, 65, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF IL-24 WITH SOLUBLE RECEPTORS IL-22RA AND IL-20RB 
1031, 5h9fH, 0.5611, 2.29, 0.103, 352, 58, CRYSTAL STRUCTURE OF E. COLI CASCADE BOUND TO A PAM-CONTAINING DSDNA TARGET AT 2.45 ANGSTROM RESOLUTION.
1032, 4wi4A, 0.5611, 3.37, 0.091, 205, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A
1033, 5w21C, 0.5610, 3.14, 0.030, 213, 66, CRYSTAL STRUCTURE OF A 1:1:1 FGF23-FGFR1C-AKLOTHO TERNARY COMPLEX
1034, 5t7aA, 0.5610, 3.00, 0.136, 93, 66, CRYSTAL STRUCTURE OF BR DERIVATIVE BHCBM56
1035, 5iwlD, 0.5610, 3.30, 0.090, 113, 67, CD47-DIABODY COMPLEX
1036, 5foaB, 0.5610, 3.60, 0.147, 902, 68, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH DAF (CCP2-4)
1037, 5fhyA, 0.5609, 3.53, 0.042, 229, 72, CRYSTAL STRUCTURE OF FLID (HAP2) FROM PSEUDOMONAS AERUGINOSA PAO1
1038, 5d1pA, 0.5609, 3.12, 0.159, 374, 69, ARCHAEAL ATP-DEPENDENT RNA LIGASE - FORM 2
1039, 1boyA, 0.5609, 3.06, 0.090, 211, 67, EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR
1040, 5x5wA, 0.5608, 3.49, 0.099, 233, 71, CRYSTAL STRUCTURE OF PSEUDORABIES VIRUS GLYCOPROTEIN D
1041, 6ghcB, 0.5606, 3.32, 0.097, 286, 72, MODIFICATION DEPENDENT ECOKMCRA RESTRICTION ENDONUCLEASE 
1042, 5ti1C, 0.5606, 3.56, 0.116, 429, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1043, 4qgbB, 0.5606, 3.19, 0.082, 216, 73, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN G219V TTHL1
1044, 4mz2A, 0.5606, 3.38, 0.086, 111, 70, CRYSTAL STRUCTURE OF THE VOLTAGE-GATED SODIUM CHANNEL BETA 4 SUBUNIT EXTRACELLULAR DOMAIN
1045, 5hccB, 0.5605, 3.42, 0.103, 647, 68, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND DERMACENTOR ANDERSONI RACI3.
1046, 5hj2D, 0.5604, 3.41, 0.101, 197, 69, INTEGRIN ALPHA2BETA1 I-DOMAIN
1047, 4v9lY, 0.5604, 3.03, 0.104, 228, 67, 
1048, 5n04A, 0.5603, 3.26, 0.074, 234, 68, X-RAY CRYSTAL STRUCTURE OF AN LPMO
1049, 4f9tA, 0.5602, 3.45, 0.108, 226, 74, RIBOSOMAL PROTEIN L1 FROM THERMUS THERMOPHILUS WITH SUBSTITUTION THR217ALA
1050, 4lq4A, 0.5601, 3.04, 0.137, 211, 73, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN L1 FROM METHANOCOCCUS JANNASCHII WITH DELETION OF 8 RESIDUES FROM C-TERMINUS
1051, 2ov7A, 0.5601, 3.41, 0.095, 134, 74, THE FIRST DOMAIN OF THE RIBOSOMAL PROTEIN L1 FROM THERMUS THERMOPHILUS
1052, 2i07B, 0.5601, 3.52, 0.149, 901, 67, HUMAN COMPLEMENT COMPONENT C3B
1053, 5o35B, 0.5600, 3.58, 0.132, 912, 68, STRUCTURE OF COMPLEMENT PROTEINS COMPLEX
1054, 4zmaT, 0.5600, 3.09, 0.074, 198, 68, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (ST) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
1055, 1i0eB, 0.5600, 3.49, 0.080, 365, 75, CRYSTAL STRUCTURE OF CREATINE KINASE FROM HUMAN MUSCLE
1056, 5i0xB, 0.5599, 3.28, 0.075, 158, 67, COPPER-BOUND M90I VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
1057, 2wiiB, 0.5599, 3.54, 0.132, 896, 68, COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4
1058, 2firT, 0.5599, 3.08, 0.074, 191, 68, CRYSTAL STRUCTURE OF DFPR-VIIA/STF
1059, 5hj2A, 0.5598, 3.37, 0.101, 196, 69, INTEGRIN ALPHA2BETA1 I-DOMAIN
1060, 4wi9A, 0.5598, 3.36, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A
1061, 4bj3A, 0.5598, 3.31, 0.118, 183, 68, INTEGRIN ALPHA2 I DOMAIN E318W-COLLAGEN COMPLEX
1062, 3l2dC, 0.5598, 3.67, 0.070, 367, 71, GLYCOCYAMINE KINASE BETA-BETA HOMODIMER FROM MARINE WORM NAMALYCASTIS SP.
1063, 6mshH, 0.5597, 3.17, 0.014, 191, 69, struct.pdbx_descriptor               26S proteasome  
1064, 2n59A, 0.5597, 3.36, 0.030, 101, 67, SOLUTION STRUCTURE OF R. PALUSTRIS CSGH
1065, 3dgcR, 0.5596, 3.37, 0.088, 202, 68, STRUCTURE OF IL-22/IL-22R1
1066, 3b83E, 0.5595, 3.07, 0.136, 99, 66, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1067, 2aerT, 0.5595, 3.08, 0.074, 192, 68, CRYSTAL STRUCTURE OF BENZAMIDINE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX.
1068, 4nwnB, 0.5594, 3.25, 0.030, 157, 67, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1069, 4bsvB, 0.5594, 3.60, 0.090, 210, 67, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1
1070, 1fg9C, 0.5594, 3.14, 0.119, 210, 67, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
1071, 4be5B, 0.5593, 3.20, 0.091, 234, 66, V. CHOLERA BIOFILM SCAFFOLDING PROTEIN RBMA
1072, 3sgkA, 0.5593, 3.68, 0.088, 209, 68, UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE
1073, 5ti1F, 0.5592, 3.50, 0.101, 429, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1074, 5i0vA, 0.5592, 3.35, 0.044, 159, 68, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER OXIDIZING CONDITIONS
1075, 5boaF, 0.5592, 3.46, 0.088, 192, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB BOUND TO THE DISACCHARIDE RECEPTOR GB2
1076, 3uc2B, 0.5592, 2.84, 0.062, 125, 64, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
1077, 1jmaA, 0.5592, 3.24, 0.072, 259, 69, CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM
1078, 5t7aB, 0.5591, 3.05, 0.152, 92, 66, CRYSTAL STRUCTURE OF BR DERIVATIVE BHCBM56
1079, 5h9xA, 0.5591, 2.79, 0.190, 412, 63, CRYSTAL STRUCTURE OF GH FAMILY 64 LAMINARIPENTAOSE-PRODUCING BETA-13- GLUCANASE FROM PAENIBACILLUS BARENGOLTZII
1080, 4ph8A, 0.5591, 3.17, 0.075, 150, 67, CRYSTAL STRUCTURE OF AGGA THE MAJOR SUBUNIT OF AGGREGATIVE ADHERENCE FIMBRIAE TYPE I (AAF/I) FROM THE ESCHERICHIA COLI O4H104
1081, 3qa3E, 0.5591, 3.30, 0.104, 186, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
1082, 2y7qB, 0.5591, 2.97, 0.078, 287, 64, THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI
1083, 2c3aB, 0.5591, 3.30, 0.042, 274, 72, STRUCTURE OF UNLIGANDED HSV GD REVEALS A MECHANISM FOR RECEPTOR-MEDIATED ACTIVATION OF VIRUS ENTRY
1084, 5uq8BB, 0.5590, 3.26, 0.110, 225, 73, 70S ribosome complex with dnaX mRNA stem-loop and E-site tRNA ( out  conformation)
1085, 5hj2E, 0.5590, 3.46, 0.100, 196, 70, INTEGRIN ALPHA2BETA1 I-DOMAIN
1086, 3qa3G, 0.5590, 3.31, 0.104, 187, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
1087, 3t2gA, 0.5589, 3.06, 0.116, 383, 69, FRUCTOSE-16-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS Y229F VARIANT WITH DHAP
1088, 3irpX, 0.5589, 3.06, 0.030, 418, 66, CRYSTAL STRUCTURE OF FUNCTIONAL REGION OF UAFA FROM STAPHYLOCOCCUS SAPROPHYTICUS AT 1.50 ANGSTROM RESOLUTION
1089, 2hixA, 0.5589, 2.88, 0.123, 577, 65, ATP DEPENDENT DNA LIGASE FROM S. SOLFATARICUS BOUND TO ATP
1090, 1s7hD, 0.5589, 2.96, 0.047, 184, 64, STRUCTURAL GENOMICS 2.2A CRYSTAL STRUCTURE OF PROTEIN YKOF FROM BACILLUS SUBTILIS
1091, 3blxN, 0.5588, 3.25, 0.057, 345, 70, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
1092, 2vplA, 0.5588, 3.46, 0.108, 137, 74, THE STRUCTURE OF THE COMPLEX BETWEEN THE FIRST DOMAIN OF L1 PROTEIN FROM THERMUS THERMOPHILUS AND MRNA FROM METHANOCOCCUS JANNASCHII
1093, 4wlpA, 0.5587, 3.49, 0.029, 296, 68, CRYSTAL STRUCTURE OF UCH37-NFRKB INHIBITED DEUBIQUITYLATING COMPLEX
1094, 4hafA, 0.5587, 3.55, 0.104, 209, 67, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)
1095, 2iceB, 0.5587, 3.54, 0.132, 183, 68, CRIG BOUND TO C3C
1096, 4wi9B, 0.5586, 3.35, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A
1097, 3blxF, 0.5586, 3.25, 0.057, 345, 70, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
1098, 2d6fC, 0.5586, 2.95, 0.109, 485, 64, CRYSTAL STRUCTURE OF GLU-TRNA(GLN) AMIDOTRANSFERASE IN THE COMPLEX WITH TRNA(GLN)
1099, 6e3kD, 0.5585, 3.20, 0.106, 203, 66, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1100, 3lzrB, 0.5585, 3.48, 0.059, 158, 68, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.73 A AT PH 9 AND MANGANESE PEAK WAVELENGTH (1.893 A)
1101, 4zfjC, 0.5584, 3.28, 0.071, 227, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC APO FORM
1102, 3qhtC, 0.5584, 2.81, 0.078, 93, 64, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-1 BOUND TO YEAST SUMO
1103, 5xjeA, 0.5583, 3.57, 0.090, 213, 67, CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1104, 5ti1E, 0.5583, 3.33, 0.104, 429, 67, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1105, 5hcdB, 0.5583, 3.43, 0.103, 647, 68, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS MICROPLUS RACI2
1106, 3blxJ, 0.5583, 3.25, 0.057, 345, 70, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
1107, 3blxD, 0.5583, 3.25, 0.057, 345, 70, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
1108, 1ijbA, 0.5583, 3.43, 0.143, 202, 70, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN
1109, 1fg9E, 0.5583, 2.84, 0.109, 193, 64, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
1110, 1dwuA, 0.5583, 3.30, 0.162, 213, 74, RIBOSOMAL PROTEIN L1
1111, 6i2xC, 0.5582, 3.43, 0.103, 648, 68, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SMALL MOLECULE INHIBITOR AND CVF 
1112, 4u7uU, 0.5582, 2.34, 0.102, 354, 59, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
1113, 1lilB, 0.5582, 3.67, 0.074, 212, 68, BENCE JONES PROTEIN CLE A LAMBDA III IMMUNOGLOBULIN LIGHT- CHAIN DIMER
1114, 5x8lD, 0.5581, 3.20, 0.119, 116, 67, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
1115, 3blxH, 0.5581, 3.25, 0.057, 345, 70, YEAST ISOCITRATE DEHYDROGENASE (APO FORM)
1116, 2qkiB, 0.5581, 3.47, 0.149, 184, 67, HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN
1117, 2ji1C, 0.5581, 2.95, 0.092, 125, 65, X-RAY STRUCTURE OF WILD-TYPE SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII
1118, 2b2xA, 0.5581, 3.38, 0.130, 188, 69, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
1119, 5hj2C, 0.5580, 3.22, 0.118, 197, 68, INTEGRIN ALPHA2BETA1 I-DOMAIN
1120, 5dk2B, 0.5580, 3.68, 0.088, 208, 68, FC HETERODIMER E356K/D399K + K392D/K409D
1121, 4v8yFC, 0.5580, 3.45, 0.108, 225, 74, 
1122, 3b83G, 0.5580, 3.05, 0.123, 99, 65, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1123, 2wahB, 0.5580, 3.42, 0.091, 209, 66, CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
1124, 6j2xRA, 0.5579, 3.35, 0.071, 197, 70, struct.pdbx_descriptor              
1125, 6nojA, 0.5578, 3.39, 0.104, 125, 67, PD-L1 IGV DOMAIN V76T WITH FRAGMENT 
1126, 6gfeH, 0.5578, 3.59, 0.104, 429, 67, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
1127, 6bw6A, 0.5578, 3.71, 0.082, 368, 73, HUMAN GPT (DPAGT1) H129 VARIANT IN COMPLEX WITH TUNICAMYCIN
1128, 5c6pB, 0.5578, 3.16, 0.046, 91, 65, PROTEIN C
1129, 4cmmB, 0.5578, 3.28, 0.090, 119, 67, STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA V1
1130, 6fb3C, 0.5577, 3.16, 0.121, 1836, 66, TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN
1131, 5mpdW, 0.5577, 3.39, 0.042, 197, 72, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1132, 4zfjG, 0.5577, 3.28, 0.071, 225, 70, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC APO FORM
1133, 4u7uI, 0.5577, 2.35, 0.102, 355, 59, CRYSTAL STRUCTURE OF RNA-GUIDED IMMUNE CASCADE COMPLEX FROM E.COLI
1134, 4mywC, 0.5577, 3.39, 0.071, 232, 70, STRUCTURE OF HSV-2 GD BOUND TO NECTIN-1
1135, 3umyA, 0.5577, 3.48, 0.108, 228, 74, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN T217A TTHL1 IN COMPLEX WITH 80NT 23S RNA FROM THERMUS THERMOPHILUS
1136, 1mccA, 0.5577, 3.68, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1137, 1j9cT, 0.5577, 2.98, 0.090, 210, 67, CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
1138, 6e3lD, 0.5576, 3.20, 0.121, 202, 66, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1139, 5h9yA, 0.5576, 2.80, 0.190, 412, 63, CRYSTAL STRUCTURE OF GH FAMILY 64 LAMINARIPENTAOSE-PRODUCING BETA-13- GLUCANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEXED WITH LAMINARIHEXAOSE.
1140, 4wi8A, 0.5576, 3.40, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A
1141, 2p9rB, 0.5576, 3.46, 0.087, 97, 69, HUMAN ALPHA2-MACROGLOGULIN IS COMPOSED OF MULTIPLE DOMAINS AS PREDICTED BY HOMOLOGY WITH COMPLEMENT COMPONENT C3
1142, 1mcqA, 0.5576, 3.68, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1143, 4wi4B, 0.5575, 3.34, 0.091, 207, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A
1144, 4bj3B, 0.5575, 3.27, 0.118, 179, 68, INTEGRIN ALPHA2 I DOMAIN E318W-COLLAGEN COMPLEX
1145, 3sgkB, 0.5575, 3.57, 0.090, 212, 67, UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE
1146, 3sgjB, 0.5575, 3.55, 0.090, 217, 67, UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE
1147, 2vkwB, 0.5575, 2.88, 0.108, 195, 65, HUMAN NCAM FN3 DOMAINS 1 AND 2
1148, 6fb3B, 0.5574, 3.16, 0.121, 1836, 66, TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN
1149, 6fb3A, 0.5574, 3.16, 0.121, 1836, 66, TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN
1150, 5fprA, 0.5574, 3.42, 0.085, 307, 71, STRUCTURE OF BACTERIAL DNA LIGASE WITH SMALL-MOLECULE LIGAND PYRIMIDIN-2-AMINE (AT371) IN AN ALTERNATE BINDING SITE.
1151, 3l2dA, 0.5574, 3.50, 0.071, 367, 70, GLYCOCYAMINE KINASE BETA-BETA HOMODIMER FROM MARINE WORM NAMALYCASTIS SP.
1152, 6fb3D, 0.5573, 3.16, 0.121, 1836, 66, TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN
1153, 4v6uTA, 0.5573, 3.12, 0.099, 216, 71, 
1154, 3nd1A, 0.5573, 3.01, 0.159, 244, 63, CRYSTAL STRUCTURE OF PRECORRIN-6A SYNTHASE FROM RHODOBACTER CAPSULATUS
1155, 2hftA, 0.5573, 3.07, 0.090, 205, 67, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION
1156, 4ku1B, 0.5572, 3.71, 0.088, 208, 68, ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING
1157, 4dmuF, 0.5572, 3.06, 0.121, 188, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
1158, 3d33A, 0.5572, 2.90, 0.046, 92, 65, CRYSTAL STRUCTURE OF A DUF3244 FAMILY PROTEIN WITH AN IMMUNOGLOBULIN- LIKE BETA-SANDWICH FOLD (BVU_0276) FROM BACTEROIDES VULGATUS ATCC 8482 AT 1.70 A RESOLUTION
1159, 1aoxA, 0.5572, 3.12, 0.119, 201, 67, I DOMAIN FROM INTEGRIN ALPHA2-BETA1
1160, 5m6wH, 0.5571, 3.34, 0.136, 913, 66, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
1161, 4v9hYA, 0.5571, 3.46, 0.108, 225, 74, 
1162, 4v8uLA, 0.5571, 3.46, 0.095, 228, 74, 
1163, 4rf7A, 0.5571, 3.41, 0.082, 692, 73, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS IN COMPLEX WITH SUBSTRATE L-ARGININE
1164, 4b7iA, 0.5571, 3.58, 0.090, 208, 67, CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS
1165, 5v4eH, 0.5570, 3.42, 0.106, 216, 66, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
1166, 5o4yE, 0.5570, 3.25, 0.104, 118, 67, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
1167, 4wi7B, 0.5570, 3.59, 0.090, 208, 67, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A
1168, 3gn6D, 0.5570, 2.74, 0.015, 290, 65, CRYSTAL STRUCTURE OF CT0912 ORFAN PROTEIN FROM CHLOROBIUM TEPIDUM WITH A FERREDOXIN-LIKE DOMAIN REPEAT (NP_661805.1) FROM CHLOROBIUM TEPIDUM TLS AT 1.80 A RESOLUTION
1169, 3d6gA, 0.5570, 3.72, 0.088, 210, 68, FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.
1170, 1oqoA, 0.5570, 3.54, 0.090, 208, 67, COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z
1171, 1ijkA, 0.5570, 3.24, 0.147, 199, 68, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN- BOTROCETIN COMPLEX
1172, 5fhyB, 0.5569, 3.56, 0.042, 229, 72, CRYSTAL STRUCTURE OF FLID (HAP2) FROM PSEUDOMONAS AERUGINOSA PAO1
1173, 5dvlA, 0.5569, 3.66, 0.088, 208, 68, FC DESIGN 20.8.37 A CHAIN HOMODIMER Y349S/T366M/K370Y/K409V
1174, 4w4nB, 0.5569, 3.57, 0.090, 207, 67, CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A
1175, 3t2eA, 0.5569, 3.06, 0.116, 385, 69, FRUCTOSE-16-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS F6P-BOUND FORM
1176, 3skuB, 0.5569, 3.32, 0.069, 223, 72, HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE HUMAN RECEPTOR NECTIN-1
1177, 3bjlA, 0.5569, 3.68, 0.088, 215, 68, LOC A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE
1178, 2y2tA, 0.5569, 3.19, 0.061, 95, 66, E. COLI CSGC IN REDUCED FORM
1179, 4v8uQC, 0.5568, 3.44, 0.095, 228, 74, 
1180, 4lh7A, 0.5568, 3.39, 0.139, 321, 72, CRYSTAL STRUCTURE OF A LIGA INHIBITOR
1181, 3ay4A, 0.5568, 3.39, 0.091, 215, 66, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1182, 1oqoB, 0.5568, 3.52, 0.090, 208, 67, COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z
1183, 6epcW, 0.5567, 3.03, 0.029, 195, 68, GROUND STATE 26S PROTEASOME (GS2)
1184, 5ti1H, 0.5567, 3.42, 0.116, 430, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1185, 4bm7A, 0.5567, 3.55, 0.090, 207, 67, CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION
1186, 3t2dA, 0.5567, 3.07, 0.116, 390, 69, FRUCTOSE-16-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS FBP-BOUND FORM
1187, 2yyaB, 0.5567, 2.79, 0.213, 423, 61, CRYSTAL STRUCTURE OF GAR SYNTHETASE FROM AQUIFEX AEOLICUS
1188, 2jjtC, 0.5567, 3.31, 0.088, 114, 68, STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
1189, 1v7pC, 0.5567, 3.24, 0.118, 193, 68, STRUCTURE OF EMS16-ALPHA2-I DOMAIN COMPLEX
1190, 1h3yA, 0.5567, 3.30, 0.062, 206, 65, CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENTHIGH SALT CONDITION
1191, 6jo8M, 0.5566, 3.51, 0.099, 258, 71, THE COMPLEX STRUCTURE OF CHIKV ENVELOPE GLYCOPROTEIN BOUND TO HUMAN MXRA8 
1192, 5tpsA, 0.5566, 3.39, 0.091, 207, 66, STRUCTURE OF A FC HETERODIMER
1193, 5thpL, 0.5566, 3.09, 0.106, 189, 66, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
1194, 6cx1E, 0.5565, 3.52, 0.099, 182, 71, CRYO-EM STRUCTURE OF SENECA VALLEY VIRUS-ANTHRAX TOXIN RECEPTOR 1 COMPLEX 
1195, 5jpqk, 0.5565, 2.99, 0.125, 182, 72, CRYO-EM STRUCTURE OF THE 90S PRE-RIBOSOME
1196, 3lznB, 0.5565, 3.64, 0.057, 158, 70, CRYSTAL STRUCTURE ANALYSIS OF THE APO P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.59 A AT PH 9
1197, 3ibsA, 0.5565, 3.34, 0.149, 200, 67, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
1198, 3etsA, 0.5565, 3.49, 0.088, 562, 68, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4- METHYLUMBELLIFERONE BOUND IN THE ACTIVE SITE
1199, 1frtC, 0.5565, 3.14, 0.062, 205, 64, CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1200, 1fc2D, 0.5565, 3.14, 0.062, 206, 64, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1201, 6d58A, 0.5563, 3.59, 0.090, 207, 67, CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3 
1202, 5k33A, 0.5563, 3.55, 0.090, 213, 67, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HER2 IN COMPLEX WITH FCAB STAB19
1203, 4rf8A, 0.5563, 3.31, 0.082, 686, 73, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS IN COMPLEX WITH ADP
1204, 4qkuD, 0.5563, 3.33, 0.134, 427, 67, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1205, 4dohE, 0.5563, 3.27, 0.103, 204, 68, IL20/IL201/IL20R2 TERNARY COMPLEX
1206, 2y2yA, 0.5563, 3.07, 0.062, 95, 65, OXIDISED FORM OF E. COLI CSGC
1207, 2icfB, 0.5563, 3.49, 0.149, 903, 67, CRIG BOUND TO C3B
1208, 5ti1A, 0.5562, 3.59, 0.159, 426, 69, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1209, 5h5tA, 0.5562, 3.43, 0.072, 196, 69, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SALMONELLA TYPHIMURIUM
1210, 5d4qA, 0.5562, 3.41, 0.091, 208, 66, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC
1211, 3uc2C, 0.5562, 2.96, 0.078, 123, 64, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
1212, 2jjtD, 0.5562, 3.32, 0.088, 114, 68, STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
1213, 1zhoG, 0.5562, 3.39, 0.110, 225, 73, THE STRUCTURE OF A RIBOSOMAL PROTEIN L1 IN COMPLEX WITH MRNA
1214, 6bz4A, 0.5561, 3.40, 0.091, 207, 66, HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A 
1215, 5xmhB, 0.5560, 3.38, 0.091, 207, 66, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
1216, 5vgpA, 0.5560, 3.58, 0.090, 209, 67, FC FRAGMENT OF HUMAN IGG1 ANTIBODY; FROM NIST MAB 
1217, 5opfA, 0.5560, 3.10, 0.060, 194, 67, STRUCTURE OF LPMO10B FROM FROM MICROMONOSPORA AURANTIACA
1218, 3wknM, 0.5560, 3.49, 0.090, 209, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1219, 3oskA, 0.5560, 3.27, 0.086, 121, 70, CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
1220, 2ji3D, 0.5559, 3.21, 0.090, 125, 67, X-RAY STRUCTURE OF THE IRON-PEROXIDE INTERMEDIATE OF SUPEROXIDE REDUCTASE (E114A MUTANT) FROM DESULFOARCULUS BAARSII
1221, 1t83A, 0.5559, 3.50, 0.090, 210, 67, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1222, 6g1eB, 0.5558, 3.59, 0.090, 206, 67, BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q) 
1223, 4xylB, 0.5558, 2.98, 0.159, 225, 63, CA. KORARCHAEUM CRYPTOFILUM ACD1 IN COMPLEX WITH COENZYME A
1224, 4reoA, 0.5558, 3.47, 0.108, 221, 74, MUTANT RIBOSOMAL PROTEIN L1 FROM THERMUS THERMOPHILUS WITH THREONINE 217 REPLACED BY VALINE
1225, 2vplC, 0.5558, 3.47, 0.108, 137, 74, THE STRUCTURE OF THE COMPLEX BETWEEN THE FIRST DOMAIN OF L1 PROTEIN FROM THERMUS THERMOPHILUS AND MRNA FROM METHANOCOCCUS JANNASCHII
1226, 6g1eA, 0.5557, 3.60, 0.090, 207, 67, BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q) 
1227, 5o4yC, 0.5557, 3.35, 0.103, 118, 68, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
1228, 5bw7A, 0.5557, 3.60, 0.090, 212, 67, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1229, 4jdzB, 0.5557, 3.05, 0.106, 445, 66, STRUCTURES OF SDRD FROM STAPHYLOCOCCUS AUREUS REVEAL THE MOLECULAR MECHANISM OF HOW THE CELL SURFACE RECEPTORS RECOGNIZE THEIR LIGANDS
1230, 3uc2A, 0.5557, 2.87, 0.062, 123, 64, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
1231, 3jsnA, 0.5557, 3.25, 0.114, 297, 70, CRYSTAL STRUCTURE OF THE ADENYLATION DOMAIN OF NAD+- DEPENDENT DNA LIGASE FROM STAPHYLOCOCCUS AUREUS
1232, 1uc6A, 0.5557, 3.11, 0.045, 109, 66, SOLUTION STRUCTURE OF THE CARBOXYL TERMINAL DOMAIN OF THE CILIARY NEUROTROPHIC FACTOR RECEPTOR
1233, 1mciA, 0.5557, 3.61, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1234, 1h3yB, 0.5557, 3.29, 0.062, 206, 65, CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENTHIGH SALT CONDITION
1235, 1ck4A, 0.5557, 3.50, 0.129, 192, 70, CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN.
1236, 6ndaL, 0.5556, 3.43, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
1237, 6ndaI, 0.5556, 3.44, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
1238, 5xjfA, 0.5556, 3.40, 0.091, 215, 66, CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1239, 5x8lB, 0.5556, 3.33, 0.103, 116, 68, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
1240, 5t2cOA, 0.5556, 3.22, 0.113, 217, 71, 
1241, 4xylD, 0.5556, 2.96, 0.156, 226, 64, CA. KORARCHAEUM CRYPTOFILUM ACD1 IN COMPLEX WITH COENZYME A
1242, 1mcdB, 0.5556, 3.59, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1243, 6fgoC, 0.5555, 3.36, 0.091, 208, 66, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
1244, 4c29A, 0.5555, 3.31, 0.145, 201, 69, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
1245, 2vzvB, 0.5555, 3.33, 0.029, 857, 68, SUBSTRATE COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA E541A WITH CHITOSAN
1246, 5thpR, 0.5554, 3.25, 0.090, 187, 67, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
1247, 4v5fLA, 0.5554, 3.36, 0.096, 228, 73, 
1248, 4kkqB, 0.5554, 3.22, 0.091, 229, 66, CRYSTAL STRUCTURE OF VIBRIO CHOLERAE RBMA (CRYSTAL FORM 1)
1249, 1t0pA, 0.5554, 3.38, 0.088, 174, 68, STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A
1250, 5hceB, 0.5553, 3.46, 0.103, 647, 68, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS APPENDICULATUS RACI1
1251, 5fo9B, 0.5553, 3.58, 0.132, 903, 68, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH CR1 (CCP15-17)
1252, 4v5fVC, 0.5553, 3.36, 0.096, 228, 73, 
1253, 4rf7B, 0.5553, 3.50, 0.081, 700, 74, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS IN COMPLEX WITH SUBSTRATE L-ARGININE
1254, 4rf6A, 0.5553, 3.44, 0.068, 696, 74, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS
1255, 2ip4B, 0.5553, 2.62, 0.115, 406, 61, CRYSTAL STRUCTURE OF GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE FROM THERMUS THERMOPHILUS HB8
1256, 2c36B, 0.5553, 3.27, 0.056, 274, 71, STRUCTURE OF UNLIGANDED HSV GD REVEALS A MECHANISM FOR RECEPTOR-MEDIATED ACTIVATION OF VIRUS ENTRY
1257, 5h5tC, 0.5552, 3.63, 0.071, 196, 70, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SALMONELLA TYPHIMURIUM
1258, 4wi7A, 0.5552, 3.38, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A
1259, 3t2bA, 0.5552, 3.08, 0.116, 379, 69, FRUCTOSE-16-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS LIGAND FREE
1260, 6eaqB, 0.5551, 3.57, 0.090, 212, 67, GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC 
1261, 5wx8A, 0.5551, 2.60, 0.047, 160, 64, HUMAN HERPESVIRUS 6A IMMEDIATE EARLY PROTEIN 2 C-TERMINAL DOMAIN
1262, 5bv8A, 0.5551, 3.31, 0.145, 209, 69, G1324S MUTATION IN VON WILLEBRAND FACTOR A1 DOMAIN
1263, 4nwnV, 0.5551, 3.39, 0.029, 157, 68, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1264, 1mckA, 0.5551, 3.71, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1265, 5mpcIA, 0.5550, 3.17, 0.088, 197, 68, 
1266, 4p04B, 0.5550, 3.42, 0.118, 563, 68, APO FORM OF BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH MPO IN THE ACTIVE SITE
1267, 4p04A, 0.5550, 3.41, 0.118, 567, 68, APO FORM OF BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH MPO IN THE ACTIVE SITE
1268, 4dmuL, 0.5550, 3.13, 0.106, 188, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
1269, 3wknI, 0.5550, 3.52, 0.090, 209, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1270, 3sgjA, 0.5550, 3.55, 0.090, 219, 67, UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE
1271, 3ettA, 0.5550, 3.50, 0.101, 564, 69, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4-NITROPHENOL BOUND IN THE ACTIVE SITE
1272, 2d6fD, 0.5550, 2.97, 0.109, 522, 64, CRYSTAL STRUCTURE OF GLU-TRNA(GLN) AMIDOTRANSFERASE IN THE COMPLEX WITH TRNA(GLN)
1273, 1t83B, 0.5550, 3.56, 0.090, 212, 67, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1274, 5h5tD, 0.5549, 3.58, 0.071, 193, 70, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SALMONELLA TYPHIMURIUM
1275, 4rtdA, 0.5549, 2.91, 0.062, 1103, 65, ESCHERICHIA COLI ALPHA-2-MACROGLOBULIN ACTIVATED BY PORCINE ELASTASE
1276, 4c2aA, 0.5549, 3.29, 0.132, 202, 68, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH R1306Q AND I1309V MUTATIONS IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
1277, 3zo0A, 0.5549, 3.51, 0.045, 208, 67, MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY
1278, 6fgoA, 0.5548, 3.55, 0.090, 209, 67, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
1279, 5d6dB, 0.5548, 3.39, 0.091, 208, 66, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA
1280, 5aoqB, 0.5548, 2.97, 0.061, 233, 66, STRUCTURAL BASIS OF NEUROHORMONE PERCEPTION BY THE RECEPTOR TYROSINE KINASE TORSO
1281, 4v4bT, 0.5548, 3.00, 0.167, 213, 72, 
1282, 4rf6B, 0.5548, 3.50, 0.081, 698, 74, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS
1283, 4dmuJ, 0.5548, 3.13, 0.106, 191, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
1284, 3qa3L, 0.5548, 3.27, 0.103, 185, 68, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
1285, 2noqG, 0.5548, 3.00, 0.167, 213, 72, STRUCTURE OF RIBOSOME-BOUND CRICKET PARALYSIS VIRUS IRES RNA
1286, 5j8oB, 0.5547, 3.13, 0.091, 124, 66, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1287, 5hyiB, 0.5547, 3.43, 0.091, 209, 66, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
1288, 5hyeA, 0.5547, 3.72, 0.088, 208, 68, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)
1289, 3elqA, 0.5547, 3.41, 0.118, 564, 68, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE
1290, 3dkaB, 0.5547, 3.65, 0.100, 141, 70, CRYSTAL STRUCTURE OF A DINB-LIKE PROTEIN (YJOA BSU12410) FROM BACILLUS SUBTILIS AT 2.30 A RESOLUTION
1291, 3agvB, 0.5547, 3.40, 0.091, 208, 66, CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX
1292, 2ck2A, 0.5547, 2.88, 0.092, 94, 65, STRUCTURE OF CORE-SWAPPED MUTANT OF FIBRONECTIN
1293, 6ndaC, 0.5546, 3.42, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
1294, 5hj2B, 0.5546, 3.26, 0.118, 196, 68, INTEGRIN ALPHA2BETA1 I-DOMAIN
1295, 5fo9E, 0.5546, 3.54, 0.149, 903, 67, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH CR1 (CCP15-17)
1296, 5fo8B, 0.5546, 3.50, 0.152, 894, 66, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH MCP (CCP1-4)
1297, 3sd2A, 0.5546, 2.69, 0.065, 83, 62, CRYSTAL STRUCTURE OF A PUTATIVE MEMBER OF DUF3244 PROTEIN FAMILY (BT_3571) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.40 A RESOLUTION
1298, 2xwjD, 0.5546, 3.56, 0.132, 901, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1299, 5jpmB, 0.5545, 3.39, 0.076, 738, 66, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
1300, 5jiiA, 0.5545, 3.60, 0.090, 207, 67, CRYSTAL STRUCTURE OF HUMAN IGG1-FC
1301, 4wi6A, 0.5545, 3.38, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A
1302, 4v5rTC, 0.5545, 3.46, 0.108, 228, 74, 
1303, 4bswA, 0.5545, 3.56, 0.090, 210, 67, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2
1304, 3qa3I, 0.5545, 3.33, 0.104, 185, 67, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
1305, 3ettB, 0.5545, 3.42, 0.118, 564, 68, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4-NITROPHENOL BOUND IN THE ACTIVE SITE
1306, 3etsB, 0.5545, 3.37, 0.104, 563, 67, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4- METHYLUMBELLIFERONE BOUND IN THE ACTIVE SITE
1307, 1uexC, 0.5545, 3.42, 0.143, 202, 70, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR A1 DOMAIN COMPLEXED WITH SNAKE VENOM BITISCETIN
1308, 5thpF, 0.5544, 3.27, 0.118, 193, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
1309, 5m76B, 0.5544, 3.70, 0.074, 211, 68, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H10
1310, 4nehA, 0.5544, 3.40, 0.090, 1084, 67, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
1311, 4c29B, 0.5544, 3.33, 0.145, 201, 69, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
1312, 2wahA, 0.5544, 3.56, 0.090, 207, 67, CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
1313, 6ndgL, 0.5543, 3.43, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
1314, 6nd9C, 0.5543, 3.44, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
1315, 6mwxP, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1316, 6mwxL, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1317, 6mwxH, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1318, 6mwxD, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1319, 6mwvP, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1320, 6mwvL, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1321, 6mwvH, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1322, 6mwvD, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1323, 6mwcP, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1324, 6mwcL, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1325, 6mwcH, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1326, 6mwcD, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1327, 6mw9P, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1328, 6mw9L, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1329, 6mw9H, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1330, 6mw9D, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1331, 6muiP, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1332, 6muiL, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1333, 6muiH, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1334, 6muiD, 0.5543, 3.68, 0.118, 211, 68, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1335, 5u4yA, 0.5543, 3.39, 0.091, 207, 66, IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A
1336, 5nlsA, 0.5543, 3.29, 0.074, 234, 68, AUXILIARY ACTIVITY 9
1337, 5anyP, 0.5543, 3.68, 0.118, 211, 68, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1338, 5anyO, 0.5543, 3.68, 0.118, 211, 68, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1339, 5anyN, 0.5543, 3.68, 0.118, 211, 68, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1340, 5anyM, 0.5543, 3.68, 0.118, 211, 68, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1341, 4v5rMA, 0.5543, 3.46, 0.108, 228, 74, 
1342, 4p06A, 0.5543, 3.49, 0.101, 564, 69, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- METHYLUMBELLIFERYL SULFATE (MUS) IN THE ACTIVE SITE
1343, 1ngqL, 0.5543, 3.68, 0.118, 211, 68, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1344, 6nddI, 0.5542, 3.45, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
1345, 6ndaF, 0.5542, 3.27, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
1346, 6fgoB, 0.5542, 3.49, 0.090, 209, 67, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
1347, 5jikA, 0.5542, 3.62, 0.090, 201, 67, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)
1348, 5ayqB, 0.5542, 3.28, 0.118, 121, 68, STRUCTURE-BASED SITE-DIRECTED PHOTO-CROSSLINKING ANALYSES OF MULTIMERIC CELL-ADHESIVE INTERACTIONS OF VGSC BETA SUBUNITS
1349, 5aoqA, 0.5542, 3.17, 0.075, 233, 67, STRUCTURAL BASIS OF NEUROHORMONE PERCEPTION BY THE RECEPTOR TYROSINE KINASE TORSO
1350, 4qkuC, 0.5542, 3.52, 0.130, 420, 69, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1351, 4p07A, 0.5542, 3.41, 0.118, 570, 68, BACTERIAL ARYL SULFOTRANSFERASE (ASST) SOAKED WITH HUMAN URINE
1352, 4nwnJ, 0.5542, 3.41, 0.029, 157, 68, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1353, 4bswB, 0.5542, 3.43, 0.091, 210, 66, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2
1354, 3b83C, 0.5542, 2.94, 0.109, 99, 64, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1355, 2xwjF, 0.5542, 3.56, 0.132, 901, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1356, 2a73B, 0.5542, 3.54, 0.132, 976, 68, HUMAN COMPLEMENT COMPONENT C3
1357, 1mqaA, 0.5542, 3.35, 0.088, 174, 68, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL
1358, 6nddL, 0.5541, 3.44, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
1359, 5nlpA, 0.5541, 3.30, 0.074, 234, 68, AUXILIARY ACTIVITY 9
1360, 5dc9B, 0.5541, 3.08, 0.061, 94, 66, CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX CRYSTAL B
1361, 5a9zC, 0.5541, 3.63, 0.122, 228, 74, 
1362, 4v4yBA, 0.5541, 3.63, 0.122, 228, 74, 
1363, 4bsvA, 0.5541, 3.54, 0.090, 210, 67, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1
1364, 3u4mA, 0.5541, 3.47, 0.108, 228, 74, CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN TTHL1 IN COMPLEX WITH 80NT 23S RNA FROM THERMUS THERMOPHILUS
1365, 3fjtB, 0.5541, 3.55, 0.090, 209, 67, CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
1366, 2rdo9, 0.5541, 3.48, 0.108, 223, 74, 50S SUBUNIT WITH EF-G(GDPNP) AND RRF BOUND
1367, 1mcsA, 0.5541, 3.63, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1368, 1m10A, 0.5541, 3.28, 0.147, 199, 68, CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN
1369, 5vh5A, 0.5540, 3.62, 0.090, 207, 67, CRYSTAL STRUCTURE OF FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB
1370, 5j7cC, 0.5540, 2.81, 0.062, 97, 64, A PICOMOLAR AFFINITY FN3 DOMAIN IN COMPLEX WITH HEN EGG-WHITE LYSOZYME
1371, 5achA, 0.5540, 3.29, 0.074, 234, 68, X-RAY STRUCTURE OF LPMO
1372, 4v5sMA, 0.5540, 3.53, 0.095, 228, 74, 
1373, 3uc2D, 0.5540, 2.87, 0.063, 109, 63, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
1374, 2jjsD, 0.5540, 3.34, 0.088, 115, 68, STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
1375, 1vrpA, 0.5540, 3.45, 0.080, 370, 75, THE 2.1 STRUCTURE OF T. CALIFORNICA CREATINE KINASE COMPLEXED WITH THE TRANSITION-STATE ANALOGUE COMPLEX ADP- MG 2+ /NO3-/CREATINE
1376, 1auqA, 0.5540, 3.07, 0.149, 208, 67, A1 DOMAIN OF VON WILLEBRAND FACTOR
1377, 6ndgI, 0.5539, 3.33, 0.103, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
1378, 6nd8F, 0.5539, 3.34, 0.103, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
1379, 5vu0A, 0.5539, 3.56, 0.090, 215, 67, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS 
1380, 5acjA, 0.5539, 3.29, 0.074, 234, 68, X-RAY STRUCTURE OF LPMO
1381, 4qkuB, 0.5539, 3.59, 0.145, 427, 69, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1382, 4p06B, 0.5539, 3.50, 0.101, 564, 69, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- METHYLUMBELLIFERYL SULFATE (MUS) IN THE ACTIVE SITE
1383, 4dmuB, 0.5539, 3.09, 0.121, 188, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
1384, 3nd1B, 0.5539, 2.82, 0.113, 249, 62, CRYSTAL STRUCTURE OF PRECORRIN-6A SYNTHASE FROM RHODOBACTER CAPSULATUS
1385, 3elqB, 0.5539, 3.40, 0.118, 566, 68, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE
1386, 1oqxA, 0.5539, 3.60, 0.090, 210, 67, G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
1387, 6fgoD, 0.5537, 3.52, 0.090, 208, 67, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
1388, 5foaD, 0.5537, 3.51, 0.149, 902, 67, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH DAF (CCP2-4)
1389, 5e4eC, 0.5537, 3.31, 0.103, 303, 68, ENGINEERED INTERLEUKIN-13 BOUND TO RECEPTOR
1390, 4rf9A, 0.5537, 3.31, 0.082, 690, 73, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS IN COMPLEX WITH L-ARGININE AND ATPGS
1391, 4q74B, 0.5537, 3.70, 0.088, 207, 68, F241A FC
1392, 6eaqA, 0.5536, 3.56, 0.090, 210, 67, GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC 
1393, 5tz2C, 0.5536, 3.35, 0.088, 114, 68, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
1394, 5acgA, 0.5536, 3.30, 0.074, 234, 68, X-RAY STRUCTURE OF LPMO
1395, 4v7fD, 0.5536, 3.27, 0.137, 217, 73, 
1396, 4v6iDA, 0.5536, 3.27, 0.137, 217, 73, 
1397, 4qkuA, 0.5536, 3.53, 0.130, 421, 69, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1398, 3wknJ, 0.5536, 3.49, 0.090, 209, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1399, 3v95A, 0.5536, 3.63, 0.090, 212, 67, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA
1400, 2xwbB, 0.5536, 3.71, 0.130, 901, 69, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
1401, 2hivA, 0.5536, 3.26, 0.182, 577, 66, ATP-DEPENDENT DNA LIGASE FROM S. SOLFATARICUS
1402, 5w5lA, 0.5535, 3.68, 0.088, 209, 68, CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT
1403, 5nsgA, 0.5535, 3.43, 0.091, 206, 66, FC DEDE HOMODIMER VARIANT
1404, 5nlrA, 0.5535, 3.29, 0.074, 234, 68, AUXILIARY ACTIVITY 9
1405, 4p94B, 0.5535, 3.49, 0.072, 130, 69, THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF (RESIDUES 35-164)
1406, 4p05A, 0.5535, 3.07, 0.141, 564, 64, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- NITROPHENYL SULFATE (PNS) IN THE ACTIVE SITE
1407, 4kjyC, 0.5535, 3.34, 0.088, 113, 68, COMPLEX OF HIGH-AFFINITY SIRP ALPHA VARIANT FD6 WITH CD47
1408, 3v8cA, 0.5535, 3.60, 0.090, 212, 67, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)
1409, 2vkwA, 0.5535, 2.98, 0.121, 197, 66, HUMAN NCAM FN3 DOMAINS 1 AND 2
1410, 5tugB, 0.5534, 3.48, 0.072, 130, 69, ARCHAELLUM PERIPLASMIC STATOR PROTEIN COMPLEX FLAF AND FLAG FROM SULFOLOBUS ACIDOCALDARIUS
1411, 5jiiB, 0.5534, 3.58, 0.090, 208, 67, CRYSTAL STRUCTURE OF HUMAN IGG1-FC
1412, 5jihA, 0.5534, 3.62, 0.090, 212, 67, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)
1413, 5iwlC, 0.5534, 3.33, 0.088, 113, 68, CD47-DIABODY COMPLEX
1414, 4v5qMA, 0.5534, 3.46, 0.108, 228, 74, 
1415, 3blvB, 0.5534, 3.23, 0.043, 342, 69, YEAST ISOCITRATE DEHYDROGENASE WITH CITRATE BOUND IN THE REGULATORY SUBUNITS
1416, 1aoxB, 0.5534, 3.26, 0.118, 201, 68, I DOMAIN FROM INTEGRIN ALPHA2-BETA1
1417, 6ndcL, 0.5533, 3.40, 0.116, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
1418, 6chfA, 0.5533, 3.63, 0.090, 211, 67, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 1) 
1419, 5hyfA, 0.5533, 3.53, 0.090, 209, 67, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)
1420, 5gsqC, 0.5533, 3.58, 0.090, 208, 67, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
1421, 4x98A, 0.5533, 3.41, 0.091, 208, 66, IMMUNOGLOBULIN FC HETERODIMER VARIANT
1422, 4q7dB, 0.5533, 3.43, 0.091, 208, 66, WILD TYPE FC (WTFC)
1423, 4jjhB, 0.5533, 3.42, 0.075, 112, 67, CRYSTAL STRUCTURE OF THE D1 DOMAIN FROM HUMAN NECTIN-4 EXTRACELLULAR FRAGMENT [PSI-NYSGRC-005624]
1424, 3t04D, 0.5533, 3.12, 0.060, 103, 67, CRYSTAL STRUCTURE OF MONOBODY 7C12/ABL1 SH2 DOMAIN COMPLEX
1425, 3lzoB, 0.5533, 3.31, 0.045, 159, 67, CRYSTAL STRUCTURE ANALYSIS OF THE COPPER-RECONSTITUTED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 10.0
1426, 3blwL, 0.5533, 3.23, 0.043, 346, 69, YEAST ISOCITRATE DEHYDROGENASE WITH CITRATE AND AMP BOUND IN THE REGULATORY SUBUNITS
1427, 3blwH, 0.5533, 3.23, 0.043, 346, 69, YEAST ISOCITRATE DEHYDROGENASE WITH CITRATE AND AMP BOUND IN THE REGULATORY SUBUNITS
1428, 1u0nA, 0.5533, 3.36, 0.159, 207, 69, THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA- BOTROCETIN COMPLEX
1429, 1bho1, 0.5533, 3.24, 0.104, 189, 67, MAC-1 I DOMAIN MAGNESIUM COMPLEX
1430, 5nlnA, 0.5532, 3.31, 0.074, 234, 68, AUXILIARY ACTIVITY 9
1431, 5boaD, 0.5532, 3.32, 0.088, 196, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB BOUND TO THE DISACCHARIDE RECEPTOR GB2
1432, 3gn6B, 0.5532, 2.80, 0.015, 290, 66, CRYSTAL STRUCTURE OF CT0912 ORFAN PROTEIN FROM CHLOROBIUM TEPIDUM WITH A FERREDOXIN-LIKE DOMAIN REPEAT (NP_661805.1) FROM CHLOROBIUM TEPIDUM TLS AT 1.80 A RESOLUTION
1433, 2dtsA, 0.5532, 3.59, 0.090, 211, 67, CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
1434, 6ndgC, 0.5531, 3.44, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
1435, 5x8lC, 0.5531, 3.20, 0.106, 116, 66, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
1436, 5nlqA, 0.5531, 3.30, 0.074, 234, 68, AUXILIARY ACTIVITY 9
1437, 5boaB, 0.5531, 3.33, 0.088, 198, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB BOUND TO THE DISACCHARIDE RECEPTOR GB2
1438, 4jmgA, 0.5531, 3.09, 0.076, 197, 66, CRYSTAL STRUCTURE OF THE SYNTHETIC PROTEIN IN COMPLEX WITH PY PEPTIDE
1439, 4d2nA, 0.5531, 3.54, 0.090, 208, 67, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
1440, 3risA, 0.5531, 2.80, 0.127, 227, 63, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UCHL5 A PROTEASOME- ASSOCIATED HUMAN DEUBIQUITINATING ENZYME REVEALS AN UNPRODUCTIVE FORM OF THE ENZYME
1441, 2xwjH, 0.5531, 3.48, 0.152, 901, 66, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1442, 1oqxB, 0.5531, 3.61, 0.090, 209, 67, G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
1443, 6nd9F, 0.5530, 3.27, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
1444, 6cjxB, 0.5530, 3.46, 0.091, 209, 66, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 2) 
1445, 5y56B, 0.5530, 3.50, 0.090, 208, 67, FC MUTANT (K392D/K409D/D399K)
1446, 5nloA, 0.5530, 3.31, 0.074, 234, 68, AUXILIARY ACTIVITY 9
1447, 5n05A, 0.5530, 3.29, 0.074, 234, 68, X-RAY CRYSTAL STRUCTURE OF AN LPMO
1448, 5icuA, 0.5530, 3.27, 0.062, 102, 65, THE CRYSTAL STRUCTURE OF COPC FROM METHYLOSINUS TRICHOSPORIUM OB3B
1449, 4wtwB, 0.5530, 3.22, 0.119, 93, 67, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN OF INTEGRIN BETA4
1450, 4v66YA, 0.5530, 3.38, 0.041, 213, 73, 
1451, 2jjsC, 0.5530, 3.34, 0.103, 115, 68, STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
1452, 2ip4A, 0.5530, 2.61, 0.115, 406, 61, CRYSTAL STRUCTURE OF GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE FROM THERMUS THERMOPHILUS HB8
1453, 1h3wM, 0.5530, 3.35, 0.062, 206, 65, STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY
1454, 5c3tA, 0.5529, 3.28, 0.075, 126, 67, PD-1 BINDING DOMAIN FROM HUMAN PD-L1
1455, 5aciA, 0.5529, 3.30, 0.074, 234, 68, X-RAY STRUCTURE OF LPMO
1456, 4wi2A, 0.5529, 3.61, 0.090, 208, 67, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)
1457, 4tnwf, 0.5529, 3.55, 0.104, 215, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1458, 4q74A, 0.5529, 3.54, 0.090, 214, 67, F241A FC
1459, 4byhB, 0.5529, 3.74, 0.088, 209, 68, CRYSTAL STRUCTURE OF SIALYLATED IGG FC
1460, 3h25A, 0.5529, 3.07, 0.103, 188, 68, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PRIMASE REPB  IN COMPLEX WITH INITIATOR DNA
1461, 2xwjB, 0.5529, 3.48, 0.152, 901, 66, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1462, 6nd9I, 0.5528, 3.27, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
1463, 5yc5B, 0.5528, 3.42, 0.091, 213, 66, CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA
1464, 5wavA, 0.5528, 3.43, 0.091, 207, 66, FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
1465, 5tztC, 0.5528, 3.28, 0.088, 110, 68, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
1466, 5dvkA, 0.5528, 3.42, 0.091, 208, 66, FC DESIGN 7.7 B CHAIN HOMODIMER T366V/K409I
1467, 3dnkA, 0.5528, 3.63, 0.090, 209, 67, ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
1468, 4v5sTC, 0.5527, 3.51, 0.095, 228, 74, 
1469, 4lnvA, 0.5527, 3.08, 0.109, 1276, 64, CRYSTAL STRUCTURE OF TEP1S
1470, 3tesC, 0.5527, 3.19, 0.076, 94, 66, CRYSTAL STRUCTURE OF TENCON
1471, 1bhq1, 0.5527, 3.17, 0.106, 189, 66, MAC-1 I DOMAIN CADMIUM COMPLEX
1472, 6nd9L, 0.5526, 3.27, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
1473, 5npmA, 0.5526, 3.52, 0.108, 211, 74, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN TTHL1 LACKING 8 N- TERMINAL RESIDUES IN COMPLEX WITH 80NT 23S RNA FROM THERMUS THERMOPHILUS 
1474, 5nkwA, 0.5526, 3.30, 0.074, 234, 68, X-RAY CRYSTAL STRUCTURE OF AN AA9 LPMO
1475, 5mpeW, 0.5526, 3.37, 0.028, 197, 71, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1476, 1ymqA, 0.5526, 2.80, 0.102, 260, 59, HAD SUPERFAMILY PHOSPHOTRANSFERASE SUBSTRATE DIVERSIFICATION: STRUCTURE AND FUNCTION ANALYSIS OF THE HAD SUBCLASS IIB SUGAR PHOSPHATASE BT4131
1477, 1mcnA, 0.5526, 3.73, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1478, 6nddF, 0.5525, 3.42, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
1479, 6hygA, 0.5525, 3.51, 0.090, 416, 67, HETEROMERIC TANDEM IGG4/IGG1 FC 
1480, 5l2hA, 0.5525, 3.18, 0.106, 97, 66, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
1481, 4p07B, 0.5525, 3.49, 0.088, 570, 68, BACTERIAL ARYL SULFOTRANSFERASE (ASST) SOAKED WITH HUMAN URINE
1482, 2hb0B, 0.5525, 2.97, 0.045, 355, 66, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1483, 5gztB, 0.5524, 3.18, 0.045, 1134, 67, CRYSTAL STRUCTURE OF CHITINASE CHIW FROM PAENIBACILLUS SP. STR. FPU-7 REVEALS A NOVEL TYPE OF BACTERIAL CELL-SURFACE-EXPRESSED MULTI- MODULAR ENZYME MACHINERY
1484, 5acfA, 0.5524, 3.29, 0.074, 234, 68, X-RAY STRUCTURE OF LPMO
1485, 4v5qTC, 0.5524, 3.49, 0.095, 228, 74, 
1486, 4cdhA, 0.5524, 3.60, 0.090, 206, 67, CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT
1487, 3t2fA, 0.5524, 3.21, 0.130, 389, 69, FRUCTOSE-16-BISPHOSPHATE ALDOLASE/PHOSPHATASE FROM THERMOPROTEUS NEUTROPHILUS SOAKED WITH EDTA AND DHAP
1488, 3f7pE, 0.5524, 3.05, 0.136, 212, 66, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN INTEGRIN BETA4 AND PLECTIN
1489, 1lwrA, 0.5524, 3.00, 0.154, 96, 65, SOLUTION STRUCTURE OF THE NCAM FIBRONECTIN TYPE III MODULE 2
1490, 1bjmB, 0.5524, 3.70, 0.088, 215, 68, LOC NAKS A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4
1491, 5thpC, 0.5523, 3.19, 0.119, 190, 67, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
1492, 4w4nA, 0.5523, 3.54, 0.090, 206, 67, CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A
1493, 4rf9B, 0.5523, 3.52, 0.081, 686, 74, CRYSTAL STRUCTURE OF DOUBLE-DOMAIN ARGININE KINASE FROM ANTHOPLEURA JAPONICAS IN COMPLEX WITH L-ARGININE AND ATPGS
1494, 4nwnP, 0.5523, 3.31, 0.045, 157, 67, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1495, 4nwnL, 0.5523, 3.33, 0.030, 157, 67, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1496, 4nqsB, 0.5523, 3.41, 0.091, 207, 66, KNOB-INTO-HOLE IGG FC
1497, 3risB, 0.5523, 2.81, 0.111, 227, 63, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UCHL5 A PROTEASOME- ASSOCIATED HUMAN DEUBIQUITINATING ENZYME REVEALS AN UNPRODUCTIVE FORM OF THE ENZYME
1498, 2xwbD, 0.5523, 3.57, 0.132, 901, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
1499, 5oamK, 0.5522, 3.52, 0.066, 328, 76, MOLECULAR BASIS OF HUMAN KINESIN-8 FUNCTION AND INHIBITION
1500, 5ggtA, 0.5522, 3.38, 0.103, 116, 68, PD-L1 IN COMPLEX WITH BMS-936559 FAB
1501, 4p05B, 0.5522, 3.38, 0.103, 564, 68, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- NITROPHENYL SULFATE (PNS) IN THE ACTIVE SITE
1502, 3t0eE, 0.5522, 2.96, 0.061, 365, 66, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
1503, 6bhyA, 0.5521, 3.57, 0.045, 209, 67, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH SINGLE GLCNAC
1504, 5w59B, 0.5521, 3.14, 0.031, 208, 65, CRYSTAL STRUCTURE OF A MONOMERIC HUMAN FGF9 IN COMPLEX WITH THE ECTODOMAIN OF HUMAN FGFR1C
1505, 5tugD, 0.5521, 3.51, 0.072, 130, 69, ARCHAELLUM PERIPLASMIC STATOR PROTEIN COMPLEX FLAF AND FLAG FROM SULFOLOBUS ACIDOCALDARIUS
1506, 4x99A, 0.5521, 3.58, 0.090, 208, 67, IMMUNOGLOBULIN FC HETERODIMERS VARIANT
1507, 4dmuD, 0.5521, 3.09, 0.121, 188, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
1508, 3s9dB, 0.5521, 3.11, 0.091, 180, 66, BINARY COMPLEX BETWEEN IFNA2 AND IFNAR2
1509, 3b83B, 0.5521, 3.16, 0.106, 92, 66, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1510, 6ndhF, 0.5520, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
1511, 6ndcI, 0.5520, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
1512, 6n8oW, 0.5520, 3.31, 0.000, 210, 73, struct.pdbx_descriptor               pre-60S ribosomal subunit  
1513, 5l2hC, 0.5520, 3.19, 0.106, 97, 66, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
1514, 5e6sE, 0.5520, 3.32, 0.088, 580, 68, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1515, 4v7eNA, 0.5520, 3.39, 0.068, 216, 74, 
1516, 3h20A, 0.5520, 3.10, 0.101, 288, 69, CRYSTAL STRUCTURE OF PRIMASE REPB 
1517, 6ndgF, 0.5519, 3.42, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
1518, 6ndbF, 0.5519, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
1519, 6nd8I, 0.5519, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
1520, 4wi3B, 0.5519, 3.44, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A
1521, 4v5zGC, 0.5519, 3.12, 0.139, 210, 72, 
1522, 4kkpA, 0.5519, 3.20, 0.092, 229, 65, CRYSTAL STRUCTURE OF VIBRIO CHOLERAE RBMA (CRYSTAL FORM 2)
1523, 3aveA, 0.5519, 3.62, 0.090, 211, 67, CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
1524, 2iceE, 0.5519, 3.50, 0.152, 183, 66, CRIG BOUND TO C3C
1525, 2ekjA, 0.5519, 3.13, 0.045, 105, 66, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN COLLAGEN ALPHA-1(XX) CHAIN
1526, 2arwA, 0.5519, 3.32, 0.045, 103, 66, THE SOLUTION STRUCTURE OF THE MEMBRANE PROXIMAL CYTOKINE RECEPTOR DOMAIN OF THE HUMAN INTERLEUKIN-6 RECEPTOR
1527, 6nnvC, 0.5518, 3.42, 0.076, 123, 66, PD-L1 IGV DOMAIN COMPLEX WITH MACRO-CYCLIC PEPTIDE 
1528, 6d4iB, 0.5518, 3.55, 0.075, 209, 67, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2 
1529, 6bhqA, 0.5518, 3.48, 0.045, 208, 67, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN
1530, 5vu0B, 0.5518, 3.42, 0.091, 216, 66, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS 
1531, 5od0H, 0.5518, 3.63, 0.090, 215, 67, CRYSTAL STRUCTURE OF ACPA E4 
1532, 5lknA, 0.5518, 3.00, 0.092, 103, 65, NMR SOLUTION STRUCTURE OF HUMAN FNIII DOMAIN 2 OF NCAM
1533, 4wi3A, 0.5518, 3.44, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A
1534, 4v6xLA, 0.5518, 3.28, 0.111, 217, 72, 
1535, 3s9dD, 0.5518, 3.08, 0.092, 186, 65, BINARY COMPLEX BETWEEN IFNA2 AND IFNAR2
1536, 1tenA, 0.5518, 3.11, 0.106, 89, 66, STRUCTURE OF A FIBRONECTIN TYPE III DOMAIN FROM TENASCIN PHASED BY MAD ANALYSIS OF THE SELENOMETHIONYL PROTEIN
1537, 6nm7B, 0.5517, 3.34, 0.088, 126, 68, PD-L1 IGV DOMAIN BOUND TO FRAGMENT 
1538, 6nm7A, 0.5517, 3.35, 0.103, 126, 68, PD-L1 IGV DOMAIN BOUND TO FRAGMENT 
1539, 5jpnA, 0.5517, 3.25, 0.090, 651, 67, STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF
1540, 5j7cD, 0.5517, 2.84, 0.062, 98, 64, A PICOMOLAR AFFINITY FN3 DOMAIN IN COMPLEX WITH HEN EGG-WHITE LYSOZYME
1541, 5hy9A, 0.5517, 3.61, 0.090, 207, 67, GLYCOSYLATED DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT
1542, 5hauIB, 0.5517, 3.46, 0.108, 135, 74, 
1543, 4wi5B, 0.5517, 3.34, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A
1544, 4c2bE, 0.5517, 3.12, 0.149, 199, 67, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
1545, 3b83F, 0.5517, 3.13, 0.121, 92, 66, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1546, 2ygtA, 0.5517, 3.17, 0.062, 282, 65, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
1547, 5it7SA, 0.5516, 3.34, 0.095, 217, 74, 
1548, 4x0rA, 0.5516, 3.14, 0.083, 201, 60, CRYSTAL STRUCTURE OF HUMAN MXB STALK DOMAIN
1549, 4wi5A, 0.5516, 3.34, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A
1550, 4qqqA, 0.5516, 2.84, 0.048, 483, 62, CRYSTAL STRUCTURE OF PNEUMOLYSIN FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MANNOSE AS A COMPONENT OF CELL MEMBRANE
1551, 1kv3C, 0.5516, 3.40, 0.074, 651, 68, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1552, 1i85C, 0.5516, 3.18, 0.101, 118, 69, CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX
1553, 6f2zA, 0.5515, 3.41, 0.091, 209, 66, STRUCTURE OF A FC MUTATNT 
1554, 6d4iA, 0.5515, 3.71, 0.074, 209, 68, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2 
1555, 5o4yB, 0.5515, 3.32, 0.103, 118, 68, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
1556, 5gsqB, 0.5515, 3.44, 0.091, 208, 66, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
1557, 5boaA, 0.5515, 3.51, 0.088, 194, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB BOUND TO THE DISACCHARIDE RECEPTOR GB2
1558, 3va2C, 0.5515, 3.19, 0.092, 307, 65, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-5 IN COMPLEX WITH ITS ALPHA RECEPTOR
1559, 3hxoA, 0.5515, 3.24, 0.162, 199, 68, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
1560, 1mcjA, 0.5515, 3.68, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1561, 5hyiC, 0.5514, 3.59, 0.090, 208, 67, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
1562, 4p94A, 0.5514, 3.51, 0.072, 116, 69, THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF (RESIDUES 35-164)
1563, 4cr4W, 0.5514, 3.26, 0.043, 197, 70, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1564, 3l2pA, 0.5514, 3.09, 0.092, 535, 65, HUMAN DNA LIGASE III RECOGNIZES DNA ENDS BY DYNAMIC SWITCHING BETWEEN TWO DNA BOUND STATES
1565, 6ndhI, 0.5513, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
1566, 6ndbI, 0.5513, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
1567, 6nd8L, 0.5513, 3.28, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
1568, 6n8nU, 0.5513, 3.32, 0.000, 210, 73, struct.pdbx_descriptor               pre-60S ribosomal subunit  
1569, 6j2qRA, 0.5513, 3.19, 0.072, 197, 69, struct.pdbx_descriptor              
1570, 5f7hC, 0.5513, 3.31, 0.076, 111, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4) COMPLEX WITH PHOSPHOSERINE
1571, 4tnwg, 0.5513, 3.60, 0.104, 211, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1572, 1mclA, 0.5513, 3.68, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1573, 6ndbC, 0.5512, 3.45, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
1574, 5wx8C, 0.5512, 2.65, 0.047, 160, 64, HUMAN HERPESVIRUS 6A IMMEDIATE EARLY PROTEIN 2 C-TERMINAL DOMAIN
1575, 2ov7C, 0.5512, 3.43, 0.096, 128, 73, THE FIRST DOMAIN OF THE RIBOSOMAL PROTEIN L1 FROM THERMUS THERMOPHILUS
1576, 2lrgA, 0.5512, 2.48, 0.066, 126, 61, NMR STRUCTURE OF THE PROTEIN YP_001300941.1 FROM BACTEROIDES VULGATUS
1577, 1mcsB, 0.5512, 3.71, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1578, 1kv3A, 0.5512, 3.39, 0.074, 651, 68, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1579, 5yc5A, 0.5511, 3.62, 0.090, 211, 67, CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA
1580, 5boaC, 0.5511, 3.34, 0.088, 198, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB BOUND TO THE DISACCHARIDE RECEPTOR GB2
1581, 4qg3A, 0.5511, 3.49, 0.095, 228, 74, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN G219V TTHL1 IN COMPLEX WITH 80NT 23S RNA FROM THERMUS THERMOPHILUS
1582, 2j6eA, 0.5511, 3.39, 0.091, 209, 66, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
1583, 6ndhC, 0.5510, 3.45, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
1584, 6ndcF, 0.5510, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
1585, 6nd8C, 0.5510, 3.40, 0.116, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
1586, 6j8jC, 0.5510, 3.27, 0.045, 120, 66, STRUCTURE OF HUMAN VOLTAGE-GATED SODIUM CHANNEL NAV1.7 IN COMPLEX WITH AUXILIARY BETA SUBUNITS; PROTX-II AND TETRODOTOXIN (Y1755 DOWN) 
1587, 6j8iC, 0.5510, 3.27, 0.045, 120, 66, STRUCTURE OF HUMAN VOLTAGE-GATED SODIUM CHANNEL NAV1.7 IN COMPLEX WITH AUXILIARY BETA SUBUNITS; PROTX-II AND TETRODOTOXIN (Y1755 UP) 
1588, 6j8hC, 0.5510, 3.27, 0.045, 120, 66, STRUCTURE OF HUMAN VOLTAGE-GATED SODIUM CHANNEL NAV1.7 IN COMPLEX WITH AUXILIARY BETA SUBUNITS; HUWENTOXIN-IV AND SAXITOXIN (Y1755 DOWN) 
1589, 6j8gC, 0.5510, 3.27, 0.045, 120, 66, STRUCTURE OF HUMAN VOLTAGE-GATED SODIUM CHANNEL NAV1.7 IN COMPLEX WITH AUXILIARY BETA SUBUNITS; HUWENTOXIN-IV AND SAXITOXIN (Y1755 UP) 
1590, 5dvnA, 0.5510, 3.42, 0.091, 208, 66, FC K392D/K409D HOMODIMER
1591, 4dz8A, 0.5510, 3.58, 0.090, 209, 67, HUMAN IGG1 FC FRAGMENT HETERODIMER
1592, 3aveB, 0.5510, 3.39, 0.091, 208, 66, CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
1593, 1l6xA, 0.5510, 3.56, 0.090, 207, 67, FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
1594, 1kv3D, 0.5510, 3.40, 0.074, 651, 68, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1595, 1kv3B, 0.5510, 3.40, 0.074, 651, 68, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1596, 5x8lA, 0.5509, 3.16, 0.106, 113, 66, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
1597, 5niuD, 0.5509, 3.24, 0.119, 127, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1598, 5h5tB, 0.5509, 3.51, 0.072, 195, 69, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SALMONELLA TYPHIMURIUM
1599, 4uf5A, 0.5509, 3.51, 0.030, 293, 67, CRYSTAL STRUCTURE OF UCH-L5 IN COMPLEX WITH INHIBITORY FRAGMENT OF INO80G
1600, 4kjyA, 0.5509, 3.35, 0.088, 113, 68, COMPLEX OF HIGH-AFFINITY SIRP ALPHA VARIANT FD6 WITH CD47
1601, 3wknD, 0.5509, 3.57, 0.090, 209, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1602, 6nm8B, 0.5508, 3.25, 0.104, 126, 67, IGV-V76T BMS COMPOUND 105 
1603, 6ndcC, 0.5508, 3.41, 0.116, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
1604, 6hyfB, 0.5508, 3.24, 0.134, 100, 67, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN FROM RAT BETA4 INTEGRIN; A BINDING SITE FOR PERIAXIN 
1605, 4v65YA, 0.5508, 3.34, 0.041, 213, 73, 
1606, 4fxkA, 0.5508, 3.21, 0.090, 651, 67, HUMAN COMPLEMENT C4
1607, 2mcg1, 0.5508, 3.77, 0.088, 215, 68, THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
1608, 1bjmA, 0.5508, 3.71, 0.088, 215, 68, LOC NAKS A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4
1609, 5lg1B, 0.5507, 3.38, 0.106, 208, 66, ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU
1610, 4v42BA, 0.5507, 3.49, 0.108, 224, 74, 
1611, 4fxgA, 0.5507, 3.31, 0.075, 651, 67, COMPLEMENT C4 IN COMPLEX WITH MASP-2
1612, 4eq2A, 0.5507, 3.29, 0.191, 206, 68, CRYSTAL STRUCTURE ANALYSIS OF CHICKEN INTERFERON GAMMA RECEPTOR ALPHA CHAIN
1613, 487dH, 0.5507, 3.49, 0.108, 224, 74, SEVEN RIBOSOMAL PROTEINS FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP OF THE LARGE 50S SUBUNIT AT 7.5 ANGSTROMS RESOLUTION
1614, 3wvrA, 0.5507, 3.23, 0.123, 423, 65, STRUCTURE OF ATP GRASP PROTEIN WITH AMP
1615, 3wn5A, 0.5507, 3.43, 0.091, 212, 66, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
1616, 2rgsB, 0.5507, 3.57, 0.045, 207, 67, FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
1617, 1oakA, 0.5507, 3.22, 0.147, 196, 68, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
1618, 1ml5c, 0.5507, 3.49, 0.108, 224, 74, STRUCTURE OF THE E. COLI RIBOSOMAL TERMINATION COMPLEX WITH RELEASE FACTOR 2
1619, 1ad2A, 0.5507, 3.49, 0.108, 224, 74, RIBOSOMAL PROTEIN L1 MUTANT WITH SERINE 179 REPLACED BY CYSTEINE
1620, 6nnvA, 0.5506, 3.29, 0.103, 119, 68, PD-L1 IGV DOMAIN COMPLEX WITH MACRO-CYCLIC PEPTIDE 
1621, 6nddC, 0.5506, 3.37, 0.103, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
1622, 4qviA, 0.5506, 3.53, 0.095, 229, 74, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN M218L TTHL1 IN COMPLEX WITH 80NT 23S RNA FROM THERMUS THERMOPHILUS
1623, 4fxgD, 0.5506, 3.31, 0.075, 651, 67, COMPLEMENT C4 IN COMPLEX WITH MASP-2
1624, 4eq3A, 0.5506, 3.24, 0.194, 203, 67, CRYSTAL STRUCTURE ANALYSIS OF SELENOMETHIONINE (SE-MET) SUBSTITUTED CHICKEN INTERFERON GAMMA RECEPTOR ALPHA CHAIN
1625, 3dj9A, 0.5506, 3.57, 0.090, 107, 67, CRYSTAL STRUCTURE OF AN ISOLATED UNGLYCOSYLATED ANTIBODY CH2 DOMAIN
1626, 2dtsB, 0.5506, 3.44, 0.091, 208, 66, CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
1627, 1mcdA, 0.5506, 3.64, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1628, 1kv3E, 0.5506, 3.55, 0.072, 651, 69, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1629, 1fnsA, 0.5506, 3.09, 0.149, 196, 67, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
1630, 5uq7BB, 0.5505, 3.34, 0.096, 225, 73, 70S ribosome complex with dnaX mRNA stemloop and E-site tRNA ( in  conformation)
1631, 5m2eD, 0.5505, 3.22, 0.072, 418, 69, struct.pdbx_descriptor               Isocitrate dehydrogenase [NADP] (E.C.1.1.1.42)  
1632, 5j8oA, 0.5505, 3.26, 0.104, 122, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1633, 5iw6A, 0.5505, 3.61, 0.090, 209, 67, ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT
1634, 4zqkA, 0.5505, 3.46, 0.103, 115, 68, STRUCTURE OF THE COMPLEX OF HUMAN PROGRAMMED DEATH-1 (PD-1) AND ITS LIGAND PD-L1.
1635, 3qt2A, 0.5505, 3.15, 0.092, 307, 65, STRUCTURE OF A CYTOKINE LIGAND-RECEPTOR COMPLEX
1636, 3irzA, 0.5505, 3.45, 0.088, 398, 68, CRYSTAL STRUCTURE OF FUNCTIONAL REGION OF UAFA FROM STAPHYLOCOCCUS SAPROPHYTICUS IN P212121 FORM
1637, 1lilA, 0.5505, 3.70, 0.074, 212, 68, BENCE JONES PROTEIN CLE A LAMBDA III IMMUNOGLOBULIN LIGHT- CHAIN DIMER
1638, 5v4eG, 0.5504, 3.54, 0.104, 219, 67, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
1639, 5i0xA, 0.5504, 3.27, 0.088, 153, 68, COPPER-BOUND M90I VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
1640, 5e6sC, 0.5504, 3.31, 0.088, 578, 68, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1641, 4zflI, 0.5504, 3.50, 0.111, 229, 72, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
1642, 4w4oA, 0.5504, 3.54, 0.090, 215, 67, HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI
1643, 4uosA, 0.5504, 2.18, 0.182, 188, 55, THERMODYNAMIC HYPERSTABILITY IN PARAMETRICALLY DESIGNED HELICAL BUNDLES
1644, 4iipA, 0.5504, 2.92, 0.079, 305, 63, LEGIONELLA PNEUMOPHILA EFFECTOR
1645, 4hulB, 0.5504, 3.16, 0.046, 91, 65, MATE TRANSPORTER NORM-NG IN COMPLEX WITH CS+ AND MONOBODY
1646, 3hrzA, 0.5504, 3.22, 0.075, 614, 67, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
1647, 1zlgA, 0.5504, 3.47, 0.119, 680, 67, SOLUTION STRUCTURE OF THE EXTRACELLULAR MATRIX PROTEIN ANOSMIN-1
1648, 5v4eD, 0.5503, 3.64, 0.104, 200, 67, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
1649, 5hj2F, 0.5503, 3.35, 0.103, 195, 68, INTEGRIN ALPHA2BETA1 I-DOMAIN
1650, 5e6rA, 0.5503, 3.24, 0.088, 581, 68, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1651, 4v8mQA, 0.5503, 3.38, 0.055, 214, 73, 
1652, 4v4aAB, 0.5503, 3.33, 0.120, 213, 75, 
1653, 4v49DB, 0.5503, 3.33, 0.120, 213, 75, 
1654, 4ov6F, 0.5503, 3.13, 0.062, 99, 65, CRYSTAL STRUCTURE OF PCSK9(53-451) WITH ADNECTIN
1655, 3gn6A, 0.5503, 2.99, 0.015, 288, 67, CRYSTAL STRUCTURE OF CT0912 ORFAN PROTEIN FROM CHLOROBIUM TEPIDUM WITH A FERREDOXIN-LIKE DOMAIN REPEAT (NP_661805.1) FROM CHLOROBIUM TEPIDUM TLS AT 1.80 A RESOLUTION
1656, 2vkxE, 0.5503, 2.98, 0.108, 202, 65, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
1657, 1v94B, 0.5503, 3.27, 0.071, 423, 70, CRYSTAL STRUCTURE OF ISOCITRATE DEHYDROGENASE FROM AEROPYRUM PERNIX
1658, 1mccB, 0.5503, 3.70, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1659, 5niuB, 0.5502, 3.27, 0.104, 125, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1660, 5f7fB, 0.5502, 3.28, 0.077, 113, 65, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4)
1661, 3rzwA, 0.5502, 3.01, 0.077, 89, 65, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-9 BOUND TO HUMAN SUMO1
1662, 3pvmA, 0.5502, 3.44, 0.103, 1627, 68, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
1663, 3b83H, 0.5502, 3.14, 0.106, 94, 66, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1664, 1mzpA, 0.5502, 3.33, 0.120, 213, 75, STRUCTURE OF THE L1 PROTUBERANCE IN THE RIBOSOME
1665, 1kv3F, 0.5502, 3.40, 0.074, 651, 68, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1666, 6fvwCA, 0.5501, 3.29, 0.029, 197, 70, struct.pdbx_descriptor              
1667, 5xmhA, 0.5501, 3.35, 0.091, 208, 66, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
1668, 5vfuH, 0.5501, 3.20, 0.043, 191, 69, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1669, 5t0ib, 0.5501, 3.20, 0.043, 191, 69, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1670, 4csu5, 0.5501, 3.00, 0.103, 234, 68, CRYO-EM STRUCTURES OF THE 50S RIBOSOME SUBUNIT BOUND WITH OBGE
1671, 4bjlB, 0.5501, 3.70, 0.088, 215, 68, LOCW A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER
1672, 1mcbB, 0.5501, 3.73, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1673, 6cjcA, 0.5500, 3.42, 0.091, 207, 66, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 3) 
1674, 5vmeA, 0.5500, 3.58, 0.090, 207, 67, CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E T437R MUTANT
1675, 5n2fA, 0.5500, 3.59, 0.059, 126, 68, STRUCTURE OF PD-L1/SMALL-MOLECULE INHIBITOR COMPLEX
1676, 5e95B, 0.5500, 3.00, 0.125, 92, 64, CRYSTAL STRUCTURE OF MB(NS1)/H-RAS COMPLEX
1677, 4v6wLA, 0.5500, 3.33, 0.125, 217, 72, 
1678, 4hagA, 0.5500, 3.61, 0.090, 208, 67, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (CENTERED CRYSTAL FORM)
1679, 4d2nD, 0.5500, 3.41, 0.091, 209, 66, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
1680, 4bjlA, 0.5500, 3.61, 0.090, 215, 67, LOCW A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER
1681, 3wvqC, 0.5500, 3.19, 0.125, 423, 64, STRUCTURE OF ATP GRASP PROTEIN
1682, 3wknA, 0.5500, 3.53, 0.090, 209, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1683, 2fnbA, 0.5500, 2.99, 0.065, 95, 62, NMR STRUCTURE OF THE FIBRONECTIN ED-B DOMAIN NMR 20 STRUCTURES
1684, 6e3lC, 0.5499, 3.06, 0.108, 204, 65, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1685, 5wviT, 0.5499, 3.59, 0.043, 197, 70, 
1686, 5k65B, 0.5499, 3.38, 0.091, 212, 66, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)
1687, 4nwnF, 0.5499, 3.35, 0.030, 157, 67, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1688, 3v7mA, 0.5499, 3.65, 0.090, 209, 67, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+
1689, 3lzpA, 0.5499, 3.37, 0.059, 159, 68, CRYSTAL STRUCTURE ANALYSIS OF THE  AS-ISOLATED  P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 9.0
1690, 3g9vC, 0.5499, 3.27, 0.075, 176, 67, CRYSTAL STRUCTURE OF A SOLUBLE DECOY RECEPTOR IL-22BP BOUND TO INTERLEUKIN-22
1691, 3dnkB, 0.5499, 3.35, 0.091, 210, 66, ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
1692, 1nj9A, 0.5499, 3.58, 0.119, 212, 67, COCAINE HYDROLYTIC ANTIBODY 15A10
1693, 1ngpL, 0.5499, 3.72, 0.118, 211, 68, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1694, 1mcrB, 0.5499, 3.57, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1695, 1m15A, 0.5499, 3.40, 0.068, 356, 73, TRANSITION STATE STRUCTURE OF ARGININE KINASE
1696, 1i2aA, 0.5499, 3.17, 0.137, 212, 73, CRYSTAL STRUCTURE OF L1 RIBOSOMAL PROTEIN FROM METHANOCOCCUS JANNASCHII WITH 1.85A RESOLUTION.
1697, 4v8yAC, 0.5498, 3.36, 0.096, 225, 73, 
1698, 1bg0A, 0.5498, 3.60, 0.068, 356, 74, TRANSITION STATE STRUCTURE OF ARGININE KINASE
1699, 6ndhL, 0.5497, 3.28, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
1700, 6fczK, 0.5497, 3.55, 0.090, 210, 67, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
1701, 5v4eE, 0.5497, 3.46, 0.106, 208, 66, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
1702, 2oypA, 0.5497, 3.27, 0.092, 109, 65, T CELL IMMUNOGLOBULIN MUCIN-3 CRYSTAL STRUCTURE REVEALED A GALECTIN-9- INDEPENDENT BINDING SURFACE
1703, 6np9A, 0.5496, 3.07, 0.108, 122, 65, PD-L1 IGV DOMAIN V76T WITH FRAGMENT 
1704, 6ndbL, 0.5496, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
1705, 5y56A, 0.5496, 3.61, 0.090, 208, 67, FC MUTANT (K392D/K409D/D399K)
1706, 5dc4B, 0.5496, 3.16, 0.108, 92, 65, CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX CRYSTAL A
1707, 3hi6B, 0.5496, 3.30, 0.075, 180, 67, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
1708, 1qcnA, 0.5496, 3.48, 0.164, 400, 67, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE
1709, 1mciB, 0.5496, 3.61, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1710, 1fnaA, 0.5496, 3.16, 0.061, 91, 66, CRYSTAL STRUCTURE OF THE TENTH TYPE III CELL ADHESION MODULE OF HUMAN FIBRONECTIN
1711, 6n9tA, 0.5495, 3.56, 0.090, 207, 67, STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC 
1712, 4nqsH, 0.5495, 3.43, 0.091, 207, 66, KNOB-INTO-HOLE IGG FC
1713, 4cr2W, 0.5495, 3.46, 0.070, 197, 71, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1714, 3k71G, 0.5495, 3.46, 0.074, 1082, 68, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
1715, 6n9tB, 0.5494, 3.57, 0.090, 207, 67, STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC 
1716, 6iqhB, 0.5494, 3.63, 0.090, 207, 67, X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE 
1717, 5n2dC, 0.5494, 3.27, 0.104, 127, 67, STRUCTURE OF PD-L1/SMALL-MOLECULE INHIBITOR COMPLEX
1718, 6bhyB, 0.5493, 3.61, 0.045, 207, 67, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH SINGLE GLCNAC
1719, 5jtwA, 0.5493, 3.42, 0.088, 651, 68, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
1720, 5jpmA, 0.5493, 3.47, 0.088, 651, 68, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
1721, 5d6dA, 0.5493, 3.58, 0.090, 209, 67, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA
1722, 4zneE, 0.5493, 3.43, 0.091, 215, 66, IGG1 FC-FCGAMMARI ECD COMPLEX
1723, 4v5gTC, 0.5493, 3.45, 0.108, 228, 74, 
1724, 4m61D, 0.5493, 3.18, 0.095, 220, 63, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
1725, 4dohB, 0.5493, 3.11, 0.156, 193, 64, IL20/IL201/IL20R2 TERNARY COMPLEX
1726, 3wknN, 0.5493, 3.71, 0.088, 210, 68, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1727, 2xtlB, 0.5493, 3.38, 0.103, 452, 68, STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE
1728, 2rgsA, 0.5493, 3.61, 0.149, 206, 67, FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
1729, 1umgA, 0.5493, 3.09, 0.130, 359, 69, CRYSTAL STRUCTURE OF FRUCTOSE-16-BISPHOSPHATASE
1730, 5boaE, 0.5492, 3.35, 0.088, 191, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB BOUND TO THE DISACCHARIDE RECEPTOR GB2
1731, 4v5pTC, 0.5492, 3.50, 0.095, 228, 74, 
1732, 4v5pMA, 0.5492, 3.50, 0.095, 228, 74, 
1733, 4dohD, 0.5492, 3.08, 0.143, 193, 63, IL20/IL201/IL20R2 TERNARY COMPLEX
1734, 3wn5D, 0.5492, 3.42, 0.091, 212, 66, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
1735, 3wjjB, 0.5492, 3.51, 0.090, 206, 67, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(P238D) IN COMPLEX WITH FCGRIIB
1736, 3bpoC, 0.5492, 3.37, 0.104, 286, 67, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
1737, 1dclA, 0.5492, 3.73, 0.088, 216, 68, MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED FROM AMMONIUM SULFATE
1738, 4q6yA, 0.5491, 3.37, 0.091, 208, 66, CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)
1739, 4iikA, 0.5491, 3.30, 0.077, 303, 65, LEGIONELLA PNEUMOPHILA EFFECTOR
1740, 4dmuH, 0.5491, 3.17, 0.134, 187, 67, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
1741, 3nrpC, 0.5491, 3.29, 0.088, 151, 68, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
1742, 3c2sA, 0.5491, 3.63, 0.090, 210, 67, STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS
1743, 2x31A, 0.5491, 3.08, 0.078, 187, 64, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
1744, 6r3kD, 0.5490, 3.38, 0.103, 127, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR 
1745, 6r3kA, 0.5490, 3.35, 0.103, 126, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR 
1746, 5nixD, 0.5490, 3.38, 0.103, 127, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1747, 5nixA, 0.5490, 3.35, 0.103, 126, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1748, 5e6uA, 0.5490, 3.23, 0.088, 583, 68, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1749, 4wqyHB, 0.5490, 3.49, 0.095, 137, 74, 
1750, 4wqyC, 0.5490, 3.49, 0.095, 137, 74, 
1751, 4wquJB, 0.5490, 3.49, 0.095, 137, 74, 
1752, 4wquC, 0.5490, 3.49, 0.095, 137, 74, 
1753, 4wqfIB, 0.5490, 3.49, 0.095, 137, 74, 
1754, 4wqfC, 0.5490, 3.49, 0.095, 137, 74, 
1755, 4wpoJB, 0.5490, 3.49, 0.095, 137, 74, 
1756, 4wpoC, 0.5490, 3.49, 0.095, 137, 74, 
1757, 4v90KA, 0.5490, 3.49, 0.095, 227, 74, 
1758, 4v5gMA, 0.5490, 3.46, 0.108, 228, 74, 
1759, 4f24A, 0.5490, 3.00, 0.106, 334, 66, CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB
1760, 4byhA, 0.5490, 3.61, 0.090, 207, 67, CRYSTAL STRUCTURE OF SIALYLATED IGG FC
1761, 3tcxL, 0.5490, 3.22, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1762, 2cgrH, 0.5490, 3.32, 0.094, 214, 64, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
1763, 3wn5E, 0.5489, 3.74, 0.088, 210, 68, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
1764, 3tcxN, 0.5489, 3.22, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1765, 2xtlA, 0.5489, 3.38, 0.103, 449, 68, STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE
1766, 6df3H, 0.5488, 3.31, 0.138, 190, 65, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF IL-24 WITH SOLUBLE RECEPTORS IL-22RA AND IL-20RB 
1767, 5u52A, 0.5488, 3.61, 0.090, 207, 67, HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)
1768, 5o45A, 0.5488, 3.36, 0.088, 129, 68, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
1769, 5ggvY, 0.5488, 3.27, 0.118, 119, 68, CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB
1770, 3k6sA, 0.5488, 3.40, 0.075, 1082, 67, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
1771, 1f4yL, 0.5488, 3.71, 0.118, 210, 68, CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1772, 5zhqB, 0.5487, 3.28, 0.085, 355, 71, CRYSTAL STRUCTURE OF SCYLLA PARAMAMOSAIN ARGININE KINASE 
1773, 5iusD, 0.5487, 3.31, 0.104, 211, 67, CRYSTAL STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH HIGH AFFINITY PD-1 MUTANT
1774, 4v9kY, 0.5487, 2.93, 0.119, 228, 67, 
1775, 4humB, 0.5487, 3.04, 0.048, 91, 63, MATE TRANSPORTER NORM-NG IN COMPLEX WITH ETHIDIUM AND MONOBODY
1776, 3tcxb, 0.5487, 3.22, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1777, 3r1mA, 0.5487, 3.11, 0.130, 356, 69, STRUCURE OF BIFUNCTIONAL FRUCTOSE 16-BISPHOSPHATE ALDOLASE/PHOSPHATASE (ALDOLASE FORM)
1778, 3g9vA, 0.5487, 3.21, 0.090, 173, 67, CRYSTAL STRUCTURE OF A SOLUBLE DECOY RECEPTOR IL-22BP BOUND TO INTERLEUKIN-22
1779, 3ay4B, 0.5487, 3.43, 0.091, 216, 66, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1780, 2vuoB, 0.5487, 3.73, 0.103, 214, 68, CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
1781, 1mjnA, 0.5487, 3.34, 0.074, 179, 68, CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT
1782, 6hyfA, 0.5486, 3.14, 0.106, 106, 66, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN FROM RAT BETA4 INTEGRIN; A BINDING SITE FOR PERIAXIN 
1783, 6cjxA, 0.5486, 3.59, 0.090, 208, 67, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 2) 
1784, 5v4eA, 0.5486, 3.57, 0.104, 218, 67, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
1785, 5o9xA, 0.5486, 3.71, 0.059, 541, 68, CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS N-ACETYLPHOSPHOGLUCOSAMINE MUTATE S69A IN COMPLEX WITH GLUCOSE1;6BISPHOSPHATE 
1786, 5f7fA, 0.5486, 3.29, 0.077, 113, 65, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4)
1787, 4d2nB, 0.5486, 3.61, 0.090, 206, 67, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
1788, 3zojA, 0.5486, 3.30, 0.045, 262, 67, HIGH-RESOLUTION STRUCTURE OF PICHIA PASTORIS AQUAPORIN AQY1 AT 0.88 A
1789, 3tcxZ, 0.5486, 3.22, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1790, 2w1pA, 0.5486, 3.31, 0.045, 263, 67, 1.4 ANGSTROM CRYSTAL STRUCTURE OF P.PASTORIS AQUAPORIN AQY1 IN A CLOSED CONFORMATION AT PH 8.0
1791, 1u0oC, 0.5486, 3.30, 0.162, 195, 68, THE MOUSE VON WILLEBRAND FACTOR A1-BOTROCETIN COMPLEX
1792, 6igoA, 0.5485, 3.41, 0.045, 120, 66, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
1793, 6a67L, 0.5485, 3.52, 0.091, 212, 66, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
1794, 4xamA, 0.5485, 3.44, 0.088, 651, 68, COMPLEMENT COMPONENT C4B
1795, 4wzdAA, 0.5485, 3.49, 0.095, 135, 74, 
1796, 4nquA, 0.5485, 3.48, 0.091, 208, 66, ANTI-PARALLEL FC-KNOB (T366W) HOMODIMER
1797, 4nqtA, 0.5485, 3.69, 0.090, 208, 67, ANTI-PARALLEL FC-HOLE(T366S/L368A/Y407V) HOMODIMER
1798, 3wknB, 0.5485, 3.64, 0.090, 210, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1799, 3f74C, 0.5485, 3.18, 0.090, 180, 67, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
1800, 3au0A, 0.5485, 3.00, 0.106, 339, 66, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
1801, 6nosB, 0.5484, 3.34, 0.103, 126, 68, PD-L1 IGV DOMAIN V76T WITH FRAGMENT 
1802, 6ndeI, 0.5484, 3.32, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
1803, 4jjhA, 0.5484, 3.42, 0.090, 111, 67, CRYSTAL STRUCTURE OF THE D1 DOMAIN FROM HUMAN NECTIN-4 EXTRACELLULAR FRAGMENT [PSI-NYSGRC-005624]
1804, 3wjjA, 0.5484, 3.41, 0.091, 212, 66, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(P238D) IN COMPLEX WITH FCGRIIB
1805, 3uyoD, 0.5484, 3.14, 0.092, 94, 65, CRYSTAL STRUCTURE OF MONOBODY SH13/ABL1 SH2 DOMAIN COMPLEX
1806, 2ql1A, 0.5484, 3.75, 0.088, 209, 68, STRUCTURAL CHARACTERIZATION OF A MUTATED ADCC-ENHANCED HUMAN FC FRAGMENT
1807, 6nm8A, 0.5483, 3.41, 0.060, 125, 67, IGV-V76T BMS COMPOUND 105 
1808, 6ndfC, 0.5483, 3.49, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
1809, 5werL, 0.5483, 3.39, 0.094, 312, 64, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
1810, 5niuA, 0.5483, 3.31, 0.103, 126, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1811, 4zbhA, 0.5483, 3.56, 0.072, 119, 69, THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF
1812, 4xamB, 0.5483, 3.44, 0.088, 651, 68, COMPLEMENT COMPONENT C4B
1813, 4tnvg, 0.5483, 3.69, 0.118, 211, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1814, 2w2eA, 0.5483, 3.31, 0.045, 263, 67, 1.15 ANGSTROM CRYSTAL STRUCTURE OF P.PASTORIS AQUAPORIN AQY1 IN A CLOSED CONFORMATION AT PH 3.5
1815, 6nnvB, 0.5482, 3.09, 0.106, 121, 66, PD-L1 IGV DOMAIN COMPLEX WITH MACRO-CYCLIC PEPTIDE 
1816, 6hyfC, 0.5482, 3.16, 0.104, 91, 67, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN FROM RAT BETA4 INTEGRIN; A BINDING SITE FOR PERIAXIN 
1817, 5niuC, 0.5482, 3.09, 0.091, 126, 66, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1818, 5i0yA, 0.5482, 3.26, 0.088, 150, 68, COPPER-BOUND E46Q VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
1819, 5hyiD, 0.5482, 3.66, 0.088, 209, 68, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
1820, 5e6sA, 0.5482, 3.34, 0.088, 578, 68, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1821, 4ku1A, 0.5482, 3.60, 0.090, 207, 67, ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING
1822, 3tcxH, 0.5482, 3.22, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1823, 1mq9A, 0.5482, 3.24, 0.090, 173, 67, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT
1824, 6j30RA, 0.5481, 3.43, 0.044, 197, 68, struct.pdbx_descriptor              
1825, 5uizB, 0.5481, 3.38, 0.029, 186, 68, STRUCTURE OF T.FUSCA AA10A
1826, 5dznB, 0.5481, 3.37, 0.091, 114, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
1827, 2vuoA, 0.5481, 3.75, 0.103, 215, 68, CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
1828, 4nwnD, 0.5480, 3.53, 0.029, 157, 68, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
1829, 3wknC, 0.5480, 3.56, 0.090, 209, 67, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1830, 3bi9X, 0.5480, 3.27, 0.076, 114, 66, TIM-4
1831, 2vzsA, 0.5480, 3.42, 0.029, 857, 68, CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
1832, 1zhoE, 0.5480, 3.46, 0.110, 225, 73, THE STRUCTURE OF A RIBOSOMAL PROTEIN L1 IN COMPLEX WITH MRNA
1833, 1a8jL, 0.5480, 3.74, 0.088, 215, 68, IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME
1834, 5o4eA, 0.5479, 3.59, 0.090, 209, 67, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
1835, 4w4oB, 0.5479, 3.67, 0.088, 209, 68, HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI
1836, 3dkaA, 0.5479, 3.47, 0.118, 139, 68, CRYSTAL STRUCTURE OF A DINB-LIKE PROTEIN (YJOA BSU12410) FROM BACILLUS SUBTILIS AT 2.30 A RESOLUTION
1837, 1i8lD, 0.5479, 3.29, 0.072, 118, 69, HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX
1838, 6m87B, 0.5478, 3.36, 0.094, 215, 64, FAB 10A6 IN COMPLEX WITH MPTS 
1839, 5xjfB, 0.5478, 3.44, 0.091, 215, 66, CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1840, 5u66A, 0.5478, 3.58, 0.090, 207, 67, MODIFIED SINGLE HELIX FROM THE B-DOMAIN OF PROTEIN A BOUND TO IGG1 FC
1841, 5jpmD, 0.5478, 3.32, 0.090, 651, 67, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
1842, 3prxC, 0.5478, 3.25, 0.104, 1626, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
1843, 3prxA, 0.5478, 3.25, 0.104, 1626, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
1844, 3dgcS, 0.5478, 3.36, 0.072, 207, 69, STRUCTURE OF IL-22/IL-22R1
1845, 6nojB, 0.5477, 3.28, 0.103, 126, 68, PD-L1 IGV DOMAIN V76T WITH FRAGMENT 
1846, 5vaaB, 0.5477, 3.60, 0.045, 206, 67, CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT
1847, 5tztD, 0.5477, 3.34, 0.088, 113, 68, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
1848, 5n2dA, 0.5477, 3.22, 0.075, 125, 67, STRUCTURE OF PD-L1/SMALL-MOLECULE INHIBITOR COMPLEX
1849, 5mvgB, 0.5477, 3.72, 0.074, 209, 68, CRYSTAL STRUCTURE OF NON-AMYLOIDOGENIC LIGHT CHAIN DIMER M7
1850, 5gsqA, 0.5477, 3.55, 0.090, 208, 67, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
1851, 3ojvD, 0.5477, 3.24, 0.030, 213, 66, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
1852, 3b83A, 0.5477, 3.16, 0.136, 95, 66, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1853, 6r3kC, 0.5476, 3.12, 0.121, 125, 66, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR 
1854, 6cmxA, 0.5476, 3.29, 0.104, 1300, 67, HUMAN TENEURIN 2 EXTRA-CELLULAR REGION 
1855, 5v43B, 0.5476, 3.58, 0.104, 202, 67, ENGINEERED HUMAN IGG FC DOMAIN AGLYCO801
1856, 5nixC, 0.5476, 3.12, 0.121, 125, 66, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1857, 4qgtB, 0.5476, 3.61, 0.090, 207, 67, THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON
1858, 4c2bA, 0.5476, 3.22, 0.119, 199, 67, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
1859, 3kaaB, 0.5476, 3.07, 0.077, 109, 65, STRUCTURE OF TIM-3 IN COMPLEX WITH PHOSPHATIDYLSERINE
1860, 6rpgB, 0.5475, 3.33, 0.119, 117, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH INHIBITOR 
1861, 4xamC, 0.5475, 3.40, 0.076, 632, 66, COMPLEMENT COMPONENT C4B
1862, 4j12A, 0.5475, 3.56, 0.090, 209, 67, MONOMERIC FC
1863, 4am1A, 0.5475, 3.62, 0.081, 345, 74, CRYSTAL STRUCTURE OF THE MARINE CRUSTACEAN DECAPOD SHRIMP (LITOPENAEUS VANNAMEI) ARGININE KINASE IN THE ABSENCE OF SUBSTRATE OR LIGANDS.
1864, 3f78C, 0.5475, 3.22, 0.104, 180, 67, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
1865, 1p50A, 0.5475, 3.41, 0.068, 356, 73, TRANSITION STATE STRUCTURE OF AN ARGININE KINASE MUTANT
1866, 5ockH, 0.5474, 3.32, 0.094, 219, 64, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1 
1867, 5jtwB, 0.5474, 3.48, 0.075, 632, 67, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
1868, 1mchB, 0.5474, 3.77, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1869, 5u52B, 0.5473, 3.61, 0.090, 209, 67, HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)
1870, 5u4yB, 0.5473, 3.60, 0.090, 212, 67, IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A
1871, 5k65A, 0.5473, 3.48, 0.090, 215, 67, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)
1872, 5iw3A, 0.5473, 3.59, 0.090, 208, 67, ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT
1873, 5f7hA, 0.5473, 3.42, 0.106, 113, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4) COMPLEX WITH PHOSPHOSERINE
1874, 5dvoA, 0.5473, 3.43, 0.076, 205, 66, FC K392D/K409D HOMODIMER
1875, 5dk2E, 0.5473, 3.57, 0.090, 159, 67, FC HETERODIMER E356K/D399K + K392D/K409D
1876, 4m6aJ, 0.5473, 2.85, 0.079, 90, 63, N-TERMINAL BETA-STRAND SWAPPING IN A CONSENSUS DERIVED ALTERNATIVE SCAFFOLD DRIVEN BY STABILIZING HYDROPHOBIC INTERACTIONS
1877, 4janL, 0.5473, 3.53, 0.076, 206, 66, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
1878, 4bhlA, 0.5473, 3.50, 0.082, 348, 73, CRYSTAL STRUCTURE OF LITOPENAEUS VANNAMEI ARGININE KINASE IN BINARY COMPLEX WITH ARGININE
1879, 3qhtD, 0.5473, 2.91, 0.078, 93, 64, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-1 BOUND TO YEAST SUMO
1880, 1mcqB, 0.5473, 3.66, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1881, 1mcbA, 0.5473, 3.74, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1882, 5ubxA, 0.5472, 3.64, 0.164, 191, 67, CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C
1883, 4z9mE, 0.5472, 3.60, 0.068, 369, 73, CRYSTAL STRUCTURE OF HUMAN SARCOMERIC MITOCHONDRIAL CREATINE KINASE
1884, 4xamE, 0.5472, 3.41, 0.076, 632, 66, COMPLEMENT COMPONENT C4B
1885, 3tcxV, 0.5472, 3.14, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1886, 3qwrD, 0.5472, 3.20, 0.062, 91, 65, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH AN ADNECTIN
1887, 3pvmC, 0.5472, 3.23, 0.104, 1627, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
1888, 3pdoB, 0.5472, 3.31, 0.125, 191, 64, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP102-120
1889, 3ojvC, 0.5472, 3.24, 0.030, 213, 66, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
1890, 3is1X, 0.5472, 3.16, 0.030, 393, 66, CRYSTAL STRUCTURE OF FUNCTIONAL REGION OF UAFA FROM STAPHYLOCOCCUS SAPROPHYTICUS IN C2 FORM AT 2.45 ANGSTROM RESOLUTION
1891, 3bn3A, 0.5472, 3.11, 0.091, 180, 66, CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
1892, 2yowB, 0.5472, 3.30, 0.045, 178, 67, BACILLUS AMYLOLIQUEFACIENS CBM33
1893, 2xd4A, 0.5472, 2.81, 0.148, 421, 61, NUCLEOTIDE-BOUND STRUCTURES OF BACILLUS SUBTILIS GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE
1894, 1mcfA, 0.5472, 3.93, 0.087, 216, 69, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1895, 5dk3B, 0.5471, 3.54, 0.106, 441, 66, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
1896, 5cckL, 0.5471, 3.75, 0.088, 210, 68, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
1897, 1wgoA, 0.5471, 3.22, 0.108, 123, 65, SOLUTION STRUCTURE OF THE PKD DOMAIN FROM HUMAN VPS10 DOMAIN-CONTAINING RECEPTOR SORCS2
1898, 6ndfF, 0.5470, 3.39, 0.103, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
1899, 6nddR, 0.5470, 3.32, 0.103, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
1900, 6nd9R, 0.5470, 3.28, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
1901, 5xjeB, 0.5470, 3.44, 0.091, 215, 66, CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
1902, 5m2eB, 0.5470, 3.46, 0.071, 418, 70, struct.pdbx_descriptor               Isocitrate dehydrogenase [NADP] (E.C.1.1.1.42)  
1903, 5jp2B, 0.5470, 3.24, 0.088, 270, 68, FCHO1 MU HOMOLOGY DOMAIN (DANIO RERIO) WITH BOUND EPS15 PEPTIDE
1904, 5bn2A, 0.5470, 3.31, 0.030, 260, 67, ROOM TEMPERATURE STRUCTURE OF PICHIA PASTORIS AQUAPORIN AT 1.3 A
1905, 4acpB, 0.5470, 3.53, 0.090, 208, 67, DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
1906, 3tg8A, 0.5470, 3.49, 0.096, 214, 73, MUTANT RIBOSOMAL PROTEIN L1 LACKING ALA158 FROM THERMUS THERMOPHILUS
1907, 3tesD, 0.5470, 3.29, 0.075, 94, 67, CRYSTAL STRUCTURE OF TENCON
1908, 3fjtA, 0.5470, 3.38, 0.091, 209, 66, CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
1909, 1dclB, 0.5470, 3.74, 0.088, 216, 68, MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED FROM AMMONIUM SULFATE
1910, 6nd9O, 0.5469, 3.28, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
1911, 6cjcB, 0.5469, 3.46, 0.091, 207, 66, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 3) 
1912, 5k64B, 0.5469, 3.38, 0.091, 213, 66, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)
1913, 5dk0B, 0.5469, 3.60, 0.090, 206, 67, FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
1914, 5djcD, 0.5469, 3.60, 0.090, 207, 67, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
1915, 4s0sE, 0.5469, 3.32, 0.060, 90, 67, STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH ADNECTIN-1
1916, 4gvyA, 0.5469, 3.42, 0.068, 356, 73, CRYSTAL STRUCTURE OF ARGININE KINASE IN COMPLEX WITH L-CITRULLINE AND MGADP
1917, 3is0X, 0.5469, 3.19, 0.061, 392, 66, CRYSTAL STRUCTURE OF FUNCTIONAL REGION OF UAFA FROM STAPHYLOCOCCUS SAPROPHYTICUS IN THE PRESENCE OF CHOLESTEROL
1918, 6nnvD, 0.5468, 3.29, 0.106, 121, 66, PD-L1 IGV DOMAIN COMPLEX WITH MACRO-CYCLIC PEPTIDE 
1919, 5dk3G, 0.5468, 3.65, 0.104, 438, 67, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
1920, 4tnwM, 0.5468, 3.69, 0.104, 210, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1921, 4s0sD, 0.5468, 3.33, 0.060, 90, 67, STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH ADNECTIN-1
1922, 4f20A, 0.5468, 3.02, 0.106, 331, 66, CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB
1923, 3tcxF, 0.5468, 3.14, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1924, 3bibX, 0.5468, 3.36, 0.075, 109, 67, TIM-4 IN COMPLEX WITH PHOSPHATIDYLSERINE
1925, 6fy3Y, 0.5467, 3.50, 0.076, 202, 66, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
1926, 5vaaA, 0.5467, 3.58, 0.045, 207, 67, CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT
1927, 5mp6Q, 0.5467, 3.65, 0.075, 207, 67, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALIZING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE AT TWO ANGSTROM RESOLUTION.
1928, 5f7hE, 0.5467, 3.35, 0.076, 113, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4) COMPLEX WITH PHOSPHOSERINE
1929, 5dvmA, 0.5467, 3.44, 0.091, 207, 66, FC DESIGN 20.8.37 B CHAIN HOMODIMER E357D/S364R/Y407A
1930, 2pn5A, 0.5467, 3.17, 0.106, 1283, 66, CRYSTAL STRUCTURE OF TEP1R
1931, 6ndfI, 0.5466, 3.39, 0.103, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
1932, 6ndeL, 0.5466, 3.32, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
1933, 6ndcR, 0.5466, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
1934, 6ndcO, 0.5466, 3.28, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
1935, 6m87H, 0.5466, 3.40, 0.092, 215, 65, FAB 10A6 IN COMPLEX WITH MPTS 
1936, 5o4eD, 0.5466, 3.63, 0.090, 214, 67, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
1937, 4tnvf, 0.5466, 3.62, 0.104, 214, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1938, 4nenA, 0.5466, 3.48, 0.074, 1063, 68, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
1939, 3tcxJ, 0.5466, 3.14, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1940, 3tcxB, 0.5466, 3.14, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1941, 3qt2B, 0.5466, 3.20, 0.092, 307, 65, STRUCTURE OF A CYTOKINE LIGAND-RECEPTOR COMPLEX
1942, 3mj7A, 0.5466, 3.09, 0.091, 229, 66, CRYSTAL STRUCTURE OF THE COMPLEX OF JAML AND COXSACKIE AND ADENOVIRUS RECEPTOR CAR
1943, 1mckB, 0.5466, 3.66, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1944, 5es4A, 0.5465, 3.42, 0.090, 1080, 67, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
1945, 4hzaA, 0.5465, 3.03, 0.061, 124, 66, CRYSTAL STRUCTURE OF THE IMMUNOGLOBULIN VARIABLE DOMAIN OF NECTIN-2 IN MONOCLINIC FORM
1946, 3wn5B, 0.5465, 3.59, 0.090, 210, 67, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
1947, 3tcxR, 0.5465, 3.15, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1948, 3tcxP, 0.5465, 3.15, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1949, 3qazL, 0.5465, 3.24, 0.123, 191, 65, IL-2 MUTANT D10 TERNARY COMPLEX
1950, 1a8jH, 0.5465, 3.77, 0.088, 215, 68, IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME
1951, 6m87J, 0.5464, 3.54, 0.091, 215, 66, FAB 10A6 IN COMPLEX WITH MPTS 
1952, 5iusC, 0.5464, 3.29, 0.119, 214, 67, CRYSTAL STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH HIGH AFFINITY PD-1 MUTANT
1953, 5f7hB, 0.5464, 3.32, 0.091, 113, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4) COMPLEX WITH PHOSPHOSERINE
1954, 4zneJ, 0.5464, 3.55, 0.090, 209, 67, IGG1 FC-FCGAMMARI ECD COMPLEX
1955, 4z9mF, 0.5464, 3.60, 0.068, 369, 73, CRYSTAL STRUCTURE OF HUMAN SARCOMERIC MITOCHONDRIAL CREATINE KINASE
1956, 4lptA, 0.5464, 3.15, 0.077, 93, 65, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
1957, 4d94A, 0.5464, 3.18, 0.106, 1274, 66, CRYSTAL STRUCTURE OF TEP1R
1958, 3tcxX, 0.5464, 3.15, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1959, 3tcxD, 0.5464, 3.15, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1960, 3gdeA, 0.5464, 3.31, 0.121, 551, 66, THE CLOSED CONFORMATION OF ATP-DEPENDENT DNA LIGASE FROM ARCHAEOGLOBUS FULGIDUS
1961, 3do3A, 0.5464, 3.65, 0.090, 209, 67, HUMAN 1GG1 FC FRAGMENT 2.5 ANGSTROM STRUCTURE
1962, 1clyL, 0.5464, 3.66, 0.104, 217, 67, IGG FAB (HUMAN IGG1 KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1963, 6ndfL, 0.5463, 3.31, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
1964, 6cpdA, 0.5463, 3.31, 0.074, 126, 68, CRYSTAL STRUCTURE OF PMOD SOLUBLE DOMAIN FROM METHYLOCYSTIS SP. ATCC 49242 (ROCKWELL) 
1965, 5j89D, 0.5463, 3.40, 0.074, 124, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1966, 5j89C, 0.5463, 3.32, 0.103, 125, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1967, 5djxD, 0.5463, 3.61, 0.090, 208, 67, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
1968, 4wu1AA, 0.5463, 3.57, 0.095, 135, 74, 
1969, 4hukB, 0.5463, 3.18, 0.046, 91, 65, MATE TRANSPORTER NORM-NG IN COMPLEX WITH TPP AND MONOBODY
1970, 3tcxT, 0.5463, 3.15, 0.091, 180, 66, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
1971, 6ndaO, 0.5462, 3.44, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
1972, 6m87F, 0.5462, 3.42, 0.092, 215, 65, FAB 10A6 IN COMPLEX WITH MPTS 
1973, 6ha8FA, 0.5462, 3.46, 0.068, 212, 74, struct.pdbx_descriptor              
1974, 5nscB, 0.5462, 3.61, 0.090, 210, 67, FC DEKK HETERODIMER VARIANT
1975, 5djxA, 0.5462, 3.61, 0.090, 208, 67, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
1976, 5djcA, 0.5462, 3.60, 0.090, 207, 67, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
1977, 4lsdC, 0.5462, 2.83, 0.079, 93, 63, MYOKINE STRUCTURE
1978, 4gvzA, 0.5462, 3.52, 0.068, 356, 74, CRYSTAL STRUCTURE OF ARGININE KINASE IN COMPLEX WITH D-ARGININE MGADP AND NITRATE.
1979, 3ri5L, 0.5462, 3.61, 0.104, 210, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1980, 3f7pD, 0.5462, 3.05, 0.138, 196, 65, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN INTEGRIN BETA4 AND PLECTIN
1981, 2pkdA, 0.5462, 2.82, 0.094, 107, 64, CRYSTAL STRUCTURE OF CD84: INSITE INTO SLAM FAMILY FUNCTION
1982, 2o7nA, 0.5462, 3.11, 0.090, 180, 67, CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(35-DICHLOROPHENYL)-5-OXO-2357A-TETRAHYDRO- 1H-PYRROLO[12-A]PYRROLE-7-CARBONITRILE
1983, 6nosA, 0.5461, 3.33, 0.103, 125, 68, PD-L1 IGV DOMAIN V76T WITH FRAGMENT 
1984, 5xjmH, 0.5461, 3.35, 0.078, 220, 64, COMPLEX STRUCTURE OF ANGIOTENSIN II TYPE 2 RECEPTOR WITH FAB 
1985, 5jtwD, 0.5461, 3.47, 0.088, 651, 68, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
1986, 5j89A, 0.5461, 3.27, 0.119, 127, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
1987, 5dznA, 0.5461, 3.37, 0.091, 114, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
1988, 4lnvB, 0.5461, 2.69, 0.066, 1063, 61, CRYSTAL STRUCTURE OF TEP1S
1989, 4lh6A, 0.5461, 3.41, 0.125, 322, 72, CRYSTAL STRUCTURE OF A LIGA INHIBITOR
1990, 3v10A, 0.5461, 3.00, 0.077, 310, 65, CRYSTAL STRUCTURE OF THE COLLAGEN BINDING DOMAIN OF ERYSIPELOTHRIX RHUSIOPATHIAE SURFACE PROTEIN RSPB
1991, 2yoyA, 0.5461, 3.27, 0.045, 178, 67, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) REDUCED USING ASCORBATE
1992, 1w16A, 0.5461, 3.19, 0.109, 125, 64, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM
1993, 1fnfA, 0.5461, 3.31, 0.104, 368, 67, FRAGMENT OF HUMAN FIBRONECTIN ENCOMPASSING TYPE-III REPEATS 7 THROUGH 10
1994, 6bx5C, 0.5460, 3.08, 0.125, 97, 64, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S12
1995, 5ocxH, 0.5460, 3.53, 0.091, 218, 66, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT 
1996, 5fcuL, 0.5460, 3.72, 0.088, 212, 68, CRYSTAL STRUCTURE OF THE INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4
1997, 5dznC, 0.5460, 3.34, 0.091, 114, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
1998, 4lsdD, 0.5460, 3.16, 0.076, 93, 66, MYOKINE STRUCTURE
1999, 3riaL, 0.5460, 3.73, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2000, 3rhwL, 0.5460, 3.73, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2001, 2nncB, 0.5460, 2.90, 0.095, 115, 63, STRUCTURE OF THE SULFUR CARRIER PROTEIN SOXY FROM CHLOROBIUM LIMICOLA F THIOSULFATOPHILUM
2002, 1mfcL, 0.5460, 3.76, 0.103, 212, 68, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
2003, 1lhzB, 0.5460, 3.62, 0.075, 213, 67, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
2004, 1hngA, 0.5460, 2.96, 0.095, 175, 63, CRYSTAL STRUCTURE AT 2.8 ANGSTROMS RESOLUTION OF A SOLUBLE FORM OF THE CELL ADHESION MOLECULE CD2
2005, 6nddO, 0.5459, 3.28, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
2006, 6cpdB, 0.5459, 3.30, 0.074, 127, 68, CRYSTAL STRUCTURE OF PMOD SOLUBLE DOMAIN FROM METHYLOCYSTIS SP. ATCC 49242 (ROCKWELL) 
2007, 6a6cA, 0.5459, 2.88, 0.190, 84, 63, CRYSTAL STRUCTURE OF CARBOHYDRATE-BINDING MODULE FAMILY 56 BETA-1;3- GLUCAN BINDING DOMAIN 
2008, 5zmjL, 0.5459, 3.57, 0.076, 211, 66, CRYSTAL STRUCTURE OF THE FAB REGION OF A NEUTRALIZING FULLY HUMAN ANTIBODY AGAINST GM-CSF 
2009, 5uymZA, 0.5459, 3.37, 0.110, 134, 73, 
2010, 5nj3F, 0.5459, 3.51, 0.092, 210, 65, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
2011, 5nj3D, 0.5459, 3.51, 0.092, 210, 65, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
2012, 5m6iA, 0.5459, 3.76, 0.088, 212, 68, CRYSTAL STRUCTURE OF NON-CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER M8
2013, 5dj0B, 0.5459, 3.61, 0.090, 207, 67, FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q
2014, 4zncD, 0.5459, 3.56, 0.090, 207, 67, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
2015, 2yw2B, 0.5459, 2.79, 0.230, 423, 61, CRYSTAL STRUCTURE OF GAR SYNTHETASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH ATP
2016, 1hngB, 0.5459, 3.08, 0.109, 175, 64, CRYSTAL STRUCTURE AT 2.8 ANGSTROMS RESOLUTION OF A SOLUBLE FORM OF THE CELL ADHESION MOLECULE CD2
2017, 6r3kB, 0.5458, 3.27, 0.075, 125, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR 
2018, 6nd8O, 0.5458, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
2019, 5nixB, 0.5458, 3.27, 0.075, 125, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
2020, 5k64A, 0.5458, 3.61, 0.090, 213, 67, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)
2021, 5ijuB, 0.5458, 3.28, 0.045, 178, 67, STRUCTURE OF AN AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM BACILLUS AMYLOLIQUEFACIENS WITH CU(II) BOUND
2022, 5e5mA, 0.5458, 3.47, 0.088, 115, 68, CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY
2023, 5di8B, 0.5458, 3.63, 0.090, 207, 67, FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V
2024, 3j1sH, 0.5458, 3.38, 0.078, 218, 64, STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20
2025, 2yowA, 0.5458, 3.14, 0.045, 178, 66, BACILLUS AMYLOLIQUEFACIENS CBM33
2026, 1ospH, 0.5458, 3.38, 0.078, 218, 64, CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
2027, 6ndhR, 0.5457, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
2028, 5dvoB, 0.5457, 3.48, 0.076, 205, 66, FC K392D/K409D HOMODIMER
2029, 4qqaA, 0.5457, 2.89, 0.048, 483, 62, CRYSTAL STRUCTURE OF PNEUMOLYSIN FROM STREPTOCOCCUS PNEUMONIAE
2030, 3sgiA, 0.5457, 3.68, 0.097, 408, 72, CRYSTAL STRUCTURE OF DNA LIGASE A BRCT DOMAIN DELETED MUTANT OF MYCOBACTERIUM TUBERCULOSIS
2031, 3rifL, 0.5457, 3.72, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2032, 3bjlB, 0.5457, 3.69, 0.090, 215, 67, LOC A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE
2033, 2yoyB, 0.5457, 3.27, 0.045, 178, 67, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) REDUCED USING ASCORBATE
2034, 2j6eB, 0.5457, 3.59, 0.090, 208, 67, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2035, 5dznF, 0.5456, 3.58, 0.075, 114, 67, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
2036, 2iwgD, 0.5456, 3.64, 0.090, 207, 67, COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2037, 1sd0A, 0.5456, 3.44, 0.068, 356, 73, STRUCTURE OF ARGININE KINASE C271A MUTANT
2038, 6ndeC, 0.5455, 3.32, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
2039, 5zhqA, 0.5455, 3.48, 0.082, 355, 73, CRYSTAL STRUCTURE OF SCYLLA PARAMAMOSAIN ARGININE KINASE 
2040, 5n2fB, 0.5455, 3.26, 0.119, 124, 67, STRUCTURE OF PD-L1/SMALL-MOLECULE INHIBITOR COMPLEX
2041, 5m2eC, 0.5455, 3.23, 0.074, 418, 68, struct.pdbx_descriptor               Isocitrate dehydrogenase [NADP] (E.C.1.1.1.42)  
2042, 5jikB, 0.5455, 3.57, 0.090, 204, 67, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)
2043, 5j89B, 0.5455, 3.28, 0.119, 125, 67, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
2044, 5f7hD, 0.5455, 3.35, 0.091, 113, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4) COMPLEX WITH PHOSPHOSERINE
2045, 4ocrL, 0.5455, 3.63, 0.075, 216, 67, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.01 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2046, 4nqsA, 0.5455, 3.51, 0.090, 210, 67, KNOB-INTO-HOLE IGG FC
2047, 4lsdA, 0.5455, 3.06, 0.077, 96, 65, MYOKINE STRUCTURE
2048, 3uq8A, 0.5455, 3.37, 0.113, 322, 71, STRUCTURE OF ADENYLATION DOMAIN OF HAEMOPHILUS INFLUENZAE DNA LIGASES BOUND TO NAD+ IN ADENYLATED STATE.
2049, 3qazF, 0.5455, 3.03, 0.125, 186, 64, IL-2 MUTANT D10 TERNARY COMPLEX
2050, 6iqgB, 0.5454, 3.63, 0.090, 207, 67, X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX 
2051, 6d58B, 0.5454, 3.43, 0.091, 207, 66, CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3 
2052, 6d4mB, 0.5454, 3.71, 0.074, 209, 68, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3 
2053, 5wx8B, 0.5454, 2.93, 0.062, 160, 65, HUMAN HERPESVIRUS 6A IMMEDIATE EARLY PROTEIN 2 C-TERMINAL DOMAIN
2054, 5vj6H, 0.5454, 3.71, 0.077, 227, 65, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
2055, 5muhA, 0.5454, 3.65, 0.075, 194, 67, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H7
2056, 5m5eC, 0.5454, 3.22, 0.121, 193, 66, CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR
2057, 4zncE, 0.5454, 3.59, 0.090, 207, 67, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
2058, 4v8xTC, 0.5454, 3.48, 0.123, 120, 73, 
2059, 4v8xMA, 0.5454, 3.48, 0.123, 120, 73, 
2060, 4ixdA, 0.5454, 3.11, 0.090, 182, 67, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH IBE-667 AT 1.8A RESOLUTION
2061, 3u6gB, 0.5454, 2.41, 0.068, 121, 59, CRYSTAL STRUCTURE OF A DOMAIN OF UNKNOWN FUNCTION DUF4425 (BVU_3708) FROM BACTEROIDES VULGATUS ATCC 8482 AT 1.35 A RESOLUTION
2062, 2yoxB, 0.5454, 3.31, 0.045, 178, 67, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) AFTER PHOTOREDUCTION
2063, 2iwgA, 0.5454, 3.64, 0.090, 207, 67, COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2064, 1ivtA, 0.5454, 3.28, 0.015, 122, 68, NMR STRUCTURES OF THE C-TERMINAL GLOBULAR DOMAIN OF HUMAN LAMIN A/C
2065, 1fsuA, 0.5454, 2.99, 0.068, 474, 59, CRYSTAL STRUCTURE OF 4-SULFATASE (HUMAN)
2066, 1ayrD, 0.5454, 3.40, 0.123, 363, 65, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2067, 6ndhO, 0.5453, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
2068, 6ndeF, 0.5453, 3.32, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
2069, 6fvxCA, 0.5453, 3.37, 0.028, 197, 71, struct.pdbx_descriptor              
2070, 5hauC, 0.5453, 3.43, 0.096, 135, 73, 
2071, 5bobB, 0.5453, 3.35, 0.075, 198, 67, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB
2072, 4q97B, 0.5453, 3.28, 0.141, 108, 64, IGNAR ANTIBODY DOMAIN C1
2073, 4q97A, 0.5453, 3.28, 0.141, 108, 64, IGNAR ANTIBODY DOMAIN C1
2074, 4dz8B, 0.5453, 3.40, 0.091, 205, 66, HUMAN IGG1 FC FRAGMENT HETERODIMER
2075, 3ujjL, 0.5453, 3.53, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
2076, 3payA, 0.5453, 3.03, 0.108, 295, 65, CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION
2077, 2cfmA, 0.5453, 3.10, 0.125, 545, 64, ATP-DEPENDENT DNA LIGASE FROM PYROCOCCUS FURIOSUS
2078, 1idn1, 0.5453, 3.46, 0.101, 189, 69, MAC-1 I DOMAIN METAL FREE
2079, 1f4xL, 0.5453, 3.75, 0.118, 210, 68, CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
2080, 1adqA, 0.5453, 3.52, 0.090, 206, 67, CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
2081, 1t89B, 0.5452, 3.63, 0.075, 213, 67, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
2082, 1mfdL, 0.5452, 3.76, 0.103, 212, 68, THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
2083, 1ayrB, 0.5452, 3.41, 0.123, 363, 65, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2084, 5mhlB, 0.5451, 3.14, 0.076, 697, 66, FXIIIA IN COMPLEX WITH THE INHIBITOR MI0621
2085, 5j9aA, 0.5451, 3.45, 0.068, 356, 73, AMBIENT TEMPERATURE TRANSITION STATE STRUCTURE OF ARGININE KINASE - CRYSTAL 11/FORM II
2086, 5djxE, 0.5451, 3.60, 0.090, 207, 67, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
2087, 4ktyB, 0.5451, 3.11, 0.076, 698, 66, FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND
2088, 1ttgA, 0.5451, 2.83, 0.108, 94, 65, THE THREE-DIMENSIONAL STRUCTURE OF THE TENTH TYPE III MODULE OF FIBRONECTIN: AN INSIGHT INTO RGD-MEDIATED INTERACTIONS
2089, 6ndgO, 0.5450, 3.29, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
2090, 6bynM, 0.5450, 2.94, 0.109, 96, 64, CRYSTAL STRUCTURE OF WDR5-MB(S4) MONOBODY COMPLEX 
2091, 5o4eB, 0.5450, 3.45, 0.091, 216, 66, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
2092, 5djzA, 0.5450, 3.60, 0.090, 209, 67, FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V
2093, 4yakD, 0.5450, 3.03, 0.200, 224, 65, CA. KORARCHAEUM CRYPTOFILUM DINUCLEOTIDE FORMING ACETYL-COENZYME A SYNTHETASE 1 IN COMPLEX WITH COENZYME A ACETYL-COENZYME A AND WITH PHOSPHORYLATED PHOSPHOHISTIDINE SEGMENT (SITE I ORIENTATION)
2094, 4tnwO, 0.5450, 3.61, 0.104, 211, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2095, 3rifM, 0.5450, 3.70, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2096, 1zonA, 0.5450, 3.37, 0.088, 181, 68, CD11A I-DOMAIN WITHOUT BOUND CATION
2097, 1mclB, 0.5450, 3.76, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2098, 1e4kA, 0.5450, 3.64, 0.060, 216, 67, CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX
2099, 6mg5A, 0.5449, 3.72, 0.074, 215, 68, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO IN COMPLEX WITH COUMARIN 1 
2100, 5j99A, 0.5449, 3.49, 0.068, 356, 73, AMBIENT TEMPERATURE TRANSITION STATE STRUCTURE OF ARGININE KINASE - CRYSTAL 8/FORM I
2101, 5dznG, 0.5449, 2.96, 0.079, 113, 63, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
2102, 5djxB, 0.5449, 3.61, 0.090, 207, 67, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
2103, 6m87D, 0.5448, 3.57, 0.091, 215, 66, FAB 10A6 IN COMPLEX WITH MPTS 
2104, 5wavB, 0.5448, 3.43, 0.091, 207, 66, FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
2105, 5nscA, 0.5448, 3.59, 0.090, 209, 67, FC DEKK HETERODIMER VARIANT
2106, 5m3vA, 0.5448, 3.58, 0.091, 206, 66, BEAT FC
2107, 5m32p, 0.5448, 3.26, 0.015, 101, 67, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2108, 5f7hF, 0.5448, 3.61, 0.088, 111, 68, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4 (HTIM-4) COMPLEX WITH PHOSPHOSERINE
2109, 4gw0A, 0.5448, 3.46, 0.068, 356, 73, CRYSTAL STRUCTURE OF ARGININE KINASE IN COMPLEX WITH IMINO-L- ORNITHINE MGADP AND NITRATE.
2110, 4cc5A, 0.5448, 3.47, 0.097, 308, 72, FRAGMENT-BASED DISCOVERY OF 6 AZAINDAZOLES AS INHIBITORS OF BACTERIAL DNA LIGASE
2111, 2yoxA, 0.5448, 3.28, 0.045, 178, 67, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) AFTER PHOTOREDUCTION
2112, 2c36A, 0.5448, 3.12, 0.043, 274, 69, STRUCTURE OF UNLIGANDED HSV GD REVEALS A MECHANISM FOR RECEPTOR-MEDIATED ACTIVATION OF VIRUS ENTRY
2113, 2b5fC, 0.5448, 3.21, 0.076, 227, 66, CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 IN AN OPEN CONFORMATION TO 3.9 RESOLUTION
2114, 1f4wL, 0.5448, 3.63, 0.104, 210, 67, CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
2115, 5h5tE, 0.5447, 3.40, 0.086, 196, 70, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SALMONELLA TYPHIMURIUM
2116, 5djyB, 0.5447, 3.62, 0.090, 207, 67, FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
2117, 4x8eA, 0.5447, 3.74, 0.097, 428, 72, ERGOTHIONEINE-BIOSYNTHETIC SULFOXIDE SYNTHASE EGTB IN COMPLEX WITH N NN-TRIMETHYL-HISTIDINE
2118, 4p1xF, 0.5447, 3.44, 0.091, 255, 66, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2119, 4n0uE, 0.5447, 3.42, 0.091, 209, 66, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
2120, 3hi6A, 0.5447, 3.09, 0.076, 180, 66, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
2121, 1w15A, 0.5447, 3.18, 0.109, 132, 64, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM
2122, 3rzwB, 0.5446, 3.00, 0.078, 89, 64, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-9 BOUND TO HUMAN SUMO1
2123, 2vzvA, 0.5446, 3.53, 0.029, 857, 70, SUBSTRATE COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA E541A WITH CHITOSAN
2124, 1lgvB, 0.5446, 3.61, 0.075, 213, 67, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
2125, 6ndaR, 0.5445, 3.45, 0.101, 191, 69, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
2126, 6chfB, 0.5445, 3.63, 0.090, 208, 67, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 1) 
2127, 5dznH, 0.5445, 3.37, 0.091, 114, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
2128, 4nhgO, 0.5445, 3.62, 0.060, 207, 67, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
2129, 4llmB, 0.5445, 3.67, 0.075, 101, 67, STRUCTURE OF REDESIGNED IGG1 FIRST CONSTANT AND LAMBDA DOMAINS (CH1:CLAMBDA CONSTANT REDESIGN 1 CRD1) AT 1.75A
2130, 4a02A, 0.5445, 3.15, 0.061, 166, 66, X-RAY CRYSTALLOGRAPHIC STRUCTURE OF EFCBM33A
2131, 3s7gD, 0.5445, 3.59, 0.090, 207, 67, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
2132, 3f78B, 0.5445, 3.38, 0.088, 180, 68, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
2133, 1zhoA, 0.5445, 3.33, 0.097, 225, 72, THE STRUCTURE OF A RIBOSOMAL PROTEIN L1 IN COMPLEX WITH MRNA
2134, 5dk0A, 0.5444, 3.60, 0.090, 207, 67, FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
2135, 4z9mC, 0.5444, 3.63, 0.068, 375, 73, CRYSTAL STRUCTURE OF HUMAN SARCOMERIC MITOCHONDRIAL CREATINE KINASE
2136, 4nwnT, 0.5444, 2.99, 0.076, 157, 66, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
2137, 4nqsG, 0.5444, 3.46, 0.091, 208, 66, KNOB-INTO-HOLE IGG FC
2138, 4nhhJ, 0.5444, 3.62, 0.060, 207, 67, STRUCTURE OF 2G12 IGG DIMER
2139, 4nhhC, 0.5444, 3.62, 0.060, 207, 67, STRUCTURE OF 2G12 IGG DIMER
2140, 4nhhA, 0.5444, 3.62, 0.060, 207, 67, STRUCTURE OF 2G12 IGG DIMER
2141, 4nhgX, 0.5444, 3.62, 0.060, 207, 67, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
2142, 4nhgJ, 0.5444, 3.62, 0.060, 207, 67, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
2143, 3wjlA, 0.5444, 3.56, 0.090, 212, 67, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(V12) IN COMPLEX WITH FCGRIIB
2144, 1mfbL, 0.5444, 3.96, 0.116, 212, 69, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
2145, 1hzhH, 0.5444, 3.44, 0.091, 457, 66, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
2146, 1h3xA, 0.5444, 3.62, 0.060, 207, 67, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G0F)2
2147, 6fczH, 0.5443, 3.46, 0.091, 216, 66, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
2148, 6ct7L, 0.5443, 3.67, 0.075, 212, 67, FAB OF ANTI-A-SYNUCLEIN ANTIBODY BIIB054 IN COMPLEX WITH ACETYLATED A- SYNUCLEIN PEPTIDE (1-10) 
2149, 5wx8D, 0.5443, 2.62, 0.048, 160, 63, HUMAN HERPESVIRUS 6A IMMEDIATE EARLY PROTEIN 2 C-TERMINAL DOMAIN
2150, 2mfnA, 0.5443, 3.11, 0.061, 184, 66, SOLUTION NMR STRUCTURE OF LINKED CELL ATTACHMENT MODULES OF MOUSE FIBRONECTIN CONTAINING THE RGD AND SYNERGY REGIONS 10 STRUCTURES
2151, 1vziB, 0.5443, 3.10, 0.090, 125, 67, STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION
2152, 5x8lE, 0.5442, 3.20, 0.106, 114, 66, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
2153, 5w5lB, 0.5442, 3.62, 0.090, 210, 67, CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT
2154, 5n2dB, 0.5442, 3.40, 0.059, 124, 68, STRUCTURE OF PD-L1/SMALL-MOLECULE INHIBITOR COMPLEX
2155, 5hcdA, 0.5442, 3.66, 0.059, 981, 68, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS MICROPLUS RACI2
2156, 4wzgA, 0.5442, 3.64, 0.090, 210, 67, STRUCTURE OF HUMAN ATG101
2157, 4wi2B, 0.5442, 3.38, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)
2158, 4tnvM, 0.5442, 3.68, 0.104, 211, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2159, 4q58D, 0.5442, 3.13, 0.136, 194, 66, CRYSTAL STRUCTURE OF THE PLECTIN 1A ACTIN-BINDING DOMAIN/INTEGRIN BETA 4 FRAGMENT COMPLEX
2160, 4lb8A, 0.5442, 3.29, 0.101, 265, 69, CRYSTAL STRUCTURE OF A DUF4848 FAMILY PROTEIN (BT3222) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.49 A RESOLUTION
2161, 4kkpB, 0.5442, 3.24, 0.092, 230, 65, CRYSTAL STRUCTURE OF VIBRIO CHOLERAE RBMA (CRYSTAL FORM 2)
2162, 4janB, 0.5442, 3.66, 0.075, 206, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
2163, 1h3vB, 0.5442, 3.57, 0.061, 206, 66, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G2F)2SG P212121
2164, 6m87L, 0.5441, 3.57, 0.091, 215, 66, FAB 10A6 IN COMPLEX WITH MPTS 
2165, 6isbA, 0.5441, 2.88, 0.094, 221, 64, CRYSTAL STRUCTURE OF HUMAN CD226 
2166, 6bjhB, 0.5441, 2.59, 0.068, 144, 59, CIRV P19 MUTANT T111S IN COMPLEX WITH SIRNA 
2167, 5djcE, 0.5441, 3.62, 0.090, 207, 67, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
2168, 5bw7B, 0.5441, 3.46, 0.091, 215, 66, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
2169, 3mj9L, 0.5441, 3.65, 0.104, 209, 67, CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
2170, 3l5nB, 0.5441, 3.24, 0.154, 891, 65, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3B
2171, 2rarA, 0.5441, 2.60, 0.103, 261, 58, X-RAY CRYSTALLOGRAPHIC STRUCTURES SHOW CONSERVATION OF A TRIGONAL- BIPYRAMIDAL INTERMEDIATE IN A PHOSPHORYL-TRANSFER SUPERFAMILY.
2172, 2owoA, 0.5441, 3.43, 0.083, 586, 72, LAST STOP ON THE ROAD TO REPAIR: STRUCTURE OF E.COLI DNA LIGASE BOUND TO NICKED DNA-ADENYLATE
2173, 6ndfR, 0.5440, 3.30, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
2174, 6h1zB, 0.5440, 3.34, 0.014, 227, 69, AFGH61B WILD-TYPE 
2175, 6bx5D, 0.5440, 3.08, 0.108, 95, 65, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S12
2176, 5v43A, 0.5440, 3.61, 0.104, 209, 67, ENGINEERED HUMAN IGG FC DOMAIN AGLYCO801
2177, 4tnwh, 0.5440, 3.72, 0.103, 211, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2178, 4lqfH, 0.5440, 3.34, 0.078, 212, 64, STRUCTURE OF MURINE IGG2B A2C7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.3 ANGSTROMS
2179, 3riaM, 0.5440, 3.72, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2180, 2ji1B, 0.5440, 3.11, 0.075, 125, 67, X-RAY STRUCTURE OF WILD-TYPE SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII
2181, 1z98A, 0.5440, 3.34, 0.060, 251, 67, CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 IN A CLOSED CONFORMATION
2182, 1qcnB, 0.5440, 3.41, 0.167, 403, 66, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE
2183, 1h3vA, 0.5440, 3.57, 0.061, 207, 66, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G2F)2SG P212121
2184, 1e4kB, 0.5440, 3.65, 0.060, 216, 67, CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX
2185, 1dbkL, 0.5440, 3.58, 0.076, 216, 66, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2186, 5u8eA, 0.5439, 3.54, 0.055, 346, 73, CRYSTAL STRUCTURE OF SUBSTRATE-FREE ARGININE KINASE FROM SPIDER POLYBETES PYTHAGORICUS
2187, 5u7oL, 0.5439, 3.56, 0.076, 208, 66, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
2188, 5m6aC, 0.5439, 3.64, 0.075, 211, 67, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
2189, 5djdB, 0.5439, 3.65, 0.090, 207, 67, FC HETERODIMER DESIGN 5.1 T366V + Y407F
2190, 5dj2A, 0.5439, 3.60, 0.090, 208, 67, FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V
2191, 5bobC, 0.5439, 3.33, 0.090, 197, 67, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB
2192, 4tnwN, 0.5439, 3.63, 0.104, 211, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2193, 4mz3B, 0.5439, 3.13, 0.072, 119, 69, CRYSTAL STRUCTURE OF THE VOLTAGE-GATED SODIUM CHANNEL BETA 4 SUBUNIT EXTRACELLULAR DOMAIN C131W MUTANT
2194, 3wjlB, 0.5439, 3.44, 0.091, 208, 66, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(V12) IN COMPLEX WITH FCGRIIB
2195, 3wegA, 0.5439, 2.60, 0.119, 334, 59, CRYSTAL STRUCTURE OF THE HUMAN SQUALENE SYNTHASE IN COMPLEX WITH FARNESYL THIOPYROPHOSPHATE AND MAGNESIUM ION
2196, 3v10B, 0.5439, 3.26, 0.075, 309, 67, CRYSTAL STRUCTURE OF THE COLLAGEN BINDING DOMAIN OF ERYSIPELOTHRIX RHUSIOPATHIAE SURFACE PROTEIN RSPB
2197, 3rhwM, 0.5439, 3.72, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2198, 3kptA, 0.5439, 3.21, 0.045, 346, 66, CRYSTAL STRUCTURE OF BCPA THE MAJOR PILIN SUBUNIT OF BACILLUS CEREUS
2199, 3km9B, 0.5439, 3.37, 0.060, 1459, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
2200, 3km9A, 0.5439, 3.37, 0.060, 1459, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
2201, 3f74A, 0.5439, 3.21, 0.090, 180, 67, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
2202, 3ch8A, 0.5439, 2.84, 0.095, 190, 63, THE CRYSTAL STRUCTURE OF PDZ-FIBRONECTIN FUSION PROTEIN
2203, 2kbgA, 0.5439, 3.33, 0.106, 102, 66, SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE-III MODULE OF NCAM2
2204, 2ji2D, 0.5439, 3.10, 0.075, 125, 67, X-RAY STRUCTURE OF E114A MUTANT OF SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII IN THE NATIVE REDUCED FORM
2205, 1mcjB, 0.5439, 3.67, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2206, 1cvsC, 0.5439, 2.85, 0.032, 211, 63, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
2207, 6h41A, 0.5438, 3.16, 0.092, 309, 65, STRUCTURE OF THE COMPLEX OF THE IL-5 INHIBITORY PEPTIDE AF17121 BOUND TO THE IL-5 RECEPTOR IL-5RALPHA 
2208, 6f2zB, 0.5438, 3.42, 0.091, 208, 66, STRUCTURE OF A FC MUTATNT 
2209, 5m6aB, 0.5438, 3.63, 0.075, 214, 67, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
2210, 5dznD, 0.5438, 3.59, 0.075, 114, 67, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
2211, 3hxqA, 0.5438, 3.22, 0.119, 201, 67, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
2212, 2rb5A, 0.5438, 2.59, 0.103, 261, 58, X-RAY CRYSTALLOGRAPHIC STRUCTURES SHOW CONSERVATION OF A TRIGONAL- BIPYRAMIDAL INTERMEDIATE IN A PHOSPHORYL-TRANSFER SUPERFAMILY.
2213, 1vziA, 0.5438, 3.11, 0.075, 125, 67, STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION
2214, 6ndfO, 0.5437, 3.30, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
2215, 5oc7C, 0.5437, 3.16, 0.123, 92, 65, CRYSTAL STRUCTURE OF THE PLECKSTRIN-HOMOLOGY DOMAIN OF BCR-ABL IN COMPLEX WITH MONOBODY MB(BCR-PH_4).
2216, 5jdsA, 0.5437, 3.23, 0.076, 115, 66, CRYSTAL STRUCTURE OF PD-L1 COMPLEXED WITH A NANOBODY AT 1.7 ANGSTRON RESOLUTION
2217, 5dj8A, 0.5437, 3.58, 0.090, 208, 67, FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I
2218, 5dj6B, 0.5437, 3.63, 0.090, 207, 67, FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M
2219, 5d4qB, 0.5437, 3.61, 0.090, 208, 67, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC
2220, 3qazd, 0.5437, 3.27, 0.123, 191, 65, IL-2 MUTANT D10 TERNARY COMPLEX
2221, 3e3jC, 0.5437, 3.56, 0.054, 833, 74, CRYSTAL STRUCTURE OF AN INTERMEDIATE COMPLEX OF T7 RNAP AND 8NT OF RNA
2222, 6d0nC, 0.5436, 2.91, 0.062, 90, 64, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; V319G MUTANT 
2223, 5uhyI, 0.5436, 3.45, 0.077, 214, 65, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
2224, 5uhyG, 0.5436, 3.45, 0.077, 214, 65, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
2225, 5n48B, 0.5436, 2.94, 0.109, 92, 64, STRUCTURE OF ANTICALIN N9B IN COMPLEX WITH EXTRA-DOMAIN B OF HUMAN ONCOFETAL FIBRONECTIN
2226, 5kvgL, 0.5436, 3.45, 0.077, 214, 65, ZIKA SPECIFIC ANTIBODY ZV-67 BOUND TO ZIKA ENVELOPE DIII
2227, 5dznE, 0.5436, 3.39, 0.091, 114, 66, HUMAN T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 4
2228, 5dj8B, 0.5436, 3.63, 0.090, 207, 67, FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I
2229, 4v8nLA, 0.5436, 3.56, 0.108, 120, 74, 
2230, 4q9cA, 0.5436, 3.67, 0.075, 105, 67, IGNAR ANTIBODY DOMAIN C3
2231, 4e0sA, 0.5436, 3.32, 0.106, 1552, 66, CRYSTAL STRUCTURE OF C5B-6
2232, 3tesA, 0.5436, 3.27, 0.076, 94, 66, CRYSTAL STRUCTURE OF TENCON
2233, 3j8g5, 0.5436, 3.27, 0.127, 234, 71, ELECTRON CRYO-MICROSCOPY STRUCTURE OF ENGA BOUND WITH THE 50S RIBOSOMAL SUBUNIT
2234, 2ji2B, 0.5436, 3.11, 0.075, 125, 67, X-RAY STRUCTURE OF E114A MUTANT OF SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII IN THE NATIVE REDUCED FORM
2235, 2j1kO, 0.5436, 3.31, 0.121, 118, 66, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
2236, 5uizA, 0.5435, 3.25, 0.076, 186, 66, STRUCTURE OF T.FUSCA AA10A
2237, 5njlA, 0.5435, 2.99, 0.149, 290, 67, CWP2 FROM CLOSTRIDIUM DIFFICILE
2238, 5mtlC, 0.5435, 3.66, 0.075, 206, 67, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
2239, 5m6aD, 0.5435, 3.66, 0.075, 212, 67, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
2240, 4lsdB, 0.5435, 2.85, 0.078, 93, 64, MYOKINE STRUCTURE
2241, 4hzaB, 0.5435, 3.26, 0.059, 124, 68, CRYSTAL STRUCTURE OF THE IMMUNOGLOBULIN VARIABLE DOMAIN OF NECTIN-2 IN MONOCLINIC FORM
2242, 4gw2A, 0.5435, 3.45, 0.068, 356, 73, CRYSTAL STRUCTURE OF ARGININE KINASE IN COMPLEX WITH L-ORNITHINE MGADP AND NITRATE.
2243, 4c2bC, 0.5435, 3.30, 0.147, 199, 68, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
2244, 2q6wE, 0.5435, 3.36, 0.109, 188, 64, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
2245, 6cqjH, 0.5434, 3.57, 0.123, 182, 65, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2246, 5hnxK, 0.5434, 3.41, 0.055, 320, 73, STRUCTURAL BASIS OF BACKWARDS MOTION IN KINESIN-14: MINUS-END DIRECTED NKN664 IN THE NUCLEOTIDE-FREE STATE
2247, 5f89L, 0.5434, 3.57, 0.076, 221, 66, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALISING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE
2248, 5dj2B, 0.5434, 3.63, 0.090, 207, 67, FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V
2249, 4lsdF, 0.5434, 2.97, 0.078, 97, 64, MYOKINE STRUCTURE
2250, 4gboA, 0.5434, 3.25, 0.076, 186, 66, STRUCTURE OF T.FUSCA E7
2251, 4c2bG, 0.5434, 3.33, 0.147, 197, 68, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
2252, 3u6gA, 0.5434, 2.41, 0.068, 123, 59, CRYSTAL STRUCTURE OF A DOMAIN OF UNKNOWN FUNCTION DUF4425 (BVU_3708) FROM BACTEROIDES VULGATUS ATCC 8482 AT 1.35 A RESOLUTION
2253, 3f74B, 0.5434, 3.15, 0.090, 180, 67, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
2254, 2rbkA, 0.5434, 2.60, 0.103, 261, 58, X-RAY CRYSTALLOGRAPHIC STRUCTURES SHOW CONSERVATION OF A TRIGONAL- BIPYRAMIDAL INTERMEDIATE IN A PHOSPHORYL-TRANSFER SUPERFAMILY.
2255, 5n48D, 0.5433, 2.95, 0.109, 93, 64, STRUCTURE OF ANTICALIN N9B IN COMPLEX WITH EXTRA-DOMAIN B OF HUMAN ONCOFETAL FIBRONECTIN
2256, 4tnwZ, 0.5433, 3.64, 0.104, 215, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2257, 4s0tE, 0.5433, 2.94, 0.062, 91, 64, STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND WITH ADNECTIN-1 AND COMPOUND-1
2258, 4jc6N, 0.5433, 3.37, 0.060, 250, 67, MERCURY ACTIVATION OF THE PLANT AQUAPORIN SOPIP2;1 - STRUCTURAL AND FUNCTIONAL CHARACTERIZATION
2259, 2zpkL, 0.5433, 3.64, 0.104, 211, 67, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2260, 2dleA, 0.5433, 3.19, 0.109, 104, 64, SOLUTION STRUCTURE OF THE FOURTH FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE ETA
2261, 1ztxH, 0.5433, 3.55, 0.076, 219, 66, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2262, 1nbvH, 0.5433, 3.38, 0.095, 219, 63, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
2263, 1jvkB, 0.5433, 3.63, 0.075, 214, 67, THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
2264, 6bqoC, 0.5432, 3.33, 0.060, 95, 67, STRUCTURE OF A DUAL TOPOLOGY FLUORIDE CHANNEL WITH MONOBODY S8
2265, 6bf9D, 0.5432, 3.61, 0.106, 211, 66, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN
2266, 5g2uA, 0.5432, 3.61, 0.048, 463, 62, STRUCTURE OF BT1596A 2-O GAG SULFATASE
2267, 5djyA, 0.5432, 3.64, 0.090, 208, 67, FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
2268, 3cfbH, 0.5432, 3.45, 0.081, 213, 62, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
2269, 2ji2C, 0.5432, 3.12, 0.075, 126, 67, X-RAY STRUCTURE OF E114A MUTANT OF SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII IN THE NATIVE REDUCED FORM
2270, 2ji1D, 0.5432, 3.11, 0.075, 125, 67, X-RAY STRUCTURE OF WILD-TYPE SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII
2271, 1xuoB, 0.5432, 3.28, 0.090, 175, 67, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
2272, 6rpgA, 0.5431, 3.42, 0.103, 117, 68, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH INHIBITOR 
2273, 6njnM, 0.5431, 3.58, 0.000, 213, 66, STRUCTURE OF A COMPLEX 
2274, 6mfgE, 0.5431, 3.23, 0.079, 191, 63, HLA-DQ2-GLIA-ALPHA1 
2275, 6d4mA, 0.5431, 3.82, 0.088, 208, 68, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3 
2276, 5ijuA, 0.5431, 3.17, 0.045, 178, 66, STRUCTURE OF AN AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM BACILLUS AMYLOLIQUEFACIENS WITH CU(II) BOUND
2277, 4nx9A, 0.5431, 3.58, 0.085, 274, 71, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA FLAGELLIN FLIC
2278, 4dfcB, 0.5431, 3.40, 0.114, 121, 70, CORE UVRA/TRCF COMPLEX
2279, 3c5sB, 0.5431, 3.47, 0.097, 198, 62, CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
2280, 6n8mR, 0.5430, 3.00, 0.000, 210, 71, struct.pdbx_descriptor               pre-60S ribosomal subunit  
2281, 5ujtE, 0.5430, 3.22, 0.063, 188, 63, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
2282, 5l2hD, 0.5430, 3.20, 0.092, 96, 65, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
2283, 5djdA, 0.5430, 3.61, 0.090, 208, 67, FC HETERODIMER DESIGN 5.1 T366V + Y407F
2284, 4oj2X, 0.5430, 3.28, 0.045, 253, 67, THE STRUCTURE OF AQUAPORIN
2285, 3tesB, 0.5430, 3.27, 0.076, 94, 66, CRYSTAL STRUCTURE OF TENCON
2286, 3payC, 0.5430, 3.04, 0.108, 300, 65, CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION
2287, 2rb8A, 0.5430, 3.07, 0.092, 93, 65, HIGH RESOLUTION DESIGN OF A PROTEIN LOOP
2288, 2ji1A, 0.5430, 3.10, 0.075, 125, 67, X-RAY STRUCTURE OF WILD-TYPE SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII
2289, 1zopA, 0.5430, 3.40, 0.088, 183, 68, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
2290, 1lqsS, 0.5430, 3.40, 0.132, 206, 68, CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1
2291, 1a6aB, 0.5430, 3.31, 0.125, 187, 64, THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
2292, 5wduK, 0.5429, 3.66, 0.075, 210, 67, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
2293, 5m76A, 0.5429, 3.74, 0.074, 211, 68, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H10
2294, 5l2vA, 0.5429, 3.57, 0.103, 166, 68, CATALYTIC DOMAIN OF LPMO LMO2467 FROM LISTERIA MONOCYTOGENES
2295, 5hdwA, 0.5429, 3.23, 0.047, 131, 64, APAG DOMAIN OF FBXO3
2296, 4hunB, 0.5429, 3.25, 0.045, 91, 66, MATE TRANSPORTER NORM-NG IN COMPLEX WITH R6G AND MONOBODY
2297, 3qazU, 0.5429, 3.33, 0.121, 191, 66, IL-2 MUTANT D10 TERNARY COMPLEX
2298, 3mjfA, 0.5429, 2.89, 0.100, 418, 60, PHOSPHORIBOSYLAMINE-GLYCINE LIGASE FROM YERSINIA PESTIS
2299, 2mcg2, 0.5429, 3.78, 0.088, 215, 68, THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
2300, 2icaA, 0.5429, 3.38, 0.088, 179, 68, CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S 9R)-9-(4-CYANOPHENYL)-3-(35-DICHLOROPHENYL)-1-METHYL-24- DIOXO-137-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3- THIOPHENECARBOXYLICACID
2301, 1zooA, 0.5429, 3.40, 0.088, 183, 68, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
2302, 1z98M, 0.5429, 3.38, 0.060, 251, 67, CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 IN A CLOSED CONFORMATION
2303, 5w38A, 0.5428, 3.61, 0.090, 209, 67, 1.80A RESOLUTION STRUCTURE OF HUMAN IGG3 FC (N392K)
2304, 4qeyE, 0.5428, 3.12, 0.079, 122, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2305, 4q6yB, 0.5428, 3.60, 0.090, 206, 67, CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)
2306, 4oy7A, 0.5428, 3.49, 0.043, 196, 69, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
2307, 3b83D, 0.5428, 3.19, 0.106, 91, 66, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
2308, 1h3uB, 0.5428, 3.46, 0.061, 206, 66, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (M3N2F)2
2309, 1djsA, 0.5428, 3.13, 0.030, 202, 66, LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1
2310, 1dfxA, 0.5428, 3.10, 0.075, 125, 67, DESULFOFERRODOXIN FROM DESULFOVIBRIO DESULFURICANS ATCC 27774
2311, 6ndbO, 0.5427, 3.30, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
2312, 6aynA, 0.5427, 3.52, 0.106, 212, 66, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
2313, 5oc7B, 0.5427, 3.12, 0.123, 89, 65, CRYSTAL STRUCTURE OF THE PLECKSTRIN-HOMOLOGY DOMAIN OF BCR-ABL IN COMPLEX WITH MONOBODY MB(BCR-PH_4).
2314, 5kvmC, 0.5427, 3.21, 0.108, 95, 65, EXTRACELLULAR REGION OF MOUSE GPR56/ADGRG1 IN COMPLEX WITH FN3 MONOBODY
2315, 4ov6G, 0.5427, 2.83, 0.079, 96, 63, CRYSTAL STRUCTURE OF PCSK9(53-451) WITH ADNECTIN
2316, 2nnfB, 0.5427, 2.88, 0.095, 115, 63, STRUCTURE OF THE SULFUR CARRIER PROTEIN SOXY FROM CHLOROBIUM LIMICOLA F THIOSULFATOPHILUM
2317, 2ji2A, 0.5427, 3.10, 0.075, 126, 67, X-RAY STRUCTURE OF E114A MUTANT OF SUPEROXIDE REDUCTASE FROM DESULFOARCULUS BAARSII IN THE NATIVE REDUCED FORM
2318, 1xuoA, 0.5427, 3.40, 0.088, 181, 68, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
2319, 1h3tA, 0.5427, 3.73, 0.060, 207, 67, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (MN2F)2
2320, 5a40G, 0.5426, 2.88, 0.063, 88, 63, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2321, 5a40F, 0.5426, 2.85, 0.063, 88, 63, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2322, 4rfoL, 0.5426, 3.68, 0.075, 212, 67, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1
2323, 4nwnN, 0.5426, 2.83, 0.077, 157, 65, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
2324, 3weiA, 0.5426, 2.61, 0.119, 334, 59, CRYSTAL STRUCTURE OF THE HUMAN SQUALENE SYNTHASE Y73A MUTANT IN COMPLEX WITH PRESQUALENE PYROPHOSPHATE
2325, 3twcL, 0.5426, 3.65, 0.075, 208, 67, CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
2326, 3s7gB, 0.5426, 3.59, 0.090, 207, 67, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
2327, 3ri5M, 0.5426, 3.73, 0.103, 210, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2328, 3klsA, 0.5426, 3.37, 0.060, 1622, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
2329, 6nd8R, 0.5425, 3.21, 0.119, 191, 67, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
2330, 6mg4B, 0.5425, 3.64, 0.075, 215, 67, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO 
2331, 6d0kC, 0.5425, 2.91, 0.062, 90, 64, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; E118Q MUTANT 
2332, 6d0jC, 0.5425, 2.91, 0.062, 90, 64, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER 
2333, 5mheH, 0.5425, 3.47, 0.097, 220, 62, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH T4 
2334, 5dj0A, 0.5425, 3.63, 0.090, 208, 67, FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q
2335, 4y19B, 0.5425, 3.54, 0.138, 184, 65, IMMUNE COMPLEX
2336, 3rifK, 0.5425, 3.66, 0.104, 210, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2337, 2ji3C, 0.5425, 3.11, 0.075, 126, 67, X-RAY STRUCTURE OF THE IRON-PEROXIDE INTERMEDIATE OF SUPEROXIDE REDUCTASE (E114A MUTANT) FROM DESULFOARCULUS BAARSII
2338, 2gj7B, 0.5425, 3.61, 0.090, 207, 67, CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
2339, 1qg3B, 0.5425, 3.11, 0.136, 193, 66, CRYSTAL STRUCTURE OF A TANDEM PAIR OF FIBRONECTIN TYPE III DOMAINS FROM THE CYTOPLASMIC TAIL OF INTEGRIN ALPHA6 BETA4
2340, 1dn2B, 0.5425, 3.61, 0.090, 207, 67, FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
2341, 6ndeO, 0.5424, 3.31, 0.118, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
2342, 6n5dF, 0.5424, 3.97, 0.072, 212, 69, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
2343, 5wduB, 0.5424, 3.66, 0.075, 210, 67, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
2344, 5mybA, 0.5424, 2.76, 0.094, 190, 64, HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 2 AND 3 IN SPACE GROUP P21
2345, 5i8hL, 0.5424, 3.64, 0.075, 210, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB
2346, 4xedA, 0.5424, 3.29, 0.076, 96, 66, PKD DOMAIN OF M14-LIKE PEPTIDASE FROM THERMOPLASMATALES ARCHAEON SCGC AB-540-F20
2347, 4x8bA, 0.5424, 3.35, 0.101, 428, 69, ERGOTHIONEINE-BIOSYNTHETIC SULFOXIDE SYNTHASE EGTB APO FORM
2348, 4tnwi, 0.5424, 3.65, 0.104, 214, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2349, 4gboB, 0.5424, 3.41, 0.059, 186, 68, STRUCTURE OF T.FUSCA E7
2350, 3rkpB, 0.5424, 3.32, 0.045, 349, 67, CRYSTAL STRUCTURE OF BCPA*(D312A) THE MAJOR PILIN SUBUNIT OF BACILLUS CEREUS
2351, 3klsB, 0.5424, 3.37, 0.060, 1478, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
2352, 6nnfL, 0.5423, 3.66, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM 
2353, 6arqA, 0.5423, 3.18, 0.123, 109, 65, CRYSTAL STRUCTURE OF CD96 (D1) BOUND TO CD155/NECL-5 (D1-3) 
2354, 5x8mA, 0.5423, 3.34, 0.103, 116, 68, PD-L1 IN COMPLEX WITH DURVALUMAB
2355, 5w38B, 0.5423, 3.61, 0.090, 209, 67, 1.80A RESOLUTION STRUCTURE OF HUMAN IGG3 FC (N392K)
2356, 5hyiA, 0.5423, 3.45, 0.091, 209, 66, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
2357, 5ggrB, 0.5423, 3.57, 0.106, 212, 66, PD-1 IN COMPLEX WITH NIVOLUMAB FAB
2358, 4v3pJA, 0.5423, 3.32, 0.069, 216, 72, 
2359, 4jc6B, 0.5423, 3.37, 0.060, 252, 67, MERCURY ACTIVATION OF THE PLANT AQUAPORIN SOPIP2;1 - STRUCTURAL AND FUNCTIONAL CHARACTERIZATION
2360, 3pvmD, 0.5423, 3.26, 0.075, 1225, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
2361, 2ntfL, 0.5423, 3.77, 0.103, 211, 68, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2362, 2ntfA, 0.5423, 3.77, 0.103, 211, 68, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2363, 1jrhI, 0.5423, 3.34, 0.176, 95, 68, COMPLEX (ANTIBODY/ANTIGEN)
2364, 6fy3L, 0.5422, 3.55, 0.076, 214, 66, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2365, 5n2dD, 0.5422, 3.37, 0.103, 124, 68, STRUCTURE OF PD-L1/SMALL-MOLECULE INHIBITOR COMPLEX
2366, 5djcB, 0.5422, 3.64, 0.090, 206, 67, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
2367, 4uwqF, 0.5422, 3.15, 0.079, 87, 63, CRYSTAL STRUCTURE OF THE DISULFIDE-LINKED COMPLEX OF THE THIOSULFODYROLASE SOXB WITH THE CARRIER-PROTEIN SOXYZ FROM THERMUS THERMOPHILUS
2368, 4m6aD, 0.5422, 2.89, 0.079, 88, 63, N-TERMINAL BETA-STRAND SWAPPING IN A CONSENSUS DERIVED ALTERNATIVE SCAFFOLD DRIVEN BY STABILIZING HYDROPHOBIC INTERACTIONS
2369, 4bg4A, 0.5422, 3.65, 0.081, 355, 74, CRYSTAL STRUCTURE OF LITOPENAEUS VANNAMEI ARGININE KINASE IN TERNARY COMPLEX WITH ARGININE ADP-MG AND NO3
2370, 3s3jA, 0.5422, 3.72, 0.086, 650, 70, TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR
2371, 3gqjA, 0.5422, 3.18, 0.106, 248, 66, CRYSTAL STRUCTURE OF CELL INHIBITING FACTOR (CIF) FROM PHOTORHABDUS LUMINESCENS
2372, 3e2mB, 0.5422, 3.37, 0.088, 182, 68, LFA-1 I DOMAIN BOUND TO INHIBITORS
2373, 2aabH, 0.5422, 3.48, 0.097, 224, 62, STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM
2374, 6cqjB, 0.5421, 3.57, 0.138, 182, 65, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2375, 6aoyA, 0.5421, 3.12, 0.076, 153, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH O-NITROPHENYL BETA-GALACTOSIDE (ONPG)
2376, 5mudA, 0.5421, 3.65, 0.075, 212, 67, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H6
2377, 5bobA, 0.5421, 3.33, 0.090, 202, 67, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB
2378, 4z9mD, 0.5421, 3.63, 0.068, 375, 74, CRYSTAL STRUCTURE OF HUMAN SARCOMERIC MITOCHONDRIAL CREATINE KINASE
2379, 4rgnH, 0.5421, 3.77, 0.092, 213, 65, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2380, 3pvmB, 0.5421, 3.26, 0.075, 1225, 67, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
2381, 3f7pC, 0.5421, 3.12, 0.136, 200, 66, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN INTEGRIN BETA4 AND PLECTIN
2382, 1mcwM, 0.5421, 3.62, 0.090, 215, 67, THREE-DIMENSIONAL STRUCTURE OF A HYBRID LIGHT CHAIN DIMER. PROTEIN ENGINEERING OF A BINDING CAVITY
2383, 6ndgR, 0.5420, 3.21, 0.119, 191, 67, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
2384, 6n5bL, 0.5420, 3.76, 0.103, 211, 68, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
2385, 6d4nA, 0.5420, 3.45, 0.091, 208, 66, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4 
2386, 5i66B, 0.5420, 3.59, 0.076, 213, 66, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
2387, 5a40H, 0.5420, 2.78, 0.079, 90, 63, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2388, 4jc6D, 0.5420, 3.38, 0.060, 251, 67, MERCURY ACTIVATION OF THE PLANT AQUAPORIN SOPIP2;1 - STRUCTURAL AND FUNCTIONAL CHARACTERIZATION
2389, 4jc6A, 0.5420, 3.37, 0.060, 252, 67, MERCURY ACTIVATION OF THE PLANT AQUAPORIN SOPIP2;1 - STRUCTURAL AND FUNCTIONAL CHARACTERIZATION
2390, 4bg4B, 0.5420, 3.64, 0.081, 355, 74, CRYSTAL STRUCTURE OF LITOPENAEUS VANNAMEI ARGININE KINASE IN TERNARY COMPLEX WITH ARGININE ADP-MG AND NO3
2391, 3pn1A, 0.5420, 3.41, 0.113, 318, 71, NOVEL BACTERIAL NAD+-DEPENDENT DNA LIGASE INHIBITORS WITH BROAD SPECTRUM POTENCY AND ANTIBACTERIAL EFFICACY IN VIVO
2392, 3ed4A, 0.5420, 3.32, 0.066, 468, 61, CRYSTAL STRUCTURE OF PUTATIVE ARYLSULFATASE FROM ESCHERICHIA COLI
2393, 2zpkM, 0.5420, 3.67, 0.104, 209, 67, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2394, 1yuhL, 0.5420, 3.65, 0.090, 211, 67, FAB FRAGMENT
2395, 1cqpB, 0.5420, 3.40, 0.088, 182, 68, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
2396, 5wduS, 0.5419, 3.66, 0.075, 210, 67, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
2397, 5hceA, 0.5419, 3.36, 0.061, 982, 66, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS APPENDICULATUS RACI1
2398, 4kphH, 0.5419, 3.46, 0.081, 205, 62, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
2399, 3mugA, 0.5419, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2400, 3f78A, 0.5419, 3.13, 0.090, 180, 67, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
2401, 2gj7A, 0.5419, 3.63, 0.090, 207, 67, CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
2402, 1mfnA, 0.5419, 3.20, 0.076, 184, 66, SOLUTION NMR STRUCTURE OF LINKED CELL ATTACHMENT MODULES OF MOUSE FIBRONECTIN CONTAINING THE RGD AND SYNERGY REGIONS 20 STRUCTURES
2403, 1fq9C, 0.5419, 3.07, 0.031, 211, 64, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
2404, 1dn2A, 0.5419, 3.63, 0.090, 207, 67, FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
2405, 1cloH, 0.5419, 3.31, 0.098, 222, 61, ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
2406, 5tppL, 0.5418, 3.71, 0.075, 212, 67, CRYSTAL STRUCTURE OF DH270.5 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
2407, 5hccA, 0.5418, 3.51, 0.060, 982, 67, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND DERMACENTOR ANDERSONI RACI3.
2408, 4oy8A, 0.5418, 3.32, 0.090, 186, 67, STRUCTURE OF SCLPMO10B IN COMPLEX WITH ZINC.
2409, 4jc6H, 0.5418, 3.35, 0.060, 252, 67, MERCURY ACTIVATION OF THE PLANT AQUAPORIN SOPIP2;1 - STRUCTURAL AND FUNCTIONAL CHARACTERIZATION
2410, 3f7qB, 0.5418, 3.39, 0.152, 214, 66, FIRST PAIR OF FIBRONECTIN TYPE III DOMAINS AND PART OF THE CONNECTING SEGMENT OF THE INTEGRIN BETA4
2411, 1wejH, 0.5418, 3.32, 0.098, 223, 61, IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
2412, 1nrwA, 0.5418, 3.22, 0.127, 279, 63, THE STRUCTURE OF A HALOACID DEHALOGENASE-LIKE HYDROLASE FROM B. SUBTILIS
2413, 6h6fA, 0.5417, 3.25, 0.111, 2454, 63, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
2414, 5jihB, 0.5417, 3.45, 0.091, 212, 66, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)
2415, 5bobE, 0.5417, 3.50, 0.088, 195, 68, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB
2416, 4rgnB, 0.5417, 3.78, 0.092, 213, 65, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2417, 4jdeA, 0.5417, 3.09, 0.062, 144, 64, CRYSTAL STRUCTURE OF PUD-1/PUD-2 HETERODIMER
2418, 3t4yB, 0.5417, 3.49, 0.097, 222, 62, S25-2- KDO MONOSACCHARIDE COMPLEX
2419, 3s7gA, 0.5417, 3.57, 0.090, 208, 67, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
2420, 2ys6A, 0.5417, 2.60, 0.117, 421, 60, CRYSTAL STRUCTURE OF GAR SYNTHETASE FROM GEOBACILLUS KAUSTOPHILUS
2421, 2yetB, 0.5417, 3.40, 0.043, 226, 69, THERMOASCUS GH61 ISOZYME A
2422, 2r8jA, 0.5417, 3.30, 0.044, 511, 68, STRUCTURE OF THE EUKARYOTIC DNA POLYMERASE ETA IN COMPLEX WITH 12- D(GPG)-CISPLATIN CONTAINING DNA
2423, 1rd4A, 0.5417, 3.14, 0.090, 184, 67, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
2424, 1fccB, 0.5417, 3.51, 0.061, 206, 66, CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
2425, 1fccA, 0.5417, 3.51, 0.061, 206, 66, CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
2426, 1e0oD, 0.5417, 2.89, 0.032, 196, 62, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
2427, 6mugL, 0.5416, 3.68, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM 
2428, 6mnnD, 0.5416, 3.27, 0.095, 194, 63, 6236 TCR BOUND TO I-AB PADI4 
2429, 5t33L, 0.5416, 3.54, 0.076, 212, 66, CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1 IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.
2430, 5eukA, 0.5416, 3.54, 0.106, 212, 66, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
2431, 5dj6A, 0.5416, 3.59, 0.090, 208, 67, FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M
2432, 4v9kHC, 0.5416, 2.97, 0.119, 228, 67, 
2433, 4v6aAA, 0.5416, 3.41, 0.096, 224, 73, 
2434, 4tnvO, 0.5416, 3.63, 0.104, 211, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2435, 4hrrH, 0.5416, 3.78, 0.090, 150, 67, SCAPHARCA TETRAMERIC HEMOGLOBIN CO-STATE
2436, 3qb7C, 0.5416, 3.44, 0.119, 191, 67, INTERLEUKIN-4 MUTANT RGA BOUND TO CYTOKINE RECEPTOR COMMON GAMMA
2437, 3cfeB, 0.5416, 3.51, 0.092, 219, 65, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
2438, 2ravA, 0.5416, 2.62, 0.103, 261, 58, X-RAY CRYSTALLOGRAPHIC STRUCTURES SHOW CONSERVATION OF A TRIGONAL- BIPYRAMIDAL INTERMEDIATE IN A PHOSPHORYL-TRANSFER SUPERFAMILY.
2439, 6iekC, 0.5415, 3.69, 0.075, 218, 67, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
2440, 5u7mL, 0.5415, 3.57, 0.076, 208, 66, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
2441, 5n7cB, 0.5415, 3.32, 0.123, 116, 65, HUMAN TTR ALTERED CONFORMATION FROM SOAKING IN CUCL2.
2442, 5imrY, 0.5415, 3.50, 0.123, 228, 73, 
2443, 5ikcH, 0.5415, 3.49, 0.081, 214, 62, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2444, 4z9mA, 0.5415, 3.65, 0.068, 352, 73, CRYSTAL STRUCTURE OF HUMAN SARCOMERIC MITOCHONDRIAL CREATINE KINASE
2445, 4x98B, 0.5415, 3.63, 0.090, 204, 67, IMMUNOGLOBULIN FC HETERODIMER VARIANT
2446, 4v4pC, 0.5415, 3.49, 0.111, 221, 72, 
2447, 4qeyF, 0.5415, 3.13, 0.079, 122, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2448, 3vpcB, 0.5415, 2.86, 0.131, 282, 61, ARGX FROM SULFOLOBUS TOKODAII COMPLEXED WITH ADP
2449, 2gpqA, 0.5415, 2.41, 0.140, 217, 57, CAP-FREE STRUCTURE OF EIF4E SUGGESTS BASIS FOR ITS ALLOSTERIC REGULATION
2450, 1vzgA, 0.5415, 3.11, 0.075, 125, 67, STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION
2451, 1rd4C, 0.5415, 3.27, 0.103, 184, 68, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
2452, 6mqeB, 0.5414, 3.41, 0.123, 212, 65, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DFPH-A.15 IN COMPLEX WITH FP (RESIDUE 512-519) 
2453, 6mnmD, 0.5414, 3.27, 0.095, 194, 63, 6256 TCR BOUND TO I-AB PADI4 
2454, 6cqjE, 0.5414, 3.35, 0.109, 180, 64, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2455, 5otjA, 0.5414, 3.68, 0.075, 213, 67, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2456, 5mtlB, 0.5414, 3.50, 0.076, 198, 66, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
2457, 5di8A, 0.5414, 3.62, 0.090, 208, 67, FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V
2458, 4oy7B, 0.5414, 3.68, 0.043, 196, 70, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
2459, 4llwD, 0.5414, 3.60, 0.076, 209, 66, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE DOMAIN REDESIGN (VRD2) AT 1.95A
2460, 3tp4B, 0.5414, 3.26, 0.152, 455, 66, CRYSTAL STRUCTURE OF ENGINEERED PROTEIN AT THE RESOLUTION 1.98A NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR128
2461, 1i3rF, 0.5414, 3.42, 0.109, 216, 64, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
2462, 1i1cB, 0.5414, 3.61, 0.060, 205, 67, NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
2463, 6igoF, 0.5413, 3.46, 0.045, 119, 67, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
2464, 6e9qD, 0.5413, 3.76, 0.103, 214, 68, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
2465, 6be3L, 0.5413, 3.65, 0.090, 213, 67, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE (GLCNAC)
2466, 5x6aB, 0.5413, 3.43, 0.029, 229, 69, CRYSTAL STRUCTURE OF AN ENDOGLUCANASE PMO-5
2467, 5wcdL, 0.5413, 3.66, 0.075, 212, 67, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 04-1D02 FAB.
2468, 5mp6L, 0.5413, 3.51, 0.076, 224, 66, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALIZING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE AT TWO ANGSTROM RESOLUTION.
2469, 5i8hJ, 0.5413, 3.67, 0.075, 210, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB
2470, 5hyeC, 0.5413, 3.56, 0.090, 207, 67, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)
2471, 5h1dA, 0.5413, 3.01, 0.077, 135, 65, CRYSTAL STRUCTURE OF C-TERMINAL OF RHOGDI2
2472, 5dk2A, 0.5413, 3.65, 0.090, 207, 67, FC HETERODIMER E356K/D399K + K392D/K409D
2473, 3m10A, 0.5413, 3.40, 0.069, 347, 72, SUBSTRATE-FREE FORM OF ARGININE KINASE
2474, 1vzhA, 0.5413, 3.12, 0.075, 125, 67, STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION
2475, 6h03A, 0.5412, 3.37, 0.106, 1223, 66, struct.pdbx_descriptor              
2476, 6e62L, 0.5412, 3.68, 0.075, 213, 67, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
2477, 5v7pD, 0.5412, 3.15, 0.123, 95, 65, ATOMIC STRUCTURE OF THE EUKARYOTIC INTRAMEMBRANE RAS METHYLTRANSFERASE ICMT (ISOPRENYLCYSTEINE CARBOXYL METHYLTRANSFERASE) IN COMPLEX WITH A MONOBODY
2478, 5u92A, 0.5412, 3.54, 0.055, 346, 73, CRYSTAL STRUCTURE OF ARGININE KINASE FROM THE SPIDER POLYBETES PYTHAGORICUS IN COMPLEX WITH ARGININE
2479, 5hvwA, 0.5412, 3.65, 0.090, 210, 67, MONOMERIC IGG4 FC
2480, 5d2lO, 0.5412, 3.03, 0.045, 187, 66, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2481, 5bobD, 0.5412, 3.33, 0.090, 199, 67, CRYSTAL STRUCTURE OF THE MENINGITIS PATHOGEN STREPTOCOCCUS SUIS ADHESION FHB
2482, 4tnwL, 0.5412, 3.78, 0.103, 211, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2483, 4k3hH, 0.5412, 3.24, 0.077, 109, 65, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
2484, 4hk0D, 0.5412, 3.66, 0.075, 210, 67, UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
2485, 3s7gC, 0.5412, 3.57, 0.090, 208, 67, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
2486, 2r2hB, 0.5412, 3.50, 0.097, 215, 62, STRUCTURE OF S25-2 IN COMPLEX WITH KO
2487, 2oldB, 0.5412, 3.68, 0.074, 216, 68, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(2)21 CRYSTAL FORM
2488, 2ji3A, 0.5412, 3.11, 0.075, 126, 67, X-RAY STRUCTURE OF THE IRON-PEROXIDE INTERMEDIATE OF SUPEROXIDE REDUCTASE (E114A MUTANT) FROM DESULFOARCULUS BAARSII
2489, 1rd4B, 0.5412, 3.14, 0.090, 184, 67, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
2490, 1nc2C, 0.5412, 3.63, 0.104, 215, 67, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
2491, 1lfaB, 0.5412, 3.26, 0.088, 182, 68, CD11A I-DOMAIN WITH BOUND MN++
2492, 1i1cA, 0.5412, 3.61, 0.060, 205, 67, NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
2493, 1etzH, 0.5412, 3.67, 0.090, 228, 67, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
2494, 6njlJ, 0.5411, 3.52, 0.061, 211, 66, STRUCTURE OF A COMPLEX 
2495, 6cpgB, 0.5411, 2.93, 0.094, 89, 64, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) IN COMPLEX WITH INHIBITING MONOBODY AND AT9283 IN AN INACTIVE CONFORMATION 
2496, 6a67D, 0.5411, 3.52, 0.091, 212, 66, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
2497, 5f88A, 0.5411, 3.46, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
2498, 4wwiF, 0.5411, 3.54, 0.090, 207, 67, CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION
2499, 4tnvi, 0.5411, 3.79, 0.103, 214, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2500, 4m6aF, 0.5411, 2.82, 0.081, 89, 62, N-TERMINAL BETA-STRAND SWAPPING IN A CONSENSUS DERIVED ALTERNATIVE SCAFFOLD DRIVEN BY STABILIZING HYDROPHOBIC INTERACTIONS
2501, 4jc6J, 0.5411, 3.34, 0.060, 251, 67, MERCURY ACTIVATION OF THE PLANT AQUAPORIN SOPIP2;1 - STRUCTURAL AND FUNCTIONAL CHARACTERIZATION
2502, 3ks0J, 0.5411, 3.67, 0.104, 212, 67, CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
2503, 2y7nA, 0.5411, 3.01, 0.077, 311, 65, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 - APO FORM
2504, 2r2eB, 0.5411, 3.64, 0.094, 221, 64, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2505, 1uz8A, 0.5411, 3.74, 0.059, 218, 68, ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
2506, 1h3tB, 0.5411, 3.65, 0.119, 197, 67, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (MN2F)2
2507, 1fj1D, 0.5411, 3.26, 0.094, 213, 64, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2508, 6ha5B, 0.5410, 3.42, 0.043, 227, 69, AFGH61B L90V/D131S/M134L/A141W VARIANT 
2509, 6bz4B, 0.5410, 3.24, 0.092, 206, 65, HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A 
2510, 6bj2D, 0.5410, 3.35, 0.106, 202, 66, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
2511, 5n2kM, 0.5410, 3.68, 0.075, 212, 67, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
2512, 5m6aA, 0.5410, 3.73, 0.074, 215, 68, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
2513, 4jamL, 0.5410, 3.74, 0.075, 206, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
2514, 4cdhB, 0.5410, 3.38, 0.091, 208, 66, CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT
2515, 4a6yL, 0.5410, 3.73, 0.103, 211, 68, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
2516, 3mugC, 0.5410, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2517, 3lb6C, 0.5410, 3.08, 0.111, 250, 63, THE STRUCTURE OF IL-13 IN COMPLEX WITH IL-13RALPHA2
2518, 3ks0L, 0.5410, 3.67, 0.104, 212, 67, CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
2519, 3cfeH, 0.5410, 3.51, 0.092, 219, 65, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
2520, 1rd4D, 0.5410, 3.14, 0.090, 184, 67, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
2521, 6o1oA, 0.5409, 2.89, 0.000, 716, 62, CRYO-EM STRUCTURE OF THE T. THERMOPHILUS CSM COMPLEX BOUND TO TARGET SSRNA 
2522, 6n5dD, 0.5409, 3.57, 0.076, 212, 66, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
2523, 6if7A, 0.5409, 3.67, 0.114, 183, 70, CRYSTAL STRUCTURE OF AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM TECTARIA MACRODONTA 
2524, 6d2pL, 0.5409, 3.68, 0.075, 210, 67, CRYSTAL STRUCTURE OF IOMA-CLASS CLK31 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD- GT8 AT 2.6 A 
2525, 5kf4A, 0.5409, 3.33, 0.121, 99, 66, CRYSTAL STRUCTURE OF FN3 DOMAIN (RESIDUES P368-P466) OF HUMAN COLLAGEN XX
2526, 5b4mC, 0.5409, 3.74, 0.092, 221, 65, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2527, 4oy6A, 0.5409, 3.41, 0.044, 186, 68, STRUCTURE OF SCLPMO10B IN COMPLEX WITH COPPER.
2528, 3phoA, 0.5409, 3.46, 0.077, 216, 65, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2529, 3bpnC, 0.5409, 3.50, 0.103, 295, 68, CRYSTAL STRUCTURE OF THE IL4-IL4R-IL13RA TERNARY COMPLEX
2530, 1vzgB, 0.5409, 3.12, 0.075, 125, 67, STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION
2531, 1l9mB, 0.5409, 3.50, 0.061, 681, 66, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
2532, 6mufL, 0.5408, 3.68, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM 
2533, 6fy1L, 0.5408, 3.55, 0.076, 211, 66, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
2534, 6d4nB, 0.5408, 3.33, 0.092, 208, 65, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4 
2535, 6bjhA, 0.5408, 2.79, 0.067, 143, 60, CIRV P19 MUTANT T111S IN COMPLEX WITH SIRNA 
2536, 5ywpQ, 0.5408, 3.49, 0.077, 215, 65, JEV-2H4 FAB COMPLEX 
2537, 5v4nF, 0.5408, 3.41, 0.125, 197, 64, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
2538, 5otjL, 0.5408, 3.71, 0.075, 213, 67, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2539, 5nkqF, 0.5408, 3.03, 0.065, 86, 62, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2540, 5cezL, 0.5408, 3.67, 0.075, 211, 67, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM
2541, 5bk1L, 0.5408, 3.55, 0.106, 210, 66, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ENDOSTERIC SYNTHETIC ANTIBODY
2542, 4dgyL, 0.5408, 3.49, 0.108, 212, 65, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 FORM
2543, 3bqnC, 0.5408, 3.39, 0.088, 182, 68, LFA-1 I DOMAIN BOUND TO INHIBITORS
2544, 2v17L, 0.5408, 3.60, 0.076, 214, 66, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
2545, 2j1qA, 0.5408, 3.51, 0.097, 339, 72, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI ARGININE KINASE
2546, 2dn7A, 0.5408, 3.17, 0.045, 107, 66, SOLUTION STRUCTURES OF THE 6TH FN3 DOMAIN OF HUMAN RECEPTOR- TYPE TYROSINE-PROTEIN PHOSPHATASE F
2547, 1za6D, 0.5408, 3.61, 0.119, 324, 67, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2548, 1mceB, 0.5408, 3.88, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2549, 6isbB, 0.5407, 3.50, 0.118, 218, 68, CRYSTAL STRUCTURE OF HUMAN CD226 
2550, 5ujtH, 0.5407, 3.29, 0.063, 179, 63, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
2551, 5njdO, 0.5407, 3.57, 0.076, 213, 66, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2552, 5jopE, 0.5407, 3.45, 0.081, 208, 62, CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A
2553, 5j8bC, 0.5407, 3.47, 0.096, 136, 73, 
2554, 5djaA, 0.5407, 3.62, 0.090, 208, 67, FC HETERODIMER DESIGN 9.1 Y407M + T366I
2555, 4x99B, 0.5407, 3.50, 0.091, 205, 66, IMMUNOGLOBULIN FC HETERODIMERS VARIANT
2556, 3c6sA, 0.5407, 3.86, 0.059, 216, 68, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
2557, 2j5lC, 0.5407, 3.30, 0.098, 225, 61, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2558, 1tyoA, 0.5407, 3.53, 0.057, 427, 70, ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX IN COMPLEX WITH ETHENO-NADP
2559, 6njnJ, 0.5406, 3.61, 0.076, 211, 66, STRUCTURE OF A COMPLEX 
2560, 5itbL, 0.5406, 3.71, 0.104, 215, 67, CRYSTAL STRUCTURE OF THE ANTI-RSV F FAB 14N4
2561, 5i5kA, 0.5406, 3.52, 0.103, 1632, 68, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
2562, 4nefA, 0.5406, 3.39, 0.045, 239, 67, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2
2563, 3qwqB, 0.5406, 3.24, 0.062, 100, 65, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH AN ADNECTIN
2564, 3mugI, 0.5406, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2565, 2mblA, 0.5406, 2.40, 0.217, 120, 60, SOLUTION NMR STRUCTURE OF DE NOVO DESIGNED TOP7 FOLD PROTEIN TOP7M13 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR33
2566, 2ji3B, 0.5406, 3.12, 0.075, 125, 67, X-RAY STRUCTURE OF THE IRON-PEROXIDE INTERMEDIATE OF SUPEROXIDE REDUCTASE (E114A MUTANT) FROM DESULFOARCULUS BAARSII
2567, 2ifyA, 0.5406, 3.67, 0.079, 508, 63, STRUCTURE OF BACILLUS ANTHRACIS COFACTOR-INDEPENDENT PHOSPHOGLUCERATE MUTASE
2568, 1vzhB, 0.5406, 3.12, 0.075, 125, 67, STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION
2569, 1nfdE, 0.5406, 3.54, 0.091, 212, 66, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2570, 1lhzA, 0.5406, 3.67, 0.075, 213, 67, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
2571, 1l9nB, 0.5406, 3.51, 0.061, 673, 66, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
2572, 1acyL, 0.5406, 3.26, 0.062, 215, 64, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
2573, 6mtsL, 0.5405, 3.67, 0.075, 212, 67, CRYSTAL STRUCTURE OF VRC43.03 FAB 
2574, 4od3L, 0.5405, 3.67, 0.075, 213, 67, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2575, 3v95B, 0.5405, 3.45, 0.091, 209, 66, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA
2576, 3mj8A, 0.5405, 3.77, 0.103, 209, 68, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2577, 3hr5Q, 0.5405, 3.53, 0.106, 219, 66, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2578, 3hntL, 0.5405, 3.77, 0.060, 214, 67, CS-35 FAB COMPLEX WITH A LINEAR TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
2579, 3bpoB, 0.5405, 3.24, 0.104, 198, 67, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
2580, 3bpcB, 0.5405, 3.47, 0.097, 214, 62, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
2581, 3aqzB, 0.5405, 3.48, 0.060, 102, 67, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
2582, 2v17H, 0.5405, 3.38, 0.094, 222, 64, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
2583, 2pw2A, 0.5405, 3.46, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL
2584, 2fl5C, 0.5405, 3.69, 0.075, 209, 67, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2585, 1qg3A, 0.5405, 3.08, 0.138, 195, 65, CRYSTAL STRUCTURE OF A TANDEM PAIR OF FIBRONECTIN TYPE III DOMAINS FROM THE CYTOPLASMIC TAIL OF INTEGRIN ALPHA6 BETA4
2586, 1mcwW, 0.5405, 3.57, 0.104, 215, 67, THREE-DIMENSIONAL STRUCTURE OF A HYBRID LIGHT CHAIN DIMER. PROTEIN ENGINEERING OF A BINDING CAVITY
2587, 5xuyD, 0.5404, 2.63, 0.086, 215, 58, CRYSTAL STRUCTURE OF ATG101-ATG13HORMA 
2588, 5f89B, 0.5404, 3.53, 0.076, 222, 66, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALISING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE
2589, 4l4jA, 0.5404, 3.63, 0.119, 208, 67, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY
2590, 4k3eI, 0.5404, 3.73, 0.092, 261, 65, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
2591, 4ia4C, 0.5404, 3.36, 0.060, 245, 67, STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 AT PH 6
2592, 3wiiL, 0.5404, 3.60, 0.061, 213, 66, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2593, 2omnB, 0.5404, 3.64, 0.075, 216, 67, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P4(3)2(1)2 CRYSTAL FORM
2594, 2fseD, 0.5404, 3.29, 0.127, 186, 63, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
2595, 1ibgL, 0.5404, 3.42, 0.092, 217, 65, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
2596, 1fe8C, 0.5404, 3.31, 0.090, 187, 67, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
2597, 6nm6L, 0.5403, 3.69, 0.075, 210, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM 
2598, 6mdtL, 0.5403, 3.68, 0.075, 211, 67, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P63 SPACE GROUP 
2599, 6h1zA, 0.5403, 3.40, 0.029, 227, 69, AFGH61B WILD-TYPE 
2600, 5zv3L, 0.5403, 3.49, 0.108, 219, 65, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
2601, 5th2C, 0.5403, 3.46, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
2602, 5n47B, 0.5403, 3.30, 0.104, 183, 67, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
2603, 5k9qL, 0.5403, 3.57, 0.106, 214, 66, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2604, 5iv2A, 0.5403, 3.54, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
2605, 5fehC, 0.5403, 3.70, 0.104, 214, 67, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
2606, 4v6aEC, 0.5403, 3.35, 0.096, 220, 73, 
2607, 4gh7D, 0.5403, 3.38, 0.104, 278, 67, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
2608, 3hzkB, 0.5403, 3.48, 0.097, 222, 62, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
2609, 3cllA, 0.5403, 3.35, 0.060, 241, 67, CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 S115E MUTANT
2610, 2l3bA, 0.5403, 3.13, 0.123, 130, 65, SOLUTION NMR STRUCTURE OF THE BT_0084 LIPOPROTEIN FROM BACTEROIDES THETAIOTAOMICRON NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR376
2611, 2hw8A, 0.5403, 3.29, 0.087, 225, 69, STRUCTURE OF RIBOSOMAL PROTEIN L1-MRNA COMPLEX AT 2.1 RESOLUTION.
2612, 2b5iC, 0.5403, 3.39, 0.119, 191, 67, CYTOKINE RECEPTOR COMPLEX
2613, 1s99A, 0.5403, 2.89, 0.050, 179, 60, THE STRUCTURE AND FUNCTION OF B. SUBTILIS YKOF GENE PRODUCT: LIGAND FREE PROTEIN
2614, 1mfeL, 0.5403, 3.65, 0.104, 210, 67, RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT
2615, 1mcnB, 0.5403, 3.80, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2616, 1dqdH, 0.5403, 3.47, 0.097, 221, 62, CRYSTAL STRUCTURE OF FAB HGR-2 F6 A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
2617, 6mg5B, 0.5402, 3.67, 0.075, 215, 67, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO IN COMPLEX WITH COUMARIN 1 
2618, 6bp2L, 0.5402, 3.93, 0.074, 215, 68, THERAPEUTIC HUMAN MONOCLONAL ANTIBODY MR191 BOUND TO A MARBURGVIRUS GLYCOPROTEIN
2619, 5mtjB, 0.5402, 3.18, 0.092, 96, 65, YES1-SH2 IN COMPLEX WITH MONOBODY MB(YES_1)
2620, 4lqyA, 0.5402, 3.32, 0.131, 379, 61, CRYSTAL STRUCTURE OF HUMAN ENPP4 WITH AMP
2621, 4alrA, 0.5402, 3.37, 0.060, 166, 67, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
2622, 3vfgL, 0.5402, 3.57, 0.091, 211, 66, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2623, 3tjeL, 0.5402, 3.63, 0.075, 213, 67, CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
2624, 3mugG, 0.5402, 3.70, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2625, 3gnmL, 0.5402, 3.46, 0.062, 217, 65, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
2626, 2fl5A, 0.5402, 3.69, 0.075, 209, 67, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2627, 2ee3A, 0.5402, 3.21, 0.125, 108, 64, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN COLLAGEN ALPHA-1(XX) CHAIN
2628, 6njlM, 0.5401, 3.62, 0.076, 211, 66, STRUCTURE OF A COMPLEX 
2629, 6mnrL, 0.5401, 3.57, 0.091, 211, 66, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
2630, 6fg2E, 0.5401, 3.56, 0.076, 211, 66, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2631, 5nphL, 0.5401, 3.50, 0.062, 214, 65, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2632, 5icxA, 0.5401, 3.39, 0.108, 212, 65, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
2633, 5hyqA, 0.5401, 3.56, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
2634, 4z9mH, 0.5401, 3.55, 0.068, 365, 74, CRYSTAL STRUCTURE OF HUMAN SARCOMERIC MITOCHONDRIAL CREATINE KINASE
2635, 4hihC, 0.5401, 3.48, 0.108, 208, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
2636, 4gagH, 0.5401, 3.49, 0.097, 212, 62, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
2637, 3h0tA, 0.5401, 3.68, 0.075, 216, 67, HEPCIDIN-FAB COMPLEX
2638, 3cfcH, 0.5401, 3.47, 0.097, 213, 62, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2
2639, 3c5jB, 0.5401, 3.50, 0.138, 182, 65, CRYSTAL STRUCTURE OF HLA DR52C
2640, 2r8kB, 0.5401, 3.14, 0.076, 511, 66, STRUCTURE OF THE EUKARYOTIC DNA POLYMERASE ETA IN COMPLEX WITH 12- D(GPG)-CISPLATIN CONTAINING DNA
2641, 2jb5L, 0.5401, 3.95, 0.072, 211, 69, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-1
2642, 1ynkH, 0.5401, 3.32, 0.082, 219, 61, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
2643, 1ii4F, 0.5401, 3.04, 0.031, 200, 64, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
2644, 1aqkL, 0.5401, 3.58, 0.076, 215, 66, THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID
2645, 6qnkA, 0.5400, 3.64, 0.076, 217, 66, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
2646, 6au5A, 0.5400, 3.45, 0.108, 212, 65, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
2647, 5vk2E, 0.5400, 3.69, 0.075, 211, 67, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
2648, 5itfA, 0.5400, 3.47, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
2649, 5b6fC, 0.5400, 3.53, 0.092, 217, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
2650, 4oy7D, 0.5400, 3.51, 0.043, 196, 69, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
2651, 4odvH, 0.5400, 3.54, 0.091, 222, 66, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
2652, 4nefD, 0.5400, 3.34, 0.045, 232, 67, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2
2653, 4lsdE, 0.5400, 2.97, 0.078, 93, 64, MYOKINE STRUCTURE
2654, 4alcA, 0.5400, 3.37, 0.060, 166, 67, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXIGENASE CBM33
2655, 2pkdD, 0.5400, 3.35, 0.029, 107, 69, CRYSTAL STRUCTURE OF CD84: INSITE INTO SLAM FAMILY FUNCTION
2656, 1mceA, 0.5400, 3.64, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2657, 1iebA, 0.5400, 3.42, 0.109, 182, 64, HISTOCOMPATIBILITY ANTIGEN
2658, 6h6eC, 0.5399, 3.27, 0.111, 2417, 63, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
2659, 6arpC, 0.5399, 3.55, 0.106, 213, 66, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
2660, 5wccB, 0.5399, 3.67, 0.075, 214, 67, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 02-1F07 FAB.
2661, 5vlpL, 0.5399, 3.63, 0.076, 214, 66, PCSK9 COMPLEX WITH LDLR ANTAGONIST PEPTIDE AND FAB7G7
2662, 5v4eF, 0.5399, 3.67, 0.119, 177, 67, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
2663, 5hpmA, 0.5399, 3.56, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2664, 5b4mH, 0.5399, 3.75, 0.092, 221, 65, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2665, 4wtwA, 0.5399, 3.26, 0.119, 95, 67, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN OF INTEGRIN BETA4
2666, 4v7kFC, 0.5399, 3.56, 0.108, 120, 74, 
2667, 4tr2B, 0.5399, 3.47, 0.114, 474, 70, CRYSTAL STRUCTURE OF PVSUB1
2668, 4mayB, 0.5399, 3.28, 0.079, 181, 63, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
2669, 3gorD, 0.5399, 3.75, 0.129, 144, 70, CRYSTAL STRUCTURE OF PUTATIVE METAL-DEPENDENT HYDROLASE APC36150
2670, 2erjC, 0.5399, 3.11, 0.123, 195, 65, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
2671, 2cgrL, 0.5399, 3.81, 0.074, 219, 68, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
2672, 1p2cB, 0.5399, 3.78, 0.092, 210, 65, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2673, 1mchA, 0.5399, 3.68, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2674, 6nnjL, 0.5398, 3.70, 0.075, 210, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM 
2675, 6eluE, 0.5398, 3.51, 0.097, 222, 62, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2676, 6bkbL, 0.5398, 3.47, 0.108, 211, 65, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3A 
2677, 5xj3C, 0.5398, 3.62, 0.085, 115, 71, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
2678, 5o32A, 0.5398, 3.46, 0.104, 640, 67, THE STRUCTURE OF COMPLEMENT COMPLEX
2679, 5ksuB, 0.5398, 3.28, 0.079, 180, 63, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
2680, 4x8dA, 0.5398, 3.37, 0.101, 428, 69, ERGOTHIONEINE-BIOSYNTHETIC SULFOXIDE SYNTHASE EGTB IN COMPLEX WITH N N-DIMETHYL-HISTIDINE AND GAMMA-GLUTAMYL-CYSTEINE
2681, 4x4mA, 0.5398, 3.49, 0.091, 218, 66, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
2682, 4u6gB, 0.5398, 3.69, 0.075, 211, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE
2683, 4altA, 0.5398, 3.37, 0.060, 166, 67, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
2684, 3payD, 0.5398, 3.17, 0.149, 306, 67, CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION
2685, 3m10B, 0.5398, 3.42, 0.069, 346, 72, SUBSTRATE-FREE FORM OF ARGININE KINASE
2686, 3gorC, 0.5398, 3.75, 0.129, 147, 70, CRYSTAL STRUCTURE OF PUTATIVE METAL-DEPENDENT HYDROLASE APC36150
2687, 3cn5A, 0.5398, 3.37, 0.060, 237, 67, CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 S115E S274E MUTANT
2688, 2yetA, 0.5398, 3.34, 0.044, 226, 68, THERMOASCUS GH61 ISOZYME A
2689, 2p8lA, 0.5398, 3.47, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN
2690, 1wcbH, 0.5398, 3.48, 0.097, 222, 62, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
2691, 1tyoB, 0.5398, 3.42, 0.072, 424, 69, ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX IN COMPLEX WITH ETHENO-NADP
2692, 1rl9A, 0.5398, 3.36, 0.069, 356, 72, CRYSTAL STRUCTURE OF CREATINE-ADP ARGININE KINASE TERNARY COMPLEX
2693, 6mngD, 0.5397, 3.28, 0.095, 193, 63, 4738 TCR BOUND TO IAB PADI4 
2694, 6mkrD, 0.5397, 3.27, 0.095, 201, 63, 5287 TCR BOUND TO IAB PADI4 
2695, 6cpoE, 0.5397, 3.45, 0.125, 190, 64, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2696, 5xlia, 0.5397, 3.60, 0.076, 213, 66, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
2697, 5wk2L, 0.5397, 3.59, 0.106, 219, 66, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
2698, 5vmeB, 0.5397, 3.66, 0.119, 196, 67, CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E T437R MUTANT
2699, 5n47D, 0.5397, 3.33, 0.104, 280, 67, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
2700, 5ir1A, 0.5397, 3.47, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
2701, 5ghwL, 0.5397, 3.54, 0.076, 211, 66, CRYSTAL STRUCTURE OF BROAD NEUTRALIZING ANTIBODY 10E8 WITH LONG EPITOPE BOUND
2702, 4v7kZ, 0.5397, 3.56, 0.108, 120, 74, 
2703, 4tnvN, 0.5397, 3.64, 0.104, 211, 67, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2704, 4tnvL, 0.5397, 3.78, 0.103, 211, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2705, 4lr2A, 0.5397, 3.33, 0.131, 379, 61, CRYSTAL STRUCTURE OF HUMAN ENPP4 (APO)
2706, 4alqA, 0.5397, 3.37, 0.060, 166, 67, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
2707, 4aleA, 0.5397, 3.37, 0.060, 166, 67, STRUCTURE CHANGES OF POLYSACCHARIDE MONOOXYGENASE CBM33A FROM ENTEROCOCCUS FAECALIS BY X-RAY INDUCED PHOTOREDUCTION.
2708, 3modL, 0.5397, 3.59, 0.106, 214, 66, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
2709, 3c5sD, 0.5397, 3.47, 0.097, 208, 62, CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
2710, 2fd6H, 0.5397, 3.48, 0.097, 212, 62, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
2711, 1y6mR, 0.5397, 3.20, 0.119, 204, 67, CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
2712, 1pz5A, 0.5397, 3.41, 0.108, 215, 65, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
2713, 1nl0L, 0.5397, 3.69, 0.075, 213, 67, CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY 10C12
2714, 6mu7L, 0.5396, 3.70, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM 
2715, 6mqeL, 0.5396, 3.50, 0.123, 212, 65, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DFPH-A.15 IN COMPLEX WITH FP (RESIDUE 512-519) 
2716, 6e9uB, 0.5396, 3.78, 0.103, 215, 68, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-7 
2717, 6dfwD, 0.5396, 3.34, 0.095, 192, 63, TCR 8F10 IN COMPLEX WITH IAG7-P8G9E 
2718, 5t29L, 0.5396, 3.70, 0.075, 211, 67, CRYSTAL STRUCTURE OF 10E8 FAB LIGHT CHAIN MUTANT3 AGAINST THE MPER REGION OF THE HIV-1 ENV IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
2719, 5n6uD, 0.5396, 3.41, 0.088, 811, 68, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
2720, 5n2kG, 0.5396, 3.67, 0.075, 212, 67, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
2721, 5n09L, 0.5396, 3.76, 0.074, 213, 68, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
2722, 5ijvL, 0.5396, 3.67, 0.104, 213, 67, CRYSTAL STRUCTURE OF BOVINE FAB E03
2723, 4xnqA, 0.5396, 3.67, 0.090, 208, 67, ANTIBODY HEMAGGLUTININ COMPLEXES
2724, 4xnmA, 0.5396, 3.79, 0.088, 208, 68, ANTIBODY INFLUENZA H5 COMPLEX
2725, 4v8nRC, 0.5396, 3.55, 0.108, 120, 74, 
2726, 4ma7H, 0.5396, 3.32, 0.098, 218, 61, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
2727, 4m6aH, 0.5396, 2.88, 0.095, 89, 63, N-TERMINAL BETA-STRAND SWAPPING IN A CONSENSUS DERIVED ALTERNATIVE SCAFFOLD DRIVEN BY STABILIZING HYDROPHOBIC INTERACTIONS
2728, 4hgwB, 0.5396, 3.33, 0.098, 213, 61, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
2729, 4gayH, 0.5396, 3.71, 0.094, 212, 64, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
2730, 4bh7B, 0.5396, 3.62, 0.095, 218, 63, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI
2731, 3mj8L, 0.5396, 3.68, 0.104, 209, 67, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2732, 3f7qA, 0.5396, 3.23, 0.154, 214, 65, FIRST PAIR OF FIBRONECTIN TYPE III DOMAINS AND PART OF THE CONNECTING SEGMENT OF THE INTEGRIN BETA4
2733, 3eobJ, 0.5396, 3.17, 0.090, 179, 67, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2734, 3egsA, 0.5396, 3.49, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 SOAKED IN AMMONIUM SULFATE
2735, 2ylhA, 0.5396, 3.00, 0.077, 311, 65, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 G299W MUTANT
2736, 2p8pA, 0.5396, 3.48, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]
2737, 2bj3B, 0.5396, 2.93, 0.167, 137, 60, NIKR-APO
2738, 2b6oA, 0.5396, 3.27, 0.045, 235, 67, ELECTRON CRYSTALLOGRAPHIC STRUCTURE OF LENS AQUAPORIN-0 (AQP0) (LENS MIP) AT 1.9A RESOLUTION IN A CLOSED PORE STATE
2739, 1ii4E, 0.5396, 3.04, 0.031, 200, 64, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
2740, 1gpoM, 0.5396, 3.67, 0.076, 218, 66, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2741, 1fe8A, 0.5396, 3.24, 0.091, 186, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
2742, 6njmK, 0.5395, 3.62, 0.076, 211, 66, STRUCTURE OF A COMPLEX 
2743, 6iuvD, 0.5395, 3.59, 0.106, 215, 66, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
2744, 6haqB, 0.5395, 3.42, 0.014, 227, 69, AFGH61B WILD-TYPE COPPER LOADED 
2745, 6cdpB, 0.5395, 3.48, 0.108, 219, 65, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2746, 5wccL, 0.5395, 3.67, 0.075, 209, 67, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 02-1F07 FAB.
2747, 5v4mI, 0.5395, 3.45, 0.125, 200, 64, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
2748, 5i2iA, 0.5395, 3.56, 0.106, 213, 66, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
2749, 5cgyL, 0.5395, 3.68, 0.075, 213, 67, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
2750, 4x4mC, 0.5395, 3.49, 0.091, 212, 66, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
2751, 4u6gL, 0.5395, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE
2752, 4hiiA, 0.5395, 3.48, 0.108, 212, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
2753, 4grlB, 0.5395, 3.27, 0.079, 181, 63, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
2754, 3qazg, 0.5395, 3.27, 0.123, 191, 65, IL-2 MUTANT D10 TERNARY COMPLEX
2755, 3gorA, 0.5395, 3.76, 0.129, 149, 70, CRYSTAL STRUCTURE OF PUTATIVE METAL-DEPENDENT HYDROLASE APC36150
2756, 2x31E, 0.5395, 3.10, 0.078, 187, 64, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
2757, 2pw1A, 0.5395, 3.47, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL
2758, 2c1oB, 0.5395, 3.49, 0.097, 217, 62, ENAIIHIS FAB FRAGMENT IN THE FREE FORM
2759, 1indL, 0.5395, 3.94, 0.101, 211, 69, HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB (SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
2760, 1e6oH, 0.5395, 3.61, 0.094, 219, 64, CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
2761, 5w5mA, 0.5394, 3.68, 0.134, 207, 67, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT
2762, 5ks9B, 0.5394, 3.27, 0.063, 181, 63, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2763, 5eszB, 0.5394, 3.56, 0.106, 211, 66, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
2764, 4qeyD, 0.5394, 2.72, 0.082, 121, 61, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2765, 4hrrC, 0.5394, 3.78, 0.060, 149, 67, SCAPHARCA TETRAMERIC HEMOGLOBIN CO-STATE
2766, 4alsA, 0.5394, 3.37, 0.060, 166, 67, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
2767, 3m6fA, 0.5394, 3.14, 0.090, 180, 67, CD11A I-DOMAIN COMPLEXED WITH 6-((5S9R)-9-(4-CYANOPHENYL)-3-(35- DICHLOROPHENYL)-1-METHYL-24-DIOXO-137- TRIAZASPIRO[4.4]NON-7-YL) NICOTINIC ACID
2768, 3gorB, 0.5394, 3.75, 0.129, 149, 70, CRYSTAL STRUCTURE OF PUTATIVE METAL-DEPENDENT HYDROLASE APC36150
2769, 2dlgA, 0.5394, 3.02, 0.127, 102, 63, SOLUTION STRUCTURE OF THE 20TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B
2770, 1mcrA, 0.5394, 3.66, 0.090, 216, 67, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2771, 1i3rD, 0.5394, 3.44, 0.109, 216, 64, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
2772, 1h3uA, 0.5394, 3.74, 0.060, 207, 67, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (M3N2F)2
2773, 1cz8L, 0.5394, 3.48, 0.108, 213, 65, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2774, 1a0qH, 0.5394, 3.78, 0.108, 205, 65, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
2775, 6iekF, 0.5393, 3.70, 0.075, 218, 67, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
2776, 6d0jD, 0.5393, 2.96, 0.078, 86, 64, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER 
2777, 6be2L, 0.5393, 3.67, 0.090, 213, 67, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598)
2778, 5ywpR, 0.5393, 3.34, 0.098, 218, 61, JEV-2H4 FAB COMPLEX 
2779, 5n47F, 0.5393, 3.34, 0.104, 277, 67, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
2780, 5a40E, 0.5393, 2.91, 0.063, 90, 63, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2781, 4lptB, 0.5393, 3.25, 0.091, 98, 66, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
2782, 4lluD, 0.5393, 3.71, 0.075, 206, 67, STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
2783, 4at6K, 0.5393, 3.30, 0.046, 212, 65, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
2784, 3wvrB, 0.5393, 2.92, 0.152, 426, 66, STRUCTURE OF ATP GRASP PROTEIN WITH AMP
2785, 2ok0H, 0.5393, 3.62, 0.094, 216, 64, FAB ED10-DNA COMPLEX
2786, 1qblH, 0.5393, 3.63, 0.094, 219, 64, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
2787, 6n5dN, 0.5392, 3.71, 0.075, 212, 67, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
2788, 5vgpB, 0.5392, 3.59, 0.090, 209, 67, FC FRAGMENT OF HUMAN IGG1 ANTIBODY; FROM NIST MAB 
2789, 5kqvD, 0.5392, 3.77, 0.060, 214, 67, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2790, 4zfoL, 0.5392, 3.59, 0.106, 214, 66, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
2791, 4tnvh, 0.5392, 3.72, 0.118, 211, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2792, 4qeyB, 0.5392, 3.15, 0.079, 122, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2793, 4m7jH, 0.5392, 3.78, 0.092, 219, 65, CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
2794, 3f7rA, 0.5392, 3.40, 0.152, 214, 66, FIRST PAIR OF FIBRONECTIN TYPE III DOMAINS AND PART OF THE CONNECTING SEGMENT OF THE INTEGRIN BETA4
2795, 2d7pA, 0.5392, 3.52, 0.106, 112, 66, SOLUTION STRUCTURE OF THE 22TH FILAMIN DOMAIN FROM HUMAN FILAMIN C
2796, 1nxiA, 0.5392, 3.05, 0.116, 132, 69, SOLUTION STRUCTURE OF VIBRIO CHOLERAE PROTEIN VC0424
2797, 1eapB, 0.5392, 3.70, 0.094, 216, 64, CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
2798, 1dfbL, 0.5392, 3.69, 0.104, 212, 67, STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I
2799, 6e9qF, 0.5391, 3.71, 0.104, 215, 67, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
2800, 6db7L, 0.5391, 3.60, 0.076, 211, 66, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
2801, 6db6L, 0.5391, 3.57, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 311-11D IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
2802, 5w6dL, 0.5391, 3.70, 0.075, 211, 67, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
2803, 5w5mB, 0.5391, 3.63, 0.134, 209, 67, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT
2804, 5obfL, 0.5391, 3.62, 0.076, 217, 66, FAB. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
2805, 5n09M, 0.5391, 3.77, 0.074, 213, 68, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
2806, 5k8aE, 0.5391, 3.53, 0.106, 213, 66, NIST FAB
2807, 4oy7C, 0.5391, 3.86, 0.042, 196, 71, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
2808, 4m1dL, 0.5391, 3.68, 0.075, 216, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
2809, 4f58L, 0.5391, 3.68, 0.075, 213, 67, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
2810, 3bpnB, 0.5391, 3.27, 0.075, 199, 67, CRYSTAL STRUCTURE OF THE IL4-IL4R-IL13RA TERNARY COMPLEX
2811, 2hjfB, 0.5391, 3.49, 0.062, 212, 65, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2812, 1xgyI, 0.5391, 3.49, 0.097, 215, 62, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
2813, 1v7nJ, 0.5391, 3.76, 0.108, 217, 65, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2814, 1qbmH, 0.5391, 3.63, 0.094, 219, 64, FAB E8B ANTIBODY X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
2815, 1nldL, 0.5391, 3.60, 0.076, 219, 66, FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
2816, 1i9rL, 0.5391, 3.59, 0.106, 215, 66, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2817, 1cbvH, 0.5391, 3.51, 0.092, 219, 65, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE- DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE- FAB COMPLEX
2818, 6mg4A, 0.5390, 3.73, 0.074, 215, 68, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO 
2819, 5um8L, 0.5390, 3.74, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
2820, 5ubxB, 0.5390, 3.69, 0.149, 201, 67, CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C
2821, 5gkrB, 0.5390, 3.69, 0.090, 213, 67, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY IN COMPLEX WITH OLIGONUCLEOTIDE
2822, 5a43D, 0.5390, 2.98, 0.094, 95, 64, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2823, 4zvcA, 0.5390, 2.66, 0.034, 116, 59, CRYSTAL STRUCTURE OF MID DOMAIN OF THE E. COLI DOSC - FORM I
2824, 4odsL, 0.5390, 3.74, 0.060, 218, 67, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
2825, 4nefB, 0.5390, 3.37, 0.045, 233, 67, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2
2826, 4k3hE, 0.5390, 3.25, 0.077, 109, 65, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
2827, 4glxA, 0.5390, 3.57, 0.096, 573, 73, DNA LIGASE A IN COMPLEX WITH INHIBITOR
2828, 3mj6A, 0.5390, 3.31, 0.104, 227, 67, CRYSTAL STRUCTURE OF THE GAMMADELTA T CELL COSTIMULATORY RECEPTOR JUNCTIONAL ADHESION MOLECULE-LIKE PROTEIN JAML
2829, 2z92A, 0.5390, 3.33, 0.098, 206, 61, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2830, 2n1kA, 0.5390, 3.28, 0.062, 106, 65, STRUCTURE OF THE THIRD TYPE III DOMAIN FROM HUMAN FIBRONECTIN
2831, 1ifrA, 0.5390, 3.13, 0.063, 113, 63, STRUCTURE OF LAMIN A/C GLOBULAR DOMAIN
2832, 1ibgH, 0.5390, 3.35, 0.082, 217, 61, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
2833, 1dlhB, 0.5390, 3.38, 0.095, 188, 63, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
2834, 6njmJ, 0.5389, 3.61, 0.000, 213, 66, STRUCTURE OF A COMPLEX 
2835, 6isaA, 0.5389, 3.13, 0.108, 222, 65, MCD226 
2836, 6id4L, 0.5389, 3.56, 0.076, 216, 66, COMPLEX OF HLA-A*11:01 BINDING TO ALLOANTIBODY 2E3 
2837, 6dcaJ, 0.5389, 3.34, 0.098, 213, 61, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
2838, 6dc9L, 0.5389, 3.49, 0.108, 215, 65, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
2839, 6ck9L, 0.5389, 3.68, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM 
2840, 6aoxA, 0.5389, 3.21, 0.076, 146, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH TF ANTIGEN
2841, 5vhib, 0.5389, 3.28, 0.045, 191, 67, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
2842, 5tpsB, 0.5389, 3.67, 0.119, 192, 67, STRUCTURE OF A FC HETERODIMER
2843, 4nzrL, 0.5389, 3.60, 0.106, 214, 66, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
2844, 4g3yL, 0.5389, 3.51, 0.108, 214, 65, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
2845, 4b7lA, 0.5389, 3.35, 0.106, 328, 66, CRYSTAL STRUCTURE OF HUMAN FILAMIN B ACTIN BINDING DOMAIN WITH 1ST FILAMIN REPEAT
2846, 4at6F, 0.5389, 3.32, 0.046, 212, 65, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
2847, 3qo1A, 0.5389, 3.46, 0.108, 219, 65, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
2848, 3hnsL, 0.5389, 3.78, 0.060, 214, 67, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
2849, 3aqxA, 0.5389, 3.30, 0.061, 101, 66, CRYSTAL STRUCTURE OF BOMBYX MORI BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
2850, 2y7mA, 0.5389, 2.99, 0.077, 300, 65, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 (PT DERIVATIVE)
2851, 2w9dH, 0.5389, 3.48, 0.097, 215, 62, STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.
2852, 2vxtH, 0.5389, 3.45, 0.097, 207, 62, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
2853, 2q76D, 0.5389, 3.53, 0.095, 210, 63, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
2854, 2of5K, 0.5389, 3.20, 0.129, 100, 62, OLIGOMERIC DEATH DOMAIN COMPLEX
2855, 2jb6A, 0.5389, 3.73, 0.075, 211, 67, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-2
2856, 1z2kA, 0.5389, 3.36, 0.090, 108, 67, NMR STRUCTURE OF THE D1 DOMAIN OF THE NATURAL KILLER CELL RECEPTOR 2B4
2857, 1v7nO, 0.5389, 3.60, 0.076, 213, 66, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2858, 1mjjA, 0.5389, 3.54, 0.077, 218, 65, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2859, 6bdzH, 0.5388, 3.34, 0.098, 219, 61, ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB
2860, 5v4mC, 0.5388, 3.28, 0.127, 200, 63, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
2861, 5dm3B, 0.5388, 3.23, 0.043, 385, 69, CRYSTAL STRUCTURE OF GLUTAMINE SYNTHETASE FROM CHROMOHALOBACTER SALEXIGENS DSM 3043(CSAL_0679 TARGET EFI-550015) WITH BOUND ADP
2862, 5d96J, 0.5388, 3.33, 0.098, 215, 61, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
2863, 4rfeB, 0.5388, 3.78, 0.088, 210, 68, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
2864, 3u56A, 0.5388, 3.01, 0.045, 228, 66, CRYSTAL STRUCTURE OF MUTANT RIBOSOMAL PROTEIN T217V TTHL1 IN COMPLEX WITH 80NT 23S RNA FROM THERMUS THERMOPHILUS
2865, 3rfzB, 0.5388, 2.85, 0.131, 778, 61, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
2866, 3qaza, 0.5388, 3.36, 0.121, 191, 66, IL-2 MUTANT D10 TERNARY COMPLEX
2867, 3d0lA, 0.5388, 3.50, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671
2868, 3bt2H, 0.5388, 3.47, 0.097, 212, 62, STRUCTURE OF UROKINASE RECEPTOR UROKINASE AND VITRONECTIN COMPLEX
2869, 1lfaA, 0.5388, 3.16, 0.090, 183, 67, CD11A I-DOMAIN WITH BOUND MN++
2870, 1i9rM, 0.5388, 3.59, 0.106, 215, 66, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2871, 1cqkB, 0.5388, 3.67, 0.119, 101, 67, CRYSTAL STRUCTURE OF THE CH3 DOMAIN FROM THE MAK33 ANTIBODY
2872, 6qnkC, 0.5387, 3.64, 0.076, 217, 66, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
2873, 6mcoL, 0.5387, 3.67, 0.075, 211, 67, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
2874, 6dldB, 0.5387, 2.96, 0.049, 247, 61, CRYSTAL STRUCTURE OF IGLON5/NEGR1 HETERODIMER 
2875, 6axpA, 0.5387, 3.45, 0.108, 212, 65, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
2876, 5dk3A, 0.5387, 3.51, 0.108, 218, 65, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
2877, 4ziqA, 0.5387, 3.29, 0.092, 1450, 65, CRYSTAL STRUCTURE OF TRYPSIN ACTIVATED ALPHA-2-MACROGLOBULIN FROM ESCHERICHIA COLI.
2878, 4rgoH, 0.5387, 3.34, 0.098, 213, 61, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
2879, 4qeyI, 0.5387, 3.15, 0.079, 123, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2880, 4qeyC, 0.5387, 3.16, 0.079, 122, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2881, 4hpyL, 0.5387, 3.68, 0.075, 213, 67, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH59 IN COMPLEX WITH V2 PEPTIDE
2882, 2j1kV, 0.5387, 3.68, 0.118, 121, 68, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
2883, 2a6jA, 0.5387, 3.58, 0.077, 214, 65, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65
2884, 1nj9L, 0.5387, 3.62, 0.104, 212, 67, COCAINE HYDROLYTIC ANTIBODY 15A10
2885, 1mj7L, 0.5387, 3.63, 0.076, 218, 66, CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
2886, 1fytB, 0.5387, 3.58, 0.138, 179, 65, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
2887, 6njmO, 0.5386, 3.62, 0.076, 211, 66, STRUCTURE OF A COMPLEX 
2888, 6e9qB, 0.5386, 3.71, 0.104, 215, 67, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
2889, 6d0kD, 0.5386, 2.97, 0.078, 86, 64, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; E118Q MUTANT 
2890, 6b3dL, 0.5386, 3.69, 0.075, 207, 67, CRYSTAL STRUCTURE OF ANTI-HIV ANTIBODY PGT128 IN COMPLEX WITH A BACTERIALLY DERIVED SYNTHETIC MIMETIC OF MAN9.
2891, 5xj3I, 0.5386, 3.66, 0.085, 115, 71, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
2892, 5mudB, 0.5386, 3.75, 0.074, 212, 68, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H6
2893, 5komD, 0.5386, 3.08, 0.094, 96, 64, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83I MUTANT
2894, 5fmvA, 0.5386, 3.04, 0.077, 351, 65, CRYSTAL STRUCTURE OF HUMAN CD45 EXTRACELLULAR REGION DOMAINS D1-D4
2895, 5el5BA, 0.5386, 3.23, 0.045, 135, 66, 
2896, 4jy4A, 0.5386, 3.69, 0.075, 208, 67, CRYSTAL STRUCTURE OF HUMAN FAB PGT121 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2897, 4fbjA, 0.5386, 2.93, 0.109, 250, 64, STRUCTURE OF THE CIF:NEDD8 COMPLEX - PHOTORHABDUS LUMINESCENS CYCLE INHIBITING FACTOR IN COMPLEX WITH HUMAN NEDD8
2898, 3v77B, 0.5386, 3.79, 0.058, 221, 69, CRYSTAL STRUCTURE OF A PUTATIVE FUMARYLACETOACETATE ISOMERASE/HYDROLASE FROM OLEISPIRA ANTARCTICA
2899, 3qxdB, 0.5386, 3.44, 0.125, 189, 64, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
2900, 3ibsB, 0.5386, 3.56, 0.127, 199, 71, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
2901, 3eobI, 0.5386, 3.26, 0.103, 179, 68, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2902, 3drtA, 0.5386, 3.48, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671
2903, 1rupL, 0.5386, 3.57, 0.077, 219, 65, CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
2904, 1gigL, 0.5386, 3.92, 0.101, 210, 69, REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1 LAMBDA ANTIBODY
2905, 1cqkA, 0.5386, 3.67, 0.119, 101, 67, CRYSTAL STRUCTURE OF THE CH3 DOMAIN FROM THE MAK33 ANTIBODY
2906, 1c8pA, 0.5386, 3.25, 0.077, 102, 65, NMR STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE COMMON BETA-CHAIN IN THE GM-CSF IL-3 AND IL-5 RECEPTORS
2907, 6meiL, 0.5385, 3.57, 0.106, 214, 66, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2908, 6ii9L, 0.5385, 3.72, 0.075, 212, 67, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
2909, 6ieqL, 0.5385, 3.70, 0.075, 210, 67, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
2910, 6fg2G, 0.5385, 3.68, 0.075, 211, 67, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2911, 6d0nD, 0.5385, 2.98, 0.092, 88, 65, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; V319G MUTANT 
2912, 5wykCB, 0.5385, 3.68, 0.053, 248, 75, 
2913, 5vk2G, 0.5385, 3.68, 0.075, 211, 67, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
2914, 5l2vB, 0.5385, 3.62, 0.103, 166, 68, CATALYTIC DOMAIN OF LPMO LMO2467 FROM LISTERIA MONOCYTOGENES
2915, 5hsfB, 0.5385, 3.66, 0.119, 108, 67, 1.52 ANGSTROM CRYSTAL STRUCTURE OF FC FRAGMENT OF HUMAN IGG1.
2916, 5hi4L, 0.5385, 3.55, 0.076, 213, 66, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
2917, 5gguL, 0.5385, 3.50, 0.108, 213, 65, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
2918, 5cszL, 0.5385, 3.47, 0.108, 213, 65, CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11
2919, 4uwqC, 0.5385, 3.37, 0.136, 97, 66, CRYSTAL STRUCTURE OF THE DISULFIDE-LINKED COMPLEX OF THE THIOSULFODYROLASE SOXB WITH THE CARRIER-PROTEIN SOXYZ FROM THERMUS THERMOPHILUS
2920, 4s1dC, 0.5385, 3.32, 0.098, 212, 61, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
2921, 4qeyH, 0.5385, 3.17, 0.095, 123, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
2922, 4m6aA, 0.5385, 2.66, 0.082, 87, 61, N-TERMINAL BETA-STRAND SWAPPING IN A CONSENSUS DERIVED ALTERNATIVE SCAFFOLD DRIVEN BY STABILIZING HYDROPHOBIC INTERACTIONS
2923, 4jvwD, 0.5385, 3.83, 0.118, 105, 68, IGM C4-DOMAIN FROM MOUSE
2924, 4dw2H, 0.5385, 3.61, 0.094, 210, 64, THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112
2925, 4at6P, 0.5385, 3.72, 0.104, 212, 67, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
2926, 4at6D, 0.5385, 3.72, 0.104, 212, 67, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
2927, 4a6yA, 0.5385, 3.77, 0.103, 211, 68, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
2928, 3sy0B, 0.5385, 3.64, 0.094, 222, 64, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
2929, 3l1oH, 0.5385, 3.47, 0.081, 224, 62, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
2930, 2or9I, 0.5385, 3.50, 0.097, 228, 62, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
2931, 1s9vB, 0.5385, 3.29, 0.079, 181, 63, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
2932, 1lo0X, 0.5385, 3.59, 0.076, 219, 66, CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
2933, 1ikfH, 0.5385, 3.50, 0.097, 228, 62, A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
2934, 1fj1A, 0.5385, 3.59, 0.076, 213, 66, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2935, 1etzB, 0.5385, 3.59, 0.076, 228, 66, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
2936, 1cqpA, 0.5385, 3.44, 0.088, 182, 68, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
2937, 6n1vL, 0.5384, 3.65, 0.090, 215, 67, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY A12V163-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
2938, 6n1v4, 0.5384, 3.65, 0.090, 215, 67, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY A12V163-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
2939, 6n1v2, 0.5384, 3.65, 0.090, 215, 67, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY A12V163-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
2940, 6iscA, 0.5384, 3.19, 0.121, 219, 66, COMPLEX STRUCTURE OF MCD226-ECTO AND HCD155-D1 
2941, 6b7zF, 0.5384, 3.49, 0.106, 211, 66, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11 HEAVY CHAIN AND FAB H11 LIGHT CHAIN
2942, 6a9kH, 0.5384, 3.52, 0.097, 220, 62, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
2943, 5nmvL, 0.5384, 3.48, 0.108, 212, 65, CRYSTAL STRUCTURE OF 2F22 FAB FRAGMENT AGAINST TFPI1
2944, 5njdM, 0.5384, 3.89, 0.074, 213, 68, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2945, 5m6iB, 0.5384, 3.80, 0.088, 212, 68, CRYSTAL STRUCTURE OF NON-CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER M8
2946, 5fjqA, 0.5384, 3.59, 0.029, 180, 68, STRUCTURAL AND FUNCTIONAL ANALYSIS OF A LYTIC POLYSACCHARIDE MONOOXYGENASE IMPORTANT FOR EFFICIENT UTILIZATION OF CHITIN IN CELLVIBRIO JAPONICUS
2947, 4zncF, 0.5384, 3.67, 0.104, 195, 67, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
2948, 4utbL, 0.5384, 3.68, 0.075, 213, 67, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
2949, 4k3hA, 0.5384, 3.26, 0.077, 109, 65, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
2950, 4dfiA, 0.5384, 3.29, 0.058, 124, 69, CRYSTAL STRUCTURE OF CELL ADHESION MOLECULE NECTIN-2/CD112 MUTANT FAMP
2951, 4d9lL, 0.5384, 3.75, 0.075, 214, 67, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
2952, 4amkL, 0.5384, 3.69, 0.104, 210, 67, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
2953, 3sboA, 0.5384, 3.19, 0.125, 440, 64, STRUCTURE OF E.COLI GDH FROM NATIVE SOURCE
2954, 3lp8A, 0.5384, 2.99, 0.065, 421, 62, CRYSTAL STRUCTURE OF PHOSPHORIBOSYLAMINE-GLYCINE LIGASE FROM EHRLICHIA CHAFFEENSIS
2955, 3hr5P, 0.5384, 3.49, 0.108, 219, 65, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2956, 3drqA, 0.5384, 3.50, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION
2957, 2nncA, 0.5384, 2.94, 0.095, 110, 63, STRUCTURE OF THE SULFUR CARRIER PROTEIN SOXY FROM CHLOROBIUM LIMICOLA F THIOSULFATOPHILUM
2958, 1yy8C, 0.5384, 3.46, 0.108, 213, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
2959, 6qf5D, 0.5383, 3.37, 0.015, 220, 67, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2 CRYSTALLIZED ON A SILICON CHIP 
2960, 6njnN, 0.5383, 3.60, 0.076, 211, 66, STRUCTURE OF A COMPLEX 
2961, 6my5L, 0.5383, 3.47, 0.108, 218, 65, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
2962, 6e9hB, 0.5383, 3.66, 0.104, 215, 67, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-3 
2963, 6e63C, 0.5383, 3.59, 0.076, 212, 66, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
2964, 6a76H, 0.5383, 3.51, 0.097, 214, 62, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B5209B; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 
2965, 5dyeA, 0.5383, 3.04, 0.031, 243, 65, CRYSTAL STRUCTURE OF THE FULL LENGTH S156E MUTANT OF HUMAN AQUAPORIN 5
2966, 4yaqB, 0.5383, 3.69, 0.075, 214, 67, CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT
2967, 4s0tD, 0.5383, 2.98, 0.062, 91, 64, STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND WITH ADNECTIN-1 AND COMPOUND-1
2968, 4p3cH, 0.5383, 3.80, 0.092, 218, 65, MT1-MMP:FAB COMPLEX (FORM I)
2969, 4k3hD, 0.5383, 3.26, 0.077, 109, 65, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
2970, 4k3dM, 0.5383, 3.68, 0.104, 213, 67, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
2971, 4g6fL, 0.5383, 3.67, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE
2972, 4b53B, 0.5383, 3.66, 0.134, 101, 67, CRYSTAL STRUCTURE OF THE ISOLATED IGG4 CH3 DOMAIN
2973, 3hkfA, 0.5383, 3.60, 0.075, 205, 67, MURINE UNGLYCOSYLATED IGG FC FRAGMENT
2974, 3e8uH, 0.5383, 3.47, 0.097, 213, 62, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
2975, 3d9aH, 0.5383, 3.81, 0.092, 210, 65, HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
2976, 3cfbB, 0.5383, 3.47, 0.081, 213, 62, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
2977, 3bqmC, 0.5383, 3.16, 0.090, 182, 67, LFA-1 I DOMAIN BOUND TO INHIBITORS
2978, 3bqmB, 0.5383, 3.19, 0.090, 182, 67, LFA-1 I DOMAIN BOUND TO INHIBITORS
2979, 1yuhA, 0.5383, 3.53, 0.091, 211, 66, FAB FRAGMENT
2980, 1i85D, 0.5383, 3.02, 0.125, 111, 64, CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX
2981, 1ehlL, 0.5383, 3.59, 0.076, 217, 66, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
2982, 1dlhE, 0.5383, 3.39, 0.095, 188, 63, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
2983, 1cwvA, 0.5383, 3.12, 0.111, 484, 63, CRYSTAL STRUCTURE OF INVASIN: A BACTERIAL INTEGRIN-BINDING PROTEIN
2984, 6ndeR, 0.5382, 3.24, 0.119, 191, 67, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
2985, 6digB, 0.5382, 3.30, 0.079, 180, 63, CRYSTAL STRUCTURE OF DQ6 IN COMPLEX WITH A NEURO-PEPTIDE 
2986, 6brbD, 0.5382, 3.17, 0.078, 87, 64, NOVEL NON-ANTIBODY PROTEIN SCAFFOLD TARGETING CD40L 
2987, 6arnB, 0.5382, 3.03, 0.076, 152, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH O-METHOXYPHENYL BETA-GALACTOSIDE (OMPG)
2988, 5xj3F, 0.5382, 3.50, 0.086, 115, 70, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
2989, 5njdS, 0.5382, 3.74, 0.075, 214, 67, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2990, 5aumB, 0.5382, 3.62, 0.091, 216, 66, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
2991, 4wwiE, 0.5382, 3.65, 0.104, 179, 67, CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION
2992, 4q2zB, 0.5382, 3.70, 0.075, 212, 67, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
2993, 4hrrD, 0.5382, 3.79, 0.090, 151, 67, SCAPHARCA TETRAMERIC HEMOGLOBIN CO-STATE
2994, 4c55A, 0.5382, 3.65, 0.134, 208, 67, CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC
2995, 4bhtE, 0.5382, 3.33, 0.123, 442, 65, STRUCTURAL DETERMINANTS OF COFACTOR SPECIFICITY AND DOMAIN FLEXIBILITY IN BACTERIAL GLUTAMATE DEHYDROGENASES
2996, 4be6A, 0.5382, 3.63, 0.147, 225, 68, V. CHOLERA BIOFILM SCAFFOLDING PROTEIN RBMA
2997, 3v8oB, 0.5382, 3.32, 0.046, 188, 65, HUMAN FILAMIN C IG - LIKE DOMAINS 4 AND 5
2998, 3n5aA, 0.5382, 3.05, 0.127, 138, 63, SYNAPTOTAGMIN-7 C2B-DOMAIN CALCIUM BOUND
2999, 3j6lB, 0.5382, 3.21, 0.123, 121, 65, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
3000, 3ie4A, 0.5382, 3.48, 0.060, 101, 67, B-GLUCAN BINDING DOMAIN OF DROSOPHILA GNBP3 DEFINES A NOVEL FAMILY OF PATTERN RECOGNITION RECEPTOR
3001, 3es6B, 0.5382, 3.47, 0.045, 118, 67, CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA
3002, 2npnA, 0.5382, 2.94, 0.082, 233, 61, CRYSTAL STRUCTURE OF PUTATIVE COBALAMIN SYNTHESIS RELATED PROTEIN (COBF) FROM CORYNEBACTERIUM DIPHTHERIAE
3003, 2ipuK, 0.5382, 3.49, 0.062, 219, 65, PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE
3004, 2fl5L, 0.5382, 3.70, 0.075, 209, 67, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
3005, 1zopB, 0.5382, 3.16, 0.090, 183, 67, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
3006, 1zooB, 0.5382, 3.16, 0.090, 183, 67, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
3007, 1xf5B, 0.5382, 3.35, 0.098, 218, 61, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
3008, 1p2cE, 0.5382, 3.65, 0.094, 211, 64, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3009, 1lyqA, 0.5382, 3.32, 0.077, 101, 65, CRYSTAL STRUCTURE OF PCOC A METHIONINE RICH COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI
3010, 1fj1B, 0.5382, 3.37, 0.078, 213, 64, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3011, 1f5wB, 0.5382, 3.21, 0.123, 121, 65, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
3012, 6mfgF, 0.5381, 3.25, 0.079, 191, 63, HLA-DQ2-GLIA-ALPHA1 
3013, 6igoD, 0.5381, 3.48, 0.045, 120, 67, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
3014, 6axlB, 0.5381, 3.49, 0.108, 213, 65, CRYSTAL STRUCTURE OF FAB317 COMPLEX
3015, 5x2mJ, 0.5381, 3.49, 0.097, 217, 62, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
3016, 5v7uL, 0.5381, 3.56, 0.106, 219, 66, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-22.1 FAB
3017, 5i66A, 0.5381, 3.63, 0.094, 218, 64, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
3018, 5hi3L, 0.5381, 3.56, 0.076, 213, 66, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3019, 5dqdH, 0.5381, 3.49, 0.097, 222, 62, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3020, 4hrrE, 0.5381, 3.90, 0.059, 149, 68, SCAPHARCA TETRAMERIC HEMOGLOBIN CO-STATE
3021, 4d2nC, 0.5381, 3.68, 0.090, 205, 67, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
3022, 4aehL, 0.5381, 3.53, 0.077, 211, 65, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
3023, 3qo0A, 0.5381, 3.56, 0.106, 219, 66, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
3024, 3muhL, 0.5381, 3.67, 0.075, 212, 67, CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3025, 3l5wA, 0.5381, 3.50, 0.108, 213, 65, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
3026, 3eoaJ, 0.5381, 3.29, 0.088, 179, 68, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
3027, 2yrxA, 0.5381, 2.58, 0.133, 420, 60, CRYSTAL STRUCTURE OF GAR SYNTHETASE FROM GEOBACILLUS KAUSTOPHILUS
3028, 2vxuI, 0.5381, 3.48, 0.097, 216, 62, CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
3029, 2r1wB, 0.5381, 3.66, 0.094, 219, 64, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3030, 2ombD, 0.5381, 3.65, 0.075, 216, 67, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(1)21 CRYSTAL FORM
3031, 1u3hH, 0.5381, 3.28, 0.095, 189, 63, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
3032, 1nlbH, 0.5381, 3.51, 0.097, 218, 62, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
3033, 1lqsR, 0.5381, 3.36, 0.116, 207, 69, CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1
3034, 1it9L, 0.5381, 3.85, 0.103, 214, 68, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
3035, 1ggtB, 0.5381, 3.43, 0.091, 708, 66, THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN BLOOD COAGULATION FACTOR XIII
3036, 6ndbR, 0.5380, 3.26, 0.132, 191, 68, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
3037, 6aroB, 0.5380, 3.02, 0.076, 153, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH 8-HYDROXYQUINOLINE BETA-GALACTOSIDE
3038, 5wkoF, 0.5380, 3.59, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3039, 5tdoC, 0.5380, 3.56, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
3040, 5t1lA, 0.5380, 3.57, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
3041, 5hi5L, 0.5380, 3.56, 0.076, 213, 66, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3042, 4v8oKA, 0.5380, 3.47, 0.096, 228, 73, 
3043, 4ot1L, 0.5380, 3.66, 0.075, 214, 67, STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1
3044, 4nefC, 0.5380, 3.31, 0.045, 236, 67, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2
3045, 4ncoK, 0.5380, 3.68, 0.075, 202, 67, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122
3046, 4mdiB, 0.5380, 3.61, 0.138, 189, 65, IMMUNE RECEPTOR
3047, 4jy5L, 0.5380, 3.79, 0.074, 200, 68, CRYSTAL STRUCTURE OF HUMAN FAB PGT122 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3048, 3rdtD, 0.5380, 3.29, 0.095, 199, 63, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
3049, 3l4gD, 0.5380, 2.99, 0.131, 589, 61, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
3050, 3eoaI, 0.5380, 3.27, 0.103, 179, 68, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
3051, 3d0vA, 0.5380, 3.50, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW
3052, 3c6sC, 0.5380, 3.48, 0.062, 218, 65, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
3053, 2j1kJ, 0.5380, 3.63, 0.103, 123, 68, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
3054, 1ncnB, 0.5380, 3.50, 0.134, 110, 67, THE RECEPTOR-BINDING DOMAIN OF HUMAN B7-2
3055, 1n3yA, 0.5380, 3.45, 0.075, 189, 67, CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN
3056, 1lo0L, 0.5380, 3.61, 0.076, 219, 66, CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
3057, 1i9rY, 0.5380, 3.58, 0.106, 215, 66, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
3058, 1fj1C, 0.5380, 3.59, 0.076, 213, 66, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3059, 6njmN, 0.5379, 3.62, 0.000, 213, 66, STRUCTURE OF A COMPLEX 
3060, 6iuvL, 0.5379, 3.60, 0.106, 215, 66, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3061, 6dkjL, 0.5379, 3.58, 0.106, 213, 66, HUMAN GIPR ECD AND FAB COMPLEX 
3062, 6bivA, 0.5379, 3.44, 0.125, 189, 64, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
3063, 6b7zD, 0.5379, 3.49, 0.106, 211, 66, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11 HEAVY CHAIN AND FAB H11 LIGHT CHAIN
3064, 6azzE, 0.5379, 3.70, 0.075, 212, 67, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
3065, 6armB, 0.5379, 3.03, 0.076, 152, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH O-NITROPHENYL BETA-GALACTOSIDE (ONPG)
3066, 5v4eC, 0.5379, 3.68, 0.119, 162, 67, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
3067, 5jorB, 0.5379, 3.59, 0.078, 207, 64, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3068, 5hi3D, 0.5379, 3.59, 0.076, 213, 66, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3069, 5d8jH, 0.5379, 3.49, 0.097, 216, 62, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
3070, 5azeL, 0.5379, 3.68, 0.075, 206, 67, FAB FRAGMENT OF CALCIUM-DEPENDENT ANTIGEN BINDING ANTIBODY 6RL 9
3071, 4xrcA, 0.5379, 3.79, 0.088, 208, 68, ANTIBODY HEMAGGLUTININ COMPLEXES
3072, 4q7dA, 0.5379, 3.46, 0.091, 207, 66, WILD TYPE FC (WTFC)
3073, 4ncoG, 0.5379, 3.68, 0.075, 202, 67, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122
3074, 4k3eM, 0.5379, 3.83, 0.103, 213, 68, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
3075, 4c54B, 0.5379, 3.67, 0.134, 209, 67, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC
3076, 3wvqB, 0.5379, 2.90, 0.152, 418, 66, STRUCTURE OF ATP GRASP PROTEIN
3077, 3moaL, 0.5379, 3.58, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE
3078, 3l4gL, 0.5379, 2.99, 0.131, 589, 61, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
3079, 3ifoB, 0.5379, 3.62, 0.076, 218, 66, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
3080, 3eyoA, 0.5379, 3.47, 0.108, 213, 65, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3081, 3bqnB, 0.5379, 3.20, 0.090, 182, 67, LFA-1 I DOMAIN BOUND TO INHIBITORS
3082, 2q6wB, 0.5379, 3.38, 0.125, 188, 64, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
3083, 2bj3C, 0.5379, 3.16, 0.113, 138, 62, NIKR-APO
3084, 1xcqB, 0.5379, 3.69, 0.095, 218, 63, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3085, 1ottF, 0.5379, 3.78, 0.060, 211, 67, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
3086, 1mieL, 0.5379, 3.61, 0.076, 218, 66, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
3087, 1lo3X, 0.5379, 3.60, 0.076, 219, 66, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
3088, 6my4L, 0.5378, 3.47, 0.108, 218, 65, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
3089, 6azlA, 0.5378, 3.56, 0.106, 212, 66, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3090, 5wkoH, 0.5378, 3.56, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3091, 5jo5F, 0.5378, 3.71, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
3092, 5iopA, 0.5378, 3.59, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
3093, 5esqA, 0.5378, 3.58, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
3094, 4wcyL, 0.5378, 3.55, 0.077, 217, 65, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
3095, 4rfeL, 0.5378, 3.78, 0.088, 210, 68, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
3096, 4ncoC, 0.5378, 3.68, 0.075, 202, 67, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122
3097, 4jvwC, 0.5378, 3.83, 0.118, 108, 68, IGM C4-DOMAIN FROM MOUSE
3098, 4ia4A, 0.5378, 3.34, 0.060, 243, 67, STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 AT PH 6
3099, 4hijC, 0.5378, 3.48, 0.108, 212, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
3100, 4fccG, 0.5378, 3.32, 0.123, 442, 65, GLUTAMATE DEHYDROGENASE FROM E. COLI
3101, 4c54A, 0.5378, 3.65, 0.134, 210, 67, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC
3102, 3w14Q, 0.5378, 3.50, 0.062, 214, 65, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
3103, 3w14D, 0.5378, 3.50, 0.062, 214, 65, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
3104, 3t2nM, 0.5378, 3.69, 0.075, 212, 67, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3105, 3qq9C, 0.5378, 3.49, 0.108, 217, 65, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3106, 3mltL, 0.5378, 3.69, 0.075, 216, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3107, 3l4gJ, 0.5378, 2.99, 0.131, 589, 61, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
3108, 3l4gH, 0.5378, 2.99, 0.131, 589, 61, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
3109, 3jcbB, 0.5378, 3.68, 0.075, 202, 67, STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS ENVELOPE SPIKES BOUND WITH CD4 AND MONOCLONAL ANTIBODY 36D5
3110, 3besR, 0.5378, 3.31, 0.030, 250, 66, STRUCTURE OF A POXVIRUS IFNGBP/IFNG COMPLEX
3111, 2zkhL, 0.5378, 3.68, 0.076, 210, 66, HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
3112, 2yoaB, 0.5378, 3.39, 0.138, 149, 65, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
3113, 2yfhB, 0.5378, 3.24, 0.125, 447, 64, STRUCTURE OF A CHIMERIC GLUTAMATE DEHYDROGENASE
3114, 2htlF, 0.5378, 3.70, 0.076, 211, 66, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX
3115, 2fl5E, 0.5378, 3.70, 0.075, 209, 67, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
3116, 1xf2H, 0.5378, 3.80, 0.092, 213, 65, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
3117, 1mcfB, 0.5378, 3.78, 0.088, 216, 68, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
3118, 1j7vR, 0.5378, 3.25, 0.132, 205, 68, HUMAN IL-10 / IL-10R1 COMPLEX
3119, 1igfM, 0.5378, 3.66, 0.091, 219, 66, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
3120, 6mehL, 0.5377, 3.48, 0.108, 213, 65, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3121, 6as8B, 0.5377, 3.02, 0.076, 153, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH ORTHO-BIPHENYL-2 -CARBOXYL N-ACETYL-BETA-GALACTOSAMINOSIDE
3122, 6aoxB, 0.5377, 3.31, 0.076, 149, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH TF ANTIGEN
3123, 4v5jSC, 0.5377, 3.52, 0.096, 120, 73, 
3124, 4tnvZ, 0.5377, 3.79, 0.103, 215, 68, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3125, 4r7nN, 0.5377, 3.61, 0.106, 211, 66, FAB C2E3
3126, 4hjjL, 0.5377, 3.49, 0.108, 327, 65, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
3127, 4c56K, 0.5377, 3.33, 0.095, 189, 63, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
3128, 3u4eL, 0.5377, 3.69, 0.075, 214, 67, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3129, 3pgcE, 0.5377, 3.46, 0.125, 180, 64, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
3130, 3payB, 0.5377, 3.15, 0.167, 302, 66, CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION
3131, 3l4gB, 0.5377, 2.99, 0.131, 589, 61, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
3132, 3ffcI, 0.5377, 3.01, 0.048, 202, 63, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
3133, 3c5zH, 0.5377, 3.29, 0.095, 202, 63, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3134, 2xzcL, 0.5377, 3.55, 0.106, 214, 66, CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
3135, 2vq1A, 0.5377, 3.63, 0.076, 216, 66, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3136, 2a6dL, 0.5377, 3.68, 0.076, 214, 66, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
3137, 1u3hD, 0.5377, 3.29, 0.095, 189, 63, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
3138, 1fe8B, 0.5377, 3.26, 0.091, 186, 66, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
3139, 1eajA, 0.5377, 3.27, 0.123, 124, 65, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
3140, 1e0oB, 0.5377, 2.86, 0.032, 197, 62, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
3141, 6iqgA, 0.5376, 3.65, 0.090, 207, 67, X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX 
3142, 6e9kB, 0.5376, 3.69, 0.104, 214, 67, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-5 
3143, 6ct7B, 0.5376, 3.66, 0.075, 211, 67, FAB OF ANTI-A-SYNUCLEIN ANTIBODY BIIB054 IN COMPLEX WITH ACETYLATED A- SYNUCLEIN PEPTIDE (1-10) 
3144, 6cdin, 0.5376, 3.35, 0.047, 105, 64, CRYO-EM STRUCTURE AT 3.6 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
3145, 6cdiN, 0.5376, 3.35, 0.047, 105, 64, CRYO-EM STRUCTURE AT 3.6 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
3146, 6cdi6, 0.5376, 3.35, 0.047, 105, 64, CRYO-EM STRUCTURE AT 3.6 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
3147, 6awnC, 0.5376, 3.70, 0.075, 214, 67, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3148, 5yslF, 0.5376, 3.56, 0.092, 213, 65, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
3149, 5v4nC, 0.5376, 3.31, 0.095, 200, 63, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
3150, 5t80L, 0.5376, 3.72, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2 AND PHOSPHATIDIC ACID (06:0 PA)
3151, 5o4eC, 0.5376, 3.65, 0.119, 181, 67, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
3152, 5hsfA, 0.5376, 3.68, 0.119, 105, 67, 1.52 ANGSTROM CRYSTAL STRUCTURE OF FC FRAGMENT OF HUMAN IGG1.
3153, 5gguB, 0.5376, 3.50, 0.108, 213, 65, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
3154, 5etuA, 0.5376, 3.49, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
3155, 4ydjL, 0.5376, 3.59, 0.076, 205, 66, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
3156, 4v5jLA, 0.5376, 3.52, 0.096, 120, 73, 
3157, 4oduB, 0.5376, 3.86, 0.059, 212, 68, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
3158, 4k3dL, 0.5376, 3.75, 0.103, 215, 68, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
3159, 4k23L, 0.5376, 3.65, 0.076, 218, 66, STRUCTURE OF ANTI-UPAR FAB ATN-658
3160, 4dfhB, 0.5376, 3.16, 0.060, 123, 67, CRYSTAL STRUCTURE OF CELL ADHESION MOLECULE NECTIN-2/CD112 VARIABLE DOMAIN
3161, 3wihM, 0.5376, 3.61, 0.076, 213, 66, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
3162, 3uo1H, 0.5376, 3.53, 0.097, 216, 62, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
3163, 3sgdJ, 0.5376, 3.51, 0.097, 216, 62, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3164, 3kaaA, 0.5376, 3.61, 0.075, 107, 67, STRUCTURE OF TIM-3 IN COMPLEX WITH PHOSPHATIDYLSERINE
3165, 3c5zD, 0.5376, 3.30, 0.095, 202, 63, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3166, 2r1yB, 0.5376, 3.66, 0.094, 216, 64, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3167, 2q3zA, 0.5376, 3.58, 0.132, 655, 68, TRANSGLUTAMINASE 2 UNDERGOES LARGE CONFORMATIONAL CHANGE UPON ACTIVATION
3168, 2fseB, 0.5376, 3.30, 0.127, 186, 63, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
3169, 1otsD, 0.5376, 3.49, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
3170, 1kelH, 0.5376, 3.80, 0.092, 218, 65, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4 -NITROBENZYL-N-4 -CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
3171, 1ii4H, 0.5376, 3.04, 0.031, 200, 64, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
3172, 1d6vL, 0.5376, 3.47, 0.108, 211, 65, CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
3173, 6dc4L, 0.5375, 3.48, 0.108, 215, 65, RSV-NEUTRALIZING HUMAN ANTIBODY AM22 
3174, 6chbK, 0.5375, 3.77, 0.075, 205, 67, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
3175, 6azzB, 0.5375, 3.70, 0.075, 212, 67, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
3176, 5xlib, 0.5375, 3.63, 0.076, 213, 66, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
3177, 5v4mF, 0.5375, 3.27, 0.127, 200, 63, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
3178, 5u3nL, 0.5375, 3.50, 0.108, 215, 65, CRYSTAL STRUCTURE OF DH511.12P FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
3179, 5l0qF, 0.5375, 3.34, 0.098, 214, 61, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
3180, 5jo5L, 0.5375, 3.72, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
3181, 4zxbE, 0.5375, 3.55, 0.132, 800, 68, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
3182, 4wwiD, 0.5375, 3.60, 0.090, 201, 67, CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION
3183, 4tvpL, 0.5375, 3.70, 0.075, 210, 67, CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22
3184, 4p59L, 0.5375, 3.60, 0.106, 211, 66, HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825
3185, 4kq0D, 0.5375, 2.66, 0.068, 122, 59, CRYSTAL STRUCTURE OF DOUBLE-HELICAL CGG-REPETITIVE RNA 19MER COMPLEXED WITH RSS P19
3186, 4kq0A, 0.5375, 2.66, 0.068, 122, 59, CRYSTAL STRUCTURE OF DOUBLE-HELICAL CGG-REPETITIVE RNA 19MER COMPLEXED WITH RSS P19
3187, 4h25E, 0.5375, 3.35, 0.125, 182, 64, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
3188, 3tgxO, 0.5375, 3.10, 0.094, 208, 64, IL-21:IL21R COMPLEX
3189, 3t77B, 0.5375, 3.66, 0.094, 224, 64, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
3190, 3qnzA, 0.5375, 3.48, 0.108, 219, 65, ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA
3191, 3ikcA, 0.5375, 3.81, 0.060, 217, 67, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3192, 3ifoH, 0.5375, 3.82, 0.092, 216, 65, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
3193, 2vweJ, 0.5375, 3.55, 0.108, 214, 65, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
3194, 2or9H, 0.5375, 3.33, 0.098, 221, 61, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
3195, 2ddqL, 0.5375, 3.49, 0.062, 218, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
3196, 1q1jM, 0.5375, 3.71, 0.075, 215, 67, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
3197, 1bj1J, 0.5375, 3.59, 0.106, 213, 66, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3198, 6blhL, 0.5374, 3.71, 0.075, 211, 67, RSV G CENTRAL CONSERVED REGION BOUND TO FAB CB017.5
3199, 5n2kC, 0.5374, 3.72, 0.075, 215, 67, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3200, 5gksB, 0.5374, 3.81, 0.088, 211, 68, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY
3201, 5cp3H, 0.5374, 3.49, 0.097, 212, 62, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
3202, 5bv7B, 0.5374, 3.72, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN LCAT (L4F N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY
3203, 4r2gP, 0.5374, 3.74, 0.075, 210, 67, CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4
3204, 4lxoA, 0.5374, 3.35, 0.061, 184, 66, CRYSTAL STRUCTURE OF 910FN3-ELEGANTIN CHIMERA
3205, 4hh9A, 0.5374, 3.51, 0.108, 214, 65, ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
3206, 4gw5A, 0.5374, 3.47, 0.108, 212, 65, CQYN MEDITOPE - CETUXIMAB FAB
3207, 3u0wL, 0.5374, 3.49, 0.108, 213, 65, AD RELATED MURINE ANTIBODY FRAGMENT
3208, 3sgdH, 0.5374, 3.50, 0.097, 217, 62, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3209, 3q6gM, 0.5374, 3.79, 0.088, 209, 68, CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3210, 3pl6B, 0.5374, 3.29, 0.079, 181, 63, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3211, 3d6gB, 0.5374, 3.45, 0.091, 209, 66, FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.
3212, 2vdoL, 0.5374, 3.58, 0.077, 214, 65, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
3213, 2j1kT, 0.5374, 3.65, 0.103, 119, 68, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
3214, 2hlfD, 0.5374, 3.50, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
3215, 2hb0A, 0.5374, 3.20, 0.030, 356, 66, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
3216, 1v7nN, 0.5374, 3.49, 0.062, 212, 65, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3217, 1kemH, 0.5374, 3.48, 0.097, 218, 62, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
3218, 1h15E, 0.5374, 3.40, 0.109, 189, 64, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
3219, 5zxvD, 0.5373, 3.70, 0.075, 206, 67, STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN 
3220, 5tkjE, 0.5373, 3.50, 0.108, 219, 65, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3221, 5myxB, 0.5373, 3.78, 0.092, 216, 65, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
3222, 5mtlA, 0.5373, 3.69, 0.075, 194, 67, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
3223, 5mevL, 0.5373, 3.67, 0.104, 213, 67, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21
3224, 4r97B, 0.5373, 3.50, 0.077, 214, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
3225, 4qhnB, 0.5373, 3.70, 0.075, 208, 67, I2 (UNBOUND) FROM CH103 LINEAGE
3226, 4p5mD, 0.5373, 3.29, 0.095, 199, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
3227, 4o51C, 0.5373, 3.48, 0.108, 214, 65, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3228, 4jvwB, 0.5373, 3.92, 0.130, 109, 69, IGM C4-DOMAIN FROM MOUSE
3229, 4hiiC, 0.5373, 3.49, 0.108, 205, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
3230, 4ba8A, 0.5373, 3.57, 0.087, 102, 69, HIGH RESOLUTION NMR STRUCTURE OF THE C MU3 DOMAIN FROM IGM
3231, 3jpzA, 0.5373, 3.57, 0.041, 364, 74, CRYSTAL STRUCTURE OF LOMBRICINE KINASE
3232, 3j1sL, 0.5373, 3.56, 0.077, 214, 65, STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20
3233, 2iffH, 0.5373, 3.65, 0.094, 214, 64, STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
3234, 2ed9A, 0.5373, 3.21, 0.109, 124, 64, SOLUTION STRUCTURE OF THE THIRD FIBRONECTIN TYPE III DOMAIN OF HUMAN NETRIN RECEPTOR DCC
3235, 1s7hB, 0.5373, 3.36, 0.074, 180, 68, STRUCTURAL GENOMICS 2.2A CRYSTAL STRUCTURE OF PROTEIN YKOF FROM BACILLUS SUBTILIS
3236, 1qgcA, 0.5373, 3.51, 0.097, 220, 62, STRUCTURE OF THE COMPLEX OF A FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS
3237, 1q1jL, 0.5373, 3.71, 0.075, 215, 67, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
3238, 1ospL, 0.5373, 3.56, 0.077, 214, 65, CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
3239, 1i3rB, 0.5373, 3.45, 0.109, 216, 64, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
3240, 1b4jL, 0.5373, 3.60, 0.106, 214, 66, COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
3241, 6h6fD, 0.5372, 3.16, 0.111, 2454, 63, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
3242, 6gffL, 0.5372, 3.78, 0.092, 214, 65, STRUCTURE OF GARP (LRRC32) IN COMPLEX WITH LATENT TGF-BETA1 AND MHG-8 FAB 
3243, 6awqC, 0.5372, 3.74, 0.090, 214, 67, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
3244, 6awoC, 0.5372, 3.74, 0.090, 214, 67, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
3245, 5lngB, 0.5372, 3.22, 0.076, 154, 66, LECTIN DOMAIN OF E. COLI F9 PILUS ADHESIN FMLH
3246, 5jorA, 0.5372, 3.55, 0.077, 218, 65, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3247, 5id1A, 0.5372, 3.48, 0.108, 212, 65, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
3248, 3tnmL, 0.5372, 3.69, 0.075, 210, 67, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3249, 3t65B, 0.5372, 3.66, 0.094, 222, 64, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
3250, 3se3C, 0.5372, 2.89, 0.095, 183, 63, HUMAN IFNA2-IFNAR TERNARY COMPLEX
3251, 3ffcD, 0.5372, 3.30, 0.092, 202, 65, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
3252, 3cfbL, 0.5372, 3.65, 0.076, 218, 66, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
3253, 2y6sC, 0.5372, 3.50, 0.062, 217, 65, STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE
3254, 2v7nC, 0.5372, 3.50, 0.108, 212, 65, UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
3255, 2a6dH, 0.5372, 3.80, 0.092, 218, 65, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
3256, 1wc7B, 0.5372, 3.32, 0.098, 223, 61, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
3257, 1rziI, 0.5372, 3.38, 0.109, 211, 64, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3258, 1ggiL, 0.5372, 3.66, 0.076, 215, 66, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
3259, 1clzL, 0.5372, 3.47, 0.076, 219, 66, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
3260, 6mnoD, 0.5371, 3.30, 0.095, 193, 63, 6235 TCR BOUND TO I-AB PADI4 
3261, 6dc8L, 0.5371, 3.65, 0.076, 218, 66, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3262, 6cpgE, 0.5371, 3.04, 0.094, 88, 64, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) IN COMPLEX WITH INHIBITING MONOBODY AND AT9283 IN AN INACTIVE CONFORMATION 
3263, 5mr2C, 0.5371, 2.84, 0.067, 105, 60, CRYSTAL STRUCTURE OF RED ABALONE VERL REPEAT 2 WITH LINKER AT 2.5 A RESOLUTION
3264, 5ksaB, 0.5371, 3.31, 0.063, 190, 63, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
3265, 5kqvQ, 0.5371, 3.52, 0.062, 214, 65, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
3266, 5jo5D, 0.5371, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
3267, 5dq9H, 0.5371, 3.58, 0.076, 222, 66, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3268, 4qf1B, 0.5371, 3.68, 0.075, 210, 67, CRYSTAL STRUCTURE OF UNLIGANDED CH59UA THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59
3269, 4m61B, 0.5371, 3.50, 0.092, 220, 65, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3270, 4kq4L, 0.5371, 3.50, 0.108, 214, 65, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
3271, 4kkbF, 0.5371, 3.90, 0.059, 211, 68, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
3272, 4ia4D, 0.5371, 3.39, 0.060, 238, 67, STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 AT PH 6
3273, 4fqcL, 0.5371, 3.68, 0.075, 206, 67, CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N- GLYCAN
3274, 4f58O, 0.5371, 3.68, 0.075, 213, 67, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
3275, 3iflH, 0.5371, 3.50, 0.097, 214, 62, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX
3276, 3idnA, 0.5371, 3.50, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS
3277, 2y6sL, 0.5371, 3.50, 0.062, 217, 65, STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE
3278, 2pr4L, 0.5371, 3.50, 0.123, 213, 65, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
3279, 2hlfF, 0.5371, 3.50, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
3280, 2f5aL, 0.5371, 3.50, 0.123, 213, 65, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
3281, 2dmbA, 0.5371, 3.12, 0.094, 124, 64, SOLUTION STRUCTURE OF THE 15TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B
3282, 1xgyH, 0.5371, 3.50, 0.097, 216, 62, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
3283, 1rukL, 0.5371, 3.58, 0.077, 219, 65, CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
3284, 1otsF, 0.5371, 3.50, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
3285, 1e6oL, 0.5371, 3.61, 0.076, 210, 66, CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
3286, 6dc8H, 0.5370, 3.82, 0.077, 217, 65, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3287, 6ca7L, 0.5370, 3.50, 0.108, 213, 65, CRYSTAL STRUCTURE OF PCT64_13C; A STRAIN SPECIFIC ANTI-HIV ANTIBODY 
3288, 6c5hH, 0.5370, 3.76, 0.092, 212, 65, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
3289, 5n2kK, 0.5370, 3.78, 0.074, 214, 68, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3290, 5n2kA, 0.5370, 3.58, 0.076, 216, 66, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3291, 5l6yL, 0.5370, 3.67, 0.075, 212, 67, IL13 IN COMPLEX WITH TRALOKINUMAB
3292, 5gsqD, 0.5370, 3.65, 0.119, 194, 67, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
3293, 5ggtL, 0.5370, 3.54, 0.106, 210, 66, PD-L1 IN COMPLEX WITH BMS-936559 FAB
3294, 5cszB, 0.5370, 3.57, 0.106, 214, 66, CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11
3295, 5b6fG, 0.5370, 3.57, 0.077, 217, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3296, 4qeyG, 0.5370, 2.78, 0.098, 123, 61, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
3297, 4o51A, 0.5370, 3.48, 0.108, 214, 65, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3298, 4m9pA, 0.5370, 3.50, 0.106, 289, 66, CRYSTAL STRUCTURE OF THE HUMAN FILAMIN A IG-LIKE DOMAINS 3-5
3299, 4fccA, 0.5370, 3.32, 0.123, 442, 65, GLUTAMATE DEHYDROGENASE FROM E. COLI
3300, 4d9lN, 0.5370, 3.73, 0.075, 215, 67, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
3301, 3wvrD, 0.5370, 2.91, 0.152, 411, 66, STRUCTURE OF ATP GRASP PROTEIN WITH AMP
3302, 3wvrC, 0.5370, 2.76, 0.154, 429, 65, STRUCTURE OF ATP GRASP PROTEIN WITH AMP
3303, 3wihL, 0.5370, 3.61, 0.076, 213, 66, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
3304, 3v8cB, 0.5370, 3.43, 0.091, 209, 66, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)
3305, 3qazI, 0.5370, 3.25, 0.121, 188, 66, IL-2 MUTANT D10 TERNARY COMPLEX
3306, 3cm9C, 0.5370, 3.52, 0.076, 462, 66, SOLUTION STRUCTURE OF HUMAN SIGA2
3307, 3cm9A, 0.5370, 3.52, 0.076, 462, 66, SOLUTION STRUCTURE OF HUMAN SIGA2
3308, 2vdlL, 0.5370, 3.59, 0.077, 214, 65, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3309, 2p8mA, 0.5370, 3.51, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM
3310, 2a73A, 0.5370, 3.55, 0.103, 635, 68, HUMAN COMPLEMENT COMPONENT C3
3311, 1y6kR, 0.5370, 3.37, 0.116, 205, 69, CRYSTAL STRUCTURE OF HUMAN IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
3312, 1rziO, 0.5370, 3.38, 0.108, 211, 65, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3313, 1nc4C, 0.5370, 3.64, 0.104, 215, 67, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
3314, 1lo3L, 0.5370, 3.62, 0.076, 219, 66, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
3315, 1cicB, 0.5370, 3.47, 0.081, 217, 62, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3316, 1bbjL, 0.5370, 3.57, 0.106, 211, 66, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
3317, 1bbjA, 0.5370, 3.57, 0.106, 211, 66, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
3318, 6mu6L, 0.5369, 3.71, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM 
3319, 6msdH, 0.5369, 3.21, 0.030, 191, 67, struct.pdbx_descriptor               26S proteasome  
3320, 6azkA, 0.5369, 3.58, 0.106, 212, 66, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3321, 6a9kA, 0.5369, 3.63, 0.076, 219, 66, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
3322, 5wl2L, 0.5369, 3.81, 0.074, 211, 68, VH1-69 GERMLINE ANTIBODY WITH CDR H3 SEQUENCE OF CR9114 
3323, 5wkoD, 0.5369, 3.60, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3324, 5n4gL, 0.5369, 3.51, 0.108, 216, 65, HUMAN FAB FRAGMENT 12E1 AGAINST NHBA FROM NEISSERIA MENINGITIDIS
3325, 5ig7B, 0.5369, 3.73, 0.075, 213, 67, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
3326, 5fjqB, 0.5369, 3.49, 0.014, 180, 69, STRUCTURAL AND FUNCTIONAL ANALYSIS OF A LYTIC POLYSACCHARIDE MONOOXYGENASE IMPORTANT FOR EFFICIENT UTILIZATION OF CHITIN IN CELLVIBRIO JAPONICUS
3327, 5dc0A, 0.5369, 3.02, 0.109, 91, 64, CRYSTAL STRUCTURE OF MONOBODY GG3/ABL1 SH2 DOMAIN COMPLEX
3328, 5adoL, 0.5369, 3.57, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT
3329, 4u20AB, 0.5369, 3.38, 0.074, 190, 68, 
3330, 4lptC, 0.5369, 3.03, 0.077, 97, 65, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
3331, 4eneD, 0.5369, 3.81, 0.060, 211, 67, STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
3332, 3mobL, 0.5369, 3.44, 0.108, 213, 65, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
3333, 2y07L, 0.5369, 3.81, 0.103, 211, 68, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
3334, 2q6wA, 0.5369, 3.37, 0.094, 179, 64, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
3335, 2gfbC, 0.5369, 3.53, 0.077, 214, 65, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3336, 2dkcB, 0.5369, 3.57, 0.090, 535, 67, CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE-PHOSPHATE MUTASE A MEMBER OF THE ALPHA-D-PHOSPHOHEXOMUTASE SUPERFAMILY IN THE SUBSTRATE COMPLEX
3337, 1xgvA, 0.5369, 3.56, 0.057, 430, 70, ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX
3338, 1xddB, 0.5369, 3.19, 0.090, 182, 67, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
3339, 1nccL, 0.5369, 3.50, 0.077, 214, 65, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
3340, 1etzA, 0.5369, 3.70, 0.104, 215, 67, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
3341, 1bj8A, 0.5369, 3.39, 0.060, 109, 67, THIRD N-TERMINAL DOMAIN OF GP130 NMR MINIMIZED AVERAGE STRUCTURE
3342, 6j2cRA, 0.5368, 3.13, 0.045, 197, 67, struct.pdbx_descriptor              
3343, 6igoB, 0.5368, 3.48, 0.045, 119, 67, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
3344, 6dwiI, 0.5368, 3.63, 0.106, 211, 66, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3345, 6d4eA, 0.5368, 3.45, 0.091, 208, 66, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1. 
3346, 5x4gB, 0.5368, 3.56, 0.077, 213, 65, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
3347, 5ukoL, 0.5368, 3.69, 0.090, 211, 67, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522IA FAB
3348, 5u3lB, 0.5368, 3.48, 0.108, 213, 65, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
3349, 5o32E, 0.5368, 3.30, 0.091, 640, 66, THE STRUCTURE OF COMPLEMENT COMPLEX
3350, 5jo5B, 0.5368, 3.70, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
3351, 5iczA, 0.5368, 3.58, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
3352, 5hdqH, 0.5368, 3.78, 0.092, 213, 65, MNTC CO-STRUCTURE WITH MAB 305-78-7
3353, 5d9qM, 0.5368, 3.70, 0.075, 208, 67, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46
3354, 5b3jH, 0.5368, 3.35, 0.098, 216, 61, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3355, 4ptuA, 0.5368, 3.50, 0.108, 212, 65, CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 WITH RHAMNOSE
3356, 4p4rD, 0.5368, 3.38, 0.095, 199, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
3357, 4ozfB, 0.5368, 3.32, 0.079, 181, 63, JR5.1 PROTEIN COMPLEX
3358, 4okvC, 0.5368, 3.79, 0.092, 215, 65, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3359, 4mdjB, 0.5368, 3.63, 0.138, 191, 65, IMMUNE RECEPTOR
3360, 3qazO, 0.5368, 3.35, 0.119, 191, 67, IL-2 MUTANT D10 TERNARY COMPLEX
3361, 3phoB, 0.5368, 3.32, 0.098, 216, 61, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
3362, 2y36L, 0.5368, 3.70, 0.104, 211, 67, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
3363, 2xqbL, 0.5368, 3.74, 0.074, 202, 68, CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
3364, 2erjG, 0.5368, 3.12, 0.123, 195, 65, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
3365, 1xddA, 0.5368, 3.18, 0.090, 182, 67, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
3366, 1uz8L, 0.5368, 3.80, 0.059, 218, 68, ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
3367, 1q9wB, 0.5368, 3.51, 0.097, 226, 62, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
3368, 1i3rH, 0.5368, 3.46, 0.109, 216, 64, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
3369, 1gpoI, 0.5368, 3.51, 0.097, 212, 62, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
3370, 1fn4C, 0.5368, 3.46, 0.077, 211, 65, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
3371, 1b6dB, 0.5368, 3.59, 0.106, 212, 66, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
3372, 6mqsB, 0.5367, 3.55, 0.091, 215, 66, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3373, 6arnA, 0.5367, 3.23, 0.076, 150, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH O-METHOXYPHENYL BETA-GALACTOSIDE (OMPG)
3374, 5yupH, 0.5367, 3.64, 0.094, 219, 64, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
3375, 5vodA, 0.5367, 3.07, 0.078, 667, 64, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6
3376, 5tqaB, 0.5367, 3.56, 0.076, 211, 66, CRYSTAL STRUCTURE OF DH270.6 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
3377, 5jorD, 0.5367, 3.64, 0.078, 208, 64, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3378, 5ff6A, 0.5367, 3.49, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
3379, 5d93E, 0.5367, 3.54, 0.106, 212, 66, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
3380, 5b3jE, 0.5367, 3.35, 0.098, 215, 61, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3381, 4uomH, 0.5367, 3.33, 0.098, 217, 61, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE  ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB F5
3382, 4u1uAB, 0.5367, 3.38, 0.074, 190, 68, 
3383, 4louF, 0.5367, 3.51, 0.062, 211, 65, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
3384, 4jdvB, 0.5367, 3.50, 0.108, 208, 65, CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
3385, 4jamB, 0.5367, 3.73, 0.075, 205, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
3386, 4cc6A, 0.5367, 3.54, 0.097, 308, 72, FRAGMENT-BASED DISCOVERY OF 6 AZAINDAZOLES AS INHIBITORS OF BACTERIAL DNA LIGASE
3387, 4at6N, 0.5367, 3.71, 0.104, 212, 67, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
3388, 3u30B, 0.5367, 3.42, 0.108, 211, 65, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3389, 3qazj, 0.5367, 3.37, 0.121, 191, 66, IL-2 MUTANT D10 TERNARY COMPLEX
3390, 3l5wL, 0.5367, 3.58, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
3391, 3ghbM, 0.5367, 3.73, 0.075, 216, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
3392, 3cu7B, 0.5367, 3.41, 0.104, 1481, 67, HUMAN COMPLEMENT COMPONENT 5
3393, 3cu7A, 0.5367, 3.41, 0.104, 1625, 67, HUMAN COMPLEMENT COMPONENT 5
3394, 3bz4C, 0.5367, 3.63, 0.076, 218, 66, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3395, 1ynlH, 0.5367, 3.53, 0.081, 219, 62, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
3396, 1x9nA, 0.5367, 3.29, 0.108, 626, 65, CRYSTAL STRUCTURE OF HUMAN DNA LIGASE I BOUND TO 5 -ADENYLATED NICKED DNA
3397, 1i8mH, 0.5367, 3.80, 0.092, 213, 65, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
3398, 6qf5C, 0.5366, 3.21, 0.015, 222, 66, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2 CRYSTALLIZED ON A SILICON CHIP 
3399, 6mtnL, 0.5366, 3.74, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM 
3400, 6dc5F, 0.5366, 3.50, 0.108, 212, 65, RSV PREFUSION F IN COMPLEX WITH AM22 FAB 
3401, 6bijB, 0.5366, 3.61, 0.138, 189, 65, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
3402, 6bfsH, 0.5366, 3.50, 0.097, 211, 62, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3403, 6axkB, 0.5366, 3.72, 0.090, 214, 67, CRYSTAL STRUCTURE OF FAB311 COMPLEX
3404, 6amjL, 0.5366, 3.46, 0.108, 211, 65, CAT192 FAB WILD TYPE
3405, 6a9kB, 0.5366, 3.53, 0.095, 220, 63, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
3406, 6a77H, 0.5366, 3.77, 0.077, 217, 65, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
3407, 5x2oJ, 0.5366, 3.48, 0.097, 220, 62, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3408, 5wuvL, 0.5366, 3.58, 0.106, 213, 66, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
3409, 5uelL, 0.5366, 3.52, 0.108, 216, 65, CRYSTAL STRUCTURE OF 354NC102 FAB
3410, 5tkjB, 0.5366, 3.51, 0.108, 218, 65, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3411, 5te4L, 0.5366, 3.48, 0.108, 210, 65, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE G STRAIN X2088 GP120 CORE
3412, 5ksuE, 0.5366, 3.29, 0.079, 179, 63, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
3413, 5jorH, 0.5366, 3.65, 0.078, 211, 64, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3414, 5fb8A, 0.5366, 3.48, 0.108, 218, 65, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3415, 5ceyA, 0.5366, 3.74, 0.075, 211, 67, CRYSTAL STRUCTURE OF FAB 9H+3L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
3416, 4xx1G, 0.5366, 3.59, 0.076, 210, 66, LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1
3417, 4utbM, 0.5366, 3.69, 0.075, 210, 67, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3418, 4u4jA, 0.5366, 3.73, 0.101, 1538, 69, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN MUTANT Y1175G
3419, 4orgD, 0.5366, 3.75, 0.075, 208, 67, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
3420, 4jy4B, 0.5366, 3.72, 0.092, 232, 65, CRYSTAL STRUCTURE OF HUMAN FAB PGT121 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3421, 4al8L, 0.5366, 3.51, 0.062, 213, 65, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
3422, 3up1B, 0.5366, 3.11, 0.154, 196, 65, CRYSTAL STRUCTURE OF THE UNLIGANDED HUMAN INTERLEUKIN-7 RECEPTOR EXTRACELLULAR DOMAIN
3423, 3phqB, 0.5366, 3.71, 0.094, 213, 64, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
3424, 3okdB, 0.5366, 3.34, 0.098, 218, 61, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3425, 3ietA, 0.5366, 3.56, 0.077, 215, 65, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3426, 2x05B, 0.5366, 3.50, 0.029, 851, 69, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
3427, 2pkdC, 0.5366, 3.37, 0.029, 107, 69, CRYSTAL STRUCTURE OF CD84: INSITE INTO SLAM FAMILY FUNCTION
3428, 2i0zA, 0.5366, 3.23, 0.077, 416, 65, CRYSTAL STRUCTURE OF A FAD BINDING PROTEIN FROM BACILLUS CEREUS A PUTATIVE NAD(FAD)-UTILIZING DEHYDROGENASES
3429, 2evvC, 0.5366, 3.74, 0.118, 174, 68, CRYSTAL STRUCTURE OF THE PEBP-LIKE PROTEIN OF UNKNOWN FUNCTION HP0218 FROM HELICOBACTER PYLORI
3430, 1zhoC, 0.5366, 3.07, 0.075, 225, 67, THE STRUCTURE OF A RIBOSOMAL PROTEIN L1 IN COMPLEX WITH MRNA
3431, 1r70B, 0.5366, 3.52, 0.076, 462, 66, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
3432, 1jk8B, 0.5366, 3.29, 0.063, 190, 63, CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
3433, 1cl7L, 0.5366, 3.52, 0.062, 216, 65, ANTI HIV1 PROTEASE FAB
3434, 1bafL, 0.5366, 3.51, 0.062, 214, 65, 2.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN
3435, 6n16J, 0.5365, 3.52, 0.123, 217, 65, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3436, 6ehgA, 0.5365, 3.40, 0.090, 638, 67, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
3437, 6cpoB, 0.5365, 3.47, 0.125, 189, 64, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
3438, 6b2bD, 0.5365, 3.09, 0.094, 96, 64, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83M MUTANT
3439, 6b2aD, 0.5365, 3.11, 0.094, 96, 64, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80M MUTANT
3440, 6as8A, 0.5365, 3.23, 0.076, 153, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH ORTHO-BIPHENYL-2 -CARBOXYL N-ACETYL-BETA-GALACTOSAMINOSIDE
3441, 5wkoL, 0.5365, 3.60, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3442, 5ujtB, 0.5365, 3.29, 0.063, 188, 63, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
3443, 5oj2B, 0.5365, 3.27, 0.125, 681, 64, CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN
3444, 5ockL, 0.5365, 3.64, 0.091, 214, 66, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1 
3445, 5ksbD, 0.5365, 3.31, 0.063, 178, 63, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
3446, 5hi4D, 0.5365, 3.59, 0.076, 213, 66, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3447, 5gkrD, 0.5365, 3.72, 0.090, 206, 67, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY IN COMPLEX WITH OLIGONUCLEOTIDE
3448, 5bjzL, 0.5365, 3.58, 0.106, 213, 66, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
3449, 4ydjB, 0.5365, 3.72, 0.075, 205, 67, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
3450, 4rx4L, 0.5365, 3.48, 0.108, 212, 65, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120
3451, 4rfnL, 0.5365, 3.82, 0.088, 210, 68, CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48
3452, 4qhmD, 0.5365, 3.72, 0.075, 209, 67, I3.1 (UNBOUND) FROM CH103 LINEAGE
3453, 4p3dH, 0.5365, 3.82, 0.092, 218, 65, MT1-MMP:FAB COMPLEX (FORM II)
3454, 4ov5E, 0.5365, 3.43, 0.125, 186, 64, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
3455, 4okvB, 0.5365, 3.66, 0.076, 218, 66, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3456, 4ocxH, 0.5365, 3.47, 0.097, 210, 62, FAB COMPLEX WITH METHOTREXATE
3457, 4mqxF, 0.5365, 3.65, 0.076, 211, 66, CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT
3458, 4m7zH, 0.5365, 3.35, 0.098, 215, 61, UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB
3459, 4fqxD, 0.5365, 3.72, 0.091, 191, 66, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
3460, 4f2mD, 0.5365, 3.50, 0.062, 211, 65, CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
3461, 4b7lB, 0.5365, 3.29, 0.123, 330, 65, CRYSTAL STRUCTURE OF HUMAN FILAMIN B ACTIN BINDING DOMAIN WITH 1ST FILAMIN REPEAT
3462, 3t4aC, 0.5365, 3.60, 0.075, 296, 67, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
3463, 3rvuC, 0.5365, 3.50, 0.062, 212, 65, STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP
3464, 3rkpA, 0.5365, 3.29, 0.060, 350, 67, CRYSTAL STRUCTURE OF BCPA*(D312A) THE MAJOR PILIN SUBUNIT OF BACILLUS CEREUS
3465, 3ra7H, 0.5365, 3.50, 0.097, 225, 62, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3466, 3okeB, 0.5365, 3.66, 0.094, 217, 64, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3467, 3mugK, 0.5365, 3.71, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3468, 3e2mA, 0.5365, 3.31, 0.103, 182, 68, LFA-1 I DOMAIN BOUND TO INHIBITORS
3469, 3cm9D, 0.5365, 3.51, 0.076, 462, 66, SOLUTION STRUCTURE OF HUMAN SIGA2
3470, 3cm9B, 0.5365, 3.51, 0.076, 462, 66, SOLUTION STRUCTURE OF HUMAN SIGA2
3471, 3c60H, 0.5365, 3.45, 0.094, 201, 64, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3472, 2xwxA, 0.5365, 3.30, 0.108, 385, 65, VIBRIO CHOLERAE COLONIZATION FACTOR GBPA CRYSTAL STRUCTURE
3473, 2visA, 0.5365, 3.80, 0.103, 210, 68, INFLUENZA VIRUS HEMAGGLUTININ (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE COMPLEXED WITH A NEUTRALIZING ANTIBODY
3474, 2r23B, 0.5365, 3.51, 0.095, 222, 63, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3475, 2j4wH, 0.5365, 3.33, 0.098, 225, 61, STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX
3476, 1ii4G, 0.5365, 3.23, 0.031, 200, 65, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
3477, 1aqdK, 0.5365, 3.42, 0.109, 188, 64, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
3478, 6mqsD, 0.5364, 3.69, 0.090, 215, 67, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3479, 6mejL, 0.5364, 3.49, 0.108, 213, 65, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3480, 6e64L, 0.5364, 3.69, 0.075, 213, 67, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
3481, 6aowA, 0.5364, 3.20, 0.076, 152, 66, CRYSTAL STRUCTURE OF LECTIN DOMAIN OF F9 PILUS ADHESIN FMLH FROM E. COLI UTI89
3482, 6aodA, 0.5364, 3.58, 0.106, 207, 66, FXIA ANTIBODY COMPLEX
3483, 5t1mA, 0.5364, 3.59, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
3484, 5nivA, 0.5364, 3.49, 0.092, 212, 65, CRYSTAL STRUCTURE OF 5D3 FAB
3485, 5mykB, 0.5364, 3.49, 0.081, 218, 62, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 17 IN COMPLEX WITH MURINE ABETA-PE3-18PEGB
3486, 5icyA, 0.5364, 3.59, 0.106, 212, 66, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
3487, 5ibtL, 0.5364, 3.52, 0.108, 215, 65, UCA FAB (UNBOUND) FROM 6515 LINEAGE
3488, 5ezjB, 0.5364, 3.62, 0.076, 213, 66, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
3489, 5cd3H, 0.5364, 3.49, 0.108, 206, 65, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
3490, 4xvsL, 0.5364, 3.59, 0.106, 210, 66, CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
3491, 4kjwF, 0.5364, 3.68, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
3492, 4jfyA, 0.5364, 3.60, 0.106, 211, 66, APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
3493, 4hieA, 0.5364, 3.49, 0.108, 212, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102
3494, 4h1lB, 0.5364, 3.33, 0.125, 179, 64, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
3495, 4gmtM, 0.5364, 3.53, 0.062, 213, 65, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
3496, 4at6L, 0.5364, 3.33, 0.046, 212, 65, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
3497, 3wvqD, 0.5364, 2.94, 0.152, 429, 66, STRUCTURE OF ATP GRASP PROTEIN
3498, 3v8oA, 0.5364, 3.49, 0.045, 193, 66, HUMAN FILAMIN C IG - LIKE DOMAINS 4 AND 5
3499, 3uo1L, 0.5364, 3.48, 0.077, 218, 65, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
3500, 3skjM, 0.5364, 3.72, 0.104, 214, 67, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
3501, 3qxaE, 0.5364, 3.43, 0.125, 190, 64, HLA-DR1 BOUND WITH CLIP PEPTIDE
3502, 3lrsL, 0.5364, 3.72, 0.075, 211, 67, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3503, 3l1oL, 0.5364, 3.63, 0.091, 214, 66, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
3504, 3eyoC, 0.5364, 3.51, 0.108, 214, 65, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3505, 3cfdB, 0.5364, 3.71, 0.075, 219, 67, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3506, 2x05A, 0.5364, 3.47, 0.029, 851, 68, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
3507, 2r0zH, 0.5364, 3.28, 0.081, 216, 62, PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT
3508, 2i07A, 0.5364, 3.35, 0.091, 630, 66, HUMAN COMPLEMENT COMPONENT C3B
3509, 2gfbO, 0.5364, 3.53, 0.077, 214, 65, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3510, 2gfbK, 0.5364, 3.53, 0.077, 214, 65, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3511, 2gfbI, 0.5364, 3.64, 0.076, 214, 66, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3512, 2dwdB, 0.5364, 3.51, 0.062, 212, 65, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
3513, 2a6iB, 0.5364, 3.65, 0.095, 219, 63, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL
3514, 1xf3H, 0.5364, 3.80, 0.092, 216, 65, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
3515, 1xf2B, 0.5364, 3.78, 0.092, 213, 65, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
3516, 1cicA, 0.5364, 3.42, 0.062, 214, 65, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3517, 1bqlH, 0.5364, 3.62, 0.094, 214, 64, STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
3518, 1aqdE, 0.5364, 3.39, 0.095, 187, 63, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
3519, 6n16B, 0.5363, 3.44, 0.123, 217, 65, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3520, 6mxsB, 0.5363, 3.49, 0.108, 217, 65, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
3521, 6ii8I, 0.5363, 3.72, 0.075, 213, 67, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4B-18 
3522, 6e9iD, 0.5363, 3.68, 0.104, 214, 67, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
3523, 6db5L, 0.5363, 3.73, 0.075, 211, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
3524, 6biyB, 0.5363, 3.38, 0.125, 189, 64, HLA-DRB1 IN COMPLEX WITH HISTONE 2B PEPTIDE
3525, 5xv1D, 0.5363, 2.66, 0.086, 216, 58, CRYSTAL STRUCTURE OF ATG101-ATG13HORMA 
3526, 5uy3L, 0.5363, 3.59, 0.106, 216, 66, CRYSTAL STRUCTURE OF HUMAN FAB PGT144 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3527, 5mtlD, 0.5363, 3.51, 0.076, 200, 66, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
3528, 5jqdB, 0.5363, 3.48, 0.108, 214, 65, ANTIBODY FAB FRAGMENT
3529, 5jorF, 0.5363, 3.65, 0.078, 211, 64, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3530, 5eocM, 0.5363, 3.67, 0.076, 215, 66, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3531, 5dqjH, 0.5363, 3.34, 0.098, 222, 61, STRUCTURE OF UNLIGANDED S55-5 FAB
3532, 5b6fD, 0.5363, 3.35, 0.098, 211, 61, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3533, 4zsoB, 0.5363, 3.38, 0.066, 218, 61, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
3534, 4wi8B, 0.5363, 3.40, 0.091, 208, 66, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A
3535, 4u1vAB, 0.5363, 3.38, 0.059, 190, 68, 
3536, 4txdA, 0.5363, 3.35, 0.132, 336, 68, CRYSTAL STRUCTURE OF THERMOFILUM PENDENS CSC2
3537, 4qhkL, 0.5363, 3.70, 0.075, 209, 67, UCA (UNBOUND) FROM CH103 LINEAGE
3538, 4oziD, 0.5363, 3.34, 0.079, 181, 63, S2 PROTEIN COMPLEX
3539, 4lptE, 0.5363, 3.24, 0.046, 98, 65, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
3540, 4ktdL, 0.5363, 3.74, 0.075, 216, 67, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE136 FROM NON-HUMAN PRIMATE
3541, 4f37L, 0.5363, 3.31, 0.078, 218, 64, STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER S DISEASE A PEPTIDE
3542, 4e41B, 0.5363, 3.44, 0.125, 179, 64, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
3543, 3qxaB, 0.5363, 3.44, 0.125, 190, 64, HLA-DR1 BOUND WITH CLIP PEPTIDE
3544, 3o6mH, 0.5363, 3.35, 0.098, 218, 61, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 9-MER TAT PEPTIDE
3545, 3hzvB, 0.5363, 3.66, 0.094, 220, 64, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
3546, 3eyfA, 0.5363, 3.48, 0.108, 215, 65, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
3547, 3c60D, 0.5363, 3.45, 0.094, 201, 64, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3548, 2rblM, 0.5363, 2.96, 0.115, 80, 61, HIGH RESOLUTION DESIGN OF A PROTEIN LOOP
3549, 1xf5C, 0.5363, 3.67, 0.076, 220, 66, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
3550, 1vpoH, 0.5363, 3.82, 0.092, 221, 65, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
3551, 1i3rG, 0.5363, 3.45, 0.109, 182, 64, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
3552, 1hxyA, 0.5363, 3.32, 0.111, 180, 63, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
3553, 1ejjA, 0.5363, 3.82, 0.061, 508, 66, CRYSTAL STRUCTURAL ANALYSIS OF PHOSPHOGLYCERATE MUTASE COCRYSTALLIZED WITH 3-PHOSPHOGLYCERATE
3554, 1dn0D, 0.5363, 3.76, 0.088, 217, 68, STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
3555, 1cicD, 0.5363, 3.32, 0.098, 218, 61, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3556, 1cgsL, 0.5363, 3.64, 0.076, 219, 66, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
3557, 6mffC, 0.5362, 3.31, 0.079, 192, 63, HLA-DQ2-GLIA-OMEGA1 
3558, 6j2nRA, 0.5362, 3.42, 0.045, 197, 67, struct.pdbx_descriptor              
3559, 6gfeK, 0.5362, 3.67, 0.134, 426, 67, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
3560, 6flaL, 0.5362, 3.55, 0.077, 216, 65, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
3561, 5vl3A, 0.5362, 3.75, 0.092, 214, 65, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
3562, 5u0rL, 0.5362, 3.69, 0.075, 209, 67, CRYSTAL STRUCTURE OF DH270.UCA1 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
3563, 5t5wA, 0.5362, 3.01, 0.047, 198, 64, STRUCTURE OF AN AFFINITY MATURED LAMBDA-IFN/IFN-LAMBDAR1/IL-10RBETA RECEPTOR COMPLEX
3564, 5i8kL, 0.5362, 3.50, 0.108, 216, 65, HHH1 FAB FRAGMENT
3565, 5djaB, 0.5362, 3.68, 0.090, 207, 67, FC HETERODIMER DESIGN 9.1 Y407M + T366I
3566, 4qeyJ, 0.5362, 3.18, 0.079, 122, 63, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
3567, 4pttA, 0.5362, 3.62, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05
3568, 4ozgB, 0.5362, 3.27, 0.079, 181, 63, D2 PROTEIN COMPLEX
3569, 4kjqF, 0.5362, 3.68, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
3570, 4gw1A, 0.5362, 3.48, 0.108, 212, 65, CQFD MEDITOPE
3571, 3zkmD, 0.5362, 3.58, 0.077, 217, 65, BACE2 FAB COMPLEX
3572, 3wifB, 0.5362, 3.59, 0.077, 216, 65, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT 9CL-PGF2BETA COMPLEX
3573, 3qa3H, 0.5362, 3.49, 0.097, 224, 62, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3574, 3oknB, 0.5362, 3.36, 0.098, 216, 61, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3575, 3j5mK, 0.5362, 3.40, 0.108, 208, 65, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3576, 3j5mG, 0.5362, 3.40, 0.108, 208, 65, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3577, 3j5mC, 0.5362, 3.40, 0.108, 208, 65, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3578, 3hblC, 0.5362, 3.02, 0.113, 1067, 62, CRYSTAL STRUCTURE OF S. AUREUS PYRUVATE CARBOXYLASE T908A MUTANT
3579, 3droA, 0.5362, 3.51, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE
3580, 2vq1E, 0.5362, 3.63, 0.076, 216, 66, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3581, 2q7nA, 0.5362, 3.36, 0.030, 480, 66, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)
3582, 2h32B, 0.5362, 3.78, 0.090, 117, 67, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
3583, 1ymmB, 0.5362, 3.42, 0.095, 178, 63, TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
3584, 1q9lB, 0.5362, 3.51, 0.097, 222, 62, S25-2 FAB UNLIGANDED 2
3585, 1jl4B, 0.5362, 3.29, 0.095, 185, 63, CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
3586, 1iebC, 0.5362, 3.44, 0.109, 182, 64, HISTOCOMPATIBILITY ANTIGEN
3587, 1iakB, 0.5362, 3.29, 0.095, 185, 63, HISTOCOMPATIBILITY ANTIGEN I-AK
3588, 1hnfA, 0.5362, 3.13, 0.062, 179, 65, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE HUMAN CELL ADHESION MOLECULE CD2 AT 2.5 ANGSTROMS RESOLUTION
3589, 1fdlH, 0.5362, 3.48, 0.097, 218, 62, CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5- ANGSTROMS RESOLUTION
3590, 6qnkB, 0.5361, 3.48, 0.081, 221, 62, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
3591, 6iqhA, 0.5361, 3.68, 0.090, 207, 67, X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE 
3592, 6h6fC, 0.5361, 3.25, 0.111, 2454, 63, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
3593, 5x6aA, 0.5361, 3.31, 0.015, 229, 68, CRYSTAL STRUCTURE OF AN ENDOGLUCANASE PMO-5
3594, 5x2qH, 0.5361, 3.50, 0.097, 219, 62, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3595, 5ty6L, 0.5361, 3.49, 0.123, 212, 65, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 13-1B02 FAB.
3596, 5id0A, 0.5361, 3.58, 0.106, 212, 66, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
3597, 5f6iC, 0.5361, 3.80, 0.075, 210, 67, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH428 FROM A RHESUS MACAQUE
3598, 4whtK, 0.5361, 3.49, 0.097, 204, 62, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
3599, 4rnrD, 0.5361, 3.71, 0.075, 212, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV ANTIBODY PGT130
3600, 4pljH, 0.5361, 3.81, 0.092, 218, 65, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3601, 4p4kB, 0.5361, 3.29, 0.095, 199, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
3602, 4ov5B, 0.5361, 3.30, 0.095, 189, 63, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
3603, 4cmhC, 0.5361, 3.59, 0.106, 213, 66, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
3604, 4acpA, 0.5361, 3.55, 0.121, 198, 66, DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
3605, 3or6B, 0.5361, 3.50, 0.062, 212, 65, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3606, 3j41D, 0.5361, 3.34, 0.075, 233, 67, PSEUDO-ATOMIC MODEL OF THE AQUAPORIN-0/CALMODULIN COMPLEX DERIVED FROM ELECTRON MICROSCOPY
3607, 3j41C, 0.5361, 3.34, 0.075, 233, 67, PSEUDO-ATOMIC MODEL OF THE AQUAPORIN-0/CALMODULIN COMPLEX DERIVED FROM ELECTRON MICROSCOPY
3608, 3j41B, 0.5361, 3.34, 0.075, 233, 67, PSEUDO-ATOMIC MODEL OF THE AQUAPORIN-0/CALMODULIN COMPLEX DERIVED FROM ELECTRON MICROSCOPY
3609, 3dggD, 0.5361, 3.65, 0.094, 215, 64, CRYSTAL STRUCTURE OF FABOX108
3610, 3d9sB, 0.5361, 3.40, 0.030, 245, 67, HUMAN AQUAPORIN 5 (AQP5) - HIGH RESOLUTION X-RAY STRUCTURE
3611, 3cxdL, 0.5361, 3.55, 0.077, 213, 65, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
3612, 3chnO, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
3613, 3chnN, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
3614, 3chnM, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
3615, 3chnL, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
3616, 3c2aL, 0.5361, 3.73, 0.075, 216, 67, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
3617, 2y06L, 0.5361, 3.72, 0.104, 211, 67, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
3618, 2wngA, 0.5361, 3.20, 0.063, 307, 63, COMPLETE EXTRACELLULAR STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
3619, 2qtjO, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
3620, 2qtjN, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
3621, 2qtjM, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
3622, 2qtjL, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
3623, 2evvA, 0.5361, 3.85, 0.116, 174, 69, CRYSTAL STRUCTURE OF THE PEBP-LIKE PROTEIN OF UNKNOWN FUNCTION HP0218 FROM HELICOBACTER PYLORI
3624, 2esgM, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
3625, 2esgL, 0.5361, 3.71, 0.104, 214, 67, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
3626, 2b6pA, 0.5361, 3.34, 0.075, 261, 67, X-RAY STRUCTURE OF LENS AQUAPORIN-0 (AQP0) (LENS MIP) IN AN OPEN PORE STATE
3627, 2b39B, 0.5361, 3.66, 0.116, 1610, 69, STRUCTURE OF MAMMALIAN C3 WITH AN INTACT THIOESTER AT 3A RESOLUTION
3628, 1zlvL, 0.5361, 3.51, 0.108, 211, 65, FAB 2G12 + MAN7
3629, 1vgeL, 0.5361, 3.71, 0.104, 214, 67, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
3630, 1v7nH, 0.5361, 3.78, 0.108, 217, 65, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3631, 1ncnA, 0.5361, 3.68, 0.118, 110, 68, THE RECEPTOR-BINDING DOMAIN OF HUMAN B7-2
3632, 1mhpL, 0.5361, 3.43, 0.108, 212, 65, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
3633, 1l9nA, 0.5361, 3.38, 0.077, 673, 65, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
3634, 1ineH, 0.5361, 3.79, 0.092, 213, 65, HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB (SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
3635, 1iilG, 0.5361, 3.23, 0.031, 215, 65, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
3636, 1igaD, 0.5361, 3.71, 0.104, 214, 67, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
3637, 1igaC, 0.5361, 3.71, 0.104, 214, 67, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
3638, 6c6yB, 0.5360, 3.60, 0.121, 214, 66, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE IN COMPLEX WITH MERS RECEPTOR BINDING DOMAIN
3639, 6anpA, 0.5360, 3.52, 0.108, 214, 65, CAT192 FAB INSERTION MUTANT H5/L0
3640, 5yupL, 0.5360, 3.52, 0.077, 215, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
3641, 5vobA, 0.5360, 3.09, 0.078, 667, 64, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21
3642, 5um8E, 0.5360, 3.73, 0.075, 213, 67, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
3643, 5hi5D, 0.5360, 3.59, 0.076, 213, 66, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3644, 5dlmH, 0.5360, 3.36, 0.098, 216, 61, COMPLEX OF INFLUENZA M2E AND ANTIBODY
3645, 5czxL, 0.5360, 3.43, 0.108, 213, 65, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB
3646, 5c0sL, 0.5360, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261
3647, 4zflH, 0.5360, 3.36, 0.043, 229, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
3648, 4uikH, 0.5360, 3.78, 0.092, 218, 65, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1
3649, 4ttdL, 0.5360, 3.60, 0.076, 214, 66, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3650, 4rb4F, 0.5360, 2.51, 0.119, 384, 59, CRYSTAL STRUCTURE OF DODECAMERIC IRON-CONTAINING HEPTOSYLTRANSFERASE TIBC IN COMPLEX WITH ADP-D-BETA-D-HEPTOSE AT 3.9 ANGSTROM RESOLUTION
3651, 4p5mG, 0.5360, 3.33, 0.111, 180, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
3652, 4p5mF, 0.5360, 3.30, 0.095, 190, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
3653, 4okvD, 0.5360, 3.51, 0.062, 218, 65, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3654, 4fqxB, 0.5360, 3.60, 0.138, 187, 65, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
3655, 4c56E, 0.5360, 3.31, 0.095, 184, 63, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
3656, 3w1bA, 0.5360, 3.01, 0.062, 589, 64, CRYSTAL STRUCTURE OF HUMAN DNA LIGASE IV-ARTEMIS COMPLEX (MERCURY DERIVATIVE)
3657, 3vg0L, 0.5360, 3.63, 0.076, 213, 66, ANTIBODY FAB FRAGMENT
3658, 3v6zD, 0.5360, 3.66, 0.076, 219, 66, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3659, 3v6zB, 0.5360, 3.66, 0.076, 219, 66, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3660, 3v0vL, 0.5360, 3.58, 0.077, 212, 65, FAB WN1 222-5 UNLIGANDED
3661, 3nz8H, 0.5360, 3.80, 0.092, 217, 65, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3662, 3idiA, 0.5360, 3.52, 0.123, 213, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ
3663, 3eotH, 0.5360, 3.33, 0.098, 212, 61, CRYSTAL STRUCTURE OF LAC031 AN ENGINEERED ANTI-VLA1 FAB
3664, 2xzaL, 0.5360, 3.57, 0.106, 214, 66, CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
3665, 2i9lG, 0.5360, 3.56, 0.077, 219, 65, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3666, 1r70D, 0.5360, 3.52, 0.076, 462, 66, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
3667, 1qbmL, 0.5360, 3.48, 0.077, 214, 65, FAB E8B ANTIBODY X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
3668, 1nc4A, 0.5360, 3.69, 0.104, 211, 67, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
3669, 1mnuL, 0.5360, 3.66, 0.076, 219, 66, UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
3670, 1k2dB, 0.5360, 3.34, 0.095, 185, 63, CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
3671, 1iilH, 0.5360, 3.23, 0.031, 215, 65, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
3672, 1iilF, 0.5360, 3.23, 0.031, 200, 65, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
3673, 1iilE, 0.5360, 3.23, 0.031, 200, 65, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
3674, 6mtrL, 0.5359, 3.69, 0.075, 210, 67, CRYSTAL STRUCTURE OF VRC43.01 FAB 
3675, 6msbH, 0.5359, 3.09, 0.030, 191, 66, struct.pdbx_descriptor               26S proteasome  
3676, 6mkdD, 0.5359, 3.29, 0.095, 201, 63, 4699 TCR BOUND TO I-AB PADI4 
3677, 6gslJC, 0.5359, 3.51, 0.110, 130, 73, Structure of T. thermophilus 70S ribosome complex with mRNA; tRNAfMet and cognate tRNAArg in the A-site  
3678, 6dwiG, 0.5359, 3.59, 0.106, 211, 66, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3679, 6ccbL, 0.5359, 3.56, 0.076, 211, 66, CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB
3680, 6bx4D, 0.5359, 3.25, 0.108, 96, 65, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S9
3681, 5ye4A, 0.5359, 3.80, 0.092, 210, 65, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
3682, 5ye3A, 0.5359, 3.60, 0.076, 213, 66, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 2A7D9 FAB FRAGMENT 
3683, 5tkjH, 0.5359, 3.51, 0.108, 216, 65, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3684, 5oj2A, 0.5359, 3.11, 0.127, 680, 63, CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN
3685, 5n2kE, 0.5359, 3.69, 0.075, 214, 67, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3686, 5mvjH, 0.5359, 3.52, 0.097, 218, 62, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3687, 5mvjA, 0.5359, 3.82, 0.092, 218, 65, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3688, 5mp5C, 0.5359, 3.52, 0.097, 219, 62, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3689, 5mesL, 0.5359, 3.79, 0.103, 213, 68, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29
3690, 5jopD, 0.5359, 3.66, 0.076, 218, 66, CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A
3691, 5ihzF, 0.5359, 3.72, 0.075, 213, 67, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
3692, 5awnL, 0.5359, 3.71, 0.090, 212, 67, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB
3693, 4qhmB, 0.5359, 3.74, 0.075, 209, 67, I3.1 (UNBOUND) FROM CH103 LINEAGE
3694, 4khtL, 0.5359, 3.73, 0.075, 209, 67, TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066
3695, 4f58N, 0.5359, 3.70, 0.075, 213, 67, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
3696, 4eowL, 0.5359, 3.71, 0.075, 211, 67, CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
3697, 3zknD, 0.5359, 3.57, 0.077, 217, 65, BACE2 FAB INHIBITOR COMPLEX
3698, 3whxB, 0.5359, 3.54, 0.062, 216, 65, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE1 COMPLEX
3699, 3v6fD, 0.5359, 3.65, 0.076, 219, 66, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3700, 3u4eB, 0.5359, 3.79, 0.074, 212, 68, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3701, 3ry6B, 0.5359, 3.63, 0.119, 214, 67, COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1
3702, 3ry6A, 0.5359, 3.51, 0.061, 214, 66, COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1
3703, 3o6kH, 0.5359, 3.79, 0.092, 217, 65, CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB 11H6H1
3704, 3o2dL, 0.5359, 3.48, 0.108, 216, 65, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
3705, 3mugE, 0.5359, 3.61, 0.076, 211, 66, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3706, 3ijhA, 0.5359, 3.80, 0.060, 217, 67, STRUCTURE OF S67-27 IN COMPLEX WITH KO
3707, 3hnvL, 0.5359, 3.59, 0.076, 214, 66, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
3708, 3e3jB, 0.5359, 3.85, 0.067, 833, 75, CRYSTAL STRUCTURE OF AN INTERMEDIATE COMPLEX OF T7 RNAP AND 8NT OF RNA
3709, 2virA, 0.5359, 3.79, 0.103, 210, 68, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
3710, 2vdpL, 0.5359, 3.60, 0.077, 214, 65, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
3711, 2r1xB, 0.5359, 3.51, 0.095, 215, 63, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3712, 2qejA, 0.5359, 3.83, 0.074, 211, 68, CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
3713, 2i9lC, 0.5359, 3.55, 0.077, 219, 65, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3714, 2geeA, 0.5359, 3.39, 0.152, 188, 66, CRYSTAL STRUCTURE OF HUMAN TYPE III FIBRONECTIN EXTRADOMAIN B AND DOMAIN 8
3715, 1ynkL, 0.5359, 3.60, 0.076, 219, 66, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
3716, 1xdgB, 0.5359, 3.21, 0.090, 182, 67, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
3717, 1lo2X, 0.5359, 3.59, 0.076, 219, 66, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
3718, 1jvkA, 0.5359, 3.72, 0.075, 215, 67, THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
3719, 1indH, 0.5359, 3.31, 0.098, 213, 61, HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB (SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
3720, 1i9jL, 0.5359, 3.56, 0.077, 219, 65, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3721, 1deeB, 0.5359, 3.69, 0.090, 223, 67, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
3722, 1bogA, 0.5359, 3.52, 0.092, 214, 65, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE
3723, 6mxrL, 0.5358, 3.56, 0.106, 218, 66, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
3724, 6hv6A, 0.5358, 3.02, 0.092, 293, 65, CRYSTAL STRUCTURE OF PATOXP; A CYSTEINE PROTEASE-LIKE DOMAIN OF PHOTORHABDUS ASYMBIOTICA TOXIN PATOX 
3725, 6h6fB, 0.5358, 3.16, 0.111, 2454, 63, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
3726, 5x90H, 0.5358, 2.80, 0.119, 167, 59, STRUCTURE OF DOTL(656-783)-ICMS-ICMW-LVGA DERIVED FROM LEGIONELLA PNEUMOPHILA
3727, 5vvmA, 0.5358, 3.45, 0.091, 298, 66, CRYSTAL STRUCTURE OF HUMAN CDH23 EC21-23 
3728, 5vh3B, 0.5358, 3.44, 0.108, 214, 65, CRYSTAL STRUCTURE OF FAB FRAGMENT OF THE ANTI-TNFA ANTIBODY INFLIXIMAB IN A C-CENTERED ORTHORHOMBIC CRYSTAL FORM
3729, 5v4mL, 0.5358, 3.29, 0.127, 200, 63, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
3730, 5odbB, 0.5358, 3.81, 0.103, 207, 68, CRYSTAL STRUCTURE OF THE RA-ASSOCIATED MAB D10 (CHIMERIC FAB FRAGMENT) 
3731, 5mthL, 0.5358, 3.65, 0.076, 219, 66, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3732, 5kw9L, 0.5358, 3.61, 0.106, 219, 66, STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY
3733, 5cexA, 0.5358, 3.72, 0.075, 207, 67, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
3734, 5bq7B, 0.5358, 3.74, 0.075, 201, 67, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
3735, 4x5xC, 0.5358, 3.33, 0.111, 177, 63, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
3736, 4x5wB, 0.5358, 3.31, 0.095, 188, 63, HLA-DR1 WITH CLIP102-120(M107W)
3737, 4tr2A, 0.5358, 3.52, 0.127, 471, 71, CRYSTAL STRUCTURE OF PVSUB1
3738, 4s1dP, 0.5358, 3.66, 0.076, 210, 66, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
3739, 4m6nL, 0.5358, 3.71, 0.075, 216, 67, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
3740, 4lnvC, 0.5358, 3.23, 0.062, 1276, 65, CRYSTAL STRUCTURE OF TEP1S
3741, 4leeA, 0.5358, 3.13, 0.061, 313, 66, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
3742, 4l5fL, 0.5358, 3.59, 0.077, 213, 65, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
3743, 4l29S, 0.5358, 3.54, 0.123, 276, 65, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
3744, 4knqA, 0.5358, 2.68, 0.068, 122, 59, CRYSTAL STRUCTURE OF 1NT-5 -OVERHANGING DOUBLE-HELICAL CCG-REPETITIVE RNA 20MER COMPLEXED WITH RSS P19
3745, 4kk6F, 0.5358, 3.66, 0.076, 211, 66, STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
3746, 4b53A, 0.5358, 3.67, 0.134, 103, 67, CRYSTAL STRUCTURE OF THE ISOLATED IGG4 CH3 DOMAIN
3747, 3v6fF, 0.5358, 3.65, 0.076, 219, 66, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3748, 2yrzA, 0.5358, 3.28, 0.119, 118, 67, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE III DOMAIN OF HUMAN INTEGRIN BETA-4
3749, 2vdqL, 0.5358, 3.53, 0.077, 214, 65, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
3750, 2gfbM, 0.5358, 3.64, 0.076, 214, 66, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3751, 2a7bA, 0.5358, 3.80, 0.085, 120, 71, ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH
3752, 2a6dB, 0.5358, 3.49, 0.097, 219, 62, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
3753, 1p7kB, 0.5358, 3.81, 0.092, 217, 65, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
3754, 1o75A, 0.5358, 3.34, 0.136, 399, 66, TP47 THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM
3755, 1j8hB, 0.5358, 3.36, 0.125, 180, 64, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
3756, 1hi6A, 0.5358, 3.52, 0.092, 214, 65, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
3757, 1fe8N, 0.5358, 3.56, 0.077, 211, 65, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
3758, 1eapA, 0.5358, 3.64, 0.076, 213, 66, CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
3759, 6b70D, 0.5357, 3.68, 0.091, 211, 66, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN AND INSULIN
3760, 6ayzC, 0.5357, 3.59, 0.106, 213, 66, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
3761, 6atzB, 0.5357, 3.44, 0.125, 188, 64, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
3762, 5wnaL, 0.5357, 3.50, 0.108, 211, 65, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE CENTRAL CONSERVED REGION OF RSV 2 G
3763, 5ud9L, 0.5357, 3.59, 0.076, 205, 66, CRYSTAL STRUCTURE OF 354BG18 FAB
3764, 5u3jL, 0.5357, 3.53, 0.108, 215, 65, CRYSTAL STRUCTURE OF DH511.1 FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
3765, 5njdW, 0.5357, 3.74, 0.075, 214, 67, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
3766, 5jorC, 0.5357, 3.60, 0.077, 218, 65, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3767, 5iq9L, 0.5357, 3.73, 0.075, 210, 67, CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
3768, 5if0B, 0.5357, 3.52, 0.108, 206, 65, CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A
3769, 5dmgD, 0.5357, 3.50, 0.108, 217, 65, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3770, 5cgyD, 0.5357, 3.70, 0.075, 212, 67, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
3771, 4rnrB, 0.5357, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV ANTIBODY PGT130
3772, 4p5mB, 0.5357, 3.59, 0.123, 199, 65, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
3773, 4ma8H, 0.5357, 3.33, 0.098, 218, 61, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
3774, 4h1lE, 0.5357, 3.34, 0.125, 179, 64, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
3775, 4gxuN, 0.5357, 3.73, 0.075, 213, 67, CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ
3776, 4fs0A, 0.5357, 3.27, 0.059, 218, 68, CRYSTAL STRUCTURE OF MUTANT F136D OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2
3777, 4fn0C, 0.5357, 3.36, 0.059, 219, 68, CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2 2ND CRYSTAL FORM
3778, 4bh8B, 0.5357, 3.79, 0.092, 218, 65, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL
3779, 3zkmL, 0.5357, 3.57, 0.077, 217, 65, BACE2 FAB COMPLEX
3780, 3wvqA, 0.5357, 2.94, 0.152, 429, 66, STRUCTURE OF ATP GRASP PROTEIN
3781, 3v6fB, 0.5357, 3.66, 0.076, 219, 66, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3782, 3q3gH, 0.5357, 3.49, 0.097, 224, 62, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3783, 3oazL, 0.5357, 3.46, 0.108, 213, 65, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3784, 3nz8L, 0.5357, 3.53, 0.062, 218, 65, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3785, 3ifoL, 0.5357, 3.51, 0.062, 218, 65, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
3786, 3idjA, 0.5357, 3.50, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS
3787, 3bz4A, 0.5357, 3.51, 0.062, 216, 65, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3788, 2zjsL, 0.5357, 3.72, 0.076, 214, 66, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
3789, 2yfhC, 0.5357, 3.35, 0.123, 447, 65, STRUCTURE OF A CHIMERIC GLUTAMATE DEHYDROGENASE
3790, 2vdmL, 0.5357, 3.60, 0.077, 214, 65, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
3791, 2q8aL, 0.5357, 3.60, 0.076, 214, 66, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3792, 2ok0L, 0.5357, 3.44, 0.062, 219, 65, FAB ED10-DNA COMPLEX
3793, 2of5I, 0.5357, 3.10, 0.129, 100, 62, OLIGOMERIC DEATH DOMAIN COMPLEX
3794, 2gfbA, 0.5357, 3.64, 0.076, 214, 66, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3795, 1qvyA, 0.5357, 3.27, 0.077, 138, 65, CRYSTAL STRUCTURE OF RHOGDI K(199200)R DOUBLE MUTANT
3796, 1nsnL, 0.5357, 3.49, 0.077, 217, 65, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
3797, 1mhhD, 0.5357, 3.80, 0.092, 214, 65, ANTIBODY-ANTIGEN COMPLEX
3798, 1deeF, 0.5357, 3.70, 0.090, 223, 67, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
3799, 6ghdB, 0.5356, 3.13, 0.063, 119, 63, STRUCTURAL ANALYSIS OF THE TERNARY COMPLEX BETWEEN LAMIN A/C; BAF AND EMERIN IDENTIFIES AN INTERFACE DISRUPTED IN AUTOSOMAL RECESSIVE PROGEROID DISEASES 
3800, 6e62C, 0.5356, 3.69, 0.075, 213, 67, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
3801, 6cnrL, 0.5356, 3.58, 0.108, 211, 65, ADUCANUMAB APO FAB 
3802, 6atiE, 0.5356, 3.48, 0.125, 190, 64, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
3803, 5yslA, 0.5356, 3.72, 0.078, 211, 64, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
3804, 5xlic, 0.5356, 3.41, 0.094, 220, 64, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
3805, 5vocA, 0.5356, 3.24, 0.076, 662, 66, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21 - LOW RESOLUTION DATASET FOR INITIAL PHASING BY SAD
3806, 5vjqB, 0.5356, 3.70, 0.076, 212, 66, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3807, 5uv8A, 0.5356, 2.90, 0.033, 259, 60, INTERLEUKIN-3 RECEPTOR COMPLEX
3808, 5ksbC, 0.5356, 3.50, 0.078, 181, 64, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
3809, 5hdqL, 0.5356, 3.57, 0.061, 218, 66, MNTC CO-STRUCTURE WITH MAB 305-78-7
3810, 5fobA, 0.5356, 3.40, 0.104, 642, 67, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH SMALLPOX INHIBITOR OF COMPLEMENT (SPICE)
3811, 5eiiL, 0.5356, 3.50, 0.108, 212, 65, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
3812, 5dyeD, 0.5356, 3.31, 0.030, 253, 66, CRYSTAL STRUCTURE OF THE FULL LENGTH S156E MUTANT OF HUMAN AQUAPORIN 5
3813, 5d96C, 0.5356, 3.50, 0.097, 214, 62, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
3814, 4p23D, 0.5356, 3.30, 0.095, 200, 63, J809.B5 TCR BOUND TO IAB/3K
3815, 4lptD, 0.5356, 3.28, 0.091, 94, 66, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
3816, 4hijA, 0.5356, 3.49, 0.108, 209, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
3817, 3v77C, 0.5356, 3.78, 0.058, 221, 69, CRYSTAL STRUCTURE OF A PUTATIVE FUMARYLACETOACETATE ISOMERASE/HYDROLASE FROM OLEISPIRA ANTARCTICA
3818, 3j42L, 0.5356, 3.72, 0.060, 212, 67, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3819, 3j42J, 0.5356, 3.72, 0.060, 212, 67, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3820, 3j42H, 0.5356, 3.72, 0.060, 212, 67, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3821, 2q76B, 0.5356, 3.65, 0.094, 213, 64, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
3822, 2jelL, 0.5356, 3.78, 0.060, 217, 67, JEL42 FAB/HPR COMPLEX
3823, 2htkD, 0.5356, 3.69, 0.076, 211, 66, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX
3824, 2fr4B, 0.5356, 3.34, 0.098, 214, 61, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
3825, 2b1aL, 0.5356, 3.77, 0.075, 215, 67, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
3826, 1xf5D, 0.5356, 3.80, 0.092, 218, 65, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
3827, 1s9vE, 0.5356, 3.30, 0.079, 180, 63, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
3828, 1ntlA, 0.5356, 3.45, 0.076, 551, 66, MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
3829, 1i8mB, 0.5356, 3.79, 0.092, 213, 65, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
3830, 1hklL, 0.5356, 3.49, 0.108, 214, 65, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
3831, 1eo8H, 0.5356, 3.81, 0.092, 217, 65, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
3832, 6ccbE, 0.5355, 3.66, 0.075, 211, 67, CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB
3833, 6bgaA, 0.5355, 3.32, 0.111, 182, 63, 2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE 
3834, 5uylZA, 0.5355, 3.31, 0.111, 134, 72, 
3835, 5tdoA, 0.5355, 3.59, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
3836, 4xvuD, 0.5355, 3.51, 0.108, 216, 65, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3837, 4wf1AB, 0.5355, 3.41, 0.059, 190, 68, 
3838, 4ttdD, 0.5355, 3.60, 0.076, 214, 66, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3839, 4n9gB, 0.5355, 3.45, 0.109, 214, 64, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
3840, 4lvoC, 0.5355, 3.75, 0.092, 214, 65, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2
3841, 4leeD, 0.5355, 3.30, 0.075, 313, 67, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
3842, 4l1dB, 0.5355, 3.37, 0.136, 110, 66, VOLTAGE-GATED SODIUM CHANNEL BETA3 SUBUNIT IG DOMAIN
3843, 4kjwD, 0.5355, 3.68, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
3844, 3okkB, 0.5355, 3.35, 0.098, 217, 61, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3845, 2fjfG, 0.5355, 3.59, 0.106, 211, 66, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3846, 2fecL, 0.5355, 3.65, 0.076, 211, 66, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
3847, 1tjgL, 0.5355, 3.62, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
3848, 1m7dA, 0.5355, 3.57, 0.077, 215, 65, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
3849, 1lgvA, 0.5355, 3.73, 0.075, 213, 67, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
3850, 1igyD, 0.5355, 3.69, 0.104, 434, 67, STRUCTURE OF IMMUNOGLOBULIN
3851, 1cftA, 0.5355, 3.67, 0.106, 214, 66, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE
3852, 1aqdB, 0.5355, 3.45, 0.109, 187, 64, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
3853, 6mxrB, 0.5354, 3.48, 0.108, 217, 65, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
3854, 6ieqE, 0.5354, 3.72, 0.075, 213, 67, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
3855, 6id4D, 0.5354, 3.60, 0.076, 215, 66, COMPLEX OF HLA-A*11:01 BINDING TO ALLOANTIBODY 2E3 
3856, 6c5hL, 0.5354, 3.37, 0.062, 216, 65, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
3857, 6blrB, 0.5354, 3.29, 0.095, 198, 63, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E6SS
3858, 6bliH, 0.5354, 3.51, 0.108, 214, 65, RSV G PEPTIDE BOUND TO FAB CB002.5
3859, 6bizB, 0.5354, 3.38, 0.125, 189, 64, HLA-DRB1 IN COMPLEX WITH CITRULLINATED HISTONE 2B PEPTIDE
3860, 5vk2L, 0.5354, 3.73, 0.075, 212, 67, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
3861, 5vjqC, 0.5354, 3.80, 0.092, 207, 65, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3862, 5njdU, 0.5354, 3.61, 0.076, 215, 66, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
3863, 5n2kI, 0.5354, 3.71, 0.075, 214, 67, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3864, 5k9jL, 0.5354, 3.44, 0.108, 212, 65, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
3865, 5jnyD, 0.5354, 3.69, 0.075, 214, 67, CRYSTAL STRUCTURE OF 10E8 FAB
3866, 5ivzA, 0.5354, 3.59, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
3867, 5eocL, 0.5354, 3.68, 0.076, 216, 66, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3868, 4zflL, 0.5354, 3.42, 0.043, 227, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
3869, 4zflF, 0.5354, 3.43, 0.043, 230, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
3870, 4pljD, 0.5354, 3.34, 0.098, 216, 61, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3871, 4kklF, 0.5354, 3.68, 0.076, 211, 66, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
3872, 4hihA, 0.5354, 3.50, 0.108, 212, 65, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
3873, 4h26E, 0.5354, 3.30, 0.095, 188, 63, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
3874, 4a5wA, 0.5354, 3.41, 0.104, 1528, 67, CRYSTAL STRUCTURE OF C5B6
3875, 3t2nL, 0.5354, 3.72, 0.075, 211, 67, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3876, 3s37L, 0.5354, 3.51, 0.108, 212, 65, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3877, 3oklB, 0.5354, 3.35, 0.098, 222, 61, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
3878, 3m1mA, 0.5354, 2.77, 0.143, 320, 63, CRYSTAL STRUCTURE OF THE PRIMASE-POLYMERASE FROM SULFOLOBUS ISLANDICUS
3879, 3idgA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD
3880, 3ghbL, 0.5354, 3.73, 0.075, 216, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
3881, 2x31C, 0.5354, 3.19, 0.079, 187, 63, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
3882, 2vxuL, 0.5354, 3.52, 0.062, 214, 65, CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
3883, 2qejB, 0.5354, 3.86, 0.074, 209, 68, CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
3884, 25c8L, 0.5354, 3.49, 0.062, 212, 65, CATALYTIC ANTIBODY 5C8 FAB-HAPTEN COMPLEX
3885, 1xdgA, 0.5354, 3.22, 0.090, 182, 67, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
3886, 1v7nK, 0.5354, 3.77, 0.108, 217, 65, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3887, 1u95A, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
3888, 1u93A, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)
3889, 1u92A, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)
3890, 1u91A, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)
3891, 1u8qA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
3892, 1u8pA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
3893, 1u8oA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
3894, 1u8nA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
3895, 1u8mA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
3896, 1u8lA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
3897, 1u8jA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
3898, 1u8iA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
3899, 1u8hA, 0.5354, 3.62, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
3900, 1rumL, 0.5354, 3.62, 0.092, 218, 65, CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
3901, 1i8mA, 0.5354, 3.56, 0.077, 213, 65, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
3902, 1cvsD, 0.5354, 2.94, 0.032, 196, 63, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
3903, 1cfnA, 0.5354, 3.53, 0.092, 214, 65, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE
3904, 1bm3L, 0.5354, 3.68, 0.076, 214, 66, IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX
3905, 6k7oL, 0.5353, 3.47, 0.109, 218, 64, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3906, 6ieaL, 0.5353, 3.58, 0.076, 218, 66, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
3907, 6gvwD, 0.5353, 2.64, 0.143, 239, 63, CRYSTAL STRUCTURE OF THE BRCA1-A COMPLEX 
3908, 6e9iL, 0.5353, 3.69, 0.104, 213, 67, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
3909, 6c6yL, 0.5353, 3.59, 0.121, 214, 66, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE IN COMPLEX WITH MERS RECEPTOR BINDING DOMAIN
3910, 6c5jL, 0.5353, 3.57, 0.091, 217, 66, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 1) 
3911, 6bpcC, 0.5353, 3.68, 0.076, 212, 66, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
3912, 5x5xL, 0.5353, 3.50, 0.108, 217, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OSTEOCALCIN C-TERMINAL PEPTIDE ANTIBODY KTM219
3913, 5x2oL, 0.5353, 3.63, 0.076, 216, 66, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3914, 5w6cL, 0.5353, 3.75, 0.075, 214, 67, UCA FAB (UNBOUND) FROM 6649 LINEAGE
3915, 5utyL, 0.5353, 3.72, 0.075, 208, 67, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M N300M N302M T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM
3916, 5u6aA, 0.5353, 3.51, 0.108, 214, 65, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- PEG3-MEDITOPE
3917, 5kjrL, 0.5353, 3.51, 0.076, 212, 66, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1.
3918, 5ikcA, 0.5353, 3.49, 0.077, 213, 65, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
3919, 5i6xC, 0.5353, 3.79, 0.059, 214, 68, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3920, 5cexC, 0.5353, 3.74, 0.075, 213, 67, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
3921, 4z7wD, 0.5353, 3.32, 0.079, 180, 63, T316 COMPLEX
3922, 4yhlL, 0.5353, 3.64, 0.106, 218, 66, REVERSAL AGENT FOR DABIGATRAN
3923, 4p5mE, 0.5353, 3.35, 0.111, 180, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
3924, 4ouuB, 0.5353, 3.50, 0.097, 210, 62, ANTI-MT1-MMP MONOCLONAL ANTIBODY
3925, 4odwH, 0.5353, 3.62, 0.078, 214, 64, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
3926, 4ocwL, 0.5353, 3.72, 0.075, 211, 67, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.06 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
3927, 4md4B, 0.5353, 3.62, 0.138, 189, 65, IMMUNE RECEPTOR
3928, 4kkcE, 0.5353, 3.64, 0.094, 221, 64, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
3929, 4jegB, 0.5353, 3.02, 0.109, 93, 64, CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX
3930, 4hrrG, 0.5353, 3.79, 0.060, 149, 67, SCAPHARCA TETRAMERIC HEMOGLOBIN CO-STATE
3931, 4h25B, 0.5353, 3.51, 0.108, 188, 65, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
3932, 4gxvL, 0.5353, 3.59, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
3933, 4eneF, 0.5353, 3.66, 0.076, 211, 66, STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
3934, 3tnmB, 0.5353, 3.70, 0.075, 210, 67, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3935, 3nmsA, 0.5353, 3.59, 0.103, 641, 68, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT C3C
3936, 3mltG, 0.5353, 3.72, 0.075, 213, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3937, 3i2cH, 0.5353, 3.82, 0.092, 222, 65, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
3938, 3haeL, 0.5353, 3.72, 0.090, 211, 67, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3939, 3g6aA, 0.5353, 3.70, 0.075, 210, 67, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
3940, 3cm9O, 0.5353, 3.72, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SIGA2
3941, 3cm9M, 0.5353, 3.72, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SIGA2
3942, 3cfdH, 0.5353, 3.59, 0.076, 220, 66, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3943, 2xwjA, 0.5353, 3.59, 0.103, 640, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
3944, 2p24B, 0.5353, 3.29, 0.095, 194, 63, I-AU/MBP125-135
3945, 2of5J, 0.5353, 3.05, 0.129, 100, 62, OLIGOMERIC DEATH DOMAIN COMPLEX
3946, 2icfA, 0.5353, 3.28, 0.106, 642, 66, CRIG BOUND TO C3B
3947, 2iamA, 0.5353, 3.36, 0.111, 179, 63, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3948, 2i9lA, 0.5353, 3.67, 0.076, 219, 66, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3949, 2g75B, 0.5353, 3.73, 0.090, 211, 67, CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
3950, 2evvD, 0.5353, 3.86, 0.116, 173, 69, CRYSTAL STRUCTURE OF THE PEBP-LIKE PROTEIN OF UNKNOWN FUNCTION HP0218 FROM HELICOBACTER PYLORI
3951, 2dkcA, 0.5353, 3.70, 0.088, 536, 68, CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE-PHOSPHATE MUTASE A MEMBER OF THE ALPHA-D-PHOSPHOHEXOMUTASE SUPERFAMILY IN THE SUBSTRATE COMPLEX
3952, 1wejL, 0.5353, 3.52, 0.062, 214, 65, IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
3953, 1uywN, 0.5353, 3.56, 0.077, 211, 65, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3954, 1um4L, 0.5353, 3.60, 0.106, 219, 66, CATALYTIC ANTIBODY 21H3 WITH HAPTEN
3955, 1nc2A, 0.5353, 3.67, 0.104, 211, 67, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
3956, 1jhkH, 0.5353, 3.47, 0.097, 205, 62, CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2
3957, 1igyB, 0.5353, 3.69, 0.104, 434, 67, STRUCTURE OF IMMUNOGLOBULIN
3958, 1iebB, 0.5353, 3.41, 0.125, 214, 64, HISTOCOMPATIBILITY ANTIGEN
3959, 1i1aC, 0.5353, 3.68, 0.060, 205, 67, CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
3960, 1es0B, 0.5353, 3.35, 0.095, 190, 63, CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
3961, 1bj1L, 0.5353, 3.51, 0.108, 213, 65, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3962, 6mu3L, 0.5352, 3.51, 0.108, 211, 65, ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT 
3963, 5wcaL, 0.5352, 3.73, 0.075, 211, 67, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 27-1C08 FAB.
3964, 5w24L, 0.5352, 3.60, 0.076, 215, 66, CRYSTAL STRUCTURE OF 5C4 FAB
3965, 5uknL, 0.5352, 3.73, 0.090, 211, 67, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522UCA FAB
3966, 5t6lB, 0.5352, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
3967, 5nkqE, 0.5352, 2.98, 0.063, 87, 63, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
3968, 5k8aA, 0.5352, 3.59, 0.106, 213, 66, NIST FAB
3969, 4hkxB, 0.5352, 3.74, 0.075, 201, 67, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB
3970, 4fq1L, 0.5352, 3.46, 0.091, 207, 66, CRYSTAL STRUCTURE OF PGT121 FAB
3971, 3hc0L, 0.5352, 3.51, 0.108, 212, 65, BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3972, 3c5jA, 0.5352, 3.29, 0.111, 178, 63, CRYSTAL STRUCTURE OF HLA DR52C
3973, 2xwjG, 0.5352, 3.59, 0.103, 640, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
3974, 2xwjE, 0.5352, 3.59, 0.103, 640, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
3975, 2xwjC, 0.5352, 3.59, 0.103, 640, 68, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
3976, 2xgpB, 0.5352, 3.43, 0.044, 511, 68, YEAST DNA POLYMERASE ETA IN COMPLEX WITH C8-2- ACETYLAMINOFLUORENE CONTAINING DNA
3977, 2vweC, 0.5352, 3.55, 0.108, 214, 65, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
3978, 2uylB, 0.5352, 3.81, 0.092, 213, 65, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3979, 2htkF, 0.5352, 3.69, 0.076, 211, 66, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX
3980, 2gfbE, 0.5352, 3.64, 0.076, 214, 66, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3981, 2bmkH, 0.5352, 3.35, 0.098, 221, 61, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
3982, 1tjiL, 0.5352, 3.63, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
3983, 1rurL, 0.5352, 3.53, 0.077, 217, 65, CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9- 1.
3984, 1qfhB, 0.5352, 3.57, 0.090, 212, 67, DIMERIZATION OF GELATION FACTOR FROM DICTYOSTELIUM DISCOIDEUM: CRYSTAL STRUCTURE OF ROD DOMAINS 5 AND 6
3985, 1p7kH, 0.5352, 3.79, 0.092, 220, 65, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
3986, 1ncdL, 0.5352, 3.56, 0.076, 214, 66, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3987, 1fgnL, 0.5352, 3.58, 0.091, 214, 66, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
3988, 1eqjA, 0.5352, 3.79, 0.061, 508, 66, CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM BACILLUS STEAROTHERMOPHILUS COMPLEXED WITH 2-PHOSPHOGLYCERATE
3989, 1emtL, 0.5352, 3.68, 0.076, 214, 66, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
3990, 6mu8L, 0.5351, 3.72, 0.075, 211, 67, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM 
3991, 6flbH, 0.5351, 3.34, 0.115, 213, 61, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
3992, 6eesA, 0.5351, 3.53, 0.114, 2023, 70, FITTED MODEL OF S. POMBE MDN1 INTO THE CRYO-EM MAP OBTAINED IN THE PRESENCE OF ATP AND RBIN-1 
3993, 6csfL, 0.5351, 3.64, 0.091, 213, 66, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
3994, 6csfA, 0.5351, 3.50, 0.097, 214, 62, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
3995, 5ywpN, 0.5351, 3.31, 0.098, 218, 61, JEV-2H4 FAB COMPLEX 
3996, 5vjqF, 0.5351, 3.49, 0.077, 212, 65, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3997, 5uemL, 0.5351, 3.61, 0.106, 213, 66, CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
3998, 5nbwB, 0.5351, 3.81, 0.092, 216, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
3999, 5mr3H, 0.5351, 2.71, 0.066, 111, 61, CRYSTAL STRUCTURE OF RED ABALONE EGG VERL REPEAT 2 WITH LINKER IN COMPLEX WITH SPERM LYSIN AT 1.8 A RESOLUTION
4000, 5if0L, 0.5351, 3.61, 0.106, 206, 66, CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A
4001, 5i75C, 0.5351, 3.75, 0.090, 214, 67, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
4002, 5gqhA, 0.5351, 2.60, 0.085, 901, 59, CRYO-EM STRUCTURE OF PAECAS3-ACRF3 COMPLEX
4003, 5fykE, 0.5351, 3.65, 0.075, 213, 67, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
4004, 5dmiL, 0.5351, 3.59, 0.106, 213, 66, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
4005, 5dftA, 0.5351, 3.18, 0.092, 89, 65, STRUCTURE OF THE ELEVENTH TYPE III DOMAIN FROM HUMAN FIBRONECTIN
4006, 5dd6B, 0.5351, 3.58, 0.121, 213, 66, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
4007, 5czvL, 0.5351, 3.60, 0.106, 211, 66, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20350 FAB
4008, 5albL, 0.5351, 3.71, 0.075, 210, 67, TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR
4009, 4zvcB, 0.5351, 2.68, 0.034, 115, 59, CRYSTAL STRUCTURE OF MID DOMAIN OF THE E. COLI DOSC - FORM I
4010, 4x80L, 0.5351, 3.60, 0.077, 213, 65, CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
4011, 4tsbL, 0.5351, 3.59, 0.076, 214, 66, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
4012, 4qxuH, 0.5351, 3.36, 0.098, 220, 61, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
4013, 4qhlB, 0.5351, 3.59, 0.076, 209, 66, I3.2 (UNBOUND) FROM CH103 LINEAGE
4014, 4mcyB, 0.5351, 3.46, 0.125, 189, 64, IMMUNE RECEPTOR
4015, 4lvnC, 0.5351, 3.32, 0.098, 216, 61, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX
4016, 4kk5F, 0.5351, 3.67, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4017, 4kk5D, 0.5351, 3.67, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4018, 4kjpD, 0.5351, 3.67, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4019, 3vrlL, 0.5351, 3.72, 0.076, 214, 66, CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB
4020, 3v77D, 0.5351, 3.83, 0.058, 221, 69, CRYSTAL STRUCTURE OF A PUTATIVE FUMARYLACETOACETATE ISOMERASE/HYDROLASE FROM OLEISPIRA ANTARCTICA
4021, 3s34L, 0.5351, 3.61, 0.106, 214, 66, STRUCTURE OF THE 1121B FAB FRAGMENT
4022, 3rkdH, 0.5351, 3.77, 0.092, 218, 65, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4023, 3qc5X, 0.5351, 3.27, 0.136, 352, 66, GSPB
4024, 3ohxD, 0.5351, 3.60, 0.103, 641, 68, MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
4025, 3ohxA, 0.5351, 3.60, 0.103, 641, 68, MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
4026, 3mmeL, 0.5351, 3.84, 0.074, 211, 68, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4027, 3l3oD, 0.5351, 3.60, 0.103, 639, 68, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
4028, 3l3oA, 0.5351, 3.60, 0.103, 639, 68, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
4029, 3g6dL, 0.5351, 3.60, 0.076, 210, 66, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO607 FAB AND IL-13
4030, 3g5yB, 0.5351, 3.55, 0.079, 210, 63, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
4031, 3dsfL, 0.5351, 3.65, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE
4032, 3cviL, 0.5351, 3.47, 0.062, 209, 65, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
4033, 3c6sE, 0.5351, 3.50, 0.062, 216, 65, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4034, 2r2bB, 0.5351, 3.52, 0.095, 214, 63, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4035, 2i9lE, 0.5351, 3.67, 0.076, 219, 66, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
4036, 2evvB, 0.5351, 3.86, 0.116, 175, 69, CRYSTAL STRUCTURE OF THE PEBP-LIKE PROTEIN OF UNKNOWN FUNCTION HP0218 FROM HELICOBACTER PYLORI
4037, 1yqvH, 0.5351, 3.67, 0.094, 215, 64, THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION
4038, 1otuF, 0.5351, 3.54, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
4039, 1ncbL, 0.5351, 3.58, 0.076, 214, 66, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
4040, 1k8iB, 0.5351, 3.68, 0.077, 190, 65, CRYSTAL STRUCTURE OF MOUSE H2-DM
4041, 1himJ, 0.5351, 3.55, 0.077, 217, 65, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION
4042, 1hilB, 0.5351, 3.36, 0.082, 214, 61, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
4043, 1faiL, 0.5351, 3.50, 0.062, 214, 65, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
4044, 6mxsL, 0.5350, 3.58, 0.106, 218, 66, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
4045, 6ii8L, 0.5350, 3.59, 0.076, 213, 66, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4B-18 
4046, 6h04A, 0.5350, 3.54, 0.044, 1219, 68, CLOSED CONFORMATION OF THE MEMBRANE ATTACK COMPLEX 
4047, 6f7tA, 0.5350, 3.73, 0.090, 217, 67, CRYSTAL STRUCTURE OF AN FAB FRAGMENT IN COMPLEX WITH A PEPTIDE FROM BACILLUS SUBTILIS RNASE Y 
4048, 6cxlL, 0.5350, 3.64, 0.106, 213, 66, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5 
4049, 6bzvH, 0.5350, 3.63, 0.106, 215, 66, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4050, 6bzvD, 0.5350, 3.60, 0.106, 215, 66, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4051, 6birB, 0.5350, 3.44, 0.125, 186, 64, HLA-DRB1 IN COMPLEX WITH CITRULLINATED VIMENTIN PEPTIDE
4052, 6atfB, 0.5350, 3.45, 0.125, 189, 64, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
4053, 5w6gL, 0.5350, 3.75, 0.075, 214, 67, HUMAN ANTIBODY 6649 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS
4054, 5vgaB, 0.5350, 3.81, 0.092, 224, 65, ALTERNATIVE MODEL FOR FAB 36-65
4055, 5t1kA, 0.5350, 3.60, 0.106, 213, 66, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4056, 5my4B, 0.5350, 3.35, 0.098, 217, 61, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 17 IN COMPLEX WITH HUMAN ABETA-PE3-12PEGB
4057, 5mp5H, 0.5350, 3.52, 0.097, 218, 62, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
4058, 5ijvC, 0.5350, 3.83, 0.103, 213, 68, CRYSTAL STRUCTURE OF BOVINE FAB E03
4059, 5h35G, 0.5350, 3.55, 0.062, 217, 65, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
4060, 5h2bA, 0.5350, 3.36, 0.098, 216, 61, STRUCTURE OF A NOVEL ANTIBODY G196
4061, 5eiiB, 0.5350, 3.52, 0.108, 212, 65, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
4062, 5bvjC, 0.5350, 3.43, 0.108, 214, 65, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
4063, 4zsoD, 0.5350, 3.37, 0.066, 219, 61, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
4064, 4p5mH, 0.5350, 3.58, 0.123, 191, 65, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
4065, 4p3dA, 0.5350, 3.80, 0.092, 218, 65, MT1-MMP:FAB COMPLEX (FORM II)
4066, 4n9gF, 0.5350, 3.49, 0.108, 214, 65, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
4067, 4n0yL, 0.5350, 3.72, 0.075, 212, 67, STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526
4068, 4ma1H, 0.5350, 3.79, 0.092, 217, 65, UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
4069, 4kk9E, 0.5350, 3.78, 0.092, 221, 65, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4070, 4hxaL, 0.5350, 3.57, 0.077, 213, 65, CRYSTAL STRUCTURE OF 13D9 FAB
4071, 4h88L, 0.5350, 3.57, 0.077, 213, 65, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
4072, 4gbxD, 0.5350, 3.71, 0.091, 191, 66, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
4073, 3zknL, 0.5350, 3.57, 0.077, 217, 65, BACE2 FAB INHIBITOR COMPLEX
4074, 3sboB, 0.5350, 3.28, 0.125, 440, 64, STRUCTURE OF E.COLI GDH FROM NATIVE SOURCE
4075, 3ru8L, 0.5350, 3.52, 0.108, 213, 65, STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB
4076, 3oazK, 0.5350, 3.52, 0.108, 213, 65, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4077, 3nz8B, 0.5350, 3.54, 0.062, 217, 65, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4078, 3gi9H, 0.5350, 3.51, 0.081, 217, 62, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
4079, 3g5xA, 0.5350, 3.57, 0.077, 214, 65, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
4080, 3c5sA, 0.5350, 3.54, 0.077, 218, 65, CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
4081, 2zkhH, 0.5350, 3.67, 0.094, 209, 64, HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
4082, 2x4sA, 0.5350, 3.66, 0.136, 275, 66, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
4083, 2x4pA, 0.5350, 3.60, 0.121, 275, 66, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
4084, 2winG, 0.5350, 3.36, 0.091, 638, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
4085, 2winE, 0.5350, 3.36, 0.091, 638, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
4086, 2winC, 0.5350, 3.36, 0.091, 638, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
4087, 2winA, 0.5350, 3.36, 0.091, 638, 66, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
4088, 2vdkL, 0.5350, 3.60, 0.077, 214, 65, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
4089, 2of5L, 0.5350, 3.26, 0.127, 100, 63, OLIGOMERIC DEATH DOMAIN COMPLEX
4090, 2j4wL, 0.5350, 3.68, 0.091, 212, 66, STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX
4091, 2h2sC, 0.5350, 3.84, 0.092, 221, 65, CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-
4092, 2ck0H, 0.5350, 3.55, 0.095, 211, 63, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
4093, 1t5wE, 0.5350, 3.39, 0.095, 190, 63, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
4094, 1n0xM, 0.5350, 3.48, 0.108, 215, 65, CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
4095, 1i8lB, 0.5350, 3.34, 0.077, 199, 65, HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX
4096, 1fbiP, 0.5350, 3.48, 0.077, 214, 65, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
4097, 1e4xM, 0.5350, 3.55, 0.077, 214, 65, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
4098, 1ct8B, 0.5350, 3.35, 0.098, 220, 61, CATALYTIC ANTIBODY 7C8 COMPLEX
4099, 6mfgC, 0.5349, 3.48, 0.078, 181, 64, HLA-DQ2-GLIA-ALPHA1 
4100, 6dhbA, 0.5349, 3.57, 0.104, 108, 67, CRYSTAL STRUCTURE OF THE HUMAN TIM-3 WITH BOUND CALCIUM 
4101, 6cw3B, 0.5349, 3.59, 0.106, 213, 66, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
4102, 6c5kA, 0.5349, 3.19, 0.100, 215, 60, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
4103, 6b0gC, 0.5349, 3.51, 0.108, 218, 65, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1245
4104, 6avnL, 0.5349, 3.60, 0.076, 205, 66, CRYSTAL STRUCTURE OF UNBOUND ANTI-HIV ANTIBODY FAB PGV19 AT 2.5 A 
4105, 5x2mL, 0.5349, 3.64, 0.076, 217, 66, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4106, 5wl2B, 0.5349, 3.73, 0.075, 211, 67, VH1-69 GERMLINE ANTIBODY WITH CDR H3 SEQUENCE OF CR9114 
4107, 5t85L, 0.5349, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2 AND PHOSPHATIDYLGLYCEROL (06:0 PG)
4108, 5t6lL, 0.5349, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
4109, 5t4zB, 0.5349, 3.79, 0.090, 210, 67, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
4110, 5o7pA, 0.5349, 3.55, 0.108, 213, 65, HER3 IN COMPLEX WITH FAB MF3178 
4111, 5iq9B, 0.5349, 3.75, 0.075, 210, 67, CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
4112, 5i6zC, 0.5349, 3.80, 0.059, 214, 68, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
4113, 5fehA, 0.5349, 3.73, 0.104, 212, 67, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
4114, 5erwA, 0.5349, 3.51, 0.063, 212, 63, STRUCTURE OF HCV E2 GLYCOPROTEIN ANTIGENIC EPITOPE II BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC84-26
4115, 4z7wB, 0.5349, 3.30, 0.079, 180, 63, T316 COMPLEX
4116, 4uimB, 0.5349, 3.62, 0.076, 214, 66, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
4117, 4rfnC, 0.5349, 3.83, 0.088, 210, 68, CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48
4118, 4qhmH, 0.5349, 3.74, 0.075, 209, 67, I3.1 (UNBOUND) FROM CH103 LINEAGE
4119, 4qeyA, 0.5349, 2.66, 0.098, 123, 61, CRYSTAL STRUCTURE OF A DUF4425 FAMILY PROTEIN (BACOVA_05332) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.52 A RESOLUTION
4120, 4md5B, 0.5349, 3.62, 0.138, 190, 65, IMMUNE RECEPTOR
4121, 4lexL, 0.5349, 3.46, 0.108, 217, 65, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
4122, 4kjqD, 0.5349, 3.69, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4123, 4hixL, 0.5349, 3.47, 0.108, 219, 65, CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE
4124, 4h26B, 0.5349, 3.31, 0.095, 188, 63, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
4125, 4fqkL, 0.5349, 3.72, 0.075, 214, 67, INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX
4126, 4fqjL, 0.5349, 3.72, 0.075, 215, 67, INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4127, 4be5A, 0.5349, 3.80, 0.147, 224, 68, V. CHOLERA BIOFILM SCAFFOLDING PROTEIN RBMA
4128, 3vg0H, 0.5349, 3.80, 0.092, 219, 65, ANTIBODY FAB FRAGMENT
4129, 3eyfC, 0.5349, 3.44, 0.108, 215, 65, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
4130, 2vdnL, 0.5349, 3.60, 0.077, 213, 65, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
4131, 2uylV, 0.5349, 3.68, 0.076, 216, 66, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4132, 2q6wD, 0.5349, 3.37, 0.094, 180, 64, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
4133, 2nz9E, 0.5349, 3.62, 0.106, 216, 66, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
4134, 2gjzH, 0.5349, 3.64, 0.078, 221, 64, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
4135, 2gjzB, 0.5349, 3.64, 0.078, 221, 64, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
4136, 1um5L, 0.5349, 3.62, 0.106, 216, 66, CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
4137, 1t5wB, 0.5349, 3.39, 0.095, 190, 63, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
4138, 1ngpH, 0.5349, 3.66, 0.094, 215, 64, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
4139, 1ct8D, 0.5349, 3.35, 0.098, 220, 61, CATALYTIC ANTIBODY 7C8 COMPLEX
4140, 1aqdH, 0.5349, 3.45, 0.125, 187, 64, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
4141, 6my4B, 0.5348, 3.49, 0.108, 217, 65, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
4142, 6mlkL, 0.5348, 3.51, 0.108, 217, 65, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
4143, 6foeB, 0.5348, 3.48, 0.108, 214, 65, BAXB01 FAB FRAGMENT
4144, 6e9gB, 0.5348, 3.81, 0.103, 214, 68, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-2 
4145, 6bqbL, 0.5348, 3.51, 0.108, 219, 65, MGG4 FAB IN COMPLEX WITH PEPTIDE
4146, 6awpC, 0.5348, 3.50, 0.092, 214, 65, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
4147, 5x2mH, 0.5348, 3.66, 0.094, 219, 64, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4148, 5occL, 0.5348, 3.73, 0.090, 216, 67, CRYSTAL STRUCTURE OF CD32B (FC GAMMA RECEPTOR IIB) IN COMPLEX WITH HUMAN IGG1 FAB FRAGMENT (6G08) 
4149, 5ksbB, 0.5348, 3.34, 0.063, 179, 63, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
4150, 5kf4B, 0.5348, 3.29, 0.136, 99, 66, CRYSTAL STRUCTURE OF FN3 DOMAIN (RESIDUES P368-P466) OF HUMAN COLLAGEN XX
4151, 5i76A, 0.5348, 3.53, 0.108, 213, 65, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4152, 5c5xD, 0.5348, 3.41, 0.030, 244, 67, CRYSTAL STRUCTURE OF THE S156E MUTANT OF HUMAN AQUAPORIN 5
4153, 4yhyC, 0.5348, 3.51, 0.108, 210, 65, CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS
4154, 4whtL, 0.5348, 3.88, 0.074, 215, 68, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4155, 4u59A, 0.5348, 3.56, 0.101, 1537, 69, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN REACTED WITH METHYLAMINE
4156, 4u0rC, 0.5348, 3.55, 0.062, 217, 65, PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY 9AD4
4157, 4tscL, 0.5348, 3.57, 0.076, 214, 66, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
4158, 4qgtA, 0.5348, 3.68, 0.119, 205, 67, THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON
4159, 4q2zL, 0.5348, 3.72, 0.075, 212, 67, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
4160, 4p5tD, 0.5348, 3.31, 0.095, 199, 63, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
4161, 4p4kF, 0.5348, 3.39, 0.095, 199, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
4162, 4nhhN, 0.5348, 3.55, 0.061, 206, 66, STRUCTURE OF 2G12 IGG DIMER
4163, 4nhhD, 0.5348, 3.55, 0.061, 206, 66, STRUCTURE OF 2G12 IGG DIMER
4164, 4nhhB, 0.5348, 3.55, 0.061, 206, 66, STRUCTURE OF 2G12 IGG DIMER
4165, 4nhgY, 0.5348, 3.55, 0.061, 206, 66, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
4166, 4nhgP, 0.5348, 3.55, 0.061, 206, 66, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
4167, 4nhgN, 0.5348, 3.55, 0.061, 206, 66, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
4168, 4m5yL, 0.5348, 3.71, 0.075, 211, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
4169, 4kkrA, 0.5348, 3.16, 0.138, 224, 65, CRYSTAL STRUCTURE OF VIBRIO CHOLERAE RBMA (CRYSTAL FORM 3)
4170, 4jreL, 0.5348, 3.66, 0.106, 211, 66, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
4171, 4jn2A, 0.5348, 3.64, 0.106, 219, 66, AN ANTIDOTE FOR DABIGATRAN
4172, 4fqkF, 0.5348, 3.72, 0.075, 213, 67, INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX
4173, 4dn4L, 0.5348, 3.58, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A
4174, 3v4uL, 0.5348, 3.52, 0.077, 218, 65, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4175, 3ojdB, 0.5348, 3.69, 0.094, 224, 64, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
4176, 3mlrL, 0.5348, 3.66, 0.075, 219, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
4177, 3if1A, 0.5348, 3.57, 0.077, 215, 65, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4178, 3cmoL, 0.5348, 3.55, 0.062, 210, 65, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
4179, 3bz4G, 0.5348, 3.66, 0.076, 216, 66, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
4180, 2vpqA, 0.5348, 3.18, 0.109, 447, 64, CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE FROM S. AUREUS COMPLEXED WITH AMPPNP
4181, 2vc2L, 0.5348, 3.60, 0.077, 214, 65, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
4182, 2uylN, 0.5348, 3.35, 0.098, 213, 61, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4183, 2exyF, 0.5348, 3.54, 0.062, 211, 65, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
4184, 2dquH, 0.5348, 3.67, 0.094, 222, 64, CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
4185, 1y6nR, 0.5348, 3.39, 0.116, 202, 69, CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 MUTANT (A87I) COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
4186, 1q0yL, 0.5348, 3.72, 0.090, 212, 67, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
4187, 1ncwL, 0.5348, 3.65, 0.076, 219, 66, CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
4188, 1mf2N, 0.5348, 3.79, 0.092, 221, 65, ANTI HIV1 PROTEASE FAB COMPLEX
4189, 1igjC, 0.5348, 3.66, 0.076, 216, 66, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
4190, 1h3xB, 0.5348, 3.55, 0.061, 206, 66, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G0F)2
4191, 1ggbL, 0.5348, 3.63, 0.076, 215, 66, MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
4192, 1d5xB, 0.5348, 3.37, 0.125, 183, 64, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
4193, 6h5nE, 0.5347, 3.75, 0.090, 212, 67, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
4194, 6foeL, 0.5347, 3.45, 0.108, 214, 65, BAXB01 FAB FRAGMENT
4195, 6cqnB, 0.5347, 3.31, 0.095, 190, 63, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4196, 6cqlB, 0.5347, 3.42, 0.095, 190, 63, CRYSTAL STRUCTURE OF A TCR 
4197, 6by2B, 0.5347, 3.52, 0.062, 212, 65, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
4198, 6ayzD, 0.5347, 3.61, 0.106, 211, 66, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
4199, 5wkoJ, 0.5347, 3.62, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4200, 5vkdL, 0.5347, 3.52, 0.108, 213, 65, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF EBOLA (BUNDIBUGYO) NUCLEOPROTEIN IN COMPLEX WITH FAB FRAGMENT 
4201, 5tr8L, 0.5347, 3.65, 0.076, 212, 66, CRYSTAL STRUCTURE OF VACCINE-ELICITED PAN- INFLUENZA H1N1 NEUTRALIZING MURINE ANTIBODY 441D6. 
4202, 5mx3H, 0.5347, 3.81, 0.092, 219, 65, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4203, 5mr3D, 0.5347, 2.78, 0.066, 110, 61, CRYSTAL STRUCTURE OF RED ABALONE EGG VERL REPEAT 2 WITH LINKER IN COMPLEX WITH SPERM LYSIN AT 1.8 A RESOLUTION
4204, 5ifhL, 0.5347, 3.72, 0.075, 211, 67, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  2 CASE P11475
4205, 5iesL, 0.5347, 3.44, 0.108, 206, 65, CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.16 A
4206, 5esaB, 0.5347, 3.52, 0.062, 212, 65, CRYSTAL STRUCTURE OF ANTI-HCV E2 ANTIBODY HC84-26
4207, 5e08L, 0.5347, 3.52, 0.108, 215, 65, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
4208, 5d9qL, 0.5347, 3.57, 0.076, 208, 66, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46
4209, 5cwsG, 0.5347, 3.57, 0.106, 208, 66, CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE
4210, 4xc1L, 0.5347, 3.63, 0.106, 214, 66, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE
4211, 4p5tH, 0.5347, 3.32, 0.095, 199, 63, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
4212, 4p57D, 0.5347, 3.32, 0.095, 196, 63, MHC TCR PEPTIDE COMPLEX
4213, 4ozfA, 0.5347, 3.56, 0.078, 181, 64, JR5.1 PROTEIN COMPLEX
4214, 4njaH, 0.5347, 3.64, 0.094, 221, 64, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
4215, 4mauL, 0.5347, 3.51, 0.108, 216, 65, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
4216, 4leeB, 0.5347, 3.31, 0.075, 313, 67, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
4217, 4l4jB, 0.5347, 3.70, 0.119, 182, 67, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY
4218, 4kxzI, 0.5347, 3.61, 0.106, 212, 66, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4219, 4kklD, 0.5347, 3.68, 0.076, 211, 66, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4220, 4f58M, 0.5347, 3.69, 0.075, 213, 67, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4221, 4etqH, 0.5347, 3.34, 0.082, 215, 61, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4222, 4am0A, 0.5347, 3.65, 0.094, 211, 64, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4223, 3qa3D, 0.5347, 3.49, 0.097, 224, 62, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4224, 3m9iA, 0.5347, 3.31, 0.060, 220, 67, ELECTRON CRYSTALLOGRAPHIC STRUCTURE OF LENS AQUAPORIN-0 (AQP0) (LENS MIP) IN E. COLI POLAR LIPIDS
4225, 3klhC, 0.5347, 3.62, 0.076, 211, 66, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
4226, 3ijsA, 0.5347, 3.82, 0.059, 217, 68, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4227, 3gi8L, 0.5347, 3.67, 0.076, 220, 66, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
4228, 3eo0C, 0.5347, 3.64, 0.106, 215, 66, STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
4229, 3aqzA, 0.5347, 3.47, 0.075, 100, 67, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
4230, 3aqxB, 0.5347, 3.46, 0.090, 100, 67, CRYSTAL STRUCTURE OF BOMBYX MORI BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
4231, 2xqyK, 0.5347, 3.64, 0.076, 218, 66, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4232, 2vxqL, 0.5347, 3.59, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
4233, 2vitA, 0.5347, 3.80, 0.103, 210, 68, INFLUENZA VIRUS HEMAGGLUTININ MUTANT WITH THR 155 REPLACED BY ILE COMPLEXED WITH A NEUTRALIZING ANTIBODY
4234, 2vdrL, 0.5347, 3.55, 0.077, 214, 65, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
4235, 2g75D, 0.5347, 3.72, 0.090, 211, 67, CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
4236, 2ez0F, 0.5347, 3.54, 0.062, 211, 65, CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC IN COMPLEX WITH A FAB FRAGMENT
4237, 1w0yT, 0.5347, 3.09, 0.077, 188, 65, TF7A_3771 COMPLEX
4238, 1ub6L, 0.5347, 3.76, 0.060, 213, 67, CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND
4239, 1ub6B, 0.5347, 3.76, 0.060, 213, 67, CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND
4240, 1t04A, 0.5347, 3.63, 0.106, 214, 66, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
4241, 1nudB, 0.5347, 3.46, 0.076, 673, 66, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (3 CALCIUMS ACTIVE FORM)
4242, 1igcH, 0.5347, 3.68, 0.094, 222, 64, IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS
4243, 1hh9A, 0.5347, 3.67, 0.106, 214, 66, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
4244, 1deeD, 0.5347, 3.70, 0.090, 223, 67, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
4245, 6rcvB, 0.5346, 3.71, 0.075, 211, 67, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
4246, 5yslD, 0.5346, 3.58, 0.108, 213, 65, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
4247, 5w23M, 0.5346, 3.65, 0.076, 215, 66, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
4248, 5ucbL, 0.5346, 3.53, 0.108, 210, 65, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH ENGINEERED SWITCH RESIDUE REGION.
4249, 5tqaL, 0.5346, 3.58, 0.076, 211, 66, CRYSTAL STRUCTURE OF DH270.6 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
4250, 5njdQ, 0.5346, 3.81, 0.075, 213, 67, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
4251, 5iltL, 0.5346, 3.74, 0.104, 213, 67, CRYSTAL STRUCTURE OF BOVINE FAB A01
4252, 5i74C, 0.5346, 3.79, 0.059, 214, 68, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
4253, 5f88C, 0.5346, 3.51, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
4254, 5cjsE, 0.5346, 3.74, 0.075, 211, 67, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4255, 4zfkB, 0.5346, 3.43, 0.043, 231, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC WITH GLUTAMINE
4256, 4xcnK, 0.5346, 3.49, 0.108, 214, 65, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4257, 4uq3C, 0.5346, 3.31, 0.125, 275, 64, CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
4258, 4nrxL, 0.5346, 3.63, 0.106, 213, 66, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4259, 4kknA, 0.5346, 3.55, 0.101, 117, 69, CRYSTAL STRUCTURE OF BOVINE CTLA-4 PSI-NYSGRC-012704
4260, 4kkbD, 0.5346, 3.68, 0.076, 211, 66, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4261, 4kk9D, 0.5346, 3.91, 0.059, 211, 68, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4262, 4fccJ, 0.5346, 3.36, 0.123, 442, 65, GLUTAMATE DEHYDROGENASE FROM E. COLI
4263, 4dgiH, 0.5346, 3.34, 0.098, 218, 61, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
4264, 3wfbL, 0.5346, 3.54, 0.062, 213, 65, REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4265, 3v52L, 0.5346, 3.59, 0.076, 218, 66, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4266, 3utzD, 0.5346, 3.52, 0.108, 212, 65, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
4267, 3tv3L, 0.5346, 3.70, 0.075, 205, 67, CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
4268, 3tnnB, 0.5346, 3.74, 0.075, 212, 67, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
4269, 3rkdD, 0.5346, 3.50, 0.097, 218, 62, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4270, 3k2mC, 0.5346, 3.16, 0.077, 101, 65, CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX
4271, 3ikcC, 0.5346, 3.80, 0.060, 217, 67, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
4272, 3igaB, 0.5346, 3.52, 0.062, 212, 65, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
4273, 3ggwA, 0.5346, 3.55, 0.077, 218, 65, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE
4274, 3c6sB, 0.5346, 3.65, 0.094, 209, 64, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4275, 2x4sD, 0.5346, 3.64, 0.121, 275, 66, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
4276, 2uylA, 0.5346, 3.67, 0.076, 218, 66, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4277, 2of5H, 0.5346, 3.06, 0.113, 100, 62, OLIGOMERIC DEATH DOMAIN COMPLEX
4278, 2jb6L, 0.5346, 3.77, 0.075, 210, 67, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-2
4279, 2h9gA, 0.5346, 3.51, 0.108, 211, 65, CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
4280, 1xf4B, 0.5346, 3.82, 0.092, 213, 65, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4281, 1xf3L, 0.5346, 3.51, 0.062, 213, 65, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4282, 1t6wA, 0.5346, 3.03, 0.111, 99, 63, RATIONAL DESIGN OF A CALCIUM-BINDING ADHESION PROTEIN NMR 20 STRUCTURES
4283, 1ottD, 0.5346, 3.54, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
4284, 1oakL, 0.5346, 3.54, 0.077, 212, 65, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
4285, 1hh6A, 0.5346, 3.68, 0.106, 214, 66, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
4286, 1c5dB, 0.5346, 3.51, 0.113, 215, 62, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
4287, 6h6fE, 0.5345, 3.20, 0.111, 2454, 63, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
4288, 5y2kF, 0.5345, 3.59, 0.076, 208, 66, A HUMAN ANTIBODY AF4H1L1 
4289, 5u3oL, 0.5345, 3.62, 0.106, 216, 66, CRYSTAL STRUCTURE OF DH511.2_K3 FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
4290, 5u3lL, 0.5345, 3.50, 0.108, 214, 65, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
4291, 5tihL, 0.5345, 3.52, 0.062, 212, 65, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
4292, 5t0yB, 0.5345, 3.64, 0.076, 212, 66, 2A10 ANTIBODY FAB FRAGMENT
4293, 5ocxL, 0.5345, 3.69, 0.076, 216, 66, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT 
4294, 5nuzH, 0.5345, 3.51, 0.097, 215, 62, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
4295, 5l0qC, 0.5345, 3.57, 0.095, 213, 63, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4296, 5i30L, 0.5345, 3.61, 0.076, 212, 66, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
4297, 5epmF, 0.5345, 3.52, 0.062, 218, 65, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
4298, 5dqjA, 0.5345, 3.83, 0.092, 222, 65, STRUCTURE OF UNLIGANDED S55-5 FAB
4299, 5d9qE, 0.5345, 3.58, 0.076, 208, 66, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46
4300, 4yr6B, 0.5345, 3.53, 0.062, 212, 65, FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE
4301, 4xh2D, 0.5345, 3.61, 0.106, 210, 66, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
4302, 4x5xD, 0.5345, 3.29, 0.127, 198, 63, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
4303, 4w29HC, 0.5345, 3.38, 0.101, 228, 69, 
4304, 4tujD, 0.5345, 3.58, 0.077, 217, 65, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4305, 4qt5H, 0.5345, 3.68, 0.095, 207, 63, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
4306, 4kjpF, 0.5345, 3.67, 0.076, 211, 66, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4307, 4h88H, 0.5345, 3.34, 0.098, 218, 61, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
4308, 4glrK, 0.5345, 3.73, 0.075, 207, 67, STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235
4309, 3ujiL, 0.5345, 3.72, 0.075, 208, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE
4310, 3qxdE, 0.5345, 3.43, 0.125, 189, 64, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
4311, 3ejyD, 0.5345, 3.67, 0.076, 211, 66, STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER CLC-EC1
4312, 3cm9N, 0.5345, 3.73, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SIGA2
4313, 3cm9L, 0.5345, 3.73, 0.104, 214, 67, SOLUTION STRUCTURE OF HUMAN SIGA2
4314, 2y6sH, 0.5345, 3.50, 0.097, 206, 62, STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE
4315, 2y6sD, 0.5345, 3.50, 0.097, 206, 62, STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE
4316, 2vzoA, 0.5345, 3.53, 0.029, 850, 69, CRYSTAL STRUCTURE OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
4317, 2vxuM, 0.5345, 3.53, 0.062, 214, 65, CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
4318, 2icwA, 0.5345, 3.35, 0.111, 176, 63, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
4319, 2c32A, 0.5345, 3.37, 0.075, 233, 67, CO-AXIAL ASSOCIATION OF RECOMBINANT EYE LENS AQUAPORIN-0 OBSERVED IN LOOSELY PACKED 3D-CRYSTALS
4320, 2bmkB, 0.5345, 3.35, 0.098, 223, 61, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
4321, 1ymgA, 0.5345, 3.37, 0.075, 233, 67, THE CHANNEL ARCHITECTURE OF AQUAPORIN O AT 2.2 ANGSTROM RESOLUTION
4322, 1xcqA, 0.5345, 3.56, 0.077, 220, 65, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4323, 1w72L, 0.5345, 3.60, 0.091, 210, 66, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
4324, 1nakM, 0.5345, 3.53, 0.077, 217, 65, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4325, 1mlbB, 0.5345, 3.35, 0.098, 218, 61, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
4326, 1l9mA, 0.5345, 3.39, 0.077, 675, 65, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
4327, 1i9jH, 0.5345, 3.84, 0.092, 220, 65, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
4328, 1frgL, 0.5345, 3.67, 0.076, 217, 66, CRYSTAL STRUCTURE SEQUENCE AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
4329, 1fn4A, 0.5345, 3.47, 0.092, 211, 65, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
4330, 1c5cL, 0.5345, 3.50, 0.108, 214, 65, DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX
4331, 1c5bL, 0.5345, 3.50, 0.108, 214, 65, DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM
4332, 1b2wL, 0.5345, 3.43, 0.108, 214, 65, COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
4333, 6idhH, 0.5344, 3.51, 0.097, 217, 62, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
4334, 6cw3D, 0.5344, 3.44, 0.108, 213, 65, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
4335, 6bpcB, 0.5344, 3.34, 0.082, 213, 61, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4336, 6b0wL, 0.5344, 3.62, 0.076, 209, 66, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 1710 ANTIBODY
4337, 5wduV, 0.5344, 3.69, 0.075, 213, 67, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
4338, 5u3mL, 0.5344, 3.48, 0.108, 216, 65, CRYSTAL STRUCTURE OF DH511.11P FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
4339, 5nyxP, 0.5344, 3.52, 0.108, 199, 65, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
4340, 5n6uC, 0.5344, 3.42, 0.103, 811, 68, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
4341, 5mu2J, 0.5344, 3.55, 0.077, 218, 65, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4342, 5e2vL, 0.5344, 3.53, 0.108, 216, 65, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
4343, 5cp7H, 0.5344, 3.50, 0.097, 212, 62, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4344, 5bv7L, 0.5344, 3.72, 0.075, 210, 67, CRYSTAL STRUCTURE OF HUMAN LCAT (L4F N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY
4345, 5bk1D, 0.5344, 3.51, 0.108, 209, 65, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ENDOSTERIC SYNTHETIC ANTIBODY
4346, 5bk0C, 0.5344, 3.61, 0.106, 214, 66, CRYSTAL STRUCTURE OF 663 FAB BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5- MER
4347, 4zs7L, 0.5344, 3.59, 0.076, 210, 66, STRUCTURAL MIMICRY OF RECEPTOR INTERACTION BY ANTAGONISTIC IL-6 ANTIBODIES
4348, 4lldB, 0.5344, 3.71, 0.075, 101, 67, STRUCTURE OF WILD-TYPE IGG1 ANTIBODY HEAVY CHAIN CONSTANT DOMAIN 1 AND LIGHT CHAIN LAMBDA CONSTANT DOMAIN (IGG1 CH1:CLAMBDA) AT 1.19A
4349, 4ik7A, 0.5344, 3.36, 0.092, 116, 65, CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH INDOMETHACIN
4350, 4i4tF, 0.5344, 2.78, 0.083, 357, 60, CRYSTAL STRUCTURE OF TUBULIN-RB3-TTL-ZAMPANOLIDE COMPLEX
4351, 4gxuQ, 0.5344, 3.75, 0.077, 227, 65, CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ
4352, 4am0F, 0.5344, 3.65, 0.076, 212, 66, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4353, 3x3fL, 0.5344, 3.51, 0.108, 214, 65, TRAIL-R2 EXTRACELLULAR REGION COMPLEXED TO A FAB FRAGMENT FROM HUMAN AGONIST ANTIBODY KMTR2
4354, 3okoB, 0.5344, 3.66, 0.094, 219, 64, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
4355, 3mx0C, 0.5344, 3.36, 0.077, 406, 65, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
4356, 3mluL, 0.5344, 3.80, 0.074, 218, 68, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
4357, 3gbmL, 0.5344, 3.60, 0.076, 208, 66, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
4358, 3cvhH, 0.5344, 3.81, 0.092, 213, 65, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
4359, 3c6sG, 0.5344, 3.68, 0.076, 216, 66, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4360, 2vzsB, 0.5344, 3.34, 0.000, 857, 68, CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
4361, 2icwD, 0.5344, 3.35, 0.111, 176, 63, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
4362, 2hrpH, 0.5344, 3.80, 0.092, 226, 65, ANTIGEN-ANTIBODY COMPLEX
4363, 2feeL, 0.5344, 3.51, 0.062, 211, 65, STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
4364, 1sjhA, 0.5344, 3.36, 0.111, 179, 63, HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
4365, 1qgc4, 0.5344, 3.54, 0.092, 217, 65, STRUCTURE OF THE COMPLEX OF A FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS
4366, 6n16L, 0.5343, 3.52, 0.123, 217, 65, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
4367, 6gxxH, 0.5343, 3.84, 0.092, 219, 65, FAB FRAGMENT OF AN ANTIBODY SELECTIVE FOR ALPHA-1-ANTITRYPSIN IN THE NATIVE CONFORMATION 
4368, 6glxD, 0.5343, 3.72, 0.075, 213, 67, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 4E8 
4369, 6ddmA, 0.5343, 3.62, 0.106, 215, 66, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
4370, 6dc5C, 0.5343, 3.65, 0.106, 213, 66, RSV PREFUSION F IN COMPLEX WITH AM22 FAB 
4371, 6cqjD, 0.5343, 3.61, 0.109, 182, 64, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4372, 6co3L, 0.5343, 3.60, 0.106, 211, 66, ADUCANUMAB ABETA COMPLEX 
4373, 5xajD, 0.5343, 3.58, 0.076, 213, 66, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
4374, 5ukqH, 0.5343, 3.72, 0.092, 220, 65, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB
4375, 5mp1C, 0.5343, 3.65, 0.094, 214, 64, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
4376, 5el4BA, 0.5343, 3.62, 0.096, 133, 73, 
4377, 4p4kA, 0.5343, 3.35, 0.111, 178, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
4378, 4oz4H, 0.5343, 3.81, 0.092, 219, 65, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4379, 4ouuH, 0.5343, 3.49, 0.097, 211, 62, ANTI-MT1-MMP MONOCLONAL ANTIBODY
4380, 4nzuL, 0.5343, 3.51, 0.108, 211, 65, CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB  FROM A MULTIPLE MYELOMA PATIENT
4381, 4l29A, 0.5343, 3.53, 0.123, 276, 65, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
4382, 4iizA, 0.5343, 3.35, 0.092, 116, 65, CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH LUMIRACOXIB
4383, 4gxvM, 0.5343, 3.59, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4384, 4fxkB, 0.5343, 3.13, 0.062, 697, 64, HUMAN COMPLEMENT C4
4385, 4fg6F, 0.5343, 3.65, 0.076, 211, 66, STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4386, 4evnB, 0.5343, 3.76, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4387, 4bhtA, 0.5343, 3.31, 0.123, 442, 65, STRUCTURAL DETERMINANTS OF COFACTOR SPECIFICITY AND DOMAIN FLEXIBILITY IN BACTERIAL GLUTAMATE DEHYDROGENASES
4388, 4am0E, 0.5343, 3.65, 0.078, 212, 64, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4389, 3wfhB, 0.5343, 3.67, 0.076, 216, 66, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX
4390, 3se4A, 0.5343, 3.10, 0.123, 285, 65, HUMAN IFNW-IFNAR TERNARY COMPLEX
4391, 3i9pA, 0.5343, 3.36, 0.092, 116, 65, CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN - WILD TYPE
4392, 3f12C, 0.5343, 3.52, 0.108, 213, 65, GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
4393, 3ejyF, 0.5343, 3.55, 0.061, 211, 66, STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER CLC-EC1
4394, 3dvnA, 0.5343, 3.59, 0.106, 212, 66, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN
4395, 3d9sC, 0.5343, 3.41, 0.030, 243, 67, HUMAN AQUAPORIN 5 (AQP5) - HIGH RESOLUTION X-RAY STRUCTURE
4396, 3d9sA, 0.5343, 3.40, 0.030, 245, 67, HUMAN AQUAPORIN 5 (AQP5) - HIGH RESOLUTION X-RAY STRUCTURE
4397, 3bz4E, 0.5343, 3.50, 0.062, 216, 65, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
4398, 3baeH, 0.5343, 3.37, 0.066, 219, 61, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
4399, 3apnA, 0.5343, 3.02, 0.079, 563, 63, CRYSTAL STRUCTURE OF THE HUMAN WILD-TYPE PAD4 PROTEIN
4400, 2op4L, 0.5343, 3.70, 0.104, 212, 67, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
4401, 2khaA, 0.5343, 3.05, 0.062, 113, 65, SOLUTION STRUCTURE OF A PATHOGEN RECOGNITION DOMAIN FROM A LEPIDOPTERAN INSECT PLODIA INTERPUNCTELLA
4402, 2g5bA, 0.5343, 3.65, 0.076, 217, 66, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4403, 2fbjL, 0.5343, 3.63, 0.076, 213, 66, REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
4404, 2atyB, 0.5343, 3.47, 0.076, 376, 66, COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG
4405, 2a6kB, 0.5343, 3.51, 0.097, 218, 62, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
4406, 1zauA, 0.5343, 3.76, 0.096, 321, 73, ADENYLATION DOMAIN OF NAD+ DEPENDENT DNA LIGASE FROM M.TUBERCULOSIS
4407, 1py9A, 0.5343, 3.52, 0.149, 116, 67, THE CRYSTAL STRUCTURE OF AN AUTOANTIGEN IN MULTIPLE SCLEROSIS
4408, 1mlcB, 0.5343, 3.32, 0.098, 218, 61, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
4409, 1bfoD, 0.5343, 3.48, 0.097, 216, 62, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4410, 6oknB, 0.5342, 3.61, 0.106, 213, 66, OX40R (TNFRSF4) BOUND TO FAB 1A7 
4411, 6ghdF, 0.5342, 3.46, 0.030, 118, 66, STRUCTURAL ANALYSIS OF THE TERNARY COMPLEX BETWEEN LAMIN A/C; BAF AND EMERIN IDENTIFIES AN INTERFACE DISRUPTED IN AUTOSOMAL RECESSIVE PROGEROID DISEASES 
4412, 5wkoB, 0.5342, 3.61, 0.106, 213, 66, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4413, 5vkhB, 0.5342, 3.51, 0.062, 212, 65, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
4414, 5vjqG, 0.5342, 3.67, 0.094, 206, 64, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4415, 5tvmE, 0.5342, 3.00, 0.048, 296, 62, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI ADOMETDC/PROZYME HETERODIMER
4416, 5mykA, 0.5342, 3.68, 0.076, 219, 66, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 17 IN COMPLEX WITH MURINE ABETA-PE3-18PEGB
4417, 5l2hB, 0.5342, 3.35, 0.121, 98, 66, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
4418, 5ir1C, 0.5342, 3.50, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4419, 5i5kB, 0.5342, 3.56, 0.072, 1634, 69, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
4420, 5cd5D, 0.5342, 3.62, 0.106, 207, 66, CRYSTAL STRUCTURE OF AN IMMATURE VRC01-CLASS ANTIBODY DRVIA7 FROM A CHINESE DONOR BOUND TO CLADE A/E HIV-1 GP120 CORE
4421, 4zs6D, 0.5342, 3.56, 0.106, 210, 66, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
4422, 4ynyB, 0.5342, 3.75, 0.090, 209, 67, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
4423, 4x5xA, 0.5342, 3.40, 0.094, 179, 64, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
4424, 4v33B, 0.5342, 3.63, 0.072, 315, 69, CRYSTAL STRUCTURE OF THE PUTATIVE POLYSACCHARIDE DEACETYLASE BA0330 FROM BACILLUS ANTHRACIS
4425, 4rbpK, 0.5342, 3.54, 0.108, 213, 65, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
4426, 4r2gC, 0.5342, 3.75, 0.075, 210, 67, CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4
4427, 4q6iB, 0.5342, 3.54, 0.097, 222, 62, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
4428, 4o51E, 0.5342, 3.63, 0.106, 214, 66, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
4429, 4m7zB, 0.5342, 3.35, 0.098, 216, 61, UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB
4430, 4lsuL, 0.5342, 3.70, 0.075, 203, 67, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4431, 4kkcF, 0.5342, 3.69, 0.076, 211, 66, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4432, 4kjqE, 0.5342, 3.81, 0.092, 221, 65, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4433, 4hqqL, 0.5342, 3.74, 0.075, 212, 67, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
4434, 4evnL, 0.5342, 3.75, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4435, 4evnJ, 0.5342, 3.75, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4436, 4evnF, 0.5342, 3.75, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4437, 4eneC, 0.5342, 3.48, 0.097, 222, 62, STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
4438, 4at6A, 0.5342, 3.48, 0.097, 212, 62, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4439, 3tnnD, 0.5342, 3.72, 0.075, 212, 67, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
4440, 3sboC, 0.5342, 3.13, 0.125, 442, 64, STRUCTURE OF E.COLI GDH FROM NATIVE SOURCE
4441, 3ra7L, 0.5342, 3.48, 0.062, 211, 65, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
4442, 3qa3B, 0.5342, 3.50, 0.097, 224, 62, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4443, 3o3aA, 0.5342, 3.64, 0.121, 275, 66, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
4444, 3ijhC, 0.5342, 3.81, 0.059, 217, 68, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4445, 3hzyB, 0.5342, 3.68, 0.094, 219, 64, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4446, 3do3B, 0.5342, 3.46, 0.091, 210, 66, HUMAN 1GG1 FC FRAGMENT 2.5 ANGSTROM STRUCTURE
4447, 3cleH, 0.5342, 3.37, 0.082, 218, 61, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
4448, 2z31D, 0.5342, 3.38, 0.095, 188, 63, CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
4449, 2yn5B, 0.5342, 3.23, 0.125, 284, 64, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
4450, 2g5bG, 0.5342, 3.65, 0.076, 217, 66, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4451, 2g5bE, 0.5342, 3.65, 0.076, 217, 66, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4452, 2g5bC, 0.5342, 3.65, 0.076, 217, 66, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4453, 2c1pB, 0.5342, 3.52, 0.097, 216, 62, FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE
4454, 2aj3A, 0.5342, 3.61, 0.106, 212, 66, CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
4455, 1t3fA, 0.5342, 3.50, 0.108, 214, 65, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
4456, 1n0xL, 0.5342, 3.52, 0.108, 215, 65, CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
4457, 1mujB, 0.5342, 3.32, 0.095, 184, 63, CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
4458, 1m71A, 0.5342, 3.61, 0.091, 215, 66, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
4459, 1kfaI, 0.5342, 3.82, 0.092, 209, 65, CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
4460, 1i3rE, 0.5342, 3.49, 0.109, 182, 64, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
4461, 6o6lC, 0.5341, 3.82, 0.043, 404, 69, THE STRUCTURE OF EGTB(CABTHER) IN COMPLEX WITH HERCYNINE 
4462, 6mcoE, 0.5341, 3.75, 0.075, 213, 67, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
4463, 6gc2L, 0.5341, 3.46, 0.108, 214, 65, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
4464, 6eluC, 0.5341, 3.66, 0.076, 217, 66, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4465, 6db8L, 0.5341, 3.48, 0.108, 212, 65, STRUCTURAL BASIS FOR PROMISCUOUS BINDING AND ACTIVATION OF FLUOROGENIC DYES BY DIR2S RNA APTAMER 
4466, 6c5iH, 0.5341, 3.34, 0.098, 216, 61, UNLIGANDED S25-5 FAB 
4467, 6azmC, 0.5341, 3.63, 0.106, 219, 66, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
4468, 5wb9L, 0.5341, 3.51, 0.108, 200, 65, CRYSTAL STRUCTURE OF CD4 BINDING SITE ANTIBODY N60P23 IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 CORE 
4469, 5vjqE, 0.5341, 3.69, 0.094, 207, 64, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4470, 5mo3H, 0.5341, 3.66, 0.094, 219, 64, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
4471, 5jueL, 0.5341, 3.53, 0.062, 220, 65, CRYSTAL STRUCTURE OF UIC2 FAB
4472, 5jopL, 0.5341, 3.64, 0.076, 218, 66, CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A
4473, 5gznD, 0.5341, 3.60, 0.076, 214, 66, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
4474, 5gniA, 0.5341, 3.03, 0.138, 196, 65, THE CRYSTAL STRUCTURE OF PECAM-1 IGL1-2 TRANS-HOMOPHILIC DIMER
4475, 5girL, 0.5341, 3.60, 0.077, 212, 65, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4476, 4yr6A, 0.5341, 3.52, 0.095, 215, 63, FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE
4477, 4y89B, 0.5341, 3.19, 0.079, 109, 63, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF CEACAM7
4478, 4wtxA, 0.5341, 3.29, 0.123, 97, 65, CRYSTAL STRUCTURE OF THE FOURTH FNIII DOMAIN OF INTEGRIN BETA4
4479, 4rgmB, 0.5341, 3.54, 0.062, 213, 65, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
4480, 4m1gL, 0.5341, 3.54, 0.062, 214, 65, STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS
4481, 4le8A, 0.5341, 3.14, 0.061, 300, 66, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-299 (MATURE SEQUENCE)
4482, 4l29Q, 0.5341, 3.55, 0.123, 276, 65, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
4483, 4jfqD, 0.5341, 3.64, 0.121, 276, 66, A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
4484, 4g7yL, 0.5341, 3.52, 0.108, 211, 65, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
4485, 4fccF, 0.5341, 3.32, 0.123, 442, 65, GLUTAMATE DEHYDROGENASE FROM E. COLI
4486, 3qcvL, 0.5341, 3.45, 0.108, 218, 65, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
4487, 3npsC, 0.5341, 3.46, 0.108, 211, 65, CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
4488, 3ifoA, 0.5341, 3.53, 0.097, 216, 62, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
4489, 2vztA, 0.5341, 3.53, 0.029, 850, 69, COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA E541A WITH PNP-BETA-D-GLUCOSAMINE
4490, 2nljA, 0.5341, 3.53, 0.062, 212, 65, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
4491, 2hlfE, 0.5341, 3.62, 0.094, 221, 64, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
4492, 2c9rA, 0.5341, 3.21, 0.062, 97, 65, APO-H91F COPC
4493, 2atyA, 0.5341, 3.45, 0.076, 376, 66, COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG
4494, 1v7mH, 0.5341, 3.81, 0.108, 217, 65, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4495, 1qfuH, 0.5341, 3.68, 0.094, 223, 64, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
4496, 1q9wA, 0.5341, 3.63, 0.076, 219, 66, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
4497, 1nufA, 0.5341, 3.38, 0.077, 675, 65, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME
4498, 1nudA, 0.5341, 3.39, 0.077, 673, 65, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (3 CALCIUMS ACTIVE FORM)
4499, 1mlcA, 0.5341, 3.51, 0.062, 214, 65, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
4500, 1k2dA, 0.5341, 3.50, 0.078, 182, 64, CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
4501, 1f58H, 0.5341, 3.35, 0.098, 228, 61, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323
4502, 1e4xL, 0.5341, 3.55, 0.077, 214, 65, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
4503, 1bqlL, 0.5341, 3.68, 0.076, 212, 66, STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
4504, 6n7uB, 0.5340, 3.51, 0.108, 214, 65, APO-BDBV223 FAB 
4505, 6f7tL, 0.5340, 3.75, 0.090, 218, 67, CRYSTAL STRUCTURE OF AN FAB FRAGMENT IN COMPLEX WITH A PEPTIDE FROM BACILLUS SUBTILIS RNASE Y 
4506, 6e65L, 0.5340, 3.70, 0.075, 214, 67, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
4507, 6cseL, 0.5340, 3.50, 0.077, 213, 65, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
4508, 6cqjG, 0.5340, 3.35, 0.111, 180, 63, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4509, 6bpaC, 0.5340, 3.66, 0.076, 212, 66, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
4510, 5zxvL, 0.5340, 3.82, 0.074, 206, 68, STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN 
4511, 5utzC, 0.5340, 3.60, 0.076, 213, 66, HUMAN IL-2/FAB COMPLEX 
4512, 5nhwL, 0.5340, 3.45, 0.091, 215, 66, CRYSTAL STRUCTURE OF THE BIMAGRUMAB FAB
4513, 5nbwA, 0.5340, 3.54, 0.062, 214, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
4514, 5mx3L, 0.5340, 3.64, 0.076, 218, 66, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4515, 5laxB, 0.5340, 3.40, 0.095, 193, 63, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
4516, 5dmkB, 0.5340, 3.33, 0.095, 190, 63, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
4517, 5chnB, 0.5340, 3.61, 0.106, 218, 66, FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16
4518, 5ceyC, 0.5340, 3.59, 0.076, 207, 66, CRYSTAL STRUCTURE OF FAB 9H+3L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
4519, 5c5xF, 0.5340, 3.41, 0.030, 244, 67, CRYSTAL STRUCTURE OF THE S156E MUTANT OF HUMAN AQUAPORIN 5
4520, 5adpL, 0.5340, 3.60, 0.106, 217, 66, CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT
4521, 4xrcL, 0.5340, 3.70, 0.090, 208, 67, ANTIBODY HEMAGGLUTININ COMPLEXES
4522, 4onfH, 0.5340, 3.67, 0.094, 212, 64, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
4523, 4n2cA, 0.5340, 3.46, 0.076, 645, 66, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (F221/222A 10 MM CA2+)
4524, 4ma1B, 0.5340, 3.80, 0.092, 217, 65, UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
4525, 4m5yM, 0.5340, 3.71, 0.075, 211, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
4526, 4m1gH, 0.5340, 3.54, 0.079, 216, 63, STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS
4527, 4louD, 0.5340, 3.55, 0.062, 211, 65, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4528, 4evnN, 0.5340, 3.75, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4529, 3wexB, 0.5340, 3.30, 0.095, 195, 63, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
4530, 3vpdB, 0.5340, 3.07, 0.097, 268, 62, LYSX FROM THERMUS THERMOPHILUS COMPLEXED WITH AMP-PNP
4531, 3u7yL, 0.5340, 3.41, 0.108, 208, 65, STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV
4532, 3rvvD, 0.5340, 3.80, 0.092, 216, 65, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
4533, 3qa3K, 0.5340, 3.51, 0.097, 224, 62, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4534, 3g8dB, 0.5340, 3.22, 0.138, 444, 65, CRYSTAL STRUCTURE OF THE BIOTIN CARBOXYLASE SUBUNIT E296A MUTANT OF ACETYL-COA CARBOXYLASE FROM ESCHERICHIA COLI
4535, 3d69A, 0.5340, 3.67, 0.075, 211, 67, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12
4536, 2uylM, 0.5340, 3.68, 0.076, 216, 66, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4537, 2hfgL, 0.5340, 3.51, 0.108, 213, 65, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
4538, 2gsiB, 0.5340, 3.68, 0.094, 210, 64, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4539, 2gfbG, 0.5340, 3.61, 0.076, 214, 66, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
4540, 2ai0J, 0.5340, 3.37, 0.098, 223, 61, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
4541, 2a77H, 0.5340, 3.81, 0.092, 219, 65, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM II
4542, 1xf3B, 0.5340, 3.69, 0.094, 218, 64, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4543, 1u8kA, 0.5340, 3.43, 0.123, 214, 65, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
4544, 1plgL, 0.5340, 3.47, 0.062, 215, 65, EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)- POLYSIALIC ACID
4545, 1p2cD, 0.5340, 3.54, 0.077, 211, 65, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
4546, 1ngzA, 0.5340, 3.52, 0.108, 213, 65, CHIMERIC GERMLINE FAB 7G12-APO
4547, 1jnhA, 0.5340, 3.76, 0.104, 208, 67, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4548, 1jglH, 0.5340, 3.48, 0.097, 206, 62, CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
4549, 1ieaA, 0.5340, 3.48, 0.109, 182, 64, HISTOCOMPATIBILITY ANTIGEN
4550, 1fe8L, 0.5340, 3.77, 0.060, 211, 67, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4551, 1emtH, 0.5340, 3.37, 0.098, 208, 61, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
4552, 1ehlH, 0.5340, 3.41, 0.081, 217, 62, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
4553, 1egjL, 0.5340, 3.65, 0.061, 215, 66, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
4554, 1aupA, 0.5340, 3.36, 0.134, 427, 67, GLUTAMATE DEHYDROGENASE
4555, 6dfwB, 0.5339, 3.36, 0.095, 192, 63, TCR 8F10 IN COMPLEX WITH IAG7-P8G9E 
4556, 6d7gA, 0.5339, 3.32, 0.125, 386, 64, STRUCTURE OF 5F3 TCR IN COMPLEX WITH HLA-A2/MART-1 
4557, 6atzD, 0.5339, 3.47, 0.125, 187, 64, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
4558, 6atfE, 0.5339, 3.62, 0.123, 189, 65, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
4559, 6arpA, 0.5339, 3.50, 0.108, 213, 65, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
4560, 5x2pL, 0.5339, 3.50, 0.062, 217, 65, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4561, 5u3kL, 0.5339, 3.49, 0.108, 214, 65, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 662- 683 PEPTIDE
4562, 5t0yG, 0.5339, 3.48, 0.062, 211, 65, 2A10 ANTIBODY FAB FRAGMENT
4563, 5mvjL, 0.5339, 3.58, 0.077, 219, 65, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
4564, 5mu2F, 0.5339, 3.56, 0.077, 217, 65, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4565, 5mthA, 0.5339, 3.83, 0.092, 220, 65, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
4566, 5lspL, 0.5339, 3.64, 0.106, 212, 66, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
4567, 5lneA, 0.5339, 3.06, 0.076, 152, 66, E. COLI F9 PILUS ADHESIN FMLH BOUND TO THE THOMSEN-FRIEDENREICH (TF) ANTIGEN
4568, 5itfC, 0.5339, 3.52, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4569, 5f96L, 0.5339, 3.65, 0.106, 211, 66, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4570, 5c5xH, 0.5339, 3.42, 0.030, 244, 67, CRYSTAL STRUCTURE OF THE S156E MUTANT OF HUMAN AQUAPORIN 5
4571, 5bk3B, 0.5339, 3.60, 0.106, 217, 66, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
4572, 4zfkD, 0.5339, 3.44, 0.043, 228, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC WITH GLUTAMINE
4573, 4zfkC, 0.5339, 3.37, 0.044, 230, 68, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC WITH GLUTAMINE
4574, 4xwoJ, 0.5339, 3.59, 0.106, 215, 66, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4575, 4p4kE, 0.5339, 3.35, 0.111, 181, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
4576, 4nn5B, 0.5339, 3.31, 0.152, 197, 66, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1A
4577, 4mqxD, 0.5339, 3.79, 0.060, 211, 67, CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT
4578, 4ma7L, 0.5339, 3.66, 0.076, 213, 66, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
4579, 4lsdH, 0.5339, 3.26, 0.076, 93, 66, MYOKINE STRUCTURE
4580, 4kk8E, 0.5339, 3.65, 0.094, 221, 64, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4581, 4jfxA, 0.5339, 3.62, 0.106, 214, 66, STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4582, 4gh7B, 0.5339, 3.28, 0.154, 275, 65, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
4583, 4evnP, 0.5339, 3.75, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4584, 4evnD, 0.5339, 3.76, 0.090, 213, 67, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4585, 4d8pA, 0.5339, 3.50, 0.078, 184, 64, STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE
4586, 4aenB, 0.5339, 3.35, 0.095, 181, 63, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
4587, 3tt3L, 0.5339, 3.55, 0.077, 216, 65, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4588, 3stzB, 0.5339, 3.53, 0.062, 212, 65, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
4589, 3qrgL, 0.5339, 3.53, 0.108, 217, 65, CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
4590, 3mlvM, 0.5339, 3.70, 0.075, 219, 67, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
4591, 3hzmB, 0.5339, 3.53, 0.095, 225, 63, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
4592, 3f58H, 0.5339, 3.67, 0.094, 228, 64, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
4593, 3detF, 0.5339, 3.69, 0.076, 211, 66, STRUCTURE OF THE E148A Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1 CL-/H+ ANTIPORTER
4594, 2y07H, 0.5339, 3.59, 0.094, 215, 64, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
4595, 2xwxB, 0.5339, 3.56, 0.075, 385, 67, VIBRIO CHOLERAE COLONIZATION FACTOR GBPA CRYSTAL STRUCTURE
4596, 2vxvL, 0.5339, 3.50, 0.108, 214, 65, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
4597, 2uylX, 0.5339, 3.67, 0.076, 216, 66, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4598, 2qkiD, 0.5339, 3.49, 0.104, 632, 67, HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN
4599, 2n80B, 0.5339, 3.27, 0.077, 174, 65, P75NTR DD:RHOGDI
4600, 2ht4D, 0.5339, 3.55, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX
4601, 2hrpM, 0.5339, 3.67, 0.076, 218, 66, ANTIGEN-ANTIBODY COMPLEX
4602, 2gtzD, 0.5339, 3.64, 0.121, 275, 66, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
4603, 2fr4A, 0.5339, 3.52, 0.062, 213, 65, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
4604, 2feeI, 0.5339, 3.79, 0.092, 221, 65, STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
4605, 2ajvL, 0.5339, 3.52, 0.062, 216, 65, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH COCAINE
4606, 1zlvK, 0.5339, 3.46, 0.108, 211, 65, FAB 2G12 + MAN7
4607, 1xf4H, 0.5339, 3.82, 0.092, 213, 65, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4608, 1xf2A, 0.5339, 3.65, 0.076, 213, 66, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
4609, 1otsE, 0.5339, 3.62, 0.094, 221, 64, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
4610, 1nugA, 0.5339, 3.39, 0.077, 675, 65, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (2 CALCIUMS 1 MG INACTIVE FORM)
4611, 1fneC, 0.5339, 3.31, 0.111, 182, 63, HISTOCOMPATIBILITY ANTIGEN
4612, 1acyH, 0.5339, 3.55, 0.095, 221, 63, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
4613, 12e8P, 0.5339, 3.81, 0.092, 221, 65, 2E8 FAB FRAGMENT
4614, 6o6lB, 0.5338, 3.82, 0.058, 407, 69, THE STRUCTURE OF EGTB(CABTHER) IN COMPLEX WITH HERCYNINE 
4615, 6mtjL, 0.5338, 3.58, 0.076, 211, 66, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM 
4616, 6jbtL, 0.5338, 3.52, 0.108, 218, 65, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
4617, 6bixB, 0.5338, 3.47, 0.125, 189, 64, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
4618, 6bilB, 0.5338, 3.46, 0.125, 189, 64, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
4619, 6bftB, 0.5338, 3.52, 0.108, 214, 65, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
4620, 6aoyB, 0.5338, 3.27, 0.061, 157, 66, F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH O-NITROPHENYL BETA-GALACTOSIDE (ONPG)
4621, 5wkzL, 0.5338, 3.71, 0.075, 212, 67, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
4622, 5w5nB, 0.5338, 3.65, 0.090, 211, 67, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT
4623, 5uxqB, 0.5338, 3.61, 0.106, 217, 66, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
4624, 5ukpL, 0.5338, 3.73, 0.090, 210, 67, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.1 FAB
4625, 5tvfE, 0.5338, 2.99, 0.048, 292, 62, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI ADOMETDC/PROZYME HETERODIMER IN COMPLEX WITH INHIBITOR CGP 40215
4626, 5thpO, 0.5338, 3.39, 0.119, 191, 67, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
4627, 5t5fL, 0.5338, 3.50, 0.062, 216, 65, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
4628, 5nkqH, 0.5338, 3.13, 0.063, 87, 63, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
4629, 5mu2L, 0.5338, 3.66, 0.076, 218, 66, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4630, 5iq7L, 0.5338, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8-S74W FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
4631, 5ihuL, 0.5338, 3.73, 0.104, 213, 67, CRYSTAL STRUCTURE OF BOVINE FAB B11
4632, 5i18L, 0.5338, 3.52, 0.108, 219, 65, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
4633, 5f6hP, 0.5338, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
4634, 5f6hJ, 0.5338, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
4635, 5e99L, 0.5338, 3.73, 0.104, 213, 67, BOVINE FAB FRAGMENT F08_B11
4636, 5d7sL, 0.5338, 3.69, 0.075, 205, 67, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT
4637, 4zflB, 0.5338, 3.37, 0.043, 229, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
4638, 4yk4Y, 0.5338, 3.62, 0.106, 211, 66, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4639, 4wzdDC, 0.5338, 3.46, 0.096, 135, 73, 
4640, 4wcyH, 0.5338, 3.81, 0.092, 210, 65, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
4641, 4rwyL, 0.5338, 3.49, 0.108, 213, 65, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC131 IN COMPLEX WITH HIV-1 CLADE B YU2 GP120
4642, 4r90L, 0.5338, 3.60, 0.076, 210, 66, ANTI CD70 LLAMA GLAMA FAB 27B3
4643, 4kkaF, 0.5338, 3.70, 0.076, 211, 66, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4644, 4g7vL, 0.5338, 3.64, 0.106, 211, 66, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
4645, 4e41A, 0.5338, 3.37, 0.111, 179, 63, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4646, 3uyrL, 0.5338, 3.60, 0.076, 218, 66, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4647, 3sgeH, 0.5338, 3.53, 0.097, 217, 62, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
4648, 3mmeD, 0.5338, 3.74, 0.075, 211, 67, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4649, 3ijyD, 0.5338, 3.38, 0.115, 220, 61, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
4650, 3idmA, 0.5338, 3.63, 0.121, 214, 66, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS
4651, 3go1L, 0.5338, 3.62, 0.091, 209, 66, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN
4652, 3di2B, 0.5338, 3.19, 0.108, 195, 65, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH UNGLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
4653, 3cfbA, 0.5338, 3.55, 0.062, 218, 65, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
4654, 3aqyA, 0.5338, 3.19, 0.046, 99, 65, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN
4655, 2ypvL, 0.5338, 3.69, 0.076, 212, 66, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
4656, 2y06H, 0.5338, 3.62, 0.094, 215, 64, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
4657, 2x31D, 0.5338, 3.26, 0.104, 187, 67, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
4658, 2wbjF, 0.5338, 3.27, 0.111, 188, 63, TCR COMPLEX
4659, 2uylY, 0.5338, 3.83, 0.092, 213, 65, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4660, 2r8sL, 0.5338, 3.62, 0.106, 214, 66, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
4661, 2jhwB, 0.5338, 3.21, 0.076, 138, 66, CRYSTAL STRUCTURE OF RHOGDI E155A E157A MUTANT
4662, 2h9gL, 0.5338, 3.52, 0.108, 211, 65, CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
4663, 2h2sF, 0.5338, 3.77, 0.060, 211, 67, CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-
4664, 1xgvB, 0.5338, 3.24, 0.058, 420, 69, ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX
4665, 1um6L, 0.5338, 3.45, 0.108, 219, 65, CATALYTIC ANTIBODY 21H3
4666, 1pgrF, 0.5338, 3.47, 0.045, 209, 66, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
4667, 1pgrB, 0.5338, 3.47, 0.045, 208, 66, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
4668, 1o98A, 0.5338, 3.81, 0.061, 509, 66, 1.4A CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM BACILLUS STEAROTHERMOPHILUS COMPLEXED WITH 2-PHOSPHOGLYCERATE
4669, 1bfoF, 0.5338, 3.47, 0.097, 216, 62, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4670, 6o6mB, 0.5337, 3.82, 0.058, 406, 69, THE STRUCTURE OF EGTB (CABTHER) 
4671, 6megL, 0.5337, 3.71, 0.075, 213, 67, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4672, 6iscB, 0.5337, 3.50, 0.044, 118, 68, COMPLEX STRUCTURE OF MCD226-ECTO AND HCD155-D1 
4673, 6h0eB, 0.5337, 3.52, 0.108, 218, 65, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
4674, 6be4L, 0.5337, 3.47, 0.103, 213, 68, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)
4675, 5x4gA, 0.5337, 3.70, 0.094, 215, 64, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
4676, 5vplC, 0.5337, 3.52, 0.062, 211, 65, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
4677, 5vh4L, 0.5337, 3.52, 0.108, 213, 65, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
4678, 5vh4B, 0.5337, 3.53, 0.108, 213, 65, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
4679, 5jvdF, 0.5337, 2.79, 0.067, 348, 60, TUBULIN-TUB092 COMPLEX
4680, 5hpmC, 0.5337, 3.50, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4681, 5d96I, 0.5337, 3.50, 0.062, 214, 65, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
4682, 5bzdA, 0.5337, 3.51, 0.108, 213, 65, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
4683, 5a16H, 0.5337, 3.65, 0.076, 218, 66, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4684, 4zfoB, 0.5337, 3.61, 0.106, 213, 66, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
4685, 4yblL, 0.5337, 3.70, 0.075, 210, 67, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32
4686, 4x7sL, 0.5337, 3.51, 0.108, 218, 65, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
4687, 4rirL, 0.5337, 3.72, 0.075, 214, 67, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
4688, 4m5zL, 0.5337, 3.75, 0.075, 212, 67, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 5J8 BOUND TO 2009 PANDEMIC INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4689, 4gayA, 0.5337, 3.49, 0.097, 207, 62, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4690, 4cniB, 0.5337, 3.52, 0.108, 214, 65, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
4691, 4c83D, 0.5337, 3.56, 0.077, 213, 65, CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS
4692, 3qazX, 0.5337, 3.38, 0.121, 191, 66, IL-2 MUTANT D10 TERNARY COMPLEX
4693, 3o6mL, 0.5337, 3.57, 0.077, 216, 65, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 9-MER TAT PEPTIDE
4694, 3o0rL, 0.5337, 3.54, 0.062, 213, 65, CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4695, 3i75B, 0.5337, 3.51, 0.095, 223, 63, ANTIBODY STRUCTURE
4696, 3detD, 0.5337, 3.56, 0.062, 211, 65, STRUCTURE OF THE E148A Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1 CL-/H+ ANTIPORTER
4697, 3d9aL, 0.5337, 3.70, 0.076, 213, 66, HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
4698, 3cviH, 0.5337, 3.35, 0.098, 213, 61, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
4699, 3c5sC, 0.5337, 3.78, 0.060, 217, 67, CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
4700, 2z91A, 0.5337, 3.83, 0.092, 207, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
4701, 2xtjC, 0.5337, 3.56, 0.106, 105, 66, THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB
4702, 2x4qD, 0.5337, 3.65, 0.121, 275, 66, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
4703, 2oxgD, 0.5337, 3.03, 0.081, 111, 62, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
4704, 2gsiG, 0.5337, 3.64, 0.076, 215, 66, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4705, 1ub5B, 0.5337, 3.47, 0.062, 214, 65, CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K
4706, 1tdqA, 0.5337, 3.37, 0.167, 271, 66, STRUCTURAL BASIS FOR THE INTERACTIONS BETWEEN TENASCINS AND THE C-TYPE LECTIN DOMAINS FROM LECTICANS: EVIDENCE FOR A CROSS-LINKING ROLE FOR TENASCINS
4707, 1sjeA, 0.5337, 3.36, 0.111, 180, 63, HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
4708, 1qblL, 0.5337, 3.62, 0.076, 214, 66, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
4709, 1ntlB, 0.5337, 3.45, 0.076, 551, 66, MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4710, 1kg0B, 0.5337, 3.37, 0.095, 188, 63, STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
4711, 1jwsA, 0.5337, 3.38, 0.111, 180, 63, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
4712, 1h3pH, 0.5337, 3.66, 0.094, 214, 64, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
4713, 1fngA, 0.5337, 3.47, 0.109, 182, 64, HISTOCOMPATIBILITY ANTIGEN
4714, 1c1eL, 0.5337, 3.53, 0.077, 216, 65, CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
4715, 6qf5B, 0.5336, 3.13, 0.015, 230, 66, X-RAY STRUCTURE OF HUMAN AQUAPORIN 2 CRYSTALLIZED ON A SILICON CHIP 
4716, 6flaB, 0.5336, 3.68, 0.076, 216, 66, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
4717, 6cdoB, 0.5336, 3.46, 0.108, 219, 65, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4718, 6blxB, 0.5336, 3.33, 0.095, 197, 63, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8G9E
4719, 5x2pH, 0.5336, 3.68, 0.094, 219, 64, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4720, 5wnbL, 0.5336, 3.51, 0.108, 213, 65, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE LINEAR EPITOPE OF RSV G
4721, 5utfL, 0.5336, 3.62, 0.076, 208, 66, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M Y177W N300M N302M T320L I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A
4722, 5tvfF, 0.5336, 2.83, 0.049, 290, 61, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI ADOMETDC/PROZYME HETERODIMER IN COMPLEX WITH INHIBITOR CGP 40215
4723, 5te6L, 0.5336, 3.59, 0.106, 210, 66, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE
4724, 5mu2H, 0.5336, 3.56, 0.077, 217, 65, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4725, 5j7kA, 0.5336, 3.12, 0.095, 84, 63, LOOP GRAFTING ONTO A HIGHLY STABLE FN3 SCAFFOLD
4726, 5iopC, 0.5336, 3.51, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4727, 5i8cB, 0.5336, 3.46, 0.108, 212, 65, CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB
4728, 5hd8C, 0.5336, 3.68, 0.094, 221, 64, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
4729, 5e8dL, 0.5336, 3.61, 0.076, 210, 66, CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5
4730, 5dd0L, 0.5336, 3.61, 0.121, 211, 66, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
4731, 4rrpE, 0.5336, 3.51, 0.108, 214, 65, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
4732, 4r7dN, 0.5336, 3.45, 0.108, 211, 65, FAB HU 15C1
4733, 4p4rB, 0.5336, 3.40, 0.095, 199, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
4734, 4leeC, 0.5336, 3.15, 0.076, 313, 66, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
4735, 4kxzP, 0.5336, 3.63, 0.106, 213, 66, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4736, 4kkcD, 0.5336, 3.69, 0.076, 211, 66, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4737, 4k23H, 0.5336, 3.65, 0.094, 212, 64, STRUCTURE OF ANTI-UPAR FAB ATN-658
4738, 4f3fA, 0.5336, 3.64, 0.106, 211, 66, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4739, 4bz1L, 0.5336, 3.51, 0.077, 218, 65, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
4740, 3sgdL, 0.5336, 3.54, 0.077, 218, 65, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
4741, 3qehB, 0.5336, 3.51, 0.108, 215, 65, CRYSTAL STRUCTURE OF HUMAN N12-I15 AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
4742, 3q3gB, 0.5336, 3.66, 0.094, 224, 64, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4743, 3mnzA, 0.5336, 3.46, 0.108, 220, 65, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION
4744, 3hi6L, 0.5336, 3.52, 0.108, 210, 65, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
4745, 3fb7B, 0.5336, 3.54, 0.062, 212, 65, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
4746, 3fb5B, 0.5336, 3.54, 0.062, 212, 65, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
4747, 3f7vB, 0.5336, 3.54, 0.062, 212, 65, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
4748, 3eyqC, 0.5336, 3.58, 0.106, 212, 66, CRYSTAL STRUCTURE OF MJ5 FAB A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
4749, 1w2kT, 0.5336, 3.10, 0.077, 188, 65, TF7A_4380 COMPLEX
4750, 1qfhA, 0.5336, 3.57, 0.090, 212, 67, DIMERIZATION OF GELATION FACTOR FROM DICTYOSTELIUM DISCOIDEUM: CRYSTAL STRUCTURE OF ROD DOMAINS 5 AND 6
4751, 1q0xL, 0.5336, 3.71, 0.090, 212, 67, ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
4752, 1otuD, 0.5336, 3.55, 0.062, 211, 65, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
4753, 1lo2L, 0.5336, 3.46, 0.062, 219, 65, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
4754, 1ktdC, 0.5336, 3.46, 0.109, 182, 64, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
4755, 1f11B, 0.5336, 3.52, 0.097, 218, 62, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
4756, 1d5iL, 0.5336, 3.53, 0.108, 211, 65, UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
4757, 1bgxL, 0.5336, 3.65, 0.091, 210, 66, TAQ POLYMERASE IN COMPLEX WITH TP7 AN INHIBITORY FAB
4758, 1ahwA, 0.5336, 3.87, 0.088, 214, 68, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
4759, 6mnsL, 0.5335, 3.73, 0.090, 211, 67, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
4760, 6h0eL, 0.5335, 3.53, 0.108, 218, 65, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
4761, 6flbL, 0.5335, 3.68, 0.076, 216, 66, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
4762, 6e64B, 0.5335, 3.80, 0.074, 213, 68, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
4763, 6bzyL, 0.5335, 3.55, 0.077, 215, 65, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
4764, 5o14D, 0.5335, 3.60, 0.106, 215, 66, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
4765, 5muqH, 0.5335, 3.78, 0.092, 219, 65, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4766, 5muqA, 0.5335, 3.78, 0.092, 219, 65, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4767, 5lg1A, 0.5335, 3.63, 0.090, 209, 67, ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU
4768, 5jo4D, 0.5335, 3.52, 0.108, 209, 65, ANTIBODY FAB FRAGMENT COMPLEX
4769, 5hhxL, 0.5335, 3.60, 0.076, 213, 66, INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE
4770, 4zpvH, 0.5335, 3.36, 0.082, 213, 61, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
4771, 4zflG, 0.5335, 3.38, 0.043, 229, 69, ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE
4772, 4xc3L, 0.5335, 3.47, 0.108, 213, 65, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE
4773, 4rapG, 0.5335, 2.80, 0.117, 387, 60, CRYSTAL STRUCTURE OF BACTERIAL IRON-CONTAINING DODECAMERIC GLYCOSYLTRANSFERASE TIBC FROM ENTEROTOXIGENIC E.COLI H10407
4774, 4p57B, 0.5335, 3.32, 0.095, 197, 63, MHC TCR PEPTIDE COMPLEX
4775, 4p46D, 0.5335, 3.33, 0.095, 199, 63, J809.B5 Y31A TCR BOUND TO IAB3K
4776, 4ov5H, 0.5335, 3.40, 0.095, 189, 63, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
4777, 4md0B, 0.5335, 3.47, 0.125, 189, 64, IMMUNE RECEPTOR
4778, 4mczB, 0.5335, 3.46, 0.125, 189, 64, IMMUNE RECEPTOR
4779, 4lbeB, 0.5335, 3.55, 0.062, 212, 65, STRUCTURE OF KCSA WITH R122A MUTATION
4780, 4kvcL, 0.5335, 3.50, 0.077, 212, 65, 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
4781, 4kk8C, 0.5335, 3.51, 0.097, 221, 62, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4782, 4kjwE, 0.5335, 3.66, 0.094, 221, 64, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4783, 4ki1B, 0.5335, 3.74, 0.060, 211, 67, PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23
4784, 4j39A, 0.5335, 2.69, 0.068, 122, 59, CRYSTAL STRUCTURE OF P19 IN COMPLEX WITH DOUBLE-HELICAL 19MER RNA P(CAG)3C(CUG)3
4785, 4iizB, 0.5335, 3.35, 0.092, 115, 65, CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH LUMIRACOXIB
4786, 4hwbL, 0.5335, 3.46, 0.108, 212, 65, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4787, 4gbxA, 0.5335, 3.35, 0.111, 180, 63, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
4788, 4fqqA, 0.5335, 3.83, 0.074, 211, 68, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
4789, 4fccD, 0.5335, 3.36, 0.123, 442, 65, GLUTAMATE DEHYDROGENASE FROM E. COLI
4790, 4cadJ, 0.5335, 3.51, 0.062, 212, 65, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4791, 4cadD, 0.5335, 3.37, 0.062, 211, 64, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4792, 3s3pA, 0.5335, 3.42, 0.106, 611, 66, TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR
4793, 3rvvC, 0.5335, 3.53, 0.062, 211, 65, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
4794, 3ra7I, 0.5335, 3.36, 0.098, 225, 61, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
4795, 3oskB, 0.5335, 3.40, 0.087, 123, 69, CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
4796, 3nz8A, 0.5335, 3.80, 0.092, 217, 65, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4797, 3lrsB, 0.5335, 3.72, 0.075, 211, 67, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4798, 3jq3A, 0.5335, 3.64, 0.027, 364, 74, CRYSTAL STRUCTURE OF LOMBRICINE KINASE COMPLEXED WITH SUBSTRATE ADP
4799, 3i9gL, 0.5335, 3.61, 0.106, 213, 66, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
4800, 3bz4B, 0.5335, 3.35, 0.098, 209, 61, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
4801, 2gt9A, 0.5335, 3.65, 0.121, 275, 66, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE
4802, 2ez0D, 0.5335, 3.55, 0.062, 211, 65, CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC IN COMPLEX WITH A FAB FRAGMENT
4803, 1uwgX, 0.5335, 3.44, 0.108, 213, 65, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4804, 1qygH, 0.5335, 3.64, 0.094, 220, 64, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
4805, 1m7iA, 0.5335, 3.66, 0.076, 215, 66, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
4806, 1l7tL, 0.5335, 3.62, 0.091, 219, 66, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
4807, 1adqL, 0.5335, 3.68, 0.090, 213, 67, CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
4808, 6dwiO, 0.5334, 3.52, 0.108, 211, 65, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4809, 6a77L, 0.5334, 3.56, 0.077, 211, 65, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
4810, 5werC, 0.5334, 3.38, 0.076, 317, 66, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
4811, 5w1mA, 0.5334, 3.49, 0.109, 221, 64, MACV GP1 CR1-07 FAB COMPLEX 
4812, 5vplD, 0.5334, 3.80, 0.092, 216, 65, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
4813, 5viyI, 0.5334, 3.33, 0.094, 213, 64, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
4814, 5v4eB, 0.5334, 3.69, 0.119, 186, 67, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
4815, 5tpnL, 0.5334, 3.47, 0.109, 214, 64, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH HUMAN ANTIBODY HRSV90
4816, 5tl5L, 0.5334, 3.55, 0.108, 217, 65, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
4817, 5o35A, 0.5334, 3.33, 0.106, 642, 66, STRUCTURE OF COMPLEMENT PROTEINS COMPLEX
4818, 5mu2N, 0.5334, 3.57, 0.077, 218, 65, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4819, 5mp1J, 0.5334, 3.65, 0.094, 214, 64, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
4820, 5jnyB, 0.5334, 3.71, 0.075, 212, 67, CRYSTAL STRUCTURE OF 10E8 FAB
4821, 5ig7H, 0.5334, 3.61, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
4822, 5i2iC, 0.5334, 3.50, 0.108, 213, 65, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4823, 5eocH, 0.5334, 3.82, 0.092, 212, 65, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4824, 5do2C, 0.5334, 3.46, 0.097, 215, 62, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
4825, 4xnyL, 0.5334, 3.45, 0.108, 211, 65, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
4826, 4v5lMA, 0.5334, 3.48, 0.110, 228, 73, 
4827, 4uokL, 0.5334, 3.52, 0.077, 215, 65, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4
4828, 4qhuA, 0.5334, 3.73, 0.075, 209, 67, CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX
4829, 4ov5Q, 0.5334, 3.41, 0.095, 189, 63, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
4830, 4odtH, 0.5334, 3.76, 0.079, 226, 63, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
4831, 4ik6A, 0.5334, 3.35, 0.092, 116, 65, CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH LUMIRACOXIB
4832, 4hg4O, 0.5334, 3.58, 0.106, 214, 66, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4833, 4fg6C, 0.5334, 3.57, 0.095, 221, 63, STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4834, 3wexH, 0.5334, 3.39, 0.095, 195, 63, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
4835, 3v4uH, 0.5334, 3.70, 0.078, 216, 64, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4836, 3pnwS, 0.5334, 3.49, 0.108, 214, 65, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
4837, 3okmB, 0.5334, 3.37, 0.098, 215, 61, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
4838, 3l4gN, 0.5334, 3.09, 0.129, 589, 62, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
4839, 2x09A, 0.5334, 3.39, 0.029, 850, 68, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
4840, 2jk5B, 0.5334, 3.53, 0.062, 212, 65, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
4841, 2iffL, 0.5334, 3.54, 0.062, 212, 65, STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
4842, 2h3nB, 0.5334, 3.73, 0.090, 116, 67, CRYSTAL STRUCTURE OF A SURROGATE LIGHT CHAIN (LAMBDA5 AND VPREB) HOMODIMER
4843, 2f5bL, 0.5334, 3.47, 0.123, 214, 65, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
4844, 2ak1L, 0.5334, 3.68, 0.076, 216, 66, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH BENZOIC ACID
4845, 2a6kA, 0.5334, 3.73, 0.076, 214, 66, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
4846, 1wlhA, 0.5334, 3.73, 0.074, 308, 68, MOLECULAR STRUCTURE OF THE ROD DOMAIN OF DICTYOSTELIUM FILAMIN
4847, 1uweU, 0.5334, 3.62, 0.106, 213, 66, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4848, 1uvqB, 0.5334, 3.36, 0.078, 181, 64, CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE
4849, 1ineL, 0.5334, 3.88, 0.103, 211, 68, HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB (SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
4850, 1i7zC, 0.5334, 3.45, 0.108, 219, 65, ANTIBODY GNC92H2 BOUND TO LIGAND
4851, 1gpoH, 0.5334, 3.81, 0.092, 214, 65, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
4852, 1fe8I, 0.5334, 3.35, 0.098, 210, 61, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4853, 1fdlL, 0.5334, 3.62, 0.076, 214, 66, CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5- ANGSTROMS RESOLUTION
4854, 1bfoH, 0.5334, 3.71, 0.109, 216, 64, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4855, 6ghgB, 0.5333, 3.45, 0.108, 214, 65, VARIABLE HEAVY - VARIABLE LIGHT DOMAIN AND FAB-ARM CROSSMABS WITH CHARGED RESIDUE EXCHANGES 
4856, 6bliE, 0.5333, 3.52, 0.108, 214, 65, RSV G PEPTIDE BOUND TO FAB CB002.5
4857, 6bjzL, 0.5333, 3.46, 0.108, 214, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY CONTAINING THE FLUORESCENT NON-CANONICAL AMINO ACID L-(7- HYDROXYCOUMARIN-4-YL)ETHYLGLYCINE AT PH 5.5 
4858, 6b5mL, 0.5333, 3.53, 0.108, 217, 65, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4859, 6atiB, 0.5333, 3.49, 0.109, 190, 64, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
4860, 6al5L, 0.5333, 3.63, 0.106, 217, 66, COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
4861, 5xrqB, 0.5333, 3.58, 0.106, 212, 66, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
4862, 5wnaD, 0.5333, 3.52, 0.108, 211, 65, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE CENTRAL CONSERVED REGION OF RSV 2 G
4863, 5utzK, 0.5333, 3.71, 0.075, 215, 67, HUMAN IL-2/FAB COMPLEX 
4864, 5t1mC, 0.5333, 3.52, 0.108, 213, 65, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
4865, 5mp5E, 0.5333, 3.81, 0.092, 217, 65, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
4866, 5l9dL, 0.5333, 3.53, 0.077, 214, 65, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM I PARSIMONIOUS MODEL
4867, 5jo4C, 0.5333, 3.76, 0.077, 221, 65, ANTIBODY FAB FRAGMENT COMPLEX
4868, 5fuoL, 0.5333, 3.44, 0.108, 217, 65, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
4869, 5f9wL, 0.5333, 3.45, 0.108, 210, 65, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4870, 5eblB, 0.5333, 3.52, 0.062, 212, 65, KCSA T75G IN THE CONDUCTIVE STATE
4871, 5e2wL, 0.5333, 3.53, 0.108, 216, 65, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
4872, 4xnmL, 0.5333, 3.84, 0.088, 208, 68, ANTIBODY INFLUENZA H5 COMPLEX
4873, 4xcnI, 0.5333, 3.63, 0.106, 214, 66, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4874, 4p4rC, 0.5333, 3.39, 0.111, 178, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
4875, 4p4rA, 0.5333, 3.38, 0.111, 178, 63, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
4876, 4npyL, 0.5333, 3.60, 0.076, 212, 66, CRYSTAL STRUCTURE OF GERMLINE FAB PGT121 A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4877, 4mxvX, 0.5333, 3.51, 0.108, 211, 65, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
4878, 4kk5C, 0.5333, 3.61, 0.094, 221, 64, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4879, 4hj0Q, 0.5333, 3.68, 0.061, 210, 66, CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION
4880, 4gkoA, 0.5333, 3.66, 0.061, 209, 66, CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23
4881, 4bm7B, 0.5333, 3.70, 0.119, 183, 67, CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION
4882, 3v52H, 0.5333, 3.70, 0.078, 215, 64, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4883, 3r0nA, 0.5333, 3.45, 0.043, 128, 69, CRYSTAL STRUCTURE OF THE IMMUNOGLOBULIN VARIABLE DOMAIN OF NECTIN-2
4884, 3r08H, 0.5333, 3.38, 0.131, 216, 61, CRYSTAL STRUCTURE OF MOUSE CD3EPSILON IN COMPLEX WITH ANTIBODY 2C11 FAB
4885, 3o3bD, 0.5333, 3.32, 0.125, 275, 64, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
4886, 3l4gP, 0.5333, 3.09, 0.129, 589, 62, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
4887, 3l4gF, 0.5333, 3.09, 0.129, 589, 62, CRYSTAL STRUCTURE OF HOMO SAPIENS CYTOPLASMIC PHENYLALANYL-TRNA SYNTHETASE
4888, 3jabQ, 0.5333, 3.80, 0.092, 221, 65, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
4889, 3jabH, 0.5333, 3.80, 0.092, 221, 65, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
4890, 2w9dL, 0.5333, 3.54, 0.077, 210, 65, STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.
4891, 2hrpN, 0.5333, 3.81, 0.092, 224, 65, ANTIGEN-ANTIBODY COMPLEX
4892, 2hlfC, 0.5333, 3.63, 0.094, 221, 64, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
4893, 2exyD, 0.5333, 3.55, 0.062, 211, 65, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
4894, 2aabL, 0.5333, 3.60, 0.077, 217, 65, STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM
4895, 2a6kH, 0.5333, 3.80, 0.092, 216, 65, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
4896, 1r3iL, 0.5333, 3.54, 0.062, 212, 65, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
4897, 1pywA, 0.5333, 3.36, 0.111, 179, 63, HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ FVKQNA(MAA)AL IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
4898, 1oakH, 0.5333, 3.55, 0.095, 218, 63, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
4899, 1bfoB, 0.5333, 3.47, 0.097, 216, 62, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4900, 1a6tA, 0.5333, 3.62, 0.076, 210, 66, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
4901, 12e8H, 0.5333, 3.80, 0.092, 221, 65, 2E8 FAB FRAGMENT
4902, 7fabL, 0.5332, 3.61, 0.076, 204, 66, CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION
4903, 6rcvG, 0.5332, 3.60, 0.076, 210, 66, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
4904, 6rcoD, 0.5332, 3.60, 0.076, 215, 66, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
4905, 6oe4C, 0.5332, 3.62, 0.106, 212, 66, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
4906, 6me1B, 0.5332, 3.46, 0.108, 212, 65, CRYSTAL STRUCTURE OF THE CLADE B ISOLATE B41 MUTANT FUSION PEPTIDE (RESIDUES 512-521) IN COMPLEX WITH VRC34.01 
4907, 6iebF, 0.5332, 3.63, 0.076, 204, 66, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R15 
4908, 6hkgB, 0.5332, 3.52, 0.108, 214, 65, STRUCTURE OF FISW84 FAB FRAGMENT 
4909, 6fbjH, 0.5332, 3.53, 0.097, 214, 62, MONOCLONAL ANTIBODY TARGETING MATRIX METALLOPROTEINASE 7 
4910, 6e63L, 0.5332, 3.73, 0.075, 215, 67, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
4911, 6bftL, 0.5332, 3.52, 0.108, 213, 65, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
4912, 5yslG, 0.5332, 3.52, 0.081, 210, 62, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
4913, 5xlkB, 0.5332, 3.48, 0.057, 189, 70, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SERRATIA MARCESCENS IN SPACE GROUP I422
4914, 5xlkA, 0.5332, 3.49, 0.057, 189, 70, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SERRATIA MARCESCENS IN SPACE GROUP I422
4915, 5werI, 0.5332, 3.39, 0.077, 301, 65, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
4916, 5vh3L, 0.5332, 3.42, 0.109, 214, 64, CRYSTAL STRUCTURE OF FAB FRAGMENT OF THE ANTI-TNFA ANTIBODY INFLIXIMAB IN A C-CENTERED ORTHORHOMBIC CRYSTAL FORM
4917, 5ushL, 0.5332, 3.77, 0.090, 212, 67, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
4918, 5ueaL, 0.5332, 3.62, 0.106, 211, 66, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH HISTONE CHAPERONE ASF1
4919, 5u3pL, 0.5332, 3.64, 0.106, 214, 66, CRYSTAL STRUCTURE OF DH511.4 FAB
4920, 5mvjC, 0.5332, 3.81, 0.092, 213, 65, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
4921, 5lngD, 0.5332, 3.43, 0.060, 151, 67, LECTIN DOMAIN OF E. COLI F9 PILUS ADHESIN FMLH
4922, 5ig7E, 0.5332, 3.60, 0.076, 213, 66, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
4923, 5gz0A, 0.5332, 3.54, 0.108, 213, 65, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4924, 4zxbB, 0.5332, 3.67, 0.076, 218, 66, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
4925, 4xwoF, 0.5332, 3.51, 0.108, 215, 65, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4926, 4v7jFC, 0.5332, 3.59, 0.108, 120, 74, 
4927, 4uv4L, 0.5332, 3.62, 0.106, 217, 66, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
4928, 4r7nD, 0.5332, 3.54, 0.108, 211, 65, FAB C2E3
4929, 4p2oA, 0.5332, 3.34, 0.111, 175, 63, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK
4930, 4nkqA, 0.5332, 3.11, 0.109, 412, 64, STRUCTURE OF A CYTOKINE RECEPTOR COMPLEX
4931, 4nkiL, 0.5332, 3.60, 0.091, 212, 66, CRYSTAL STRUCTURE OF A FAB
4932, 4l29C, 0.5332, 3.55, 0.123, 276, 65, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
4933, 4kklE, 0.5332, 3.80, 0.092, 221, 65, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4934, 4kk8D, 0.5332, 3.55, 0.062, 211, 65, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4935, 4am0H, 0.5332, 3.66, 0.078, 214, 64, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4936, 4aeiI, 0.5332, 3.38, 0.098, 210, 61, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4937, 3w3bA, 0.5332, 3.30, 0.092, 116, 65, CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN
4938, 3u36F, 0.5332, 3.72, 0.075, 211, 67, CRYSTAL STRUCTURE OF PG9 FAB
4939, 3u36D, 0.5332, 3.72, 0.075, 211, 67, CRYSTAL STRUCTURE OF PG9 FAB
4940, 3tnnF, 0.5332, 3.74, 0.075, 212, 67, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
4941, 3ngbK, 0.5332, 3.83, 0.103, 210, 68, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
4942, 3mo1A, 0.5332, 3.48, 0.108, 218, 65, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4943, 3mcg1, 0.5332, 3.56, 0.091, 215, 66, THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
4944, 3d69L, 0.5332, 3.77, 0.074, 211, 68, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12
4945, 3cfcL, 0.5332, 3.54, 0.062, 219, 65, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2
4946, 2y7oA, 0.5332, 3.09, 0.076, 311, 66, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 - G299W MUTANT
4947, 2pxyD, 0.5332, 3.39, 0.095, 189, 63, CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
4948, 2gjzL, 0.5332, 3.67, 0.076, 217, 66, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
4949, 2fedD, 0.5332, 3.66, 0.076, 211, 66, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4950, 2c1pH, 0.5332, 3.51, 0.097, 215, 62, FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE
4951, 1v7mI, 0.5332, 3.81, 0.108, 217, 65, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4952, 1ub5L, 0.5332, 3.47, 0.062, 214, 65, CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K
4953, 1qkzH, 0.5332, 3.33, 0.082, 219, 61, FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G
4954, 1nakL, 0.5332, 3.64, 0.076, 217, 66, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4955, 1jwuA, 0.5332, 3.37, 0.111, 180, 63, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
4956, 1gc1L, 0.5332, 3.58, 0.108, 213, 65, HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
4957, 1deeE, 0.5332, 3.57, 0.108, 214, 65, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
4958, 6mfgA, 0.5331, 3.52, 0.078, 181, 64, HLA-DQ2-GLIA-ALPHA1 
4959, 6h0eF, 0.5331, 3.52, 0.108, 218, 65, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
4960, 6dcwL, 0.5331, 3.47, 0.108, 219, 65, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
4961, 6ca6A, 0.5331, 3.46, 0.108, 211, 65, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
4962, 6bpcF, 0.5331, 3.50, 0.062, 211, 65, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4963, 6b3sK, 0.5331, 3.45, 0.108, 213, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
4964, 6b3sD, 0.5331, 3.46, 0.108, 213, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
4965, 5xljA, 0.5331, 3.46, 0.057, 192, 70, CRYSTAL STRUCTURE OF THE FLAGELLAR CAP PROTEIN FLID D2-D3 DOMAINS FROM SERRATIA MARCESCENS IN SPACE GROUP P432
4966, 5vj6L, 0.5331, 3.72, 0.075, 211, 67, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
4967, 5tplL, 0.5331, 3.61, 0.076, 210, 66, CRYSTAL STRUCTURE OF DH270.3 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
4968, 5nbwL, 0.5331, 3.54, 0.062, 214, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
4969, 5lspT, 0.5331, 3.66, 0.106, 212, 66, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
4970, 5k8aL, 0.5331, 3.51, 0.108, 213, 65, NIST FAB
4971, 5hd8F, 0.5331, 3.56, 0.062, 211, 65, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
4972, 5fv6A, 0.5331, 3.58, 0.090, 168, 67, KPFLO11 PRESENTS A NOVEL MEMBER OF THE FLO11 FAMILY WITH A UNIQUE RECOGNITION PATTERN FOR HOMOPHILIC INTERACTIONS
4973, 5do2D, 0.5331, 3.52, 0.062, 214, 65, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
4974, 5cd3D, 0.5331, 3.61, 0.106, 206, 66, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4975, 5c5xG, 0.5331, 3.43, 0.015, 244, 67, CRYSTAL STRUCTURE OF THE S156E MUTANT OF HUMAN AQUAPORIN 5
4976, 5c5xC, 0.5331, 3.42, 0.030, 244, 67, CRYSTAL STRUCTURE OF THE S156E MUTANT OF HUMAN AQUAPORIN 5
4977, 4xcyI, 0.5331, 3.47, 0.108, 211, 65, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4978, 4xbgD, 0.5331, 3.61, 0.106, 214, 66, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4979, 4x4mD, 0.5331, 3.62, 0.090, 214, 67, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
4980, 4whtP, 0.5331, 3.69, 0.091, 215, 66, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4981, 4rirB, 0.5331, 3.60, 0.076, 214, 66, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
4982, 4r97C, 0.5331, 3.84, 0.108, 218, 65, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
4983, 4ozhB, 0.5331, 3.33, 0.079, 181, 63, S16 PROTEIN COMPLEX
4984, 4oz4B, 0.5331, 3.64, 0.076, 218, 66, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4985, 4ocsL, 0.5331, 3.69, 0.075, 212, 67, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4986, 4louE, 0.5331, 3.80, 0.092, 221, 65, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4987, 4k7pX, 0.5331, 3.46, 0.108, 213, 65, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4988, 4jg0L, 0.5331, 3.61, 0.106, 214, 66, STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4989, 4ikkA, 0.5331, 3.31, 0.092, 116, 65, CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH SULINDAC
4990, 4fqhB, 0.5331, 3.73, 0.075, 212, 67, CRYSTAL STRUCTURE OF FAB CR9114
4991, 4fccE, 0.5331, 3.35, 0.123, 442, 65, GLUTAMATE DEHYDROGENASE FROM E. COLI
4992, 3uyrH, 0.5331, 3.71, 0.078, 215, 64, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4993, 3u36L, 0.5331, 3.72, 0.075, 211, 67, CRYSTAL STRUCTURE OF PG9 FAB
4994, 3s4sE, 0.5331, 3.31, 0.095, 185, 63, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
4995, 3rkdL, 0.5331, 3.42, 0.062, 213, 64, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4996, 3qhfL, 0.5331, 3.76, 0.075, 214, 67, CRYSTAL STRUCTURE OF FAB DEL2D1 A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
4997, 3pwnD, 0.5331, 3.33, 0.125, 275, 64, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
4998, 3o2wL, 0.5331, 3.44, 0.108, 218, 65, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
4999, 3hplB, 0.5331, 3.69, 0.076, 212, 66, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
5000, 3bszD, 0.5331, 3.28, 0.092, 119, 65, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
5001, 2w0fB, 0.5331, 3.54, 0.062, 212, 65, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
